Representing term id	Representing term name	Representing term size	Representing term rank	Represented term number	gwas_adolescent_terms_by_significance.txt term rank	gwas_adult_terms_by_significance.txt term rank	gwas_child_terms_by_significance.txt term rank	gwas_infant_terms_by_significance.txt term rank	gwas_middle_adult_terms_by_significance.txt term rank	gwas_old_adult_terms_by_significance.txt term rank	gwas_older_adult_terms_by_significance.txt term rank	gwas_young_adult_terms_by_significance.txt term rank	gwas_young_child_terms_by_significance.txt term rank
3652_Illnesses of siblings: Diabetes	3652_Illnesses of siblings: Diabetes	25	1	1	1	2013	4658	948	3	3215	1	3	658
4126_Creatine kinase	4126_Creatine kinase	25	1	1	1652	1	1687	2603	19	2923	1247	410	1593
2025_10 mg response to amphetamine	2025_10 mg response to amphetamine	25	1	1	637	54	1	2201	325	1923	3373	978	2621
3867_Reticulocyte fraction of red cells (two-way meta)	3867_Reticulocyte fraction of red cells (two-way meta)	25	1	1	180	1628	1991	1	4581	2891	2547	3549	4241
442_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glycerate	442_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glycerate	25	1	1	3515	14	1384	1659	1	1241	4542	385	932
2163_PF4 - Platelet factor 4	2163_PF4 - Platelet factor 4	25	1	1	2672	4449	1762	3824	169	1	208	3511	4032
2060_C4A C4B - Complement C4b	2060_C4A C4B - Complement C4b	25	1	1	2491	20	3080	420	192	447	123	1	295
2410_METAP1 - Methionine aminopeptidase 1	2410_METAP1 - Methionine aminopeptidase 1	25	1	1	933	1374	1411	772	2112	2842	1079	2980	1
2997_FGG - Fibrinogen gamma chain	2997_FGG - Fibrinogen gamma chain	25	2	1	2	3108	229	126	3203	2360	2104	3063	1165
257_CD8:%Senescent	257_CD8:%Senescent	25	2	1	4622	2	1535	3563	3284	1112	1236	2081	4024
1038_Neck-Shaft Angle (FBAT, adjusted for multivariable)	1038_Neck-Shaft Angle (FBAT, adjusted for multivariable)	25	2	1	8	1224	2	3842	1539	1048	67	2234	1295
3951_Amyotrophic lateral sclerosis (LMM)	3951_Amyotrophic lateral sclerosis (LMM)	25	2	1	2078	4356	3505	2	2452	4106	1494	1749	1543
2059_Type 2 Diabetes	2059_Type 2 Diabetes	25	2	1	60	473	598	388	2	169	17	451	261
2306_HIST1H1C - Histone H1.2	2306_HIST1H1C - Histone H1.2	25	2	1	4464	1459	4432	2448	1185	2	380	3753	1163
1072_Systemic Lupus Erythematosus	1072_Systemic Lupus Erythematosus	25	2	1	1477	4350	1849	1079	214	1342	2	37	313
1203_Rheumatoid Arthritis	1203_Rheumatoid Arthritis	25	2	1	444	243	2159	546	821	723	267	2	255
459_Energy::Krebs cycle::citrate	459_Energy::Krebs cycle::citrate	25	2	1	4215	710	3839	4478	355	2276	1453	2779	2
3429_Fluid intelligence test - FI6 : conditional arithmetic	3429_Fluid intelligence test - FI6 : conditional arithmetic	25	3	1	3	4475	265	4411	4235	3355	1746	894	3500
2042_Attention function - Standard error of hit reaction time - Child	2042_Attention function - Standard error of hit reaction time - Child	25	3	1	1240	3	870	4032	13	67	319	486	2800
4427_Epstein Barr Virus antigen EBNA seropositivity	4427_Epstein Barr Virus antigen EBNA seropositivity	25	3	1	2544	1004	3	2350	4078	1633	2124	3807	127
98_Height SDS	98_Height SDS	25	3	1	3610	3433	1866	3	2874	3542	1941	3568	4484
498_Lipid::Fatty acid, dicarboxylate::3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF)	498_Lipid::Fatty acid, dicarboxylate::3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF)	25	3	1	1083	2547	2320	843	1163	3	719	3412	1503
4265_Ankylosing spondylitis	4265_Ankylosing spondylitis	25	3	1	3182	2455	73	1887	1852	202	3	139	2476
2017_Lithium response in Bipolar I patients - Alda Scale of 6 to 7	2017_Lithium response in Bipolar I patients - Alda Scale of 6 to 7	25	3	1	356	665	278	981	312	2390	4078	865	3
160_Hip circumference (female)	160_Hip circumference (female)	25	4	1	4	1533	3939	264	1287	1869	586	554	1856
3688_Diagnoses - secondary ICD10: E78 Disorders of lipoprotein metabolism and other lipidemias	3688_Diagnoses - secondary ICD10: E78 Disorders of lipoprotein metabolism and other lipidemias	25	4	1	1815	4	984	1274	971	1184	4437	1153	2809
3056_IL17RB - interleukin-17 receptor B	3056_IL17RB - interleukin-17 receptor B	25	4	1	571	1938	4	42	4	5	32	1912	2912
4089_Maternal history of Alzheimer's disease	4089_Maternal history of Alzheimer's disease	25	4	1	34	3568	1021	4	1216	2218	1181	739	4304
1102_High-density lipoprotein - Birth cohorts	1102_High-density lipoprotein - Birth cohorts	25	4	1	439	1167	4623	117	12	4	20	11	102
1162_Fasting proinsulin (adjusted for fasting insulin, age and sex)	1162_Fasting proinsulin (adjusted for fasting insulin, age and sex)	25	4	1	1342	78	762	784	64	22	4	479	72
208_Rheumatoid Arthritis	208_Rheumatoid Arthritis	25	4	1	64	1042	2177	24	229	780	138	4	162
3885_Lymphocyte percentage of white cells (three-way meta)	3885_Lymphocyte percentage of white cells (three-way meta)	25	4	1	3967	4539	2875	79	3334	1338	1784	4298	4
4217_Drugs used in diabetes	4217_Drugs used in diabetes	25	5	1	5	4593	2849	71	427	4131	417	468	194
655_Amino acid::Polyamine metabolism::X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide	655_Amino acid::Polyamine metabolism::X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide	25	5	1	1052	5	4243	1756	302	508	1337	9	49
2808_TPI1 - Triosephosphate isomerase	2808_TPI1 - Triosephosphate isomerase	25	5	1	3048	4159	5	2017	2193	2292	4018	3489	2754
915_Phospholipids in medium HDL	915_Phospholipids in medium HDL	25	5	1	3089	1632	3328	5	206	390	2191	580	4709
3450_Impedance measures - Impedance of arm (right)	3450_Impedance measures - Impedance of arm (right)	25	5	1	1790	1256	1997	937	5	1493	251	438	4014
3625_Treatment/medication code: levothyroxine sodium	3625_Treatment/medication code: levothyroxine sodium	25	5	1	2028	3524	3017	1064	2330	956	5	1297	4479
2920_Human-virus - gp41 C34 peptide, HIV	2920_Human-virus - gp41 C34 peptide, HIV	25	5	1	148	717	3339	310	52	101	68	5	460
1749_Urinary albumin excertion (at exam 6, GEE, adjusted for multivariable)	1749_Urinary albumin excertion (at exam 6, GEE, adjusted for multivariable)	25	5	1	599	3706	1033	355	4560	3110	2674	785	5
3601_Non-cancer illness code, self-reported: diabetes	3601_Non-cancer illness code, self-reported: diabetes	25	6	1	6	3789	4078	53	290	4700	105	128	161
2007_Parental transmission distortion	2007_Parental transmission distortion	25	6	1	2191	6	67	737	198	3746	289	1756	327
107_Tanner scale	107_Tanner scale	25	6	1	3633	3173	6	2172	426	1885	4743	3311	142
914_Concentration of medium HDL particles	914_Concentration of medium HDL particles	25	6	1	2094	1864	3335	6	222	1568	2499	395	2829
2483_GZMH - Granzyme H	2483_GZMH - Granzyme H	25	6	1	855	1925	572	3455	6	675	2780	3427	4019
764_::::X-12217	764_::::X-12217	25	6	1	259	1915	3621	968	562	6	34	2305	2518
4706_Retrolenticular part of internal capsule mean diusivities	4706_Retrolenticular part of internal capsule mean diusivities	25	6	1	1422	2700	1629	1532	72	2728	6	227	4382
1204_Rheumatoid Arthritis	1204_Rheumatoid Arthritis	25	6	1	107	276	4459	59	795	1517	361	6	212
3849_Lymphocyte percentage of white cells (two-way meta)	3849_Lymphocyte percentage of white cells (two-way meta)	25	6	1	1654	1574	2005	627	4602	688	4521	3087	6
3328_Diabetes (diagnosed by doctor)	3328_Diabetes (diagnosed by doctor)	25	7	1	7	3579	4098	133	454	3342	80	160	240
1142_Sleep duration	1142_Sleep duration	25	7	1	1737	7	833	3528	653	1874	3795	1914	1846
1036_Neck-Shaft Angle (FBAT, adjusted for age and sex)	1036_Neck-Shaft Angle (FBAT, adjusted for age and sex)	25	7	1	227	1791	7	3234	3729	3738	610	3405	511
3902_Reticulocyte count (three-way meta)	3902_Reticulocyte count (three-way meta)	25	7	1	310	510	2300	7	2732	4217	2614	4716	4505
3957_Antisocial behavior	3957_Antisocial behavior	25	7	1	1726	662	363	4309	7	1475	438	1871	3739
709_::::X-11469	709_::::X-11469	25	7	1	1673	680	2286	291	3871	7	998	1520	685
957_Total lipids in very large HDL	957_Total lipids in very large HDL	25	7	1	1939	3107	3126	1981	41	1442	7	133	3996
4227_Immunosuppressants	4227_Immunosuppressants	25	7	1	139	649	3095	49	474	610	403	7	273
2926_SELL - L-Selectin	2926_SELL - L-Selectin	25	7	1	3560	2355	2068	881	888	1546	1717	3621	7
694_::::X-11327	694_::::X-11327	25	8	1	2323	8	753	1100	1095	2821	2333	3880	223
2024_Alcohol dependence	2024_Alcohol dependence	25	8	1	1827	468	8	2104	1069	417	1596	1398	913
3646_Illnesses of mother: Alzheimer's disease/dementia	3646_Illnesses of mother: Alzheimer's disease/dementia	25	8	1	25	4376	548	8	869	2453	912	434	4425
1448_Low-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1448_Low-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	8	1	3263	319	80	1955	8	275	66	24	2038
3952_Amyotrophic lateral sclerosis (logistic)	3952_Amyotrophic lateral sclerosis (logistic)	25	8	1	2400	604	1533	3261	1470	8	53	2446	4729
3012_MAPK13 - Mitogen-activated protein kinase 13	3012_MAPK13 - Mitogen-activated protein kinase 13	25	8	1	3649	9	1737	974	47	159	8	270	1180
934_Concentration of small HDL particles	934_Concentration of small HDL particles	25	8	1	2821	327	1489	4671	27	1681	198	8	1403
4379_BRCA1/2-negative breast cancer	4379_BRCA1/2-negative breast cancer	25	8	1	2144	2120	55	362	2016	3742	1844	3199	8
1117_Pericardial adipose tissue volume	1117_Pericardial adipose tissue volume	25	9	1	9	4442	784	2518	3211	757	2362	4311	4590
1967_MMSE score (at age 65, GEE, adjusted for multivariable)	1967_MMSE score (at age 65, GEE, adjusted for multivariable)	25	9	1	4495	2189	9	1919	2897	3929	3099	2226	3237
3866_Reticulocyte count (two-way meta)	3866_Reticulocyte count (two-way meta)	25	9	1	1265	2206	1562	9	3327	2088	3445	3168	1456
986_Interleukin-18	986_Interleukin-18	25	9	1	2675	1238	936	2377	9	407	367	317	2359
1109_Subcutaneous adipose tissue volume (male)	1109_Subcutaneous adipose tissue volume (male)	25	9	1	3384	3856	839	3033	54	9	268	4173	21
4710_Superior longitudinal fasciculus mean diusivities	4710_Superior longitudinal fasciculus mean diusivities	25	9	1	2139	3562	4610	4557	22	2071	9	3808	559
4506_Right insula	4506_Right insula	25	9	1	1748	1879	1049	3405	1901	3589	4122	4192	9
4119_Aspartate aminotransferase	4119_Aspartate aminotransferase	25	10	1	10	384	4554	3230	2519	1014	422	2628	1251
1294_Diabetes incidence (FBAT, adjusted for age, sex and BMI)	1294_Diabetes incidence (FBAT, adjusted for age, sex and BMI)	25	10	1	1233	10	143	215	3925	1319	2261	3379	4392
572_Lipid::Sterol, Steroid::androsterone sulfate	572_Lipid::Sterol, Steroid::androsterone sulfate	25	10	1	175	2799	10	2396	1565	3389	4023	3259	224
1520_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	1520_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	25	10	1	549	2936	3671	10	2801	2488	4687	398	4706
4050_Anterior cruciate ligament rupture (fixed effect model)	4050_Anterior cruciate ligament rupture (fixed effect model)	25	10	1	1573	1678	77	934	10	358	179	262	105
4477_Right caudal middle frontal	4477_Right caudal middle frontal	25	10	1	2278	1827	1772	4335	202	10	209	48	1806
3308_Long-standing illness, disability or infirmity	3308_Long-standing illness, disability or infirmity	25	10	1	577	1709	3735	36	48	291	10	38	3055
1608_Viscosity I (at exam 5, FBAT, adjusted for multivariable)	1608_Viscosity I (at exam 5, FBAT, adjusted for multivariable)	25	10	1	1508	73	1530	4072	826	2005	3097	10	985
2018_Lithium response in Bipolar I patients - Alda Scale of 7 to 8	2018_Lithium response in Bipolar I patients - Alda Scale of 7 to 8	25	10	1	1284	779	26	1823	159	1594	4447	518	10
3850_Mean corpuscular hemoglobin concentration (two-way meta)	3850_Mean corpuscular hemoglobin concentration (two-way meta)	25	11	1	11	218	62	69	782	20	3412	2868	28
4615_3rd ventricle	4615_3rd ventricle	25	11	1	3553	11	3613	4001	1620	2802	4682	3932	4007
3139_F9 - Coagulation factor IXab	3139_F9 - Coagulation factor IXab	25	11	1	364	1182	11	4555	1426	3999	3411	988	2527
913_Total lipids in medium HDL	913_Total lipids in medium HDL	25	11	1	3854	2467	3919	11	865	1403	4106	1429	1387
3008_SCGB2A1 - Mammaglobin-B	3008_SCGB2A1 - Mammaglobin-B	25	11	1	4621	232	1950	4715	11	327	95	147	2030
4023_Hair (Straight/curly)	4023_Hair (Straight/curly)	25	11	1	3847	1177	3232	2363	805	11	230	4093	1286
4595_Right pericalcarine	4595_Right pericalcarine	25	11	1	4240	4665	1377	4601	392	42	11	2222	1947
3917_Adiponectin	3917_Adiponectin	25	11	1	648	2163	2799	3694	4496	3114	3984	4636	11
156_Hip circumference	156_Hip circumference	25	12	1	12	883	3060	728	2481	4218	2913	444	4474
4514_3rd ventricle	4514_3rd ventricle	25	12	1	4505	12	2988	2379	1511	3404	3024	2063	3934
4298_Thin vs extreme obese	4298_Thin vs extreme obese	25	12	1	3441	2364	12	3849	4348	4683	4550	1238	2599
3950_Amyotrophic lateral sclerosis (logistic)	3950_Amyotrophic lateral sclerosis (logistic)	25	12	1	2016	2865	3303	12	3536	3564	3949	2408	2410
1544_White matter hyperintensity volume (FBAT, adjusted for multivariable)	1544_White matter hyperintensity volume (FBAT, adjusted for multivariable)	25	12	1	4115	2217	2305	3484	1159	12	2697	3907	1690
2859_C4A C4B - Complement C4	2859_C4A C4B - Complement C4	25	12	1	839	436	369	180	160	57	12	14	925
2594_ECE1 - Endothelin-converting enzyme 1	2594_ECE1 - Endothelin-converting enzyme 1	25	12	1	3888	482	1003	810	968	3213	2413	12	1372
885_Isoleucine	885_Isoleucine	25	12	1	1983	1901	246	2984	2405	1805	3377	1693	12
537_Lipid::Lysolipid::1-linoleoylglycerophosphocholine	537_Lipid::Lysolipid::1-linoleoylglycerophosphocholine	25	13	1	13	1114	2444	1143	2900	3006	3326	4651	1650
3175_IL17RC - Interleukin-17 receptor C	3175_IL17RC - Interleukin-17 receptor C	25	13	1	2968	13	3224	332	3296	3231	526	322	91
388_Amino acid::Lysine metabolism::glutaroyl carnitine	388_Amino acid::Lysine metabolism::glutaroyl carnitine	25	13	1	4510	1565	13	913	3720	3570	219	601	1128
1833_Neck length (GEE, male, adjusted for multivariable)	1833_Neck length (GEE, male, adjusted for multivariable)	25	13	1	2446	1590	2269	13	4376	2466	3772	904	3033
1310_Fasting HbA1c (at exam 7, FBAT, adjusted for age and sex)	1310_Fasting HbA1c (at exam 7, FBAT, adjusted for age and sex)	25	13	1	524	676	968	43	3690	13	4116	1347	4190
4392_Menstrual pain medicine use	4392_Menstrual pain medicine use	25	13	1	4460	2373	2725	1624	552	170	13	2567	699
4073_General risk tolerance	4073_General risk tolerance	25	13	1	3391	50	1444	2446	121	766	172	13	2895
360_mDC:%32+	360_mDC:%32+	25	13	1	3087	3501	1123	631	3491	421	4177	4725	13
1740_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for multivariable)	1740_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for multivariable)	25	14	1	14	4068	600	453	4689	2825	263	4171	1106
1614_CD40 Ligand plasma (at exam 7, FBAT, adjusted for age and sex)	1614_CD40 Ligand plasma (at exam 7, FBAT, adjusted for age and sex)	25	14	1	4065	3768	14	1863	4338	2770	884	3509	1067
3744_Cannabis use - Ever taken cannabis	3744_Cannabis use - Ever taken cannabis	25	14	1	580	4680	983	14	4632	1154	4540	1089	713
1871_Shaft average buckling ratio (GEE, female, adjussted for multivariable)	1871_Shaft average buckling ratio (GEE, female, adjussted for multivariable)	25	14	1	1672	3051	806	3868	14	16	103	31	1529
180_Waist-hip ratio	180_Waist-hip ratio	25	14	1	2970	522	927	606	1748	14	78	425	513
1973_Morbidity-free survival (at age 65, GEE, adjusted for multivariable)	1973_Morbidity-free survival (at age 65, GEE, adjusted for multivariable)	25	14	1	207	1130	584	3803	274	198	14	2166	325
86_Lumbar Spine BMD	86_Lumbar Spine BMD	25	14	1	2418	3580	267	1724	1870	4137	2733	1730	14
4377_Resting heart rate	4377_Resting heart rate	25	15	1	15	4562	4476	4651	931	741	1684	4681	1084
75_Geographic atrophy	75_Geographic atrophy	25	15	1	3471	15	4565	2171	2849	1764	3579	1812	4527
1562_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1562_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	15	1	1679	2852	15	3570	1895	924	806	4236	3036
857_Ratio of bisLallylic bonds to total fatty acids in lipids	857_Ratio of bisLallylic bonds to total fatty acids in lipids	25	15	1	938	3791	1197	15	634	4041	2701	346	551
1271_Epworth Sleepiness Scale (GEE, adjusted for age, sex and BMI)	1271_Epworth Sleepiness Scale (GEE, adjusted for age, sex and BMI)	25	15	1	708	1522	1973	3162	15	1592	3109	4720	4711
179_Waist-hip ratio	179_Waist-hip ratio	25	15	1	3936	1419	1006	976	2646	15	51	1589	1056
4605_Right supramarginal	4605_Right supramarginal	25	15	1	215	641	957	1618	1834	4743	15	4505	383
1687_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for age and sex)	1687_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for age and sex)	25	15	1	4029	1518	1949	2513	220	1042	3619	15	1539
969_Total lipids in chylomicrons and extremely large VLDL	969_Total lipids in chylomicrons and extremely large VLDL	25	15	1	1033	135	3045	2411	37	1473	1491	110	15
159_Hip circumference (female)	159_Hip circumference (female)	25	16	1	16	1440	4724	50	785	2364	521	541	1881
3764_Depression - Recent poor appetite or overeting	3764_Depression - Recent poor appetite or overeting	25	16	1	1311	16	1439	3677	38	470	122	1148	1900
1982_Walking speed (at exam 7, FBAT)	1982_Walking speed (at exam 7, FBAT)	25	16	1	1155	988	16	3294	3255	1096	2049	3646	221
1373_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	1373_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	25	16	1	3506	1059	155	16	3095	4527	3726	447	1419
3743_Depression - Feelings of worthlessness during worst period of depression	3743_Depression - Feelings of worthlessness during worst period of depression	25	16	1	4089	241	3870	529	16	525	140	202	3219
4415_Varicella Zoster Virus seropositivity	4415_Varicella Zoster Virus seropositivity	25	16	1	995	2925	2951	2150	158	239	16	2049	2928
71_High-density lipoprotein cholesterol	71_High-density lipoprotein cholesterol	25	16	1	1062	121	3710	1141	84	229	39	16	1089
2223_CD97 - CD97 antigen	2223_CD97 - CD97 antigen	24	16	1	1424	3893	21	2871	1490	4406	523	2528	16
4091_Proxy and clinically diagnosed Alzheimer's disease	4091_Proxy and clinically diagnosed Alzheimer's disease	25	17	1	17	4537	2121	267	504	1970	565	350	4128
2781_IGF1R - Insulin-like growth factor 1 receptor	2781_IGF1R - Insulin-like growth factor 1 receptor	25	17	1	4027	17	255	2118	1395	551	633	474	1706
2807_TKT - Transketolase	2807_TKT - Transketolase	25	17	1	3136	4495	17	3269	3605	4591	3677	3106	807
69_Ulcerative Colitis	69_Ulcerative Colitis	25	17	1	1776	1491	4618	17	621	4512	837	140	1103
960_Triglycerides in very large HDL	960_Triglycerides in very large HDL	25	17	1	2859	586	740	782	17	1260	248	598	4202
3009_MMP14 - Matrix metalloproteinase-14	3009_MMP14 - Matrix metalloproteinase-14	25	17	1	1526	4262	637	195	2025	17	387	1337	3869
867_OmegaL3 fatty acids	867_OmegaL3 fatty acids	25	17	1	4095	386	3089	1561	46	2915	1065	17	386
1884_Shaft Width (FBAT, female, adjussted for multivariable)	1884_Shaft Width (FBAT, female, adjussted for multivariable)	25	17	1	1013	4690	1171	1216	3472	4490	3072	1181	17
4094_Proxy and clinically diagnosed Alzheimer's disease	4094_Proxy and clinically diagnosed Alzheimer's disease	25	18	1	18	4522	2766	73	303	295	235	183	3226
1151_Disposition index	1151_Disposition index	25	18	1	1167	18	2933	4725	1424	3825	4429	801	1358
1015_Bone Ultrasound Attenuation (GEE, adjusted for multivariable)	1015_Bone Ultrasound Attenuation (GEE, adjusted for multivariable)	25	18	1	1593	610	18	2669	1891	4481	3108	3354	2331
1351_Plasma Apolipoprotein B level (GEE, adjusted for age and sex)	1351_Plasma Apolipoprotein B level (GEE, adjusted for age and sex)	25	18	1	4085	705	504	18	2650	1400	1022	2863	3466
958_Concentration of very large HDL particles	958_Concentration of very large HDL particles	25	18	1	450	2318	2078	1153	18	4017	26	72	4277
2121_TACSTD2 - Tumor-associated calcium signal transducer 2	2121_TACSTD2 - Tumor-associated calcium signal transducer 2	25	18	1	4169	2255	475	3166	754	18	151	1369	1260
3835_Basophil percentage of granulocytes (two-way meta)	3835_Basophil percentage of granulocytes (two-way meta)	25	18	1	3681	624	3257	4576	136	64	18	1086	724
708_::::X-11452	708_::::X-11452	25	18	1	1468	53	3923	3878	405	2924	891	18	3626
4028_Alcohol dependency (fixed effect model for unrelated genotyped individuals)	4028_Alcohol dependency (fixed effect model for unrelated genotyped individuals)	25	18	1	2040	3792	3978	3615	2045	1460	2090	3059	18
4144_Mean arterial pressure	4144_Mean arterial pressure	25	19	1	19	3055	381	2677	4345	1174	1608	2778	4183
2006_Paternal transmission distortion	2006_Paternal transmission distortion	25	19	1	1577	19	117	720	132	2196	333	782	1148
1200_Genetic generalized epilepsy	1200_Genetic generalized epilepsy	25	19	1	1230	2789	19	970	2210	136	1524	1343	614
2084_KIT - Mast/stem cell growth factor receptor Kit	2084_KIT - Mast/stem cell growth factor receptor Kit	25	19	1	805	707	1648	19	1419	3844	3995	388	4365
1822_Inter-trochanteric buckling ratio (FBAT, female, adjussted for age)	1822_Inter-trochanteric buckling ratio (FBAT, female, adjussted for age)	25	19	1	2930	479	944	1465	1733	19	265	1964	4041
3820_Type 1 Diabetes	3820_Type 1 Diabetes	25	19	1	164	4146	801	707	155	471	19	49	1681
1689_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for multivariable)	1689_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for multivariable)	25	19	1	2111	1779	2116	4311	39	795	681	19	2610
214_NK:%Term	214_NK:%Term	25	19	1	3385	2693	3450	4115	3545	228	1123	4188	19
2918_SERPINA6 - Corticosteroid-binding globulin	2918_SERPINA6 - Corticosteroid-binding globulin	25	20	1	20	1668	3459	4363	1215	4483	132	1121	4176
261_CD8:%SCM	261_CD8:%SCM	25	20	1	2671	730	20	3866	3185	2307	1141	3727	4212
3798_Worry subcluster	3798_Worry subcluster	25	20	1	1364	538	3092	20	2417	1539	2812	4396	2963
933_Total lipids in small HDL	933_Total lipids in small HDL	25	20	1	1750	652	2259	4520	20	2755	467	25	452
4017_Systemic Lupus Erythematosus	4017_Systemic Lupus Erythematosus	25	20	1	2117	4056	3404	76	515	305	174	20	37
4541_Right ventral DC	4541_Right ventral DC	25	20	1	4607	474	401	690	3129	1237	2335	1186	20
1977_Hand grip (at offspring exam 7 cohort exam 27, GEE)	1977_Hand grip (at offspring exam 7 cohort exam 27, GEE)	25	21	1	21	2496	2403	2006	2603	2397	1332	1321	2500
3735_Depression - Frequency of depressed days during worst episode of depression	3735_Depression - Frequency of depressed days during worst episode of depression	25	21	1	3034	21	2781	3579	3156	3070	4189	1972	4745
3903_Reticulocyte fraction of red cells (three-way meta)	3903_Reticulocyte fraction of red cells (three-way meta)	25	21	1	373	1838	4397	21	3888	1666	2280	1734	4737
3572_Pain type(s) experienced in last month: Back pain	3572_Pain type(s) experienced in last month: Back pain	25	21	1	568	4434	3314	2623	21	1022	57	1648	4106
2631_PLG - Angiostatin	2631_PLG - Angiostatin	25	21	1	2313	2478	3440	1105	1034	21	444	1522	139
1202_Rheumatoid Arthritis	1202_Rheumatoid Arthritis	25	21	1	282	3530	317	430	189	571	21	51	848
1809_Total power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1809_Total power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	21	1	3051	723	4305	1497	3818	4621	3166	21	4252
34_Alzheimer's disease	34_Alzheimer's disease	25	22	1	22	3439	2606	274	773	1003	237	347	2706
74_Age-related Macular Degeneration	74_Age-related Macular Degeneration	25	22	1	3203	22	4693	3240	3480	1480	3716	2055	4369
1316_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age and sex)	1316_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age and sex)	25	22	1	810	2423	22	47	2502	363	2060	4503	615
3375_Time since last prostate specific antigen (PSA) test	3375_Time since last prostate specific antigen (PSA) test	25	22	1	3103	1218	2379	22	3082	39	1585	2355	4642
2737_GZMB - Granzyme B	2737_GZMB - Granzyme B	25	22	1	1687	668	4123	144	3076	1896	22	2579	2689
2285_MMP8 - Neutrophil collagenase	2285_MMP8 - Neutrophil collagenase	25	22	1	2976	433	1365	1380	74	111	90	22	307
4325_Neuroticism (MA GWAMA)	4325_Neuroticism (MA GWAMA)	24	22	1	1546	639	1481	3822	471	1101	1072	670	22
3742_Depression - Feelings of tiredness during worst episode of depression	3742_Depression - Feelings of tiredness during worst episode of depression	25	23	1	23	1559	29	441	3174	3959	4494	2924	412
838_Peptide::Dipeptide::X-14450--phenylalanylleucine	838_Peptide::Dipeptide::X-14450--phenylalanylleucine	25	23	1	1242	23	1322	4079	4359	4283	2402	1022	3796
697_::::X-11381	697_::::X-11381	25	23	1	2599	3631	23	1944	3030	145	3556	1609	3035
3773_Anxiety - Recent worrying too much about different things	3773_Anxiety - Recent worrying too much about different things	25	23	1	2721	430	2368	23	2407	3729	4215	2477	1785
3795_Neuroticism	3795_Neuroticism	25	23	1	341	44	1900	1784	23	2922	137	382	2825
4684_Retrolenticular part of internal capsule axial diusivities	4684_Retrolenticular part of internal capsule axial diusivities	25	23	1	4023	1552	4226	1664	196	23	83	1743	4680
3046_CD55 - Complement decay-accelerating factor	3046_CD55 - Complement decay-accelerating factor	25	23	1	1216	1889	647	31	2736	2173	23	1016	76
859_CH2 groups in fatty acids	859_CH2 groups in fatty acids	25	23	1	195	2303	1790	1590	167	1742	897	23	2105
971_Phospholipids in chylomicrons and extremely large VLDL	971_Phospholipids in chylomicrons and extremely large VLDL	25	23	1	387	127	4361	1437	242	4199	3471	229	23
4142_Systolic Blood Pressure	4142_Systolic Blood Pressure	25	24	1	24	1100	707	2999	4424	486	1467	3013	2257
2921_LPO - Lactoperoxidase	2921_LPO - Lactoperoxidase	25	24	1	2128	24	2342	2275	1221	2244	967	2120	838
124_Body Mass Index (male)	124_Body Mass Index (male)	25	24	1	4106	3993	24	64	2267	3666	3618	3123	887
2845_MFGE8 - Lactadherin	2845_MFGE8 - Lactadherin	25	24	1	3181	699	4418	3146	24	344	473	759	1284
3571_Pain type(s) experienced in last month: Neck or shoulder pain	3571_Pain type(s) experienced in last month: Neck or shoulder pain	25	24	1	3629	1116	2013	581	4012	24	1226	1709	667
1957_Wide Range Achievement Test (GEE, adjusted for multivariable)	1957_Wide Range Achievement Test (GEE, adjusted for multivariable)	25	24	1	1227	3087	855	2777	511	75	24	3586	1495
2063_COL18A1 - Endostatin	2063_COL18A1 - Endostatin	25	24	1	2206	3253	453	1282	2765	4737	1857	2409	24
3679_Diagnoses - main ICD10: M54 Dorsalgia	3679_Diagnoses - main ICD10: M54 Dorsalgia	25	25	1	142	25	4205	4638	957	4005	440	291	134
1770_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for multivariable)	1770_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for multivariable)	25	25	1	436	288	25	2228	3544	1467	4655	3477	4017
3464_Impedance measures - Arm fat percentage (left)	3464_Impedance measures - Arm fat percentage (left)	25	25	1	1723	4080	334	25	3841	2803	4481	3729	3298
2027_Cryptorchidism (group 1)	2027_Cryptorchidism (group 1)	25	25	1	2354	1788	227	4662	25	1528	65	244	35
3271_Comparative height size at age 10	3271_Comparative height size at age 10	25	25	1	2940	2269	1787	1788	1638	25	632	651	1840
959_Phospholipids in very large HDL	959_Phospholipids in very large HDL	25	25	1	1142	3754	2132	1610	127	1755	25	323	4457
3829_Posterior cortical atrophy	3829_Posterior cortical atrophy	25	25	1	3121	499	3423	2976	1715	3055	1658	4377	25
2028_Cryptorchidism (group 2)	2028_Cryptorchidism (group 2)	25	26	1	26	461	137	1081	119	74	236	1925	2270
4490_Right paracentral	4490_Right paracentral	25	26	1	3753	26	1536	1591	3468	2666	4373	108	4288
2023_Skin fluorescence	2023_Skin fluorescence	25	26	1	829	35	95	26	886	340	466	4414	241
1762_Prostate cancer (FBAT, adjusted for age)	1762_Prostate cancer (FBAT, adjusted for age)	25	26	1	911	2398	1645	349	26	1437	987	492	1407
3155_KRT18 - Keratin, type I cytoskeletal 18	3155_KRT18 - Keratin, type I cytoskeletal 18	25	26	1	402	1150	554	4584	926	26	547	2088	1200
2057_Ulcerative colitis	2057_Ulcerative colitis	25	26	1	3192	438	3211	301	1096	118	901	26	942
4723_Genu of corpus callosum mode of anisotropy	4723_Genu of corpus callosum mode of anisotropy	25	26	1	2712	1538	4668	280	3864	2028	266	4526	26
1471_Lipoprotein A (at exam 3, GEE, adjusted for age and sex)	1471_Lipoprotein A (at exam 3, GEE, adjusted for age and sex)	25	27	1	27	2499	2302	1426	1690	3441	701	4468	3103
3991_Mood swings (MOOD)	3991_Mood swings (MOOD)	25	27	1	461	27	4629	2075	208	2417	2544	381	432
1980_Walking speed (at offspring exam 7 cohort exam 27, FBAT)	1980_Walking speed (at offspring exam 7 cohort exam 27, FBAT)	25	27	1	696	944	27	3182	2968	2075	4313	2205	73
2253_PRKCD - Protein kinase C delta type	2253_PRKCD - Protein kinase C delta type	25	27	1	3815	1292	1686	27	3534	3374	4144	364	259
483_Lipid::Carnitine metabolism::octanoylcarnitine	483_Lipid::Carnitine metabolism::octanoylcarnitine	25	27	1	1794	2487	1694	3486	402	27	412	2122	1741
3834_Basophil percentage of white cells (two-way meta)	3834_Basophil percentage of white cells (two-way meta)	25	27	1	4179	494	3256	4448	174	82	27	1340	731
2037_Immunoglobulin A deficiency	2037_Immunoglobulin A deficiency	25	27	1	37	2178	416	900	555	2528	213	27	773
1743_Urinary albumin excertion (at exam 6, GEE, adjusted for age and sex)	1743_Urinary albumin excertion (at exam 6, GEE, adjusted for age and sex)	25	27	1	380	4218	2582	163	3736	2256	2451	1006	27
4276_Carpal tunnel syndrome	4276_Carpal tunnel syndrome	25	28	1	28	4221	3778	691	3172	1331	2083	1938	3749
4416_Toxoplasmosis seropositivity	4416_Toxoplasmosis seropositivity	25	28	1	1377	28	1603	380	1292	4524	677	4290	1218
4004_Juvenile idiopathic arthritis with vs without uveitis	4004_Juvenile idiopathic arthritis with vs without uveitis	25	28	1	3435	391	28	1734	1837	3495	1790	3794	3164
112_Body Mass Index	112_Body Mass Index	25	28	1	3250	2475	297	28	2051	3201	4101	2613	923
110_Coronary artery disease	110_Coronary artery disease	25	28	1	2258	4312	1167	2899	28	241	1301	2626	4227
195_Chronic kidney disease	195_Chronic kidney disease	25	28	1	2107	4341	4189	4074	2779	28	159	4640	2005
2403_KLK13 - Kallikrein-13	2403_KLK13 - Kallikrein-13	25	28	1	1932	2588	2567	4257	522	1337	28	4718	2099
3529_Never eat eggs, dairy, wheat, sugar: Wheat products	3529_Never eat eggs, dairy, wheat, sugar: Wheat products	25	28	1	115	4426	910	136	428	2578	278	28	410
3586_Types of physical activity in last 4 weeks: Other exercises (eg: swimming, cycling, keep fit, bowling)	3586_Types of physical activity in last 4 weeks: Other exercises (eg: swimming, cycling, keep fit, bowling)	25	29	1	29	1388	4275	1333	4731	3783	1514	1565	3647
4103_Hemoglobin A1c	4103_Hemoglobin A1c	25	29	1	1056	29	2500	1473	2491	2306	3767	157	1624
3102_PRKAA1 PRKAB1  PRKAG1 - AMP Kinase (alpha1beta1gamma1)	3102_PRKAA1 PRKAB1  PRKAG1 - AMP Kinase (alpha1beta1gamma1)	25	29	1	3166	105	2543	29	351	4122	1935	248	4142
2539_STK16 - Serine/threonine-protein kinase 16	2539_STK16 - Serine/threonine-protein kinase 16	25	29	1	4362	4117	1191	4356	29	1026	98	421	4056
3496_Hair colour (natural, before greying): Red	3496_Hair colour (natural, before greying): Red	25	29	1	4560	3282	778	454	4209	29	87	1004	1641
4579_Right cuneus	4579_Right cuneus	25	29	1	1204	3965	240	853	1977	2105	29	4518	157
3814_CD8+ T cell level	3814_CD8+ T cell level	25	29	1	1113	980	978	396	4127	1269	709	29	1707
4607_Right insula	4607_Right insula	25	29	1	1479	3310	775	3003	1177	3029	3028	1599	29
4075_Body Mass Index (male)	4075_Body Mass Index (male)	25	30	1	30	2079	1228	2215	2755	1489	3988	1251	2917
3891_Mean platelet volume (three-way meta)	3891_Mean platelet volume (three-way meta)	25	30	1	3581	30	1935	3210	3757	2828	150	3105	2617
2500_PTPN2 - Tyrosine-protein phosphatase non-receptor type 2	2500_PTPN2 - Tyrosine-protein phosphatase non-receptor type 2	25	30	1	1931	3360	30	1658	2977	2122	1621	3061	4591
860_CH2 groups to double bonds ratio	860_CH2 groups to double bonds ratio	25	30	1	177	4543	1726	30	822	1912	3568	122	585
1860_Neck cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	1860_Neck cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	25	30	1	4255	128	133	3378	30	329	1321	169	2206
2235_TNFSF4 - Tumor necrosis factor ligand superfamily member 4	2235_TNFSF4 - Tumor necrosis factor ligand superfamily member 4	25	30	1	3202	3897	2100	3353	3435	30	1584	4675	3590
2548_B2M - Beta-2-microglobulin	2548_B2M - Beta-2-microglobulin	25	30	1	3069	69	4284	4566	714	33	30	1886	3304
1606_Viscosity I (at exam 5, FBAT, adjusted for age and sex)	1606_Viscosity I (at exam 5, FBAT, adjusted for age and sex)	25	30	1	998	91	618	3930	631	1690	2808	30	250
283_CD4:%Treg(39+73-)	283_CD4:%Treg(39+73-)	25	30	1	3566	4693	649	323	3471	4615	3267	3523	30
767_::::X-12236	767_::::X-12236	25	31	1	31	1929	1630	312	2099	1707	3171	812	1709
4225_HMG CoA reductase inhibitors	4225_HMG CoA reductase inhibitors	25	31	1	4205	31	875	508	342	1680	3488	682	3525
1768_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for age and sex)	1768_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for age and sex)	25	31	1	1528	935	31	1746	697	256	1576	4212	3362
3451_Impedance measures - Impedance of arm (left)	3451_Impedance measures - Impedance of arm (left)	25	31	1	1960	3180	1283	1467	31	2150	375	1322	3538
3028_ADSL - Adenylosuccinate lyase	3028_ADSL - Adenylosuccinate lyase	25	31	1	1600	772	2985	2200	4258	31	1014	3309	1228
2441_FCGR3B - Low affinity immunoglobulin gamma Fc region receptor III-B	2441_FCGR3B - Low affinity immunoglobulin gamma Fc region receptor III-B	25	31	1	907	1463	1660	945	166	287	31	2764	1024
1347_Plasma Apolipoprotein A-I level (GEE, adjusted for age and sex)	1347_Plasma Apolipoprotein A-I level (GEE, adjusted for age and sex)	25	31	1	2830	4677	1882	1043	2154	2726	4434	1519	31
4623_Left caudate	4623_Left caudate	25	32	1	32	1426	640	859	4101	1816	2898	316	3655
45_Self-reported tiredness	45_Self-reported tiredness	25	32	1	3819	32	1587	3383	604	3078	2726	2519	4101
372_Amino acid::Cysteine, methionine, SAM, taurine metabolism::cysteine	372_Amino acid::Cysteine, methionine, SAM, taurine metabolism::cysteine	25	32	1	4244	2502	32	2307	4565	1879	866	1560	1684
1813_Biologic age by osseographic scoring system (GEE, adjusted for multivariable)	1813_Biologic age by osseographic scoring system (GEE, adjusted for multivariable)	25	32	1	4003	1762	3323	32	262	129	2551	329	2822
2666_FGR - Tyrosine-protein kinase Fgr	2666_FGR - Tyrosine-protein kinase Fgr	25	32	1	4433	1732	1496	1615	32	96	145	3323	4015
1052_Ischemic stroke	1052_Ischemic stroke	25	32	1	3046	985	2474	4665	1210	32	365	3037	1136
3501_Male-specific factors - Hair/balding pattern: Pattern 2	3501_Male-specific factors - Hair/balding pattern: Pattern 2	25	32	1	3035	2715	303	3441	1959	1110	697	32	2094
83_Lumbar Spine BMD	83_Lumbar Spine BMD	25	32	1	1277	3742	463	3139	3474	3437	3835	1852	32
3886_Mean corpuscular hemoglobin concentration (three-way meta)	3886_Mean corpuscular hemoglobin concentration (three-way meta)	25	33	1	33	1697	110	725	2174	35	3665	3094	681
2005_Maternal transmission distortion	2005_Maternal transmission distortion	25	33	1	2134	33	91	660	137	2008	242	755	550
4051_Anterior cruciate ligament rupture (random effect model)	4051_Anterior cruciate ligament rupture (random effect model)	25	33	1	3483	3512	33	1747	139	1490	844	678	138
1375_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for age and sex)	1375_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for age and sex)	25	33	1	2047	2893	1076	33	4337	4207	2180	770	1605
4426_Epstein Barr Virus antigen EA seropositivity	4426_Epstein Barr Virus antigen EA seropositivity	25	33	1	2720	1230	1107	346	33	1267	2720	618	191
4663_Splenium of corpus callosum fractional anisotropy	4663_Splenium of corpus callosum fractional anisotropy	25	33	1	2790	3484	1801	4184	579	2315	33	693	1862
3531_Never eat eggs, dairy, wheat, sugar: I eat all of the above	3531_Never eat eggs, dairy, wheat, sugar: I eat all of the above	25	33	1	135	2838	429	629	506	2580	285	33	171
4521_Left thalamus proper	4521_Left thalamus proper	25	33	1	2619	138	2621	1070	1782	3082	1540	481	33
76_Neovascular disease	76_Neovascular disease	25	34	1	4579	34	3306	4426	4279	1572	4304	2360	3916
1402_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for multivariable)	1402_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for multivariable)	25	34	1	841	4193	34	1760	1614	4570	2298	2659	3686
1472_Mean total cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	1472_Mean total cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	25	34	1	3040	3014	2702	34	316	3298	1245	863	2394
2255_RAD51 - DNA repair protein RAD51 homolog 1	2255_RAD51 - DNA repair protein RAD51 homolog 1	25	34	1	1742	3981	4108	3134	34	2128	4589	1715	1934
2816_SAA1 - Serum amyloid A-1 protein	2816_SAA1 - Serum amyloid A-1 protein	25	34	1	666	4546	3105	3541	186	34	1513	3345	4326
1230_Usual weekday bedtime (FBAT)	1230_Usual weekday bedtime (FBAT)	25	34	1	1007	769	161	1024	690	4138	4425	34	390
2016_Lithium response in Bipolar I patients - Alda Scale of 5 to 6	2016_Lithium response in Bipolar I patients - Alda Scale of 5 to 6	25	34	1	443	2121	981	932	596	1323	3977	1264	34
4542_Right vessel	4542_Right vessel	25	35	1	35	2234	596	2931	1771	4269	4156	63	4652
608_Peptide::gamma-glutamyl::gamma-glutamyltyrosine	608_Peptide::gamma-glutamyl::gamma-glutamyltyrosine	25	35	1	495	3318	35	220	1134	2359	1413	87	1655
3848_Lymphocyte count (two-way meta)	3848_Lymphocyte count (two-way meta)	25	35	1	687	1258	1719	35	1781	1209	4141	627	433
3796_Depressive symptoms	3796_Depressive symptoms	25	35	1	1295	1862	3008	1838	35	1861	601	764	818
2448_IGFBP7 - Insulin-like growth factor-binding protein 7	2448_IGFBP7 - Insulin-like growth factor-binding protein 7	25	35	1	1740	2229	3963	1254	1219	448	35	3180	4707
3244_Oily fish intake	3244_Oily fish intake	25	35	1	691	119	3928	4590	935	3538	520	35	404
4232_Anilides	4232_Anilides	25	36	1	36	4081	2578	1317	2758	4652	4090	2206	3425
1031_Neck Width (GEE, adjusted for multivariable)	1031_Neck Width (GEE, adjusted for multivariable)	25	36	1	4099	36	2025	1867	1023	1561	3048	94	2615
92_Birth weight	92_Birth weight	25	36	1	143	2227	36	2660	1431	4729	3026	973	4166
115_Variability of Body Mass Index	115_Variability of Body Mass Index	25	36	1	1046	1899	3683	1237	36	3462	706	4540	2714
2469_CAMK2B - Calcium/calmodulin-dependent protein kinase type II subunit beta	2469_CAMK2B - Calcium/calmodulin-dependent protein kinase type II subunit beta	25	36	1	3887	1203	2314	3291	547	36	2893	3394	600
3602_Non-cancer illness code, self-reported: hypothyroidism/myxoedema	3602_Non-cancer illness code, self-reported: hypothyroidism/myxoedema	25	36	1	1535	3985	3022	1257	1678	3348	36	1194	4461
1885_Shaft Width (GEE, female, adjussted for multivariable)	1885_Shaft Width (GEE, female, adjussted for multivariable)	25	36	1	4583	932	2998	4744	161	1274	1563	36	252
3687_Diagnoses - secondary ICD10: E66 Overweight and obesity	3687_Diagnoses - secondary ICD10: E66 Overweight and obesity	25	36	1	2265	3237	204	1053	4514	3922	3784	2326	36
2587_CHL1 - Neural cell adhesion molecule L1-like protein	2587_CHL1 - Neural cell adhesion molecule L1-like protein	25	37	1	4397	37	4026	2427	1546	2308	3309	1620	3918
1045_Bone Ultrasound Speed (GEE, adjusted for multivariable)	1045_Bone Ultrasound Speed (GEE, adjusted for multivariable)	25	37	1	4483	3422	37	3631	3232	3590	4118	2543	233
1385_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	1385_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	25	37	1	3362	3760	1303	37	3372	2748	3009	1681	1272
4734_Uncinate fasciculus mode of anisotropy	4734_Uncinate fasciculus mode of anisotropy	25	37	1	301	784	4717	2349	336	37	1136	1594	3167
2289_PTHLH - Parathyroid hormone-related protein	2289_PTHLH - Parathyroid hormone-related protein	25	37	1	484	4513	3428	398	197	706	37	2494	3662
3191_Number of treatments/medications taken	3191_Number of treatments/medications taken	25	38	1	38	3069	1717	80	1560	3457	800	378	132
1097_Mean Arterial Pressure	1097_Mean Arterial Pressure	25	38	1	1825	38	4735	1384	3643	197	2877	3614	302
4561_Left pars opercularis	4561_Left pars opercularis	25	38	1	2110	2066	38	2276	131	3144	117	3619	963
3922_Heart rate variability (SDNN)	3922_Heart rate variability (SDNN)	25	38	1	2185	3840	1400	38	2171	4741	1640	3719	4102
3321_Ever had bowel cancer screening	3321_Ever had bowel cancer screening	25	38	1	3227	3144	2556	4501	3429	38	1896	3790	1513
2611_LRPAP1 - alpha-2-macroglobulin receptor-associated protein	2611_LRPAP1 - alpha-2-macroglobulin receptor-associated protein	25	38	1	1107	713	1173	2484	1213	361	38	40	1917
1624_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for multivariable)	1624_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for multivariable)	25	38	1	1760	2286	1573	1636	3444	1774	3642	1246	38
4120_Alanine aminotransferase	4120_Alanine aminotransferase	25	39	1	39	502	4473	3324	4404	1240	631	1968	170
1968_MMSE score (at age 65, FBAT, adjusted for birth-cohort)	1968_MMSE score (at age 65, FBAT, adjusted for birth-cohort)	25	39	1	2811	39	1933	771	1383	1029	4305	758	78
1364_Total cholesterol (at exam 4, FBAT, adjusted for age and sex)	1364_Total cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	39	1	1367	775	39	124	65	877	1319	306	2031
1360_Total cholesterol (at exam 2, FBAT, adjusted for age and sex)	1360_Total cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	39	1	794	3640	4186	39	128	1386	63	187	497
1445_Low-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	1445_Low-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	25	39	1	3249	591	3507	3416	2339	2951	3557	39	3230
1298_Fasting plasma glucose (at exam 5, FBAT, adjusted for age and sex)	1298_Fasting plasma glucose (at exam 5, FBAT, adjusted for age and sex)	25	39	1	468	3875	313	819	1277	1089	4470	1080	39
3524_Transport type for commuting to job workplace: Car/motor vehicle	3524_Transport type for commuting to job workplace: Car/motor vehicle	25	40	1	40	1747	2055	2884	2715	1148	2922	3211	1045
3372_Age hay fever, rhinitis or eczema diagnosed	3372_Age hay fever, rhinitis or eczema diagnosed	25	40	1	4666	40	3680	3548	2724	1375	561	4527	800
4410_Vaginal discharge: Smell	4410_Vaginal discharge: Smell	25	40	1	3542	600	40	1587	2899	1256	4105	2912	2863
4449_Left fusiform	4449_Left fusiform	25	40	1	4604	2022	3800	40	4551	1598	1748	4665	3428
3994_Sensitivity / hurt feelings (HURT)	3994_Sensitivity / hurt feelings (HURT)	25	40	1	2513	283	2048	3565	40	630	160	1283	4419
797_::::X-12729	797_::::X-12729	25	40	1	1634	3141	4158	1645	191	40	1886	2472	3096
4306_Trunk-trunk fat ratio (female)	4306_Trunk-trunk fat ratio (female)	25	40	1	1756	3356	1602	2776	503	41	40	749	475
4642_Right ventral DC	4642_Right ventral DC	25	40	1	3978	1470	162	101	2759	522	868	2906	40
3041_CD274 - Programmed cell death 1 ligand 1	3041_CD274 - Programmed cell death 1 ligand 1	25	41	1	41	3576	1353	2327	2274	3628	4314	3455	3492
4731_Superior fronto-occipital fasciculus mode of anisotropy	4731_Superior fronto-occipital fasciculus mode of anisotropy	25	41	1	781	41	3543	2732	2360	244	2117	3840	580
872_Glutamine	872_Glutamine	25	41	1	1661	1291	41	3220	1035	208	231	2727	226
170_Waist circumference (male)	170_Waist circumference (male)	25	41	1	362	2308	1088	41	2388	4307	2996	790	4045
3475_Type of accommodation lived in: A flat, maisonette or apartment	3475_Type of accommodation lived in: A flat, maisonette or apartment	25	41	1	2275	3199	3244	3169	3352	139	41	3163	4330
2391_C2 - Complement C2	2391_C2 - Complement C2	25	41	1	471	55	4436	3306	981	2555	133	41	384
2782_IL1RL1 - Interleukin-1 receptor-like 1	2782_IL1RL1 - Interleukin-1 receptor-like 1	25	41	1	889	1125	1803	2896	465	3198	3907	3928	41
854_ApoA1	854_ApoA1	25	42	1	42	2646	206	1067	417	1872	353	379	866
4364_Vigorous physical activity	4364_Vigorous physical activity	25	42	1	62	42	3653	4190	3245	4157	2029	3720	2696
2536_PRKACA - cAMP-dependent protein kinase catalytic subunit alpha	2536_PRKACA - cAMP-dependent protein kinase catalytic subunit alpha	25	42	1	697	4132	42	1281	82	2236	371	2074	1921
956_Free cholesterol in very large HDL	956_Free cholesterol in very large HDL	25	42	1	2036	2980	3184	851	42	1999	45	74	2612
2862_IL3RA - Interleukin-3 receptor subunit alpha	2862_IL3RA - Interleukin-3 receptor subunit alpha	25	42	1	1835	3303	4490	612	288	162	42	2540	1799
2986_CRK - Adapter molecule crk	2986_CRK - Adapter molecule crk	25	42	1	3945	351	2632	3912	612	624	532	42	2566
1144_Disposition index (adjusted for BMI)	1144_Disposition index (adjusted for BMI)	25	42	1	1743	1376	933	1208	130	4619	113	3227	42
1180_Insomnia (female)	1180_Insomnia (female)	25	43	1	43	1492	1716	1510	1379	2357	1520	495	1501
573_Lipid::Sterol, Steroid::cholesterol	573_Lipid::Sterol, Steroid::cholesterol	25	43	1	986	43	3692	3323	748	416	1025	1206	2971
4009_Osteoarthritis of hip or knee (hospital diagnosed)	4009_Osteoarthritis of hip or knee (hospital diagnosed)	25	43	1	629	579	43	3733	1364	1905	2942	1945	4171
4084_Type 2 Diabetes (adjusted for BMI)	4084_Type 2 Diabetes (adjusted for BMI)	25	43	1	742	467	264	4161	43	3985	59	2654	4325
3992_Miserableness (MIS)	3992_Miserableness (MIS)	25	43	1	684	2328	47	895	860	43	1519	2296	136
3376_Number of stillbirths (female)	3376_Number of stillbirths (female)	25	43	1	2372	1673	620	4155	113	716	43	4645	2595
4066_Educational attainment	4066_Educational attainment	25	43	1	321	2781	1498	560	3745	3962	4274	43	2284
760_::::X-12189	760_::::X-12189	25	43	1	2960	1163	1558	3464	2172	4241	2005	4400	43
3413_Fluid intelligence score	3413_Fluid intelligence score	25	44	1	44	1787	241	1020	4141	1125	2259	179	2276
1554_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1554_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	44	1	2816	889	44	4429	4618	4107	2629	619	508
3706_Diagnoses - secondary ICD10: Z53 Persons encntr hlth serv for spec proc & trtmt, not crd out	3706_Diagnoses - secondary ICD10: Z53 Persons encntr hlth serv for spec proc & trtmt, not crd out	25	44	1	1307	3218	2353	44	1209	2724	4041	987	2698
4498_Right precuneus	4498_Right precuneus	25	44	1	831	678	1077	4268	44	1271	1439	816	4586
530_Lipid::Lysolipid::1-arachidonoylglycerophosphocholine*	530_Lipid::Lysolipid::1-arachidonoylglycerophosphocholine*	25	44	1	340	4344	998	2053	3090	44	3480	4366	2453
312_CD4nv:%Th1	312_CD4nv:%Th1	25	44	1	842	1743	4486	474	1742	1780	44	3073	3930
856_Ratio of bisLallylic bonds to double bonds in lipids	856_Ratio of bisLallylic bonds to double bonds in lipids	25	44	1	1438	4298	1583	125	461	4212	4386	44	1600
604_Peptide::gamma-glutamyl::gamma-glutamylleucine	604_Peptide::gamma-glutamyl::gamma-glutamylleucine	25	44	1	821	2006	1572	2107	184	1642	687	1652	44
3649_Illnesses of siblings: Stroke	3649_Illnesses of siblings: Stroke	25	45	1	45	3901	2700	1643	4135	3650	4476	3587	176
3993_Irritability (IRR)	3993_Irritability (IRR)	25	45	1	1578	45	4087	897	1572	990	4630	2129	4518
2409_MEPE - Matrix extracellular phosphoglycoprotein	2409_MEPE - Matrix extracellular phosphoglycoprotein	25	45	1	328	1718	45	889	147	4030	52	1958	398
3063_JAG1 - Protein jagged-1	3063_JAG1 - Protein jagged-1	25	45	1	2424	807	4647	45	3125	2970	1479	2551	2139
3295_Guilty feelings	3295_Guilty feelings	25	45	1	2889	4715	4002	2064	45	1351	303	470	4409
698_::::X-11412	698_::::X-11412	25	45	1	2674	2359	1181	708	1465	45	477	3308	2072
3545_Mouth/teeth dental problems: Painful gums	3545_Mouth/teeth dental problems: Painful gums	25	45	1	76	1714	422	1682	1173	4555	1778	45	1564
3621_Treatment/medication code: metformin	3621_Treatment/medication code: metformin	25	45	1	327	1399	1314	915	4698	3862	1593	3453	45
401_Amino acid::Phenylalanine & tyrosine metabolism::tyrosine	401_Amino acid::Phenylalanine & tyrosine metabolism::tyrosine	25	46	1	46	2579	163	1553	1054	2835	4080	927	1510
3286_Irritability	3286_Irritability	25	46	1	2256	46	1364	1806	1115	2015	2721	2115	2964
3099_UNC5C - Netrin receptor UNC5C	3099_UNC5C - Netrin receptor UNC5C	25	46	1	3507	1318	46	1829	1799	2170	1411	1694	4134
2501_TPSB2 - Tryptase beta-2	2501_TPSB2 - Tryptase beta-2	25	46	1	3109	3974	4037	46	644	2448	1614	340	3140
1990_Age at death (FBAT, adjusted for birth-cohort)	1990_Age at death (FBAT, adjusted for birth-cohort)	25	46	1	2737	638	2629	995	2747	46	1129	934	172
2200_IGFBP1 - Insulin-like growth factor-binding protein 1	2200_IGFBP1 - Insulin-like growth factor-binding protein 1	25	46	1	3671	1098	1433	3440	1398	2347	46	3713	4691
1234_Usual weekday sleep duration (FBAT)	1234_Usual weekday sleep duration (FBAT)	25	46	1	1088	301	358	2036	1325	2399	4089	46	145
3896_Neutrophil percentage of white cells (three-way meta)	3896_Neutrophil percentage of white cells (three-way meta)	25	46	1	75	4684	4445	4346	2044	1332	1104	2536	46
155_Hip circumference	155_Hip circumference	25	47	1	47	839	4200	513	1699	3414	2403	412	4209
4122_Gamma-glutamyl transferase	4122_Gamma-glutamyl transferase	25	47	1	846	47	2566	4199	1444	403	2285	781	764
1765_Heart failure (free of MI, GEE, adjusted for age and sex)	1765_Heart failure (free of MI, GEE, adjusted for age and sex)	25	47	1	273	2878	2158	2749	1611	47	2384	2126	941
2151_TDGF1 - Teratocarcinoma-derived growth factor 1	2151_TDGF1 - Teratocarcinoma-derived growth factor 1	25	47	1	1749	3620	2347	2433	706	188	47	3101	392
3261_Alcohol intake frequency	3261_Alcohol intake frequency	25	47	1	2647	884	201	779	1543	2767	2011	47	1141
3549_Mouth/teeth dental problems: Dentures	3549_Mouth/teeth dental problems: Dentures	25	47	1	4333	198	586	3251	508	1368	1371	3152	47
1777_Heart failure (censored at interval MI, GEE, adjusted for age and sex)	1777_Heart failure (censored at interval MI, GEE, adjusted for age and sex)	25	48	1	48	4390	4285	4717	3161	1753	1681	1281	2499
3245_Non-oily fish intake	3245_Non-oily fish intake	25	48	1	4697	48	3417	1427	2513	300	1200	82	1814
1616_CD40 Ligand plasma (at exam 7, FBAT, adjusted for multivariable)	1616_CD40 Ligand plasma (at exam 7, FBAT, adjusted for multivariable)	25	48	1	2347	3339	48	2039	1873	736	94	4355	2511
2337_MRC2 - C-type mannose receptor 2	2337_MRC2 - C-type mannose receptor 2	25	48	1	4727	2285	3228	48	2132	2426	4212	1214	3368
3881_High light scatter percentage of red cells (three-way meta)	3881_High light scatter percentage of red cells (three-way meta)	25	48	1	3513	3246	3866	931	749	48	944	1860	703
2094_HMGB1 - High mobility group protein B1	2094_HMGB1 - High mobility group protein B1	25	48	1	2797	2481	593	653	292	1426	48	1217	4217
4095_Atrial Fibrillation	4095_Atrial Fibrillation	25	48	1	4668	3118	1240	3767	1255	3235	3212	2824	48
3332_Taking other prescription medications	3332_Taking other prescription medications	25	49	1	49	1261	2110	121	279	181	55	70	782
1784_PR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1784_PR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	49	1	3085	49	140	431	1293	3391	2694	1634	801
4234_Antidepressants	4234_Antidepressants	25	49	1	3620	428	49	3084	4396	2929	4260	1305	2533
1273_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI and usual sleep duration)	1273_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI and usual sleep duration)	25	49	1	378	2614	1453	1907	49	1436	3343	4679	4487
652_::::X-02269	652_::::X-02269	25	49	1	4159	2613	2012	982	4666	49	4012	3238	661
4275_Glycine level	4275_Glycine level	25	49	1	1935	2198	2819	3971	1835	4584	49	1208	1464
2258_UBE2I - SUMO-conjugating enzyme UBC9	2258_UBE2I - SUMO-conjugating enzyme UBC9	25	50	1	50	3307	407	2754	319	4558	304	4649	3593
2137_PAFAH1B2 - Platelet-activating factor acetylhydrolase IB subunit beta	2137_PAFAH1B2 - Platelet-activating factor acetylhydrolase IB subunit beta	25	50	1	3359	2671	50	633	4320	4297	1630	1921	3586
4610_Cerebellar vermal lobules VIII X	4610_Cerebellar vermal lobules VIII X	25	50	1	3255	161	2321	3326	50	2077	4290	56	2891
3258_Water intake	3258_Water intake	25	50	1	1411	3989	1304	1913	1788	50	357	1435	201
4711_Sagittal stratum mean diusivities	4711_Sagittal stratum mean diusivities	25	50	1	1191	2270	1090	1044	238	1698	50	517	2442
347_CD8:%TM (1)	347_CD8:%TM (1)	25	50	1	334	1871	3637	4007	2447	4267	3356	50	3174
3732_Depression - Fraction of day affected during worst episode of depression	3732_Depression - Fraction of day affected during worst episode of depression	25	50	1	3207	1719	2156	647	4165	2457	3379	499	50
1803_Low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1803_Low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	51	1	51	4408	4132	1999	343	3575	2096	710	3587
40_Reaction time	40_Reaction time	25	51	1	2473	51	4306	403	4655	331	127	768	54
4006_Osteoarthritis (hospital diagnosed)	4006_Osteoarthritis (hospital diagnosed)	25	51	1	854	2422	51	2617	2361	1058	2578	4305	572
169_Waist circumference (male)	169_Waist circumference (male)	25	51	1	925	3150	1637	51	2574	4534	4729	575	3584
394_Amino acid::Phenylalanine & tyrosine metabolism::3-phenylpropionate (hydrocinnamate)	394_Amino acid::Phenylalanine & tyrosine metabolism::3-phenylpropionate (hydrocinnamate)	25	51	1	4189	445	2607	2414	51	1305	226	1146	4718
3161_SEMA3E - Semaphorin-3E	3161_SEMA3E - Semaphorin-3E	25	51	1	2515	1693	916	3723	4596	51	541	2032	1236
80_Femoral Neck BMD	80_Femoral Neck BMD	25	51	1	4602	4357	824	2755	3689	3788	4645	2675	51
1035_Neck Section Modulus (GEE, adjusted for multivariable)	1035_Neck Section Modulus (GEE, adjusted for multivariable)	25	52	1	52	2076	1593	3954	1133	4335	1448	805	795
567_Lipid::Sphingolipid::palmitoyl sphingomyelin	567_Lipid::Sphingolipid::palmitoyl sphingomyelin	25	52	1	4512	52	2376	1685	501	1998	1284	694	4469
2497_PTPN11 - Tyrosine-protein phosphatase non-receptor type 11	2497_PTPN11 - Tyrosine-protein phosphatase non-receptor type 11	25	52	1	883	1220	52	2503	282	1102	2008	2810	3297
2352_C9 - Complement component C9	2352_C9 - Complement component C9	25	52	1	4017	3136	4540	52	1046	1688	2630	3140	444
2966_MMP1 - Interstitial collagenase	2966_MMP1 - Interstitial collagenase	25	52	1	3289	2391	2138	75	258	52	89	1288	2629
3815_CD4:CD8 lymphocyte ratio	3815_CD4:CD8 lymphocyte ratio	25	52	1	218	1409	1712	228	4237	1937	915	52	1545
2785_PKM2 - Pyruvate kinase PKM	2785_PKM2 - Pyruvate kinase PKM	25	52	1	4688	3464	350	3964	1985	1922	3434	2871	52
1187_Parkinson disease	1187_Parkinson disease	25	53	1	53	4363	2224	2080	3212	2350	4518	222	2541
2329_FTH1 FTL - Ferritin	2329_FTH1 FTL - Ferritin	25	53	1	562	4017	53	1905	824	575	234	2722	957
2473_CDK5 CDK5R1 - Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex	2473_CDK5 CDK5R1 - Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex	24	53	1	873	178	830	2560	53	4699	4060	3479	4335
2099_IGFBP3 - Insulin-like growth factor-binding protein 3	2099_IGFBP3 - Insulin-like growth factor-binding protein 3	25	53	1	2507	4101	3761	172	602	53	118	321	1110
1638_Myeloperoxidase (at exam 7, FBAT, adjusted for age and sex)	1638_Myeloperoxidase (at exam 7, FBAT, adjusted for age and sex)	25	53	1	4504	2942	2905	659	254	2699	2707	53	4353
2021_Squamous cell (adjusted for age)	2021_Squamous cell (adjusted for age)	25	53	1	2259	2110	149	3933	77	242	449	142	53
3931_Monogalactosylation	3931_Monogalactosylation	25	54	1	54	3766	321	466	4611	2168	908	3029	798
1524_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	1524_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	25	54	1	1801	2251	54	607	2018	2164	435	2330	3467
4417_Rubella seropositivity	4417_Rubella seropositivity	25	54	1	2887	2093	4534	54	3776	3177	2642	1662	1651
4204_Estimated glomerular filtration rate	4204_Estimated glomerular filtration rate	25	54	1	70	3142	1899	696	3875	54	259	3583	3380
4446_Left caudal middle frontal	4446_Left caudal middle frontal	25	54	1	4533	3171	4337	493	1634	4315	54	1839	2151
430_Amino acid::Valine, leucine and isoleucine metabolism::isovalerylcarnitine	430_Amino acid::Valine, leucine and isoleucine metabolism::isovalerylcarnitine	25	54	1	698	286	4351	3571	419	2932	2047	54	3945
1807_SDNN HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1807_SDNN HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	55	1	55	4266	4129	484	4166	3241	2753	309	4244
3423_Trail making test - Duration to complete alphanumeric path (trail #2)	3423_Trail making test - Duration to complete alphanumeric path (trail #2)	25	55	1	4044	941	665	55	944	1513	1457	1657	1357
4435_Influenza A IgG levels	4435_Influenza A IgG levels	25	55	1	4446	969	3542	3718	55	4286	158	480	3384
4753_Superior fronto-occipital fasciculus radial diusivities	4753_Superior fronto-occipital fasciculus radial diusivities	25	55	1	1957	564	1468	4308	519	55	1294	417	1585
3422_Trail making test - Duration to complete numeric path (trail #1)	3422_Trail making test - Duration to complete numeric path (trail #1)	25	55	1	4613	151	3525	128	1361	4242	2159	55	3622
4576_Left insula	4576_Left insula	25	55	1	4632	3261	2826	3709	3004	3551	3781	1292	55
740_::::X-11852	740_::::X-11852	25	56	1	56	2287	3252	3644	887	1649	2616	961	3695
3204_Number of days/week walked 10+ minutes	3204_Number of days/week walked 10+ minutes	25	56	1	2059	56	810	2308	1750	567	1706	2996	1616
2558_IL17B - Interleukin-17B	2558_IL17B - Interleukin-17B	25	56	1	1023	1656	56	504	1415	2848	1711	2556	4221
158_Hip circumference (male)	158_Hip circumference (male)	25	56	1	4409	3341	691	56	4180	625	3062	1875	3395
2192_FGF18 - Fibroblast growth factor 18	2192_FGF18 - Fibroblast growth factor 18	25	56	1	1286	827	1714	4174	56	1569	1239	4510	4702
116_Variability of Height	116_Variability of Height	25	56	1	3479	2923	4060	803	900	56	733	1412	2858
22_Clozapine-Induced Agranulocytosis/Granulocytopenia	22_Clozapine-Induced Agranulocytosis/Granulocytopenia	25	56	1	96	1512	4005	2529	1927	3387	56	2308	4357
1094_Systolic Blood Pressure	1094_Systolic Blood Pressure	25	56	1	1493	3898	1052	1308	364	119	280	503	56
435_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::erythrose	435_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::erythrose	25	57	1	57	335	97	1103	253	2379	391	462	938
2123_HMOX2 - Heme oxygenase 2	2123_HMOX2 - Heme oxygenase 2	25	57	1	4365	57	3281	1256	2819	2633	1987	2070	90
577_Lipid::Sterol, Steroid::epiandrosterone sulfate	577_Lipid::Sterol, Steroid::epiandrosterone sulfate	25	57	1	201	3495	57	2511	1536	4479	3593	3126	196
2030_Ulcerative colitis	2030_Ulcerative colitis	25	57	1	1432	2221	3177	57	1544	1919	2953	137	1155
2110_CD80 - T-lymphocyte activation antigen CD80	2110_CD80 - T-lymphocyte activation antigen CD80	25	57	1	619	125	2747	818	57	605	818	826	1794
1793_RR interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1793_RR interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	57	1	2834	642	382	1440	389	785	2105	57	1453
815_Lipid::Fatty acid amide::X-13183--stearamide	815_Lipid::Fatty acid amide::X-13183--stearamide	25	57	1	2774	1667	2923	2325	2312	95	456	2759	57
4522_Left caudate	4522_Left caudate	25	58	1	58	2604	295	1292	4523	2133	2324	844	4295
3746_Happiness and subjective well-being - General happiness with own health	3746_Happiness and subjective well-being - General happiness with own health	25	58	1	3180	58	1925	1774	633	4048	3906	524	454
2586_CHIT1 - Chitotriosidase-1	2586_CHIT1 - Chitotriosidase-1	25	58	1	4111	96	58	251	1422	4385	3783	1303	1034
638_Xenobiotics::Sugar, sugar substitute, starch::erythritol	638_Xenobiotics::Sugar, sugar substitute, starch::erythritol	25	58	1	3532	2301	4240	58	2091	3881	2272	2739	3957
3741_Depression - Professional informed about depression	3741_Depression - Professional informed about depression	25	58	1	2113	208	2867	4144	58	2419	501	1327	507
1507_Triglycerides (at exam 5, GEE, adjusted for age and sex)	1507_Triglycerides (at exam 5, GEE, adjusted for age and sex)	25	58	1	4643	2880	150	2047	1898	58	352	2110	1733
2708_DYNLL1 - Dynein light chain 1, cytoplasmic	2708_DYNLL1 - Dynein light chain 1, cytoplasmic	25	58	1	647	3053	464	3038	627	304	58	4444	2915
1042_Shaft Width (FBAT, adjusted for multivariable)	1042_Shaft Width (FBAT, adjusted for multivariable)	25	58	1	538	205	3425	3979	188	428	738	58	833
82_Lumbar Spine BMD (females)	82_Lumbar Spine BMD (females)	25	58	1	948	2743	318	3697	3009	1928	2681	2898	58
2375_CD33 - Myeloid cell surface antigen CD33	2375_CD33 - Myeloid cell surface antigen CD33	25	59	1	59	4667	3960	4551	4498	4255	929	1845	856
2750_PAPPA - Pappalysin-1	2750_PAPPA - Pappalysin-1	25	59	1	3849	59	3214	2785	2599	2318	3930	912	2321
1571_Mean abdominal aortic calcification - Agatston score  (at exam 7, GEE, adjusted for age and sex)	1571_Mean abdominal aortic calcification - Agatston score  (at exam 7, GEE, adjusted for age and sex)	25	59	1	4438	1195	59	3978	760	201	445	3553	1320
3522_Current employment status: Unable to work because of sickness or disability	3522_Current employment status: Unable to work because of sickness or disability	25	59	1	4263	1026	2939	2311	59	1889	125	1979	2196
4271_Worry/vulnerability factors	4271_Worry/vulnerability factors	25	59	2	1063	1885	1156	248	3028	59	1030	1675	2132
4300_Vitiligo (early onset)	4300_Vitiligo (early onset)	25	59	1	1951	211	2992	605	1713	1246	1333	59	922
2846_PCSK7 - Proprotein convertase subtilisin/kexin type 7	2846_PCSK7 - Proprotein convertase subtilisin/kexin type 7	25	59	1	897	4692	1326	3067	1188	415	1006	4686	59
2215_APOB - Apolipoprotein B	2215_APOB - Apolipoprotein B	25	60	1	1862	60	2027	2319	583	2647	1048	3593	1699
4188_Fasting insulin	4188_Fasting insulin	25	60	1	2810	1519	60	703	1509	437	111	3358	2902
146_Body Mass Index	146_Body Mass Index	25	60	1	2374	3763	1842	60	4606	3156	2966	4592	4005
887_Cholesterol esters in large HDL	887_Cholesterol esters in large HDL	25	60	1	1462	409	435	860	60	3421	239	223	2830
2648_PROC - Activated Protein C	2648_PROC - Activated Protein C	25	60	1	1527	3240	963	4424	692	772	60	2302	2222
1929_Temporal horn volume (GEE, adjusted for age and sex)	1929_Temporal horn volume (GEE, adjusted for age and sex)	25	60	1	4373	339	2996	2477	660	777	3685	60	3366
1722_Serum calcium (at exam 2, FBAT, adjusted for age and sex)	1722_Serum calcium (at exam 2, FBAT, adjusted for age and sex)	25	60	1	2331	2560	2508	2539	4130	2106	3846	2607	60
3314_Hearing difficulty/problems with background noise	3314_Hearing difficulty/problems with background noise	25	61	1	61	1966	456	2813	4694	4411	1854	4133	4286
2892_PLCG1 - 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	2892_PLCG1 - 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	25	61	1	1123	61	808	4043	3794	1643	2838	166	4231
251_CD27 on CD8 T	251_CD27 on CD8 T	25	61	1	3158	4013	61	3463	1830	149	256	1470	3772
145_Body Mass Index (female)	145_Body Mass Index (female)	25	61	1	189	3638	2936	61	2511	3770	4095	3119	3948
1830_Neck length (FBAT, female, adjusted for multivariable)	1830_Neck length (FBAT, female, adjusted for multivariable)	25	61	1	2719	578	3023	2376	61	881	413	138	231
1030_Neck Width (FBAT, adjusted for multivariable)	1030_Neck Width (FBAT, adjusted for multivariable)	25	61	1	1476	2591	1387	670	4105	61	4300	751	2200
1981_Walking speed (at offspring exam 7 cohort exam 27, GEE)	1981_Walking speed (at offspring exam 7 cohort exam 27, GEE)	25	61	1	2112	4508	2219	3355	4344	1262	61	1241	548
4018_Systemic Lupus Erythematosus	4018_Systemic Lupus Erythematosus	25	61	1	265	3090	579	642	2615	2363	1831	61	230
186_Waist-hip ratio (adjusted for BMI)	186_Waist-hip ratio (adjusted for BMI)	25	61	2	3456	2740	1969	192	2640	243	3320	1190	61
1087_Age-related Macular Degeneration	1087_Age-related Macular Degeneration	25	62	1	3347	62	4708	2835	3703	2286	3145	3197	1965
3996_Nervous feelings (NERV-FEEL)	3996_Nervous feelings (NERV-FEEL)	25	62	1	659	517	2672	62	2726	2016	4616	3770	1676
2643_CTSH - Cathepsin H	2643_CTSH - Cathepsin H	25	62	1	2060	3610	718	2145	62	1635	99	2633	3927
2878_PPBP - Connective tissue-activating peptide III	2878_PPBP - Connective tissue-activating peptide III	25	62	1	3891	2575	747	4699	458	62	406	1701	2930
3299_Frequency of tenseness / restlessness in last 2 weeks	3299_Frequency of tenseness / restlessness in last 2 weeks	25	62	1	4458	1325	2907	3116	93	3461	62	952	3812
1892_Shaft Section Modulus (FBAT, adjussted for multivariable)	1892_Shaft Section Modulus (FBAT, adjussted for multivariable)	25	62	1	68	3951	2260	3781	1488	444	4426	62	2160
4507_Cerebellar vermal lobules I V	4507_Cerebellar vermal lobules I V	25	62	1	1923	3496	3263	4740	2634	3008	4472	4301	62
950_Tyrosine	950_Tyrosine	25	63	1	63	597	154	1032	108	3535	491	109	3431
3855_Mean platelet volume (two-way meta)	3855_Mean platelet volume (two-way meta)	25	63	1	4699	63	1269	3308	2911	1699	298	2780	2097
3176_PRKCB - Protein kinase C beta type (splice variant beta-II)	3176_PRKCB - Protein kinase C beta type (splice variant beta-II)	25	63	1	1406	3296	63	1705	499	4195	1733	3544	141
978_Growth regulated oncogene (CXCL1)	978_Growth regulated oncogene (CXCL1)	25	63	1	4286	3955	1566	63	815	3587	1495	4443	177
4487_Right medial orbitofrontal	4487_Right medial orbitofrontal	25	63	1	1059	4098	1903	1670	63	970	270	1278	2214
2315_MBL2 - Mannose-binding protein C	2315_MBL2 - Mannose-binding protein C	25	63	1	2190	4461	4075	4026	1924	63	1757	3465	4115
2511_CA13 - Carbonic anhydrase 13	2511_CA13 - Carbonic anhydrase 13	25	64	1	4315	64	2709	286	403	1448	4214	182	4352
2294_AREG - Amphiregulin	2294_AREG - Amphiregulin	25	64	1	3318	618	64	577	3704	1865	1300	4566	373
3481_Milk type used: Semi-skimmed	3481_Milk type used: Semi-skimmed	25	64	1	4068	2732	1382	4294	947	796	64	531	2235
1264_Residual from predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	1264_Residual from predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	25	64	1	4680	926	2564	842	556	1851	474	64	1475
4113_Potassium	4113_Potassium	25	64	1	3643	4394	391	1180	2464	1674	3521	2623	64
4277_Meconium ileus in cystic fibrosis	4277_Meconium ileus in cystic fibrosis	25	65	1	65	4416	2759	3596	2166	2073	4341	2676	2348
3437_Doctor diagnosed hayfever or allergic rhinitis	3437_Doctor diagnosed hayfever or allergic rhinitis	25	65	1	2655	65	3783	4131	3737	3219	1958	1635	3402
1755_Cancer (GEE, adjusted for age and sex)	1755_Cancer (GEE, adjusted for age and sex)	25	65	1	638	2969	65	2369	1472	2258	1664	2877	2288
4090_Family history of Alzheimer's disease	4090_Family history of Alzheimer's disease	25	65	1	267	4326	856	65	2438	4323	3857	1171	3572
3561_Medication for pain relief, constipation, heartburn: Laxatives (e.g. Dulcolax, Senokot)	3561_Medication for pain relief, constipation, heartburn: Laxatives (e.g. Dulcolax, Senokot)	25	65	1	4476	3919	1457	1209	4121	65	1643	4499	893
1978_Hand grip (at exam 7, FBAT)	1978_Hand grip (at exam 7, FBAT)	25	65	1	3958	1142	1574	499	1279	2573	3381	65	4567
4622_Left thalamus proper	4622_Left thalamus proper	25	65	1	2104	299	4082	1927	1006	490	401	996	65
3943_HbA1c	3943_HbA1c	25	66	1	66	2498	2437	4463	794	2642	1361	2447	935
1487_Mean triglycerides from exam 1-7 (GEE, adjusted for age and sex)	1487_Mean triglycerides from exam 1-7 (GEE, adjusted for age and sex)	25	66	1	3380	66	580	4678	4250	2757	722	482	2165
1017_Femoral BMD (GEE, adjusted for multivariable)	1017_Femoral BMD (GEE, adjusted for multivariable)	25	66	1	1897	1294	66	3352	2392	2044	2293	2651	2488
1268_Epworth Sleepiness Scale (FBAT)	1268_Epworth Sleepiness Scale (FBAT)	25	66	1	3253	2404	3373	66	1603	3442	2193	191	755
1649_P-selectin (at exam 7, GEE, adjusted for multivariable)	1649_P-selectin (at exam 7, GEE, adjusted for multivariable)	25	66	1	3294	2466	365	4591	66	3291	152	3608	4627
1435_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	1435_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	25	66	1	2431	2037	1184	588	2153	66	1773	1183	481
1348_Plasma Apolipoprotein B level (FBAT, multivariate adjusted)	1348_Plasma Apolipoprotein B level (FBAT, multivariate adjusted)	25	66	1	3049	115	2653	263	409	4189	4479	66	1792
4644_Gray matter	4644_Gray matter	25	66	1	4030	3424	4124	1120	2655	2293	3498	3758	66
4093_Verbal-numerical reasoning	4093_Verbal-numerical reasoning	25	67	1	67	3726	1758	298	3312	3858	1261	4644	1483
926_Phospholipids in medium VLDL	926_Phospholipids in medium VLDL	25	67	1	620	67	2763	4672	150	3176	2190	190	831
892_Total cholesterol in large LDL	892_Total cholesterol in large LDL	25	67	2	2991	4499	3971	67	4520	1500	2415	4287	1704
720_::::X-11538	720_::::X-11538	25	67	1	4686	3165	2382	4343	67	2696	645	494	4087
1839_Neck width (GEE, female, adjusted for age)	1839_Neck width (GEE, female, adjusted for age)	25	67	1	1283	3190	2472	2019	4323	1073	1387	67	2873
3340_Had menopause (female)	3340_Had menopause (female)	25	67	1	1641	95	917	2416	307	1506	827	141	67
3284_Mood swings	3284_Mood swings	25	68	1	358	68	3509	1959	248	3180	2219	218	93
4433_Mumps IgG levels	4433_Mumps IgG levels	25	68	1	4054	3831	68	247	2561	1915	4411	1835	322
4115_Calcium	4115_Calcium	25	68	1	4617	3373	819	1109	68	274	88	3945	4581
1028_Neck Width (FBAT, adjusted for age and sex)	1028_Neck Width (FBAT, adjusted for age and sex)	25	68	1	2228	4379	2441	1128	4695	68	4221	1062	2168
1688_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for multivariable)	1688_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for multivariable)	25	68	1	367	1888	2341	764	1953	2144	1829	68	3730
2214_FGA FGB FGG - Fibrinogen	2214_FGA FGB FGG - Fibrinogen	25	68	1	1747	4485	4246	371	1606	590	3537	4731	68
228_Lymph:%DP T	228_Lymph:%DP T	25	69	1	69	2411	1097	2553	4003	2499	2654	3298	1614
1441_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	1441_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	25	69	1	2953	72	69	1936	1191	3467	4237	4315	2107
886_Total cholesterol in large HDL	886_Total cholesterol in large HDL	25	69	1	1595	1021	896	1501	69	2512	351	257	2310
479_Lipid::Carnitine metabolism::cis-4-decenoyl carnitine	479_Lipid::Carnitine metabolism::cis-4-decenoyl carnitine	25	69	1	589	2084	257	4372	91	69	457	3342	1196
4562_Left pars orbitalis	4562_Left pars orbitalis	25	69	1	898	2383	2296	872	1098	1028	69	3153	1701
1603_tPA (at exam 5, GEE, adjusted for age and sex)	1603_tPA (at exam 5, GEE, adjusted for age and sex)	25	69	1	80	1307	3984	3955	3057	1787	4365	69	1050
4357_Albuminuria	4357_Albuminuria	25	69	1	736	2453	333	1181	2677	3464	4552	4374	69
3818_Asthma, hay fever or eczema	3818_Asthma, hay fever or eczema	25	70	1	3895	70	4494	1755	4435	2875	557	983	902
1355_Plasma Apolipoprotein C3 level (GEE, adjusted for age and sex)	1355_Plasma Apolipoprotein C3 level (GEE, adjusted for age and sex)	25	70	1	2849	3926	70	793	317	120	131	3751	1519
4527_Left accumbens area	4527_Left accumbens area	25	70	1	1005	1227	4504	70	1457	2487	4637	4123	2569
2032_Prognosis in Crohn's Disease	2032_Prognosis in Crohn's Disease	25	70	1	1407	3216	4427	1324	70	658	112	2511	300
3582_Types of transport used (excluding work): Walk	3582_Types of transport used (excluding work): Walk	25	70	1	4187	1205	1267	3221	2882	70	2972	4282	582
954_Total cholesterol in very large HDL	954_Total cholesterol in very large HDL	25	70	1	530	2905	360	273	221	720	70	319	1440
1530_Ankle-brachial index (at exam 6, FBAT, adjusted for age and sex)	1530_Ankle-brachial index (at exam 6, FBAT, adjusted for age and sex)	25	70	1	1392	3459	736	3523	1630	4094	4617	1884	70
4736_Anterior limb of internal capsule radial diusivities	4736_Anterior limb of internal capsule radial diusivities	25	71	1	71	230	3342	3037	645	2651	3437	2215	4177
3655_Smoking status: Previous vs Current	3655_Smoking status: Previous vs Current	25	71	1	2164	71	587	1896	667	3688	3592	2145	2677
3811_Basophil count	3811_Basophil count	25	71	1	4090	1608	71	4471	1734	1141	1606	4118	1438
3990_Neuroticism sum score	3990_Neuroticism sum score	25	71	1	322	238	4064	1315	71	2174	1309	1222	425
4293_Depression	4293_Depression	25	71	1	2771	4548	1553	1086	1332	71	1295	1459	476
1975_Morbidity-free survival (at age 65, GEE, adjusted for birth-cohort)	1975_Morbidity-free survival (at age 65, GEE, adjusted for birth-cohort)	25	71	1	346	2056	692	4137	3285	726	71	3564	359
1747_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for multivariable)	1747_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for multivariable)	25	71	1	2188	2915	3594	2060	4672	774	1135	71	4497
3415_Reaction time test - Mean time to correctly identify matches	3415_Reaction time test - Mean time to correctly identify matches	25	71	1	1443	172	2739	885	2613	4562	3243	1943	71
3558_Medication for pain relief, constipation, heartburn: Ibuprofen (e.g. Nurofen)	3558_Medication for pain relief, constipation, heartburn: Ibuprofen (e.g. Nurofen)	25	72	1	72	2141	1061	2798	995	848	4157	3002	1371
2559_ITGA1 ITGB1 - Integrin alpha-I: beta-1 complex	2559_ITGA1 ITGB1 - Integrin alpha-I: beta-1 complex	25	72	1	1215	3128	72	2709	2068	1422	748	312	182
1194_Ulcerative colitis	1194_Ulcerative colitis	25	72	1	955	4627	2767	72	1842	3210	1980	124	2220
502_Lipid::Fatty acid, dicarboxylate::tetradecanedioate	502_Lipid::Fatty acid, dicarboxylate::tetradecanedioate	25	72	1	3409	3323	305	3327	1343	72	882	3008	140
3323_Ever had prostate specific antigen (PSA) test	3323_Ever had prostate specific antigen (PSA) test	25	72	1	3030	2965	2006	3338	170	601	72	4100	1022
168_Waist circumference	168_Waist circumference	25	73	1	73	1362	3313	356	2144	3679	2992	777	3970
4599_Right precuneus	4599_Right precuneus	25	73	1	349	2850	285	4159	73	1960	1913	1721	3460
4002_Guilty feelings (GUILT)	4002_Guilty feelings (GUILT)	25	73	1	3351	3183	3809	4627	142	73	660	981	4261
2350_WISP1 - WNT1-inducible-signaling pathway protein 1	2350_WISP1 - WNT1-inducible-signaling pathway protein 1	25	73	1	1430	2242	2004	3150	3128	2160	73	4151	4375
3806_White blood cell count	3806_White blood cell count	25	73	1	134	1385	2969	1353	2584	2779	2685	73	1832
3307_Overall health rating	3307_Overall health rating	25	74	1	74	1483	2922	2673	1290	1623	3806	3689	3151
1292_Diabetes incidence (FBAT, adjusted for age and sex)	1292_Diabetes incidence (FBAT, adjusted for age and sex)	25	74	1	882	74	1007	506	3389	463	2028	2364	2237
4376_Hypothyroidism	4376_Hypothyroidism	25	74	1	2090	1432	74	578	1737	3357	4656	3501	3639
3489_Cereal type: Biscuit cereal (e.g. Weetabix)	3489_Cereal type: Biscuit cereal (e.g. Weetabix)	25	74	1	3332	1241	2591	74	1890	4413	522	4424	4506
2735_FN1 - Fibronectin	2735_FN1 - Fibronectin	25	74	1	3026	1923	3072	2641	176	2719	74	4691	4336
4475_Left insula	4475_Left insula	25	74	1	2829	1164	2915	1988	1309	3090	3736	4350	74
4043_Height	4043_Height	25	75	1	2730	75	1731	1730	1357	684	792	220	495
2924_TXNDC12 - Thioredoxin domain-containing protein 12	2924_TXNDC12 - Thioredoxin domain-containing protein 12	25	75	1	3059	187	75	341	564	667	1825	4661	92
500_Lipid::Fatty acid, dicarboxylate::hexadecanedioate	500_Lipid::Fatty acid, dicarboxylate::hexadecanedioate	25	75	1	4293	808	1466	2231	75	130	109	544	534
3399_Tinnitus	3399_Tinnitus	25	75	1	1022	1131	3565	2292	2300	1035	75	3159	3659
3822_Primary biliary cirrhosis	3822_Primary biliary cirrhosis	25	75	1	1861	1684	3944	1152	237	1638	128	75	668
825_::::X-13619	825_::::X-13619	25	75	1	1793	1253	1845	3120	359	458	1812	92	75
378_Amino acid::Glutathione metabolism::cysteine-glutathione disulfide	378_Amino acid::Glutathione metabolism::cysteine-glutathione disulfide	25	76	1	2669	76	3380	1998	4406	4294	4640	1664	721
747_::::X-12029	747_::::X-12029	25	76	1	2363	862	76	2680	2962	2377	1039	4697	4531
4335_Overall activity	4335_Overall activity	25	76	1	793	405	1945	4489	76	751	3724	460	2140
4636_Right caudate	4636_Right caudate	25	76	1	753	4284	3434	4428	618	76	840	4460	2233
353_IgE+B:%27+	353_IgE+B:%27+	25	76	1	2226	2879	3068	1957	672	769	76	4632	4576
3910_Vertical cup-disc ratio	3910_Vertical cup-disc ratio	25	76	1	3486	4372	1894	4722	2131	2114	2924	76	1064
1594_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for age and sex)	1594_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for age and sex)	25	77	1	77	3295	169	903	2581	583	2669	3457	251
829_::::X-13859	829_::::X-13859	25	77	1	4056	77	4683	3303	600	4533	3800	907	552
863_Double bonds in fatty acids	863_Double bonds in fatty acids	25	77	1	3195	1610	2040	77	154	2928	2531	335	357
3676_Diagnoses - main ICD10: M16 Osteoarthritis of hip	3676_Diagnoses - main ICD10: M16 Osteoarthritis of hip	25	77	1	2150	4322	3792	1224	151	77	171	540	3769
2340_CCL18 - C-C motif chemokine 18	2340_CCL18 - C-C motif chemokine 18	25	77	1	2576	2235	1172	303	2620	223	77	2378	529
1409_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for age and sex)	1409_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for age and sex)	25	77	1	3157	295	2625	4233	2389	1902	3019	77	3852
3882_High light scatter reticulocyte count (three-way meta)	3882_High light scatter reticulocyte count (three-way meta)	25	77	1	4717	3911	2498	672	1662	693	2501	2201	77
3210_Usual walking pace	3210_Usual walking pace	25	78	1	78	4009	879	1614	4650	1308	2656	792	2719
1814_Femoral Neck BMD (FBAT, female, adjusted for multivariable)	1814_Femoral Neck BMD (FBAT, female, adjusted for multivariable)	25	78	1	4744	4364	78	2516	4034	4724	1312	1108	2960
1503_Triglycerides (at exam 3, GEE, adjusted for age and sex)	1503_Triglycerides (at exam 3, GEE, adjusted for age and sex)	25	78	1	1972	507	1626	78	1110	4340	2349	1489	1907
2825_FGF16 - Fibroblast growth factor 16	2825_FGF16 - Fibroblast growth factor 16	25	78	1	1087	111	840	2482	78	4184	306	578	1380
3959_Antisocial behavior (female)	3959_Antisocial behavior (female)	25	78	1	2224	796	1155	82	165	78	588	1385	95
1951_Visual scanning and motor speed (GEE, adjusted for multivariable)	1951_Visual scanning and motor speed (GEE, adjusted for multivariable)	25	78	1	4234	2166	1775	2960	2555	2416	4499	78	198
2426_BGN - Biglycan	2426_BGN - Biglycan	25	79	1	79	2851	4603	3538	3552	3490	2853	440	3539
598_Peptide::Fibrinogen cleavage peptide::ADpSGEGDFXAEGGGVR*	598_Peptide::Fibrinogen cleavage peptide::ADpSGEGDFXAEGGGVR*	25	79	1	3394	79	415	3002	2740	3108	1665	1984	4675
2591_DDR2 - Discoidin domain-containing receptor 2	2591_DDR2 - Discoidin domain-containing receptor 2	25	79	1	1963	3783	79	1475	3979	3193	3025	2807	4717
3417_Neuroticism score	3417_Neuroticism score	25	79	1	257	164	2180	3605	79	2869	482	1192	850
2542_THBS1 - Thrombospondin-1	2542_THBS1 - Thrombospondin-1	25	79	1	2983	2609	343	2593	840	79	644	3902	870
3095_IL27RA - Interleukin-27 receptor subunit alpha	3095_IL27RA - Interleukin-27 receptor subunit alpha	25	79	1	448	1679	191	2479	783	1334	79	3224	2700
309_CD4nv:%Th2	309_CD4nv:%Th2	25	79	1	3546	729	4663	313	1106	2301	2253	79	3875
81_Lumbar Spine BMD (males)	81_Lumbar Spine BMD (males)	25	79	1	1886	1615	1016	3266	3672	2756	2815	2866	79
628_Xenobiotics::Drug::salicylate	628_Xenobiotics::Drug::salicylate	25	80	1	1994	80	2548	254	217	2381	212	1642	858
2549_FGF1 - Fibroblast growth factor 1	2549_FGF1 - Fibroblast growth factor 1	25	80	1	4140	993	3480	411	80	1076	4428	2845	4596
2817_CRP - C-reactive protein	2817_CRP - C-reactive protein	25	80	1	2203	3126	4199	4570	1282	80	572	2920	2287
4165_Juvenile Myoclonic Epilepsy (JME)	4165_Juvenile Myoclonic Epilepsy (JME)	25	80	1	1047	179	3983	1218	591	588	3288	80	1657
187_Waist-hip ratio (male, adjusted for BMI)	187_Waist-hip ratio (male, adjusted for BMI)	25	80	1	2914	790	2492	2087	3636	983	2418	3891	80
167_Waist circumference	167_Waist circumference	25	81	1	81	3997	1781	304	4124	3415	4124	2788	4621
2371_VEGFC - Vascular endothelial growth factor C	2371_VEGFC - Vascular endothelial growth factor C	25	81	1	3095	81	793	4467	380	2619	2234	161	377
802_::::X-12776	802_::::X-12776	25	81	1	4635	4440	81	1994	1724	2140	4046	343	3319
4111_Uric acid	4111_Uric acid	25	81	1	105	646	2124	81	1161	320	1646	146	2851
4588_Right medial orbitofrontal	4588_Right medial orbitofrontal	25	81	1	3832	4574	4416	1158	81	482	246	1221	1278
1222_Mean Hippocampus	1222_Mean Hippocampus	25	81	1	755	2439	3582	3456	1619	81	1081	3314	2552
3662_Cancer register - Behaviour of cancer tumour: Carcinoma in situ	3662_Cancer register - Behaviour of cancer tumour: Carcinoma in situ	25	81	1	268	3326	805	189	390	1606	81	1563	1435
1475_Mean total cholesterol from exam 1-7 (GEE, adjusted for age and sex)	1475_Mean total cholesterol from exam 1-7 (GEE, adjusted for age and sex)	25	81	1	660	2950	2272	1194	4329	3921	4137	81	2380
1295_Diabetes incidence (GEE, adjusted for age, sex and BMI)	1295_Diabetes incidence (GEE, adjusted for age, sex and BMI)	25	81	1	1287	4135	1127	4635	1816	4331	2910	1233	81
798_::::X-12734	798_::::X-12734	25	82	1	82	1660	310	4341	3845	4461	1537	2616	716
4092_Reaction time	4092_Reaction time	25	82	1	4554	82	4192	1140	3589	2911	902	1562	2701
2938_F9 - Coagulation factor IX	2938_F9 - Coagulation factor IX	25	82	1	826	1127	82	2237	839	2410	2761	564	1012
754_::::X-12093	754_::::X-12093	25	82	1	618	1180	2482	2314	985	764	82	2404	4050
458_Energy::Krebs cycle::alpha-ketoglutarate	458_Energy::Krebs cycle::alpha-ketoglutarate	25	82	1	3943	3883	2409	1142	3897	1469	2207	2481	82
3190_Number of self-reported non-cancer illnesses	3190_Number of self-reported non-cancer illnesses	25	83	1	83	4398	3297	580	1199	1447	531	418	1748
1491_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for age and sex)	1491_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for age and sex)	25	83	1	3569	83	726	261	1629	4120	1044	2837	2563
2797_PEBP1 - Phosphatidylethanolamine-binding protein 1	2797_PEBP1 - Phosphatidylethanolamine-binding protein 1	25	83	1	4425	3138	83	1728	2839	3402	3937	1046	3088
428_Amino acid::Valine, leucine and isoleucine metabolism::isobutyrylcarnitine	428_Amino acid::Valine, leucine and isoleucine metabolism::isobutyrylcarnitine	25	83	1	4678	2993	2593	83	1212	440	887	3030	4454
28_Extraversion (NEO-FFI)	28_Extraversion (NEO-FFI)	25	83	1	4329	2656	3416	2212	83	2452	778	2451	4287
338_NKeff:%Kir+ (3)	338_NKeff:%Kir+ (3)	25	83	1	2897	1859	2579	977	698	83	312	3525	1430
1620_CD40 Ligand serum (at exam 7, FBAT, adjusted for multivariable)	1620_CD40 Ligand serum (at exam 7, FBAT, adjusted for multivariable)	25	83	1	2321	3188	4655	352	4010	4006	3993	83	370
2186_AZU1 - Azurocidin	2186_AZU1 - Azurocidin	25	83	1	523	3621	4047	3712	3827	1661	4354	3099	83
4689_Sagittal stratum axial diusivities	4689_Sagittal stratum axial diusivities	25	84	1	84	885	2387	2030	391	1118	134	2664	174
4629_Left ventral DC	4629_Left ventral DC	25	84	1	3808	84	1404	2838	2476	143	2677	1455	3296
2297_CNTN1 - Contactin-1	2297_CNTN1 - Contactin-1	25	84	1	1128	392	84	2558	1270	3479	3127	501	2724
4223_Calcium channel blockers	4223_Calcium channel blockers	25	84	1	1186	3603	4699	84	3248	2167	2139	3721	1266
3418_Fluid intelligence test - Number of fluid intelligence questions attempted within time limit	3418_Fluid intelligence test - Number of fluid intelligence questions attempted within time limit	25	84	1	1660	744	3207	3217	964	84	1374	1478	3222
3168_CD27 - CD27 antigen	3168_CD27 - CD27 antigen	24	84	1	1625	4294	737	4731	512	1462	84	680	2010
476_Lipid::Carnitine metabolism::3-dehydrocarnitine*	476_Lipid::Carnitine metabolism::3-dehydrocarnitine*	25	84	1	492	2054	3075	1090	2684	4436	4575	84	1452
382_Amino acid::Glycine, serine and threonine metabolism::N-acetylthreonine	382_Amino acid::Glycine, serine and threonine metabolism::N-acetylthreonine	25	84	1	3126	3157	419	3797	1076	2751	3525	4281	84
1633_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for multivariable)	1633_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for multivariable)	25	85	1	85	1262	2252	397	993	2815	2670	880	1321
3740_Depression - Depression possibly related to stressful or traumatic event	3740_Depression - Depression possibly related to stressful or traumatic event	25	85	1	3176	85	2155	2425	2456	92	3081	2598	2726
722_::::X-11546	722_::::X-11546	25	85	1	3256	1561	85	1706	3862	2829	1419	4260	3170
3846_High light scatter reticulocyte count (two-way meta)	3846_High light scatter reticulocyte count (two-way meta)	25	85	1	3254	4370	2208	85	2414	206	2523	2209	217
3147_CASP10 - Caspase-10	3147_CASP10 - Caspase-10	25	85	1	3171	4469	4727	2055	85	1036	509	642	4279
3517_How are people in household related to participant: Husband, wife or partner	3517_How are people in household related to participant: Husband, wife or partner	25	85	1	2369	2168	2541	4201	699	85	376	4139	3481
4430_Varicella Zoster Virus IgG levels	4430_Varicella Zoster Virus IgG levels	25	85	1	2099	3284	211	4650	569	578	85	622	988
1976_Hand grip (at offspring exam 7 cohort exam 27, FBAT)	1976_Hand grip (at offspring exam 7 cohort exam 27, FBAT)	25	85	1	4312	771	1914	648	762	3413	2030	85	4184
247_CD56 on 2+NK eff	247_CD56 on 2+NK eff	25	85	1	4682	2144	2741	4657	1166	1918	3070	539	85
4167_Parkinson disease of sibling pairs (tier 1)	4167_Parkinson disease of sibling pairs (tier 1)	25	86	1	86	3682	4407	3536	2924	3091	4679	1163	3630
903_Phospholipids in large VLDL	903_Phospholipids in large VLDL	25	86	1	407	86	4251	3004	534	4316	4441	148	605
3159_OMD - Osteomodulin	3159_OMD - Osteomodulin	25	86	1	878	2444	86	3681	873	782	4598	555	493
2936_ANG - Angiogenin	2936_ANG - Angiogenin	25	86	1	2557	4388	3209	86	4569	3690	3828	4538	1664
492_Lipid::Essential fatty acid::linolenate [alpha or gamma; (18:3n3 or 6)]	492_Lipid::Essential fatty acid::linolenate [alpha or gamma; (18:3n3 or 6)]	25	86	1	1267	3711	2150	3127	86	2009	801	638	1607
2747_CCL13 - C-C motif chemokine 13	2747_CCL13 - C-C motif chemokine 13	25	86	1	1926	1906	538	1874	266	86	1393	497	2550
2124_Human-virus - Protein E7_HPV16	2124_Human-virus - Protein E7_HPV16	25	86	1	2009	2508	2975	2895	3199	4711	86	2194	3813
127_Height (female)	127_Height (female)	25	86	1	3443	418	3989	850	1401	461	1219	86	544
989_Interleukin-2	989_Interleukin-2	25	86	1	3348	1842	3493	2756	3739	3088	905	2926	86
1910_Temporal horn volume (FBAT, adjusted for multivariable)	1910_Temporal horn volume (FBAT, adjusted for multivariable)	25	87	1	87	1683	2434	4227	2554	3828	4216	1325	3906
942_Concentration of small VLDL particles	942_Concentration of small VLDL particles	25	87	1	746	87	2131	3834	100	2259	1701	269	639
949_Total phosphoglycerides	949_Total phosphoglycerides	25	87	1	3325	1342	87	2572	252	2564	2389	3595	2515
147_Body Mass Index (male > 50 yrs)	147_Body Mass Index (male > 50 yrs)	25	87	1	1390	1302	1817	87	2687	2510	2010	1762	2777
3254_Salt added to food	3254_Salt added to food	25	87	1	4256	721	2164	3651	87	398	3489	2966	4243
3474_Type of accommodation lived in: A house or bungalow	3474_Type of accommodation lived in: A house or bungalow	25	87	1	3119	767	4322	4006	2965	87	2257	4614	3328
1724_Serum calcium (at exam 2, FBAT, adjusted for age, sex and serum creatinine)	1724_Serum calcium (at exam 2, FBAT, adjusted for age, sex and serum creatinine)	25	87	1	4582	4433	4557	3545	2845	3835	2194	1882	87
2276_CYP3A4 - Cytochrome P450 3A4	2276_CYP3A4 - Cytochrome P450 3A4	25	88	1	88	132	1835	1954	1129	4186	1289	1747	4127
972_Triglycerides in chylomicrons and extremely large VLDL	972_Triglycerides in chylomicrons and extremely large VLDL	25	88	1	247	88	4465	2155	540	2670	4605	192	337
3755_Mental distress - Ever sought or received professional help for mental distress	3755_Mental distress - Ever sought or received professional help for mental distress	25	88	1	3344	3473	88	4337	3644	531	4034	1759	3737
2874_CBX5 - Chromobox protein homolog 5	2874_CBX5 - Chromobox protein homolog 5	25	88	1	1266	1739	2408	88	268	1795	655	127	3216
889_Total lipids in large HDL	889_Total lipids in large HDL	25	88	1	1044	811	642	1273	88	1877	338	243	4516
3613_Treatment/medication code: simvastatin	3613_Treatment/medication code: simvastatin	25	88	1	3067	1310	3081	314	1590	88	4184	2709	1975
54_Subjective well being	54_Subjective well being	25	88	1	2932	2790	603	3959	523	1111	2624	88	3909
3979_Estimated BMD	3979_Estimated BMD	25	88	1	383	1616	217	2061	2412	3002	4058	778	88
3461_Impedance measures - Arm fat mass (right)	3461_Impedance measures - Arm fat mass (right)	25	89	2	89	1530	254	780	4296	955	4551	767	2579
900_Free cholesterol in large VLDL	900_Free cholesterol in large VLDL	25	89	1	480	89	4100	3801	479	4231	4650	213	417
849_::::X-18601	849_::::X-18601	25	89	1	1100	1479	89	4250	3530	4580	3563	2375	4716
3186_Hip circumference	3186_Hip circumference	25	89	1	475	4401	1153	89	3655	1521	3383	820	2848
4026_Childhood idiopathic nephrotic syndrome	4026_Childhood idiopathic nephrotic syndrome	25	89	1	1637	316	4193	1902	89	365	96	131	3244
4638_Right pallidum	4638_Right pallidum	25	89	1	2831	3600	4705	3827	3624	89	3117	4476	4585
1370_Total cholesterol (at exam 7, FBAT, adjusted for age and sex)	1370_Total cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	89	1	2449	1090	1707	2187	1759	2659	1973	89	895
2038_Attention function - Alerting - Child	2038_Attention function - Alerting - Child	25	89	1	1471	2375	223	3199	2580	2342	551	956	89
2128_IL10RB - Interleukin-10 receptor subunit beta	2128_IL10RB - Interleukin-10 receptor subunit beta	25	90	1	1111	90	148	1042	263	4535	3551	1088	785
2363_RARRES2 - Retinoic acid receptor responder protein 2	2363_RARRES2 - Retinoic acid receptor responder protein 2	25	90	1	2441	4140	90	2455	4561	3524	4427	3097	2244
3185_Waist circumference	3185_Waist circumference	25	90	1	232	2673	409	90	2878	1878	4026	362	2648
1341_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age, sex and BMI)	1341_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age, sex and BMI)	24	90	1	3278	257	3627	2540	90	982	1770	189	705
3471_Impedance measures - Trunk predicted mass	3471_Impedance measures - Trunk predicted mass	25	90	1	3080	2456	2574	3502	2823	90	2741	728	843
1287_Visceral fat by CT (GEE, adjusted for age, sex, smoking, menopause)	1287_Visceral fat by CT (GEE, adjusted for age, sex, smoking, menopause)	25	90	1	3502	4138	943	1023	326	1222	2093	90	2258
2048_Periodontal complex trait 3 - Aa trait	2048_Periodontal complex trait 3 - Aa trait	25	91	1	91	2302	2319	2461	806	595	110	1277	4424
4670_Anterior limb of internal capsule axial diusivities	4670_Anterior limb of internal capsule axial diusivities	25	91	1	1699	1792	207	91	3345	1204	4680	4344	2318
4011_Broad depression	4011_Broad depression	25	91	1	4389	3713	704	3257	550	91	1167	684	1172
3685_Diagnoses - secondary ICD10: E03 Other hypothyroidism	3685_Diagnoses - secondary ICD10: E03 Other hypothyroidism	25	91	1	4032	3249	1786	2090	3640	3963	91	3321	3439
2431_CD48 - CD48 antigen	2431_CD48 - CD48 antigen	25	91	1	3935	3504	302	3951	3323	1920	4449	91	3232
2295_BMP7 - Bone morphogenetic protein 7	2295_BMP7 - Bone morphogenetic protein 7	25	92	1	92	1023	3764	3469	3857	4145	2886	1078	1162
1720_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for multivariable)	1720_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for multivariable)	25	92	1	2141	92	286	1882	374	3379	2584	171	1285
2364_ULBP1 - NKG2D ligand 1	2364_ULBP1 - NKG2D ligand 1	25	92	1	3410	1168	92	4516	2000	2948	4631	2003	3678
43_Social deprivation	43_Social deprivation	25	92	1	4335	3485	3632	92	4265	3072	766	1639	2424
365_Amino acid::Alanine and aspartate metabolism::asparagine	365_Amino acid::Alanine and aspartate metabolism::asparagine	25	92	1	3877	174	4719	1906	92	2549	2246	695	156
1974_Morbidity-free survival (at age 65, FBAT, adjusted for birth-cohort)	1974_Morbidity-free survival (at age 65, FBAT, adjusted for birth-cohort)	25	92	1	1889	3642	3720	3445	293	3741	92	2366	2113
4469_Left rostral middle frontal	4469_Left rostral middle frontal	25	93	1	93	1191	3168	1499	384	3541	2583	1138	1138
3000_GRN - Granulins	3000_GRN - Granulins	25	93	1	4361	93	1834	2849	182	574	203	1274	2780
643_Xenobiotics::Xanthine metabolism::1-methylxanthine	643_Xenobiotics::Xanthine metabolism::1-methylxanthine	25	93	1	102	3440	93	2072	4465	4100	4210	1099	4739
896_Concentration of large LDL particles	896_Concentration of large LDL particles	25	93	1	2861	4439	4079	93	2880	3066	2239	2992	852
4707_Splenium of corpus callosum mean diusivities	4707_Splenium of corpus callosum mean diusivities	25	93	1	3561	2926	4450	4413	298	93	166	1406	4309
1509_Triglycerides (at exam 6, GEE, adjusted for age and sex)	1509_Triglycerides (at exam 6, GEE, adjusted for age and sex)	25	93	1	3735	182	557	4663	563	1123	93	2363	2590
3458_Impedance measures - Leg fat-free mass (left)	3458_Impedance measures - Leg fat-free mass (left)	25	93	2	4078	524	2677	4530	539	252	492	93	3081
2034_Primary sclerosing cholangitis	2034_Primary sclerosing cholangitis	25	94	1	94	2779	1378	1684	4385	4079	2589	134	1581
921_Total cholesterol in medium VLDL	921_Total cholesterol in medium VLDL	25	94	1	1066	94	1885	3815	171	3284	2439	307	1028
4070_Ever smoker	4070_Ever smoker	25	94	1	1773	4391	94	3312	1464	2794	899	3173	2012
3758_Anxiety - Recent easy annoyance or irritability	3758_Anxiety - Recent easy annoyance or irritability	25	94	1	357	3384	4688	94	2170	2157	3071	2037	3221
890_Concentration of large HDL particles	890_Concentration of large HDL particles	25	94	1	966	347	690	1334	94	3385	735	232	4096
2159_PLA2G2A - Phospholipase A2, membrane associated	2159_PLA2G2A - Phospholipase A2, membrane associated	25	94	1	2315	3828	2856	393	1038	94	527	4276	653
3113_IMPDH1 - Inosine-5'-monophosphate dehydrogenase 1	3113_IMPDH1 - Inosine-5'-monophosphate dehydrogenase 1	25	94	1	2813	2130	124	3527	3706	4366	1553	2052	94
4143_Diastolic Blood Pressure	4143_Diastolic Blood Pressure	25	95	1	95	1558	1111	2162	3089	2979	2919	3310	1698
2275_CYCS - Cytochrome c	2275_CYCS - Cytochrome c	25	95	1	4475	1460	1743	95	2843	4601	1431	2701	673
888_Free cholesterol in large HDL	888_Free cholesterol in large HDL	25	95	1	1245	724	1420	1985	95	4076	393	264	3607
1404_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for age and sex)	1404_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	96	1	4000	3101	96	1568	3971	3582	4446	889	3494
2889_KYNU - Kynureninase	2889_KYNU - Kynureninase	25	96	1	2080	3670	1701	96	905	1956	611	4567	4441
52_Number of children ever born (male)	52_Number of children ever born (male)	25	96	1	1863	3872	2878	3559	96	2759	283	2365	3440
1858_Neck cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	1858_Neck cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	25	96	1	3074	581	3091	4700	750	2962	2575	96	986
2442_FCGR1A - High affinity immunoglobulin gamma Fc receptor I	2442_FCGR1A - High affinity immunoglobulin gamma Fc receptor I	25	96	1	4212	2565	3603	1832	3310	1065	4364	1037	96
1178_Insomnia	1178_Insomnia	25	97	1	97	3309	3956	1002	3591	3642	870	1223	1052
3311_Other eye problems	3311_Other eye problems	25	97	1	595	97	3424	1313	2070	2079	142	891	129
3032_FAP - Seprase	3032_FAP - Seprase	25	97	1	3187	3487	3691	97	757	4095	2160	4051	190
3300_Frequency of tiredness / lethargy in last 2 weeks	3300_Frequency of tiredness / lethargy in last 2 weeks	25	97	1	4630	607	827	2731	97	1416	1852	918	2570
376_Amino acid::Glutamate metabolism::pyroglutamine*	376_Amino acid::Glutamate metabolism::pyroglutamine*	25	97	1	4386	1132	2976	2820	656	97	544	1919	2626
678_::::X-09108	678_::::X-09108	25	97	1	2952	1097	2049	826	546	1191	97	3908	4262
4152_Relative wall thickness	4152_Relative wall thickness	25	97	1	4673	2050	250	557	148	1932	2534	97	3546
4361_Atrial fibrillation	4361_Atrial fibrillation	25	97	1	993	4253	2364	2788	3660	4705	1865	4165	97
4226_Thyroid preparations	4226_Thyroid preparations	25	98	1	98	1802	2232	1487	4198	4342	223	1828	4731
4386_Epithelial ovarian cancer (Borderline serous and mucinous)	4386_Epithelial ovarian cancer (Borderline serous and mucinous)	25	98	1	1739	98	179	537	2124	2640	4740	3190	4609
2617_KDR - Vascular endothelial growth factor receptor 2	2617_KDR - Vascular endothelial growth factor receptor 2	25	98	1	4341	3567	98	3735	1114	906	1499	2131	3667
3414_Birth weight	3414_Birth weight	25	98	1	3537	2549	3891	98	1449	4475	4597	1831	823
891_Phospholipids in large HDL	891_Phospholipids in large HDL	25	98	1	1572	270	1482	1327	98	4321	1034	266	2360
1604_tPA (at exam 5, FBAT, adjusted for multivariable)	1604_tPA (at exam 5, FBAT, adjusted for multivariable)	25	98	1	2236	1858	203	2134	1033	98	809	2347	2147
1251_Percent predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	1251_Percent predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	25	98	1	1933	4235	2673	1182	3053	2678	2864	98	2889
2858_C3 - Complement C3b	2858_C3 - Complement C3b	25	98	1	587	429	1836	2746	2241	3757	3973	465	98
287_CD4:%Treg(73+)	287_CD4:%Treg(73+)	25	99	1	99	2919	3467	1942	1651	4661	1277	838	1184
768_Peptide::Dipeptide::X-12244--N-acetylcarnosine	768_Peptide::Dipeptide::X-12244--N-acetylcarnosine	25	99	1	2046	99	2448	1753	3866	1317	3036	3853	2812
3052_EPHB6 - Ephrin type-B receptor 6	3052_EPHB6 - Ephrin type-B receptor 6	25	99	1	2329	363	99	3988	231	474	651	1438	1185
1467_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	1467_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	25	99	1	2219	4477	2147	99	4259	1609	1264	3800	679
4665_Superior fronto-occipital fasciculus fractional anisotropy	4665_Superior fronto-occipital fasciculus fractional anisotropy	25	99	1	796	2238	3058	1094	99	1981	1268	1801	4034
1396_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for multivariable)	1396_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for multivariable)	25	99	1	4540	1786	3136	3281	1254	99	4503	856	4569
1811_Very low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1811_Very low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	99	1	4660	2726	2249	663	1085	210	1390	99	135
2946_C3 - C3a anaphylatoxin	2946_C3 - C3a anaphylatoxin	25	99	1	689	2343	4496	3578	2328	1619	1215	1954	99
625_Xenobiotics::Drug::ibuprofen	625_Xenobiotics::Drug::ibuprofen	25	100	1	100	3895	307	3828	951	1010	804	1846	4620
91_Childhood obesity	91_Childhood obesity	25	100	1	169	100	1617	2042	1230	3271	4715	588	1941
4318_Anti-Mullerian hormone	4318_Anti-Mullerian hormone	25	100	1	2749	2154	100	719	2336	2041	2912	1873	271
2687_ETHE1 - Persulfide dioxygenase ETHE1, mitochondrial	2687_ETHE1 - Persulfide dioxygenase ETHE1, mitochondrial	25	100	1	4185	1816	2804	100	1169	276	2425	532	758
4733_Sagittal stratum mode of anisotropy	4733_Sagittal stratum mode of anisotropy	25	100	1	4213	853	4414	2313	1310	100	1488	1368	3990
955_Cholesterol esters in very large HDL	955_Cholesterol esters in very large HDL	25	100	1	354	3943	591	1195	538	1216	100	512	3184
561_Lipid::Medium chain fatty acid::undecanoate (11:0)	561_Lipid::Medium chain fatty acid::undecanoate (11:0)	25	100	1	680	306	3031	4025	2013	2992	3632	100	2531
3638_Illnesses of mother: Heart disease	3638_Illnesses of mother: Heart disease	25	100	1	4405	3465	3673	4472	1003	233	481	3742	100
4266_Asthma (child-onset)	4266_Asthma (child-onset)	25	101	1	101	274	4722	2230	2538	1404	201	3260	2327
3593_Mineral and other dietary supplements: Glucosamine	3593_Mineral and other dietary supplements: Glucosamine	25	101	1	3340	101	4182	2082	3410	3790	1557	2950	3903
3637_Illnesses of father: Prostate cancer	3637_Illnesses of father: Prostate cancer	25	101	1	1877	3458	101	3089	3670	3196	2556	3304	2439
2041_Attention function - Hit reaction time - Child	2041_Attention function - Hit reaction time - Child	25	101	1	1769	1178	3529	2399	101	1449	1055	2537	1920
487_Lipid::Essential fatty acid::dihomo-linolenate (20:3n3 or n6)	487_Lipid::Essential fatty acid::dihomo-linolenate (20:3n3 or n6)	25	101	1	1775	2721	1936	4318	4640	411	101	4398	3491
4037_Autism spectrum disorder	4037_Autism spectrum disorder	25	101	1	2340	519	2854	3639	283	3894	4673	101	4105
2097_CFI - Complement factor I	2097_CFI - Complement factor I	25	101	1	1632	2818	2636	3976	958	2389	3481	4463	101
1513_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	1513_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	25	102	1	3014	102	1747	468	434	1940	3225	259	2703
3978_Lean body mass (appendicular)	3978_Lean body mass (appendicular)	25	102	1	4045	3419	102	2589	3154	1079	1118	104	3853
3845_High light scatter percentage of red cells (two-way meta)	3845_High light scatter percentage of red cells (two-way meta)	25	102	1	4167	4663	2029	102	1435	216	2196	2304	909
782_Amino acid::Amino fatty acid::X-12510--2-aminooctanoic acid	782_Amino acid::Amino fatty acid::X-12510--2-aminooctanoic acid	25	102	1	1594	165	2468	3698	102	4647	1649	703	2622
3187_Standing height	3187_Standing height	25	102	1	2727	898	3676	3286	462	102	560	409	2577
695_::::X-11334	695_::::X-11334	25	102	1	3454	4605	2633	2334	1382	711	102	3750	3333
1613_von Willebrand Factor (at exam 5, GEE, adjusted for multivariable)	1613_von Willebrand Factor (at exam 5, GEE, adjusted for multivariable)	25	102	1	1347	540	513	1229	1007	2554	1153	102	2795
4692_Anterior limb of internal capsule mean diusivities	4692_Anterior limb of internal capsule mean diusivities	25	103	1	103	855	1664	3754	411	1335	2287	3617	1502
3753_Traumatic events - Repeated disturbing thoughts of stressful experience in past month	3753_Traumatic events - Repeated disturbing thoughts of stressful experience in past month	25	103	1	2673	103	1376	511	328	4273	865	582	1047
1557_Mean common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1557_Mean common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	103	1	4452	2618	103	1825	4004	1967	2265	2668	596
937_Total lipids in small LDL	937_Total lipids in small LDL	25	103	1	1826	1041	4380	103	3074	1030	3333	1917	3166
2981_CAPG - Macrophage-capping protein	2981_CAPG - Macrophage-capping protein	25	103	1	2305	1076	494	1531	103	4227	1776	3236	1803
2010_High-density lipoprotein cholesterol	2010_High-density lipoprotein cholesterol	25	103	1	2616	2414	1502	4272	4084	103	3743	4038	2589
1585_D-dimer (at exam 6, GEE, adjusted for multivariable)	1585_D-dimer (at exam 6, GEE, adjusted for multivariable)	25	103	1	1010	2464	605	4018	3150	1458	1358	103	726
751_::::X-12056	751_::::X-12056	25	103	1	4648	3680	4408	3372	3820	3789	2013	3906	103
2741_IL25 - Interleukin-25	2741_IL25 - Interleukin-25	25	104	1	104	565	3052	461	4081	4019	3016	3450	1990
219_Lymph:%CD8	219_Lymph:%CD8	25	104	1	2931	104	3657	3513	654	1226	2226	1815	3894
2462_ABL1 - Tyrosine-protein kinase ABL1	2462_ABL1 - Tyrosine-protein kinase ABL1	25	104	1	1911	776	104	505	4495	2333	4381	743	3543
2036_Cisplatin-associated ototoxicity	2036_Cisplatin-associated ototoxicity	25	104	1	3660	1950	1070	104	2935	4382	2789	4291	647
2183_CRLF2 - Cytokine receptor-like factor 2	2183_CRLF2 - Cytokine receptor-like factor 2	25	104	1	3885	3653	1671	2579	104	288	232	1344	1385
2743_IL6R - Interleukin-6 receptor subunit alpha	2743_IL6R - Interleukin-6 receptor subunit alpha	25	104	1	905	290	394	2729	2357	104	162	2723	3122
3397_Shortness of breath walking on level ground	3397_Shortness of breath walking on level ground	25	104	1	1904	4188	2144	1391	665	302	104	3360	880
4244_Rapid automised naming and rapid alternating stimulus test performance	4244_Rapid automised naming and rapid alternating stimulus test performance	25	104	1	2822	3986	2532	2800	833	2047	1291	2548	104
3678_Diagnoses - main ICD10: M23 Internal derangement of knee	3678_Diagnoses - main ICD10: M23 Internal derangement of knee	25	105	1	863	533	105	1261	2324	2169	4697	1848	2190
3883_Immature fraction of reticulocytes (three-way meta)	3883_Immature fraction of reticulocytes (three-way meta)	25	105	1	4407	3657	1584	105	1702	426	2709	4243	1065
884_Triglycerides in IDL	884_Triglycerides in IDL	25	105	1	3571	154	247	2578	105	4404	1725	951	3751
423_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxovalerate	423_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxovalerate	25	105	1	4269	1897	4296	3473	4215	105	832	3716	1182
1805_PNN50 HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1805_PNN50 HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	105	1	4605	338	3163	4423	3081	3699	194	105	1426
4224_Agents acting on the renin-angiotensin system	4224_Agents acting on the renin-angiotensin system	25	106	1	106	1077	3315	4044	1314	2939	4482	3962	3456
1699_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for age and sex)	1699_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for age and sex)	25	106	1	245	106	4474	1062	606	3730	3573	4370	4344
4054_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	4054_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	106	1	3834	3577	106	1200	1139	613	4188	144	1891
1349_Plasma Apolipoprotein B level (GEE, multivariate adjusted)	1349_Plasma Apolipoprotein B level (GEE, multivariate adjusted)	25	106	1	3948	640	338	106	3522	4544	558	2930	3461
790_::::X-12696	790_::::X-12696	25	106	1	408	866	3639	4639	106	354	2273	203	3473
2960_IGHD  IGK@ IGL@ - Immunoglobulin D	2960_IGHD  IGK@ IGL@ - Immunoglobulin D	25	106	1	410	659	328	3729	3277	106	3858	1316	520
3178_SLAMF7 - SLAM family member 7	3178_SLAMF7 - SLAM family member 7	25	106	1	168	1136	701	1259	810	2937	106	2561	3208
3823_Systemic Lupus Erythematosus	3823_Systemic Lupus Erythematosus	25	106	1	226	1592	195	852	1031	3465	589	106	438
2984_CTSZ - Cathepsin Z	2984_CTSZ - Cathepsin Z	25	106	1	1296	2336	176	1835	4227	4026	3455	1842	106
407_Amino acid::Tryptophan metabolism::kynurenine	407_Amino acid::Tryptophan metabolism::kynurenine	25	107	1	1398	107	2400	1246	1865	1463	653	4703	2069
2131_IL2RG - Cytokine receptor common subunit gamma	2131_IL2RG - Cytokine receptor common subunit gamma	25	107	1	2367	2805	107	4719	3712	564	2206	3558	1735
2567_CPB2 - Carboxypeptidase B2	2567_CPB2 - Carboxypeptidase B2	25	107	1	1122	2817	3437	107	2993	4146	1765	4475	3457
3734_Depression - Duration of worst depression	3734_Depression - Duration of worst depression	25	107	1	682	849	1796	2138	107	234	1645	1624	3099
2081_IL12A IL12B - Interleukin-12	2081_IL12A IL12B - Interleukin-12	25	107	1	1786	1086	1000	4452	4248	107	4197	1152	186
1646_P-selectin (at exam 7, FBAT, adjusted for age and sex)	1646_P-selectin (at exam 7, FBAT, adjusted for age and sex)	25	107	1	1682	3132	1426	1011	941	3386	107	2657	3803
869_OmegaL7 and L9 and saturated fatty acids	869_OmegaL7 and L9 and saturated fatty acids	25	107	1	2804	874	4202	2797	1654	4222	3284	107	816
12_Schizophrenia/Bipolar disorder	12_Schizophrenia/Bipolar disorder	25	107	1	2848	3681	4398	4176	3821	4256	2698	837	107
3984_Heart rate increase	3984_Heart rate increase	25	108	1	108	3650	3697	3686	882	1340	2296	195	1815
923_Free cholesterol in medium VLDL	923_Free cholesterol in medium VLDL	25	108	1	881	108	2573	3747	244	4603	2484	275	669
471_Lipid::Bile acid metabolism::taurocholate	471_Lipid::Bile acid metabolism::taurocholate	25	108	1	4347	3779	108	3762	3338	949	4171	1330	280
916_Total cholesterol in medium LDL	916_Total cholesterol in medium LDL	25	108	1	3079	1724	4152	108	4191	3264	2338	4198	1382
2632_CKB CKM - Creatine kinase M-type:Creatine kinase B-type heterodimer	2632_CKB CKM - Creatine kinase M-type:Creatine kinase B-type heterodimer	25	108	1	3667	408	2410	2320	4251	108	1909	804	4053
2203_IL17F - Interleukin-17F	2203_IL17F - Interleukin-17F	25	108	1	4058	2593	298	1098	2860	311	108	2942	2262
2770_AKR1A1 - Alcohol dehydrogenase [NADP(+)]	2770_AKR1A1 - Alcohol dehydrogenase [NADP(+)]	25	108	1	1436	4545	3661	2805	568	220	989	2176	108
2580_BMP10 - Bone morphogenetic protein 10	2580_BMP10 - Bone morphogenetic protein 10	25	109	1	109	1429	3162	2708	4213	3240	2964	3228	2322
3034_SPTAN1 - Spectrin alpha chain, non-erythrocytic 1	3034_SPTAN1 - Spectrin alpha chain, non-erythrocytic 1	25	109	1	3951	109	445	2827	315	2677	2636	1456	916
1521_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	1521_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	25	109	1	1958	2009	109	930	3403	951	336	1271	1094
2956_GOT1 - Aspartate aminotransferase, cytoplasmic	2956_GOT1 - Aspartate aminotransferase, cytoplasmic	25	109	1	3839	2545	3187	109	3342	2197	4359	2978	4256
1640_Myeloperoxidase (at exam 7, FBAT, adjusted for multivariable)	1640_Myeloperoxidase (at exam 7, FBAT, adjusted for multivariable)	25	109	1	2767	1692	4597	1745	109	910	1423	155	3168
3199_Distance between home and job workplace	3199_Distance between home and job workplace	25	109	1	3765	2284	3822	1640	3022	109	3585	4618	2628
1406_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for multivariable)	1406_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for multivariable)	25	109	1	3480	3031	2172	1448	2699	270	1139	1431	109
576_Lipid::Sterol, Steroid::dehydroisoandrosterone sulfate (DHEA-S)	576_Lipid::Sterol, Steroid::dehydroisoandrosterone sulfate (DHEA-S)	25	110	1	110	3511	1998	531	1423	2061	1169	1098	1041
904_Triglycerides in large VLDL	904_Triglycerides in large VLDL	25	110	1	348	110	4539	3638	423	3658	4519	256	331
131_Hip circumference (female, adjusted for BMI)	131_Hip circumference (female, adjusted for BMI)	25	110	1	2216	2225	2863	110	1989	3030	3207	1487	488
1196_Asthma (female)	1196_Asthma (female)	25	110	1	4743	1247	506	4253	110	2338	114	197	1867
1309_Fasting HbA1c (at exam 5, GEE, adjusted for age and sex)	1309_Fasting HbA1c (at exam 5, GEE, adjusted for age and sex)	25	110	1	2440	313	3191	2745	276	110	1543	282	4174
961_Total lipids in very large VLDL	961_Total lipids in very large VLDL	25	110	1	2250	1383	1501	2959	666	4372	4193	590	110
3017_AK1 - Adenylate kinase isoenzyme 1	3017_AK1 - Adenylate kinase isoenzyme 1	25	111	1	111	3720	3345	1665	1998	3732	3293	3787	3123
1927_Lateral ventricular volume (GEE, adjusted for age and sex)	1927_Lateral ventricular volume (GEE, adjusted for age and sex)	25	111	1	3853	1735	111	1203	1088	113	135	2193	169
120_Obesity class 1	120_Obesity class 1	25	111	1	363	3684	4020	111	3726	2007	2752	4693	4582
3677_Diagnoses - main ICD10: M17 Osteoarthritis of knee	3677_Diagnoses - main ICD10: M17 Osteoarthritis of knee	25	111	1	4272	573	4054	1157	111	261	952	2435	117
4454_Left lateral orbitofrontal	4454_Left lateral orbitofrontal	25	111	1	4677	1752	2771	3490	117	2268	1087	111	788
3631_Illnesses of father: Bowel cancer	3631_Illnesses of father: Bowel cancer	25	111	1	403	478	3732	3029	4321	3910	2659	3508	111
3927_Total-body lean mass	3927_Total-body lean mass	25	112	1	112	4316	1109	2981	2541	3211	3038	4074	3911
4741_Corticospinal tract radial diusivities	4741_Corticospinal tract radial diusivities	25	112	1	4046	112	2214	2495	1904	565	2527	979	1252
2698_SBDS - Ribosome maturation protein SBDS	2698_SBDS - Ribosome maturation protein SBDS	25	112	1	4259	325	112	1731	3431	3469	2644	4404	453
3813_CD4+ T cell level	3813_CD4+ T cell level	25	112	1	1196	1650	980	112	1736	1793	143	1087	477
2033_Cluster headache	2033_Cluster headache	25	112	1	3990	1229	3803	4329	112	1559	1917	688	262
1150_Corrected insulin response (adjusted for insulin sensitivity index)	1150_Corrected insulin response (adjusted for insulin sensitivity index)	25	112	1	2026	1252	4269	432	4194	112	2198	3763	2239
4513_CSF	4513_CSF	25	112	1	2208	635	1292	2837	4603	2391	3307	112	2169
2672_MAPKAPK2 - MAP kinase-activated protein kinase 2	2672_MAPKAPK2 - MAP kinase-activated protein kinase 2	25	112	1	4182	4359	4266	1850	3804	4719	2983	2591	112
2795_PFDN5 - Prefoldin subunit 5	2795_PFDN5 - Prefoldin subunit 5	25	113	1	113	1891	705	3763	4054	2477	3094	2956	244
564_Lipid::Monoacylglycerol::1-palmitoylglycerol (1-monopalmitin)	564_Lipid::Monoacylglycerol::1-palmitoylglycerol (1-monopalmitin)	25	113	1	4352	113	3378	4252	4196	330	3384	4286	2684
3904_White blood cell count (three-way meta)	3904_White blood cell count (three-way meta)	25	113	1	460	1757	113	598	2658	515	618	658	666
245_CD34 on Stem	245_CD34 on Stem	25	113	1	994	736	2832	113	3881	3818	3129	2153	727
1281_Sagittal diameter by CT (GEE, adjusted for age and sex)	1281_Sagittal diameter by CT (GEE, adjusted for age and sex)	25	113	1	4202	234	3879	2386	657	810	2288	113	4222
72_Triglycerides cholesterol	72_Triglycerides cholesterol	25	113	1	2868	719	2596	3185	1155	1571	3749	563	113
4208_Blood urea nitrogen	4208_Blood urea nitrogen	25	114	1	114	492	1371	2011	2151	854	825	1843	3799
803_::::X-12786	803_::::X-12786	25	114	1	4264	114	1874	2264	3263	1294	1864	604	636
2141_GDI2 - Rab GDP dissociation inhibitor beta	2141_GDI2 - Rab GDP dissociation inhibitor beta	25	114	1	3637	3406	114	4379	2685	4407	4415	1992	1346
2834_CHST2 - Carbohydrate sulfotransferase 2	2834_CHST2 - Carbohydrate sulfotransferase 2	25	114	1	630	1094	4560	114	354	268	592	3799	4738
941_Total lipids in small VLDL	941_Total lipids in small VLDL	25	114	1	771	202	2309	4653	114	1950	3504	466	1289
2211_PPBP - Neutrophil-activating peptide 2	2211_PPBP - Neutrophil-activating peptide 2	25	114	1	1901	1867	744	1973	323	114	635	1962	1195
1453_Low-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	1453_Low-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	25	114	1	3775	4234	3702	1019	3876	4552	4388	114	3830
4029_Alcohol dependency (random effect model for unrelated genotyped individuals)	4029_Alcohol dependency (random effect model for unrelated genotyped individuals)	25	114	1	3522	4033	3706	3620	998	907	2655	1965	114
1227_Life span	1227_Life span	25	115	1	1208	4045	115	3066	3092	3610	3494	3737	570
132_Waist circumference (male)	132_Waist circumference (male)	25	115	1	1027	3963	222	115	4600	3228	1789	3690	2631
4184_Total cholesterol	4184_Total cholesterol	25	115	1	1782	269	1930	528	115	2806	3587	1161	734
1671_Bilirubin (at exam 2, GEE, adjusted for age and sex)	1671_Bilirubin (at exam 2, GEE, adjusted for age and sex)	25	115	1	3083	2114	2531	2794	1990	115	670	2103	1114
2677_PAK6 - Serine/threonine-protein kinase PAK 6	2677_PAK6 - Serine/threonine-protein kinase PAK 6	25	115	1	1435	970	528	3695	858	131	115	3589	3295
4187_HbA1c	4187_HbA1c	25	115	1	3720	958	703	961	3133	606	507	115	1049
1728_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for multivariable)	1728_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for multivariable)	25	115	1	3511	830	1130	4397	741	3057	698	3848	115
1928_Temporal horn volume (FBAT, adjusted for age and sex)	1928_Temporal horn volume (FBAT, adjusted for age and sex)	25	116	1	116	2361	3711	2971	1951	3043	3572	707	3956
1499_Triglycerides (at exam 1, GEE, adjusted for age and sex)	1499_Triglycerides (at exam 1, GEE, adjusted for age and sex)	25	116	1	1657	116	1767	1904	1233	617	3866	361	4136
26_Agression	26_Agression	25	116	1	4116	3255	116	1817	1703	4409	3996	806	2432
1394_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for age and sex)	1394_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	116	1	879	1576	2216	116	3103	4432	1464	3221	921
3680_Diagnoses - main ICD10: N39 Other disorders of urinary system	3680_Diagnoses - main ICD10: N39 Other disorders of urinary system	25	116	1	2364	2901	1080	1366	116	1165	425	847	1007
4624_Left putamen	4624_Left putamen	25	116	1	2025	3412	2557	637	2012	116	938	4068	469
2995_FCAR - Immunoglobulin alpha Fc receptor	2995_FCAR - Immunoglobulin alpha Fc receptor	25	116	1	4295	1019	849	3704	797	158	116	1584	218
3343_Age at first live birth (female)	3343_Age at first live birth (female)	25	116	1	866	2932	4588	751	4673	2022	3156	116	1897
641_Xenobiotics::Xanthine metabolism::1,7-dimethylurate	641_Xenobiotics::Xanthine metabolism::1,7-dimethylurate	25	116	1	2500	3268	128	4149	281	3743	1605	1580	116
31_Conscientiousness (NEO-FFI)	31_Conscientiousness (NEO-FFI)	25	117	1	117	1984	2389	4736	1659	4448	4709	4408	2037
4400_Menstruation quality of life impact: Edema	4400_Menstruation quality of life impact: Edema	25	117	1	3969	117	1174	2453	228	2111	1705	3157	3146
3470_Impedance measures - Trunk fat-free mass	3470_Impedance measures - Trunk fat-free mass	25	117	1	3604	1304	2509	1646	2506	117	2657	457	1352
4614_CSF	4614_CSF	25	117	1	4715	1833	296	3087	4233	4622	2312	117	581
519_Lipid::Long chain fatty acid::eicosenoate (20:1n9 or 11)	519_Lipid::Long chain fatty acid::eicosenoate (20:1n9 or 11)	25	118	1	118	4086	4710	3157	4634	2500	2350	4295	1837
1489_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for multivariable)	1489_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for multivariable)	25	118	1	1745	118	1551	687	2458	3701	896	4471	4160
4429_Cytomegalovirus seropositivity	4429_Cytomegalovirus seropositivity	25	118	1	3545	2267	118	3188	892	3984	2158	691	4181
618_Xenobiotics::Benzoate metabolism::hippurate	618_Xenobiotics::Benzoate metabolism::hippurate	25	118	1	1513	2122	4521	118	2672	1405	3053	3485	1728
2178_NCR2 - Natural cytotoxicity triggering receptor 2	2178_NCR2 - Natural cytotoxicity triggering receptor 2	25	118	1	4195	2541	4227	1634	118	160	582	1224	3419
1686_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for age and sex)	1686_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for age and sex)	25	118	1	1016	2115	3001	1844	2409	1798	4262	118	943
2933_BMPR2 - Bone morphogenetic protein receptor type-2	2933_BMPR2 - Bone morphogenetic protein receptor type-2	25	118	1	2600	1356	2104	3262	988	852	121	3551	118
1123_Subcutaneous adipose tissue attenuation	1123_Subcutaneous adipose tissue attenuation	25	119	1	119	3903	3086	1607	1844	1417	985	1854	3300
202_Estimated glomerular filtration rate based on cystain C	202_Estimated glomerular filtration rate based on cystain C	25	119	1	4589	4094	119	3894	1265	4598	3594	4561	3535
895_Total lipids in large LDL	895_Total lipids in large LDL	25	119	1	2885	3262	3999	119	4327	1866	2586	4049	1542
1389_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	1389_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	25	119	1	768	4090	1814	3109	2363	164	119	3021	3346
1425_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1425_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	119	1	3088	4156	1233	1211	2857	2752	4440	119	4002
3206_Number of days/week of moderate physical activity 10+ minutes	3206_Number of days/week of moderate physical activity 10+ minutes	25	119	1	606	3956	3855	1382	2863	3252	515	919	119
1828_Spine Neck BMD (FBAT, male, adjusted for multivariable)	1828_Spine Neck BMD (FBAT, male, adjusted for multivariable)	25	120	1	120	1201	3930	1956	3610	3901	4660	705	970
2443_FCN2 - Ficolin-2	2443_FCN2 - Ficolin-2	25	120	1	3161	120	2431	4193	1527	1173	4383	780	3042
2312_JAM2 - Junctional adhesion molecule B	2312_JAM2 - Junctional adhesion molecule B	25	120	1	3518	309	120	960	585	589	3847	2929	3283
3436_Weight	3436_Weight	25	120	1	2579	1078	3512	120	1220	2792	282	4340	4139
2524_HIPK3 - Homeodomain-interacting protein kinase 3	2524_HIPK3 - Homeodomain-interacting protein kinase 3	25	120	1	2411	4468	4089	1726	120	1004	783	2098	869
3319_Wheeze or whistling in the chest in last year	3319_Wheeze or whistling in the chest in last year	25	120	1	1078	1620	2362	4267	3658	1243	120	4491	3818
2872_PRSS22 - Brain-specific serine protease 4	2872_PRSS22 - Brain-specific serine protease 4	25	120	1	3751	1485	447	3810	3600	2925	1885	120	2423
4414_Total IgA levels	4414_Total IgA levels	25	120	1	3308	3120	2516	4313	3147	1326	3647	4633	120
3880_Hemoglobin concentration (three-way meta)	3880_Hemoglobin concentration (three-way meta)	25	121	1	121	4082	3724	3503	2981	141	2437	2858	1745
3502_Male-specific factors - Hair/balding pattern: Pattern 3	3502_Male-specific factors - Hair/balding pattern: Pattern 3	25	121	1	297	180	121	2653	1438	2039	3952	196	2596
2022_Fibrotic idiopathic interstitial pneumonias	2022_Fibrotic idiopathic interstitial pneumonias	25	121	1	838	965	300	678	463	121	1033	1032	367
929_Other polyunsaturated fatty acids than 18:2	929_Other polyunsaturated fatty acids than 18:2	25	121	1	122	3135	3664	643	2135	2024	3777	121	3199
733_::::X-11818	733_::::X-11818	25	121	1	4241	4733	2850	377	1995	771	1459	3506	121
4033_Alcohol dependency (unrelated genotyped individuals)	4033_Alcohol dependency (unrelated genotyped individuals)	25	122	1	1706	122	3634	4703	3682	562	1822	3897	688
4302_Arms-arm fat ratio (female)	4302_Arms-arm fat ratio (female)	25	122	1	3218	1621	122	2052	1297	1817	1369	971	2764
4003_Juvenile idiopathic arthritis with vs without uveitis	4003_Juvenile idiopathic arthritis with vs without uveitis	25	122	1	1893	1528	3948	122	2592	1520	4684	2704	1447
4083_Type 2 Diabetes	4083_Type 2 Diabetes	25	122	1	2294	801	1462	3430	122	2950	514	3125	3013
4036_Alcohol dependency (unrelated genotyped individuals)	4036_Alcohol dependency (unrelated genotyped individuals)	25	122	1	1134	4336	1513	2544	1695	122	2041	4187	3323
2610_OLR1 - Oxidized low-density lipoprotein receptor 1	2610_OLR1 - Oxidized low-density lipoprotein receptor 1	25	122	1	1772	258	2517	1992	2372	3708	4606	899	122
1483_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for age and sex)	1483_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for age and sex)	25	123	1	123	3820	2575	1617	4077	2617	4312	879	2982
2000_Weight	2000_Weight	25	123	1	3638	123	1092	3133	1892	4602	1680	2744	277
1353_Plasma Apolipoprotein C3 level (GEE, multivariate adjusted)	1353_Plasma Apolipoprotein C3 level (GEE, multivariate adjusted)	25	123	1	1201	1695	123	1231	2125	3463	2409	3417	2039
897_Phospholipids in large LDL	897_Phospholipids in large LDL	25	123	1	2447	4264	4128	123	4691	1218	2337	4148	1911
3118_MAP2K4 - Dual specificity mitogen-activated protein kinase kinase 4	3118_MAP2K4 - Dual specificity mitogen-activated protein kinase kinase 4	25	123	1	1020	2996	2308	394	123	3085	275	2735	2238
4558_Left middle temporal	4558_Left middle temporal	25	123	1	172	4231	340	2801	2322	123	914	4201	2004
2197_HPX - Hemopexin	2197_HPX - Hemopexin	25	123	1	2722	3396	2674	905	400	251	720	123	2749
2821_NGF - beta-nerve growth factor	2821_NGF - beta-nerve growth factor	25	123	1	2063	289	1889	2957	3678	1384	355	2597	123
1701_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for multivariable)	1701_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for multivariable)	25	124	1	124	210	3279	1828	138	3508	1344	3004	4168
1763_Prostate cancer (GEE, adjusted for age)	1763_Prostate cancer (GEE, adjusted for age)	25	124	1	1864	124	2297	1776	1914	3683	4084	4288	3341
4147_Posterior wall thickness	4147_Posterior wall thickness	25	124	1	4379	913	4541	1122	124	4609	2526	1115	754
183_Waist-hip ratio (female)	183_Waist-hip ratio (female)	25	124	1	3894	3042	3780	1394	3870	124	2722	1553	1971
1016_Femoral BMD (FBAT, adjusted for multivariable)	1016_Femoral BMD (FBAT, adjusted for multivariable)	25	124	1	1635	1331	615	1447	3657	2429	124	515	3762
2307_IFNG - Interferon gamma	2307_IFNG - Interferon gamma	25	124	1	4493	3733	2190	4262	4447	973	3276	2303	124
3111_PDK1 - [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	3111_PDK1 - [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	25	125	1	125	1848	563	4362	2797	4504	3932	928	1644
2792_PA2G4 - Proliferation-associated protein 2G4	2792_PA2G4 - Proliferation-associated protein 2G4	25	125	1	4190	2540	125	3472	1208	4027	3386	2653	2193
4243_Rapid automised naming of objects	4243_Rapid automised naming of objects	25	125	1	3275	4613	2258	3573	125	1121	437	2367	2412
2119_ERBB3 - Receptor tyrosine-protein kinase erbB-3	2119_ERBB3 - Receptor tyrosine-protein kinase erbB-3	25	125	1	2231	3140	1143	369	1037	125	3193	2656	1307
1061_Multiple Sclerosis	1061_Multiple Sclerosis	25	125	1	626	1846	4638	150	1323	1285	1272	125	1275
3133_CALR - Calreticulin	3133_CALR - Calreticulin	25	125	1	641	3312	4644	2972	2343	569	2994	3399	125
1376_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	1376_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	25	126	1	126	4338	2676	1582	4326	2370	3695	833	4643
348_CD8:%R5+	348_CD8:%R5+	25	126	1	3688	126	1892	1627	3773	3434	2804	3403	3158
1422_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1422_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	126	1	252	4414	126	3411	1635	1695	1794	2237	4229
203_Chronic kidney disease	203_Chronic kidney disease	25	126	1	3576	1408	3002	973	126	2834	170	2743	1451
3192_Length of time at current address	3192_Length of time at current address	25	126	1	2244	995	4619	3148	4270	126	983	1386	396
1584_D-dimer (at exam 6, FBAT, adjusted for multivariable)	1584_D-dimer (at exam 6, FBAT, adjusted for multivariable)	25	126	1	1319	1638	2807	4417	1276	1860	126	1407	254
1026_Femoral Neck Length (FBAT, adjusted for multivariable)	1026_Femoral Neck Length (FBAT, adjusted for multivariable)	25	126	1	4539	1280	4270	3874	2347	3608	4721	126	671
2397_GP6 - Platelet glycoprotein VI	2397_GP6 - Platelet glycoprotein VI	25	126	1	830	1622	2343	2184	2425	3184	2024	1913	126
766_::::X-12231	766_::::X-12231	25	127	1	127	762	1578	2606	1723	3853	505	408	3579
495_Lipid::Fatty acid metabolism (also BCAA metabolism)::propionylcarnitine	495_Lipid::Fatty acid metabolism (also BCAA metabolism)::propionylcarnitine	25	127	1	3983	817	127	173	256	650	2066	3492	3141
1933_Parietal brain volume (GEE, adjusted for age and sex)	1933_Parietal brain volume (GEE, adjusted for age and sex)	25	127	1	4331	2909	4395	127	3898	191	3958	1445	3926
1259_Residual from predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	1259_Residual from predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	25	127	1	868	4402	4531	2302	1911	127	2760	646	4108
2951_FGA FGB FGG - D-dimer	2951_FGA FGB FGG - D-dimer	25	128	1	128	3026	653	4296	4626	979	3768	3079	3806
129_Hip circumference (female)	129_Hip circumference (female)	25	128	1	1545	2100	3144	1052	970	128	3813	4126	406
263_DNT:%CD127+TEF	263_DNT:%CD127+TEF	25	128	1	4337	1312	2690	2283	3576	1498	2264	4058	128
121_Obesity class 2	121_Obesity class 2	25	129	1	129	1918	1941	3621	3621	1245	2646	3647	1535
506_Lipid::Glycerolipid metabolism::choline	506_Lipid::Glycerolipid metabolism::choline	25	129	1	178	129	3461	2221	1530	2049	3971	277	4242
3114_HMGCR - 3-hydroxy-3-methylglutaryl-coenzyme A reductase	3114_HMGCR - 3-hydroxy-3-methylglutaryl-coenzyme A reductase	25	129	1	3006	3043	129	2131	1059	138	1814	2786	2077
2377_IDUA - alpha-L-iduronidase	2377_IDUA - alpha-L-iduronidase	25	129	1	2227	1964	2886	129	551	1728	2770	620	1465
877_HDL diameter	877_HDL diameter	25	129	1	578	820	602	3580	129	4675	214	377	4501
2827_IFNL1 - Interferon lambda-1	2827_IFNL1 - Interferon lambda-1	25	129	1	4710	1965	2779	2081	3194	2496	129	4183	4046
1570_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1570_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	129	1	3677	2403	1139	3413	4076	3965	2944	129	4744
1469_Lipoprotein A (at exam 3, GEE, adjusted for multivariable)	1469_Lipoprotein A (at exam 3, GEE, adjusted for multivariable)	25	130	1	130	3909	2638	1693	2450	2394	1598	4622	2456
3696_Diagnoses - secondary ICD10: K21 Gastro-esophageal reflux disease	3696_Diagnoses - secondary ICD10: K21 Gastro-esophageal reflux disease	25	130	1	676	130	698	2501	994	3115	2054	1719	3052
2133_LTBR - Tumor necrosis factor receptor superfamily member 3	2133_LTBR - Tumor necrosis factor receptor superfamily member 3	25	130	1	2137	1957	130	3354	1152	2952	1090	4500	2493
2890_BIRC7 - Baculoviral IAP repeat-containing protein 7 Isoform beta	2890_BIRC7 - Baculoviral IAP repeat-containing protein 7 Isoform beta	25	130	1	2773	3835	1876	130	2656	2155	1197	4611	1492
4399_Menstruation quality of life impact: Depression	4399_Menstruation quality of life impact: Depression	25	130	1	1086	2625	4013	2775	134	171	130	1514	3002
1307_Insulin sensitivity (GEE, adjusted for age and sex)	1307_Insulin sensitivity (GEE, adjusted for age and sex)	25	130	1	3500	4709	3489	1695	1468	920	216	130	318
3694_Diagnoses - secondary ICD10: I48 Atrial fibrillation and flutter	3694_Diagnoses - secondary ICD10: I48 Atrial fibrillation and flutter	25	130	1	1234	4734	2494	3759	2316	4687	2818	3380	130
3819_Multiple Sclerosis	3819_Multiple Sclerosis	25	131	1	131	1947	4714	4206	4114	3130	1317	1069	3504
2098_IGFBP2 - Insulin-like growth factor-binding protein 2	2098_IGFBP2 - Insulin-like growth factor-binding protein 2	25	131	1	2450	131	769	1943	1689	2406	845	2319	3059
3505_Non-butter spread type details: Soft (tub) margarine	3505_Non-butter spread type details: Soft (tub) margarine	25	131	1	4517	3873	131	4107	3059	1083	1093	4140	4020
4499_Right rostral anterior cingulate	4499_Right rostral anterior cingulate	25	131	1	4059	266	2053	131	4576	2766	3264	579	1258
1705_Follicle stimulating hormone (at exam 3, GEE, adjusted for multivariable)	1705_Follicle stimulating hormone (at exam 3, GEE, adjusted for multivariable)	25	131	1	3466	4163	2261	921	2585	4142	1956	2291	131
2262_CTF1 - Cardiotrophin-1	2262_CTF1 - Cardiotrophin-1	25	132	1	132	967	3975	3558	719	3351	724	2428	1628
1660_Alkaline phosphatase (at exam 2, FBAT, adjusted for multivariable)	1660_Alkaline phosphatase (at exam 2, FBAT, adjusted for multivariable)	25	132	1	3314	1606	132	1495	1843	225	1619	2061	1082
3289_Nervous feelings	3289_Nervous feelings	25	132	1	770	400	3950	132	2628	833	3669	3985	2278
4322_Depressive symptoms (univariate)	4322_Depressive symptoms (univariate)	25	132	1	1903	2704	4385	1405	2785	132	3310	2624	597
1607_Viscosity I (at exam 5, GEE, adjusted for age and sex)	1607_Viscosity I (at exam 5, GEE, adjusted for age and sex)	25	132	1	3714	204	3229	2743	4244	1330	1046	132	1115
2800_RAN - GTP-binding nuclear protein Ran	2800_RAN - GTP-binding nuclear protein Ran	25	133	1	133	4157	3112	3772	3632	3930	286	4167	1721
2627_IGHG1 IGHG2 IGHG3 IGHG4 IGK@ IGL@ - Immunoglobulin G	2627_IGHG1 IGHG2 IGHG3 IGHG4 IGK@ IGL@ - Immunoglobulin G	25	133	1	3183	133	4571	2608	2636	538	3317	528	4364
832_::::X-14086	832_::::X-14086	25	133	1	1064	2143	997	2977	133	1927	640	849	1143
1352_Plasma Apolipoprotein C3 level (FBAT, multivariate adjusted)	1352_Plasma Apolipoprotein C3 level (FBAT, multivariate adjusted)	25	133	1	3110	3368	2872	4143	239	133	1103	2484	2019
4428_Epstein Barr Virus antigen VCA seropositivity	4428_Epstein Barr Virus antigen VCA seropositivity	25	133	1	4671	1101	2513	901	808	377	1719	4274	133
1100_Diastolic Blood Pressure - Birth cohorts	1100_Diastolic Blood Pressure - Birth cohorts	25	134	1	760	134	4394	2147	776	4326	1686	4708	2831
930_Phosphatidylcholine and other cholines	930_Phosphatidylcholine and other cholines	25	134	1	1950	863	134	4231	520	3752	1189	3572	4068
2793_PON1 - Serum paraoxonase/arylesterase 1	2793_PON1 - Serum paraoxonase/arylesterase 1	25	134	1	516	4119	3401	134	541	1628	366	1960	760
1141_Chronotype	1141_Chronotype	25	134	1	4436	3344	4062	3296	820	134	2039	2469	4679
3468_Impedance measures - Trunk fat percentage	3468_Impedance measures - Trunk fat percentage	25	135	1	184	4651	135	309	3346	4161	4369	2292	3982
2367_AURKA - Aurora kinase A	2367_AURKA - Aurora kinase A	25	135	1	4445	4480	2801	135	4103	1476	4643	415	1774
2625_MSR1 - Macrophage scavenger receptor types I and II	2625_MSR1 - Macrophage scavenger receptor types I and II	25	135	1	3153	1506	2859	1035	135	3693	1515	906	4657
4578_Right caudal middle frontal	4578_Right caudal middle frontal	25	135	1	4415	4411	3530	4055	518	135	530	1530	1763
1062_Psoriasis	1062_Psoriasis	25	135	1	2867	369	818	2486	1298	3162	384	135	3299
1070_Familial Parkinson Disease	1070_Familial Parkinson Disease	25	136	1	136	375	4310	1647	1434	4257	2592	3442	1076
943_Phospholipids in small VLDL	943_Phospholipids in small VLDL	25	136	1	500	136	2772	4098	178	3997	2591	363	996
2300_EDAR - Tumor necrosis factor receptor superfamily member EDAR	2300_EDAR - Tumor necrosis factor receptor superfamily member EDAR	25	136	1	588	2377	136	2417	2550	3227	2214	2734	622
1066_Multiple Sclerosis	1066_Multiple Sclerosis	25	136	1	2615	3655	2622	4345	271	1503	136	178	2857
4641_Right accumbens area	4641_Right accumbens area	25	136	1	555	3212	326	358	4086	3378	4048	136	2948
4221_Diuretics	4221_Diuretics	25	137	1	137	1146	2223	4100	1618	1415	3570	2174	278
1238_Rate of decline FEF25-75 (FBAT, adjusted for multiple covariates)	1238_Rate of decline FEF25-75 (FBAT, adjusted for multiple covariates)	25	137	1	1842	137	2070	199	145	4345	4024	250	3396
1778_Heart failure (censored at interval MI, FBAT, adjusted for multivariable)	1778_Heart failure (censored at interval MI, FBAT, adjusted for multivariable)	25	137	1	2906	2758	1627	137	1519	678	2429	668	539
660_::::X-04495	660_::::X-04495	25	137	1	4569	1211	2035	1783	3618	137	1868	3550	1685
4327_Well-being spectrum	4327_Well-being spectrum	25	137	1	2520	2419	1470	259	2269	1019	2836	3397	137
626_Xenobiotics::Drug::metoprolol acid metabolite*	626_Xenobiotics::Drug::metoprolol acid metabolite*	25	138	1	138	2765	2137	3345	2834	952	2609	1779	2633
2866_KNG1 - Kininogen-1	2866_KNG1 - Kininogen-1	25	138	1	1605	1856	138	2235	1242	1068	1227	3639	2281
1623_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for age and sex)	1623_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for age and sex)	25	138	1	3310	3521	2251	138	3000	1239	3269	1147	467
3870_Basophil percentage of white cells (three-way meta)	3870_Basophil percentage of white cells (three-way meta)	25	139	1	3609	139	3605	2640	2121	584	1085	3605	361
3500_Male-specific factors - Hair/balding pattern: Pattern 1	3500_Male-specific factors - Hair/balding pattern: Pattern 1	25	139	1	473	658	139	2137	2303	2734	3874	4213	1442
967_Phospholipids in very small VLDL	967_Phospholipids in very small VLDL	25	139	1	665	1115	2515	139	1815	2737	3933	3555	3067
21_Age of smoking initiation	21_Age of smoking initiation	25	139	1	1333	3802	3099	3270	933	1581	139	1475	1168
3559_Medication for pain relief, constipation, heartburn: Paracetamol	3559_Medication for pain relief, constipation, heartburn: Paracetamol	25	140	1	140	4271	4366	2963	2257	4013	4566	3247	4159
964_Triglycerides in very large VLDL	964_Triglycerides in very large VLDL	25	140	1	497	140	4582	3065	498	3173	4363	296	155
3884_Lymphocyte count (three-way meta)	3884_Lymphocyte count (three-way meta)	25	140	1	206	1516	761	140	738	2127	3943	414	819
4087_Neuroticism	4087_Neuroticism	24	140	1	1510	261	1448	4012	140	1671	490	430	334
3188_Pulse rate (automated reading)	3188_Pulse rate (automated reading)	25	140	1	144	2160	3740	1412	1826	140	888	4044	1787
3844_Hemoglobin concentration (two-way meta)	3844_Hemoglobin concentration (two-way meta)	25	141	1	141	3999	3805	3593	4425	556	1256	2369	2218
3581_Types of transport used (excluding work): Car/motor vehicle	3581_Types of transport used (excluding work): Car/motor vehicle	25	141	1	3973	141	1005	4568	2404	1349	1632	4320	1743
3227_Usual side of head for mobile phone use	3227_Usual side of head for mobile phone use	25	141	1	3038	3737	141	3358	2483	4082	637	4600	4098
3079_NRCAM - Neuronal cell adhesion molecule	3079_NRCAM - Neuronal cell adhesion molecule	25	141	1	1034	3971	4510	141	4687	3647	4273	1383	4370
681_::::X-10346	681_::::X-10346	25	141	1	4042	2774	4558	3410	141	2709	1427	1376	220
4635_Right thalamus proper	4635_Right thalamus proper	25	141	1	4535	2047	4031	3752	240	429	141	661	2556
575_Lipid::Sterol, Steroid::cortisone	575_Lipid::Sterol, Steroid::cortisone	25	142	1	3417	142	4252	1924	1264	2686	993	3303	644
2388_CTSS - Cathepsin S	2388_CTSS - Cathepsin S	25	142	1	2929	2433	142	3876	1227	1631	2536	4319	3465
3460_Impedance measures - Arm fat percentage (right)	3460_Impedance measures - Arm fat percentage (right)	25	142	1	1777	4201	209	142	3367	2991	4465	2979	4577
206_Serum Urate	206_Serum Urate	25	142	1	1613	1860	2817	2599	4466	142	3448	4225	591
2052_Age-related Macular Degeneration	2052_Age-related Macular Degeneration	25	143	1	4411	143	3857	2354	3325	638	2037	1458	2551
3274_Ease of skin tanning	3274_Ease of skin tanning	25	143	1	4638	2688	1201	143	3571	1039	1683	723	3549
2250_KPNA2 - Importin subunit alpha-1	2250_KPNA2 - Importin subunit alpha-1	25	143	1	3748	4124	3996	3263	143	4449	180	3963	3213
1237_Usual weekday sleep duration (GEE, adjusted for age, sex and BMI)	1237_Usual weekday sleep duration (GEE, adjusted for age, sex and BMI)	25	143	1	2512	1784	4497	2028	3900	1372	3068	143	2817
4239_Latent naming speed	4239_Latent naming speed	25	143	1	1029	3614	960	2088	1447	3118	4201	4007	143
3587_Types of physical activity in last 4 weeks: Strenuous sports	3587_Types of physical activity in last 4 weeks: Strenuous sports	25	144	1	1905	144	577	4134	1931	2362	2522	4528	1906
3003_HPGD - 15-hydroxyprostaglandin dehydrogenase [NAD(+)]	3003_HPGD - 15-hydroxyprostaglandin dehydrogenase [NAD(+)]	25	144	1	1156	760	144	491	2799	4249	3771	4359	3234
2381_NAAA - N-acylethanolamine-hydrolyzing acid amidase	2381_NAAA - N-acylethanolamine-hydrolyzing acid amidase	25	144	1	1895	3079	1381	2344	144	3727	2565	2479	2109
4442_Epstein Barr Virus antigen EBNA IgG levels	4442_Epstein Barr Virus antigen EBNA IgG levels	25	144	1	557	2089	3121	680	2686	144	1075	3156	1755
1972_Morbidity-free survival (at age 65, FBAT, adjusted for multivariable)	1972_Morbidity-free survival (at age 65, FBAT, adjusted for multivariable)	25	144	1	1978	4642	3013	3341	921	2345	144	2093	979
2765_TG - Thyroglobulin	2765_TG - Thyroglobulin	25	144	1	2818	2158	4259	494	1796	4168	2075	4262	144
735_::::X-11843	735_::::X-11843	25	145	1	145	2559	2710	4016	2868	2812	1356	3045	4276
940_Free cholesterol in small VLDL	940_Free cholesterol in small VLDL	25	145	1	1073	145	1393	4056	493	4730	2822	999	2236
1002_Monokine induced by interferon-gamma (CXCL9)	1002_Monokine induced by interferon-gamma (CXCL9)	25	145	1	4568	1701	145	816	4456	4477	4413	1395	1131
1859_Neck cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	1859_Neck cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	25	145	1	3339	816	1147	145	4552	4666	4654	543	882
1449_Low-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1449_Low-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	145	1	405	3421	1742	2356	4449	3566	4626	145	4522
4328_Estimated bone mineral density from heel ultrasounds	4328_Estimated bone mineral density from heel ultrasounds	25	146	1	146	1910	248	2927	2957	3989	3636	621	149
3803_Mean corpuscular hemoglobin	3803_Mean corpuscular hemoglobin	25	146	1	2089	146	681	879	4453	4499	1069	2431	3828
1930_Occipital brain volume (FBAT, adjusted for age and sex)	1930_Occipital brain volume (FBAT, adjusted for age and sex)	25	146	1	3225	2321	146	2234	2123	4296	1016	3078	1711
144_Body Mass Index (male)	144_Body Mass Index (male)	25	146	1	1948	2354	417	146	2564	3373	3723	1120	1999
2820_DYRK3 - Dual specificity tyrosine-phosphorylation-regulated kinase 3	2820_DYRK3 - Dual specificity tyrosine-phosphorylation-regulated kinase 3	25	146	1	2430	3003	4412	2845	146	1582	2157	2908	1157
465_Lipid::Bile acid metabolism::deoxycholate	465_Lipid::Bile acid metabolism::deoxycholate	25	146	1	3141	1264	991	4733	823	146	1119	3767	3554
1579_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1579_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	146	1	418	186	2270	551	175	1314	146	2216	2464
4582_Right inferior parietal	4582_Right inferior parietal	25	146	1	2349	1138	1434	2044	399	1357	421	167	146
53_Educational attainment	53_Educational attainment	25	147	1	147	2526	2090	924	2566	3874	2860	484	3073
1900_Troch Neck BMD (FBAT, male, adjussted for multivariable)	1900_Troch Neck BMD (FBAT, male, adjussted for multivariable)	25	147	1	678	147	3825	4405	1274	3832	4509	690	3508
4140_Mean corpuscular hemoglobin concentration	4140_Mean corpuscular hemoglobin concentration	25	147	1	773	2966	147	3705	3928	1921	3914	3818	1892
1617_CD40 Ligand plasma (at exam 7, GEE, adjusted for multivariable)	1617_CD40 Ligand plasma (at exam 7, GEE, adjusted for multivariable)	25	147	1	2571	1568	4339	147	2235	1001	540	3830	1652
793_::::X-12717	793_::::X-12717	25	147	1	3304	4436	3309	2059	284	147	1721	3189	1798
2332_GFAP - Glial fibrillary acidic protein	2332_GFAP - Glial fibrillary acidic protein	25	147	1	3639	3837	4457	4575	796	433	147	1710	633
963_Phospholipids in very large VLDL	963_Phospholipids in very large VLDL	25	147	1	260	197	4155	1799	580	3063	4527	413	147
2505_BCL2A1 - Bcl-2-related protein A1	2505_BCL2A1 - Bcl-2-related protein A1	25	148	1	3485	148	2056	4480	449	4260	1944	3268	2634
893_Cholesterol esters in large LDL	893_Cholesterol esters in large LDL	25	148	1	2339	3918	4552	148	3547	1584	1590	3118	2212
452_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::heme*	452_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::heme*	25	148	1	3200	1599	2560	4301	157	148	960	845	3688
2129_IL12RB1 - Interleukin-12 receptor subunit beta-1	2129_IL12RB1 - Interleukin-12 receptor subunit beta-1	25	148	1	2711	2367	4681	2464	599	1224	148	2328	4358
3941_Body Mass Index (female)	3941_Body Mass Index (female)	25	148	1	4418	3746	662	1091	4723	3652	3006	3704	148
4664_Superior corona radiata fractional anisotropy	4664_Superior corona radiata fractional anisotropy	25	149	1	149	902	1591	2405	2522	3613	3391	1850	1844
225_B Mem:%IgE	225_B Mem:%IgE	25	149	1	4083	149	3615	4669	2061	2534	643	1928	3334
3058_IL22RA2 - Interleukin-22 receptor subunit alpha-2	3058_IL22RA2 - Interleukin-22 receptor subunit alpha-2	25	149	1	2371	4327	3535	149	2399	4008	3126	1049	304
4134_Lymphocyte count	4134_Lymphocyte count	25	149	1	1180	3025	159	4021	149	1466	2097	3569	3445
235_CD123 on mDC	235_CD123 on mDC	25	149	1	4683	3472	3501	575	1812	1187	149	3068	2463
1862_Neck cross-sectional moment of inertia (FBAT, female, adjussted for age)	1862_Neck cross-sectional moment of inertia (FBAT, female, adjussted for age)	25	149	1	303	3197	1819	2266	2774	1288	3662	149	4054
3686_Diagnoses - secondary ICD10: E11 Type 2 diabetes mellitus	3686_Diagnoses - secondary ICD10: E11 Type 2 diabetes mellitus	25	150	1	150	4192	4429	920	1250	4001	188	2471	558
2370_DIABLO - Diablo homolog, mitochondrial	2370_DIABLO - Diablo homolog, mitochondrial	25	150	1	3316	150	3082	572	1136	3424	3186	446	1843
3144_ANXA6 - Annexin A6	3144_ANXA6 - Annexin A6	25	150	1	4092	1063	3041	3174	979	150	346	4145	3331
1991_Age at death (GEE, adjusted for birth-cohort)	1991_Age at death (GEE, adjusted for birth-cohort)	25	150	1	3709	625	2165	2973	3723	3626	3444	150	3866
2939_F10 - Coagulation Factor X	2939_F10 - Coagulation Factor X	25	150	1	258	815	1715	866	3983	3456	3843	2217	150
529_Lipid::Long chain fatty acid::stearidonate (18:4n3)	529_Lipid::Long chain fatty acid::stearidonate (18:4n3)	25	151	1	151	3286	3704	1104	2468	2501	4436	1967	1930
749_::::X-12039	749_::::X-12039	25	151	1	1181	945	151	3100	322	4112	1383	525	2901
1915_Parietal brain volume (GEE, adjusted for multivariable)	1915_Parietal brain volume (GEE, adjusted for multivariable)	25	151	1	4518	4498	2526	151	3423	1899	2695	449	4592
4259_Facial attractiveness (female-coder, male samples)	4259_Facial attractiveness (female-coder, male samples)	25	151	1	3220	2322	3233	1660	4405	151	1615	3894	2732
2264_CD22 - B-cell receptor CD22	2264_CD22 - B-cell receptor CD22	25	151	1	1918	310	2649	1111	2077	4612	2359	151	3049
2652_ADAM9 - Disintegrin and metalloproteinase domain-containing protein 9	2652_ADAM9 - Disintegrin and metalloproteinase domain-containing protein 9	25	151	1	4118	3196	2239	2614	3230	2323	1682	3443	151
596_Peptide::Dipeptide::pro-hydroxy-pro	596_Peptide::Dipeptide::pro-hydroxy-pro	25	152	1	152	3628	1613	2919	232	2358	1436	1632	999
1095_Diastolic Blood Pressure	1095_Diastolic Blood Pressure	25	152	1	937	152	4197	1785	1965	452	3576	3622	512
2182_SHH - Sonic hedgehog protein	2182_SHH - Sonic hedgehog protein	25	152	1	181	1992	152	4535	1854	1682	4109	2160	4204
3840_Eosinophil percentage of granulocytes (two-way meta)	3840_Eosinophil percentage of granulocytes (two-way meta)	25	152	1	2907	933	1223	152	3477	3820	1594	1350	1186
3584_Types of transport used (excluding work): Cycle	3584_Types of transport used (excluding work): Cycle	25	152	1	490	340	2453	2005	152	3811	2131	4624	2084
174_Waist circumference (adjusted for BMI)	174_Waist circumference (adjusted for BMI)	25	152	2	4105	1689	1205	1033	2725	152	1232	719	200
3494_Coffee type: Ground coffee (include espresso, filter etc)	3494_Coffee type: Ground coffee (include espresso, filter etc)	25	152	1	627	2265	196	1481	4381	1009	1368	152	2993
2202_IL16 - Interleukin-16	2202_IL16 - Interleukin-16	25	152	1	4647	3452	3552	3086	2428	2813	4229	2187	152
3684_Diagnoses - main ICD10: R31 Hematuria	3684_Diagnoses - main ICD10: R31 Hematuria	25	153	1	153	2135	680	4588	3860	4329	842	477	4523
4422_Herpes simplex virus 2 seropositivity	4422_Herpes simplex virus 2 seropositivity	25	153	1	1866	153	2798	2549	745	4517	3011	959	2002
1670_Bilirubin (at exam 2, FBAT, adjusted for age and sex)	1670_Bilirubin (at exam 2, FBAT, adjusted for age and sex)	25	153	1	3964	4576	153	3094	3858	2247	4498	1363	1590
3788_Insomnia (female)	3788_Insomnia (female)	25	153	1	1671	3904	796	153	2688	3866	2561	1196	4616
721_::::X-11540	721_::::X-11540	25	153	1	1702	1282	3644	1144	153	4733	192	464	1405
3081_NRXN3 - Neurexin-3-beta	3081_NRXN3 - Neurexin-3-beta	25	153	1	1589	978	537	3178	1171	1163	153	2415	324
2157_IGFBP6 - Insulin-like growth factor-binding protein 6	2157_IGFBP6 - Insulin-like growth factor-binding protein 6	25	153	1	1831	3529	1230	208	893	180	204	153	1988
3989_Heart rate recovery at 50 secnds	3989_Heart rate recovery at 50 secnds	25	153	1	256	1053	1342	4046	3179	899	3478	1365	153
2635_TNF - Tumor necrosis factor	2635_TNF - Tumor necrosis factor	25	154	1	154	2567	3997	4303	2230	3001	3468	3873	2965
148_Body Mass Index (male <= 50 yrs)	148_Body Mass Index (male <= 50 yrs)	25	154	1	211	2191	2392	154	1950	2879	4164	450	3681
4035_Alcohol dependency (unrelated individuals)	4035_Alcohol dependency (unrelated individuals)	25	154	1	924	4194	1703	3164	1711	154	2400	2712	4728
1067_Type 1 Diabetes	1067_Type 1 Diabetes	25	154	1	389	4267	1307	243	2902	4016	154	293	2001
3322_Most recent bowel cancer screening	3322_Most recent bowel cancer screening	25	154	1	1630	183	1906	776	1340	395	956	154	525
4000_Suffer from 'nerves' (SUF-NERV)	4000_Suffer from 'nerves' (SUF-NERV)	25	154	1	2681	4567	3185	1161	2266	1194	2323	3816	154
3895_Neutrophil count (three-way meta)	3895_Neutrophil count (three-way meta)	25	155	1	155	2882	969	1265	4421	370	2222	1426	1842
2914_OLFM4 - Olfactomedin-4	2914_OLFM4 - Olfactomedin-4	25	155	1	3971	155	1990	554	588	2281	4158	210	3988
143_Body Mass Index	143_Body Mass Index	25	155	1	1314	2316	1971	155	2460	3202	2867	2417	1472
1179_Insomnia (male)	1179_Insomnia (male)	25	155	1	1517	3917	4273	4324	4138	155	1307	4129	232
357_earlyB:%27+38-	357_earlyB:%27+38-	25	155	1	4732	2759	2334	919	1196	1132	155	4336	4228
543_Lipid::Lysolipid::1-palmitoylglycerophosphocholine	543_Lipid::Lysolipid::1-palmitoylglycerophosphocholine	25	156	1	156	1930	1257	1928	2735	4245	919	1782	3453
2824_FGF12 - Fibroblast growth factor 12	2824_FGF12 - Fibroblast growth factor 12	25	156	1	2770	156	3568	4581	2537	4093	3142	570	4670
2458_HFE2 - Hemojuvelin	2458_HFE2 - Hemojuvelin	25	156	1	4276	1868	156	3151	890	3010	1013	3319	3732
1654_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for age and sex)	1654_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for age and sex)	25	156	1	3281	4476	166	156	4469	1978	2330	1548	1951
2560_HAMP - Hepcidin	2560_HAMP - Hepcidin	25	156	1	2439	4389	1904	1363	156	535	321	4233	3756
3617_Treatment/medication code: atenolol	3617_Treatment/medication code: atenolol	25	156	1	1329	2048	3858	4181	3525	156	2183	3162	3493
3809_Monocyte count	3809_Monocyte count	25	156	1	1221	1527	170	2705	1026	4742	156	1427	1353
175_Waist circumference (male, adjusted for BMI)	175_Waist circumference (male, adjusted for BMI)	25	156	2	1913	2858	1086	4093	2705	524	623	156	586
2616_TLR4 LY96 - Toll-like receptor 4:Lymphocyte antigen 96 complex	2616_TLR4 LY96 - Toll-like receptor 4:Lymphocyte antigen 96 complex	25	157	1	157	2974	492	429	3889	3631	2627	2873	248
611_Peptide::Polypeptide::HWESASXX*	611_Peptide::Polypeptide::HWESASXX*	25	157	1	1938	157	1497	1460	420	553	4594	2831	1995
1321_Adiponectin (GEE, adjusted for age, sex and BMI)	1321_Adiponectin (GEE, adjusted for age, sex and BMI)	25	157	1	2657	1378	157	1016	1394	986	4699	249	3144
4471_Left superior parietal	4471_Left superior parietal	25	157	1	3573	683	4464	157	2992	3226	1089	3086	4118
2293_ACVRL1 - Serine/threonine-protein kinase receptor R3	2293_ACVRL1 - Serine/threonine-protein kinase receptor R3	25	157	1	290	1187	470	2659	375	157	4439	4138	2946
3278_Father still alive	3278_Father still alive	25	157	1	3430	3259	4413	3460	881	611	157	1761	1083
172_Waist circumference (female)	172_Waist circumference (female)	25	158	1	158	3294	2787	742	4557	1870	3004	1582	4610
1947_Visual memory composite score (GEE, adjusted for multivariable)	1947_Visual memory composite score (GEE, adjusted for multivariable)	25	158	1	1771	158	3030	569	2627	1550	4387	4574	635
1019_Lumbar Spine BMD (GEE, adjusted for multivariable)	1019_Lumbar Spine BMD (GEE, adjusted for multivariable)	25	158	1	2334	4020	158	4312	4623	4665	3238	3382	3278
3119_MAPK9 - Mitogen-activated protein kinase 9	3119_MAPK9 - Mitogen-activated protein kinase 9	25	158	1	3612	421	3624	158	4030	473	751	3515	2900
1965_MMSE score (at exam 5, GEE, adjusted for age)	1965_MMSE score (at exam 5, GEE, adjusted for age)	25	158	1	1079	446	4672	4240	3259	3880	3727	158	3182
4241_Rapid alternating stimulus test for letters/numbers	4241_Rapid alternating stimulus test for letters/numbers	25	158	1	3210	962	1145	3662	4570	3249	4252	1318	158
1379_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	1379_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	25	159	1	159	3663	3491	2978	1955	1510	1777	2467	2101
3548_Mouth/teeth dental problems: Toothache	3548_Mouth/teeth dental problems: Toothache	25	159	1	1581	159	3384	3160	2119	1712	1678	1981	3951
917_Cholesterol esters in medium LDL	917_Cholesterol esters in medium LDL	25	159	3	2704	4305	4548	159	4035	2885	1405	3563	1480
1122_Pericardial adipose tissue volume (adjusted for height and weight, female)	1122_Pericardial adipose tissue volume (adjusted for height and weight, female)	25	159	1	2351	614	2212	285	3893	4722	3210	3103	159
2515_CSNK2A1 - Casein kinase II subunit alpha	2515_CSNK2A1 - Casein kinase II subunit alpha	25	160	1	160	4604	4574	4433	1516	1850	2718	1748	2758
20_Number of cigarettes smoked per day	20_Number of cigarettes smoked per day	25	160	1	3364	160	576	2199	4294	3011	4279	2944	2535
2015_Lithium response in Bipolar I patients - Alda Scale of 4 to 5	2015_Lithium response in Bipolar I patients - Alda Scale of 4 to 5	25	160	1	397	2038	160	382	267	4689	4167	789	175
1372_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	1372_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	25	160	1	701	1877	486	160	2480	997	3979	4701	1031
188_Waist-hip ratio (male, adjusted for BMI)	188_Waist-hip ratio (male, adjusted for BMI)	25	160	1	3628	797	2503	1977	4607	932	1428	4239	160
3130_TYK2 - Non-receptor tyrosine-protein kinase TYK2	3130_TYK2 - Non-receptor tyrosine-protein kinase TYK2	25	161	1	161	307	3708	2303	1960	362	3088	4324	2899
3492_Coffee type: Decaffeinated coffee (any type)	3492_Coffee type: Decaffeinated coffee (any type)	25	161	1	2490	4683	3343	496	1370	161	210	926	2967
1642_Osteoprotegerin (at exam 7, FBAT, adjusted for age and sex)	1642_Osteoprotegerin (at exam 7, FBAT, adjusted for age and sex)	25	161	1	952	1807	985	1589	1485	2816	161	4653	1653
2019_Lung canger (adjusted for age)	2019_Lung canger (adjusted for age)	25	162	1	162	633	424	3246	2444	705	2873	923	2525
756_Nucleotide::NAD metabolism::X-12095--N1-methyl-3-pyridone-4-carboxamide	756_Nucleotide::NAD metabolism::X-12095--N1-methyl-3-pyridone-4-carboxamide	25	162	1	1529	162	738	2965	2254	1852	990	3981	427
1327_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	1327_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	25	162	1	3264	3403	884	4067	162	3747	3900	2005	3571
1283_Sagittal diameter by CT (GEE, adjusted for age, sex, smoking and menopause)	1283_Sagittal diameter by CT (GEE, adjusted for age, sex, smoking and menopause)	25	162	1	4558	791	3894	2074	1146	637	2866	162	3872
4378_High blood pressure	4378_High blood pressure	25	163	1	163	455	3875	2711	381	2830	3611	4067	4689
970_Concentration of chylomicrons and extremely large VLDL particles	970_Concentration of chylomicrons and extremely large VLDL particles	25	163	1	537	163	4641	2009	368	4022	4438	288	264
4668_Uncinate fasciculus fractional anisotropy	4668_Uncinate fasciculus fractional anisotropy	25	163	1	3453	681	289	1908	163	3454	1168	4508	3305
184_Waist-hip ratio (female)	184_Waist-hip ratio (female)	25	163	1	3600	3071	2608	2043	3392	163	2092	1804	1864
4316_Smoking cessation	4316_Smoking cessation	25	163	1	1751	1942	3698	1768	1818	2384	163	3640	2386
1291_Waist circumference by CT (GEE, adjusted for age, sex, smoking and menopause)	1291_Waist circumference by CT (GEE, adjusted for age, sex, smoking and menopause)	25	163	1	1018	1685	2075	3740	425	359	3148	163	748
79_Femoral Neck BMD (females)	79_Femoral Neck BMD (females)	25	163	1	3229	3353	758	2888	3901	1325	2878	4083	163
3238_Exposure to tobacco smoke at home	3238_Exposure to tobacco smoke at home	25	164	1	3070	2416	164	2045	2798	4049	1732	2901	2773
2031_Inflammatory Bowel Disease	2031_Inflammatory Bowel Disease	25	164	1	2223	2665	1471	164	739	917	262	255	993
3754_Traumatic events - Felt very upset when reminded of stressful expresince in past month	3754_Traumatic events - Felt very upset when reminded of stressful expresince in past month	25	164	1	4025	1990	1780	1085	164	3260	295	2828	1703
2239_TIE1 - Tyrosine-protein kinase receptor Tie-1, soluble	2239_TIE1 - Tyrosine-protein kinase receptor Tie-1, soluble	25	164	1	3691	2145	2963	2274	2141	1059	164	2402	3252
2813_BOC - Brother of CDO	2813_BOC - Brother of CDO	25	164	1	702	2132	1746	1609	598	316	663	164	3080
2009_Hypertriglyceridemia	2009_Hypertriglyceridemia	25	164	1	3448	378	3137	1931	4593	3954	4187	1889	164
1429_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1429_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	165	1	165	4466	1516	3250	3087	4648	2673	969	389
1573_Mean abdominal aortic calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1573_Mean abdominal aortic calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	165	1	4177	2649	165	4040	502	425	506	3624	3758
3174_CST1 - Cystatin-SN	3174_CST1 - Cystatin-SN	25	165	1	3535	3822	1793	165	1493	1193	650	4713	2367
4523_Left putamen	4523_Left putamen	25	165	1	1404	3084	1031	2528	630	165	1324	4625	287
7_Anxiety disorder (factor score)	7_Anxiety disorder (factor score)	25	165	1	2974	4737	2630	2807	272	306	165	2449	1060
3137_SLC25A18 - Mitochondrial glutamate carrier 2	3137_SLC25A18 - Mitochondrial glutamate carrier 2	25	165	1	4679	4245	2298	2392	1593	1601	2348	165	4514
2695_PSMA6 - Proteasome subunit alpha type-6	2695_PSMA6 - Proteasome subunit alpha type-6	25	165	1	2962	2501	402	2879	2116	3809	3844	2533	165
1851_Neck average buckling ratio (GEE, female, adjussted for multivariable)	1851_Neck average buckling ratio (GEE, female, adjussted for multivariable)	25	166	1	166	671	1520	3967	3751	1086	3870	1713	872
3039_TNFAIP6 - Tumor necrosis factor-inducible gene 6 protein	3039_TNFAIP6 - Tumor necrosis factor-inducible gene 6 protein	25	166	1	2999	166	1968	621	4000	1451	3218	1418	952
1630_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for age and sex)	1630_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for age and sex)	25	166	1	950	404	4335	166	4045	516	177	822	1206
3235_Current tobacco smoking	3235_Current tobacco smoking	25	166	1	723	2157	1202	1918	3950	166	3191	4335	3533
266_DPT:%Exhausted	266_DPT:%Exhausted	25	166	1	1008	2259	1682	2256	2578	2701	3394	3768	166
4535_Right caudate	4535_Right caudate	25	167	1	167	2362	3349	4682	1594	207	1148	1547	1487
3573_Pain type(s) experienced in last month: Stomach or abdominal pain	3573_Pain type(s) experienced in last month: Stomach or abdominal pain	25	167	1	3761	167	4493	2065	977	232	4005	1027	4373
1193_Crohn's Disease	1193_Crohn's Disease	25	167	1	3257	2058	167	533	2718	237	3167	4728	2934
3923_Heart rate variability (RMSSD)	3923_Heart rate variability (RMSSD)	25	167	1	1567	2933	2957	167	2575	455	4280	2382	2174
441_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glucose	441_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glucose	25	167	1	4585	2459	371	3539	1876	167	669	2327	3118
4395_Menstruation quality of life impact: Acne	4395_Menstruation quality of life impact: Acne	25	167	1	543	825	3143	2204	201	445	167	2121	3804
3293_Suffer from 'nerves'	3293_Suffer from 'nerves'	25	167	1	738	4207	3487	2196	2213	841	2717	3780	167
2758_TGFB2 - Transforming growth factor beta-2	2758_TGFB2 - Transforming growth factor beta-2	25	168	1	4740	168	4507	1680	2129	4098	2027	488	1909
3370_Duration of other exercises	3370_Duration of other exercises	25	168	1	3603	4288	168	4063	2651	3983	3416	3172	2981
2395_WFIKKN1 - WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1	2395_WFIKKN1 - WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1	25	168	1	2809	757	1473	168	3501	546	2605	3122	3600
727_::::X-11787	727_::::X-11787	25	168	1	1455	688	180	2502	168	2722	774	1741	3145
1823_Inter-trochanteric buckling ratio (GEE, female, adjussted for age)	1823_Inter-trochanteric buckling ratio (GEE, female, adjussted for age)	25	168	1	1598	3179	1398	1054	1353	168	1542	180	3228
89_Infant head circumference	89_Infant head circumference	25	168	1	4162	3675	2485	1827	4102	677	168	4028	2805
2945_GCG - Glucagon	2945_GCG - Glucagon	25	168	1	1102	1644	874	2735	732	1514	2682	168	2363
962_Concentration of very large VLDL particles	962_Concentration of very large VLDL particles	25	168	1	1653	576	1537	4322	410	2773	4107	285	168
807_::::X-12833	807_::::X-12833	25	169	1	395	169	3090	1271	838	2096	2002	314	3016
4172_Social support - Leisure/social activities: Pub or social club	4172_Social support - Leisure/social activities: Pub or social club	25	169	1	2758	285	2947	169	1545	2604	1409	384	3841
1081_Alzheimer's disease	1081_Alzheimer's disease	25	169	1	174	3538	1589	845	1693	539	169	2008	1950
3469_Impedance measures - Trunk fat mass	3469_Impedance measures - Trunk fat mass	25	170	1	170	3425	1065	425	3402	4480	3008	1622	2152
898_Total cholesterol in large VLDL	898_Total cholesterol in large VLDL	25	170	1	764	170	3341	3936	379	3909	3660	268	1204
2269_PCNA - Proliferating cell nuclear antigen	2269_PCNA - Proliferating cell nuclear antigen	25	170	1	2199	2460	569	170	4494	3974	4091	1000	1515
2907_HSD17B1 - Estradiol 17-beta-dehydrogenase 1	2907_HSD17B1 - Estradiol 17-beta-dehydrogenase 1	25	170	1	545	4646	1463	3064	1524	3023	3454	170	3316
3143_CD70 - CD70 antigen	3143_CD70 - CD70 antigen	25	171	1	171	3164	3813	3415	1100	4721	945	565	4537
2109_ANGPT2 - Angiopoietin-2	2109_ANGPT2 - Angiopoietin-2	25	171	1	2165	171	2592	3821	475	618	906	1930	1859
876_Total cholesterol in HDL	876_Total cholesterol in HDL	25	171	1	735	3010	171	390	517	1087	1038	448	2373
2430_FCER2 - Low affinity immunoglobulin epsilon Fc receptor	2430_FCER2 - Low affinity immunoglobulin epsilon Fc receptor	25	171	1	1359	4109	4387	171	4468	3018	2672	3600	1839
905_18:2, linoleic acid (LA)	905_18:2, linoleic acid (LA)	25	172	1	3743	1054	172	1637	1980	4128	3475	3114	3972
2380_ARSB - Arylsulfatase B	2380_ARSB - Arylsulfatase B	25	172	1	2581	1446	2143	4646	172	2884	1389	3540	2223
4348_Coronary artery disease and high-density lipoprotein cholesterol (bivariate)	4348_Coronary artery disease and high-density lipoprotein cholesterol (bivariate)	25	172	1	3438	294	3402	530	185	172	197	238	4647
1605_tPA (at exam 5, GEE, adjusted for multivariable)	1605_tPA (at exam 5, GEE, adjusted for multivariable)	25	172	1	330	3788	3490	2632	3913	3571	4430	172	4549
4424_Hepatitis B HBs antigen seropositivity	4424_Hepatitis B HBs antigen seropositivity	25	173	1	173	2658	4330	3908	4216	2727	1996	878	718
1831_Neck length (GEE, female, adjusted for multivariable)	1831_Neck length (GEE, female, adjusted for multivariable)	25	173	1	3880	173	3769	3676	2137	2320	4092	3254	4466
1574_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1574_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	173	1	2052	2552	173	2489	3796	3313	4136	4025	3968
4068_Automobile speeding propensity	4068_Automobile speeding propensity	25	173	1	737	2305	2997	1285	173	2664	648	3592	4579
2982_CA1 - Carbonic anhydrase 1	2982_CA1 - Carbonic anhydrase 1	25	173	1	337	908	1042	3711	850	173	176	3513	3550
4581_Right fusiform	4581_Right fusiform	25	173	1	4382	4465	2836	1921	3648	175	173	3325	1923
1014_Bone Ultrasound Attenuation (FBAT, adjusted for multivariable)	1014_Bone Ultrasound Attenuation (FBAT, adjusted for multivariable)	25	173	1	2583	377	1642	1966	4110	1250	418	173	2991
1909_Lateral ventricular volume (GEE, adjusted for multivariable)	1909_Lateral ventricular volume (GEE, adjusted for multivariable)	25	173	1	2290	696	474	1528	3742	501	1506	274	173
4533_Right cerebellum white matter	4533_Right cerebellum white matter	25	174	1	2489	1582	174	3380	275	4463	3945	4405	593
29_Openness to Experience (NEO-FFI)	29_Openness to Experience (NEO-FFI)	25	174	1	594	2697	467	174	3553	1518	2031	3784	434
3444_Impedance measures - Whole body water mass	3444_Impedance measures - Whole body water mass	25	174	2	3586	4304	3469	2273	2565	174	1623	475	1221
1721_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for multivariable)	1721_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for multivariable)	25	174	1	734	2864	1435	2351	3130	4014	2080	174	2575
4019_Age spot	4019_Age spot	25	175	1	2735	175	1777	998	902	1647	2548	4445	4524
2150_CKM - Creatine kinase M-type	2150_CKM - Creatine kinase M-type	25	175	1	4659	4362	175	287	2540	1055	872	4218	3868
911_Cholesterol esters in medium HDL	911_Cholesterol esters in medium HDL	25	175	1	235	3858	965	175	4463	1388	921	3662	2940
1523_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	1523_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	25	175	1	3449	1013	658	365	3031	2198	175	2233	2138
3033_SIRT2 - NAD-dependent protein deacetylase sirtuin-2	3033_SIRT2 - NAD-dependent protein deacetylase sirtuin-2	25	175	1	1356	3656	4634	2911	180	3392	568	175	2558
2544_PRSS3 - Trypsin-3	2544_PRSS3 - Trypsin-3	25	176	1	176	1746	2369	419	3505	4284	3492	939	3248
1299_Fasting plasma glucose (at exam 5, GEE, adjusted for age and sex)	1299_Fasting plasma glucose (at exam 5, GEE, adjusted for age and sex)	24	176	1	3579	176	2796	4280	412	3293	3897	569	2300
1387_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	1387_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	25	176	1	4384	3518	3733	176	4662	1929	4555	635	4571
1024_Femoral Neck Length (FBAT, adjusted for age and sex)	1024_Femoral Neck Length (FBAT, adjusted for age and sex)	25	176	1	3424	4617	4235	3533	1368	2242	1096	176	3693
3962_Gestational weight gain (maternal, late)	3962_Gestational weight gain (maternal, late)	25	177	1	3467	177	3964	3993	1981	3046	3620	1507	2198
4148_Left ventricular internal dimension in diastole	4148_Left ventricular internal dimension in diastole	25	177	1	2007	673	177	2698	4478	2778	2036	1155	3768
3124_IMPDH2 - Inosine-5'-monophosphate dehydrogenase 2	3124_IMPDH2 - Inosine-5'-monophosphate dehydrogenase 2	25	177	1	2271	3305	1741	177	2887	2774	3224	3535	4342
3253_Cereal intake	3253_Cereal intake	25	177	1	3572	298	1106	890	177	4351	370	756	712
1044_Bone Ultrasound Speed (FBAT, adjusted for multivariable)	1044_Bone Ultrasound Speed (FBAT, adjusted for multivariable)	25	177	1	2448	3374	3890	1221	4097	177	1218	1414	4607
1600_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for multivariable)	1600_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for multivariable)	25	177	1	292	235	2235	2049	1514	2202	516	177	1120
68_Crohn's Disease	68_Crohn's Disease	25	178	1	1686	1395	178	908	3313	1880	819	4360	3043
95_Birth weight	95_Birth weight	25	178	1	1380	3349	1764	178	2783	3869	3637	4557	1786
1172_Heart rate	1172_Heart rate	25	178	1	311	3410	2218	4234	2884	178	1177	4597	1964
4749_Posterior thalamic radiation (include optic radiation) radial diusivities	4749_Posterior thalamic radiation (include optic radiation) radial diusivities	25	178	1	3821	2962	2790	3247	527	2880	178	2424	4040
3485_Bread type: White	3485_Bread type: White	25	178	1	4149	3935	2303	422	1627	2768	2841	2806	178
1631_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for age and sex)	1631_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for age and sex)	25	179	1	179	1819	1821	2543	4417	467	3135	1513	3335
1791_QT interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1791_QT interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	179	1	2687	3281	545	179	4563	2720	4635	4605	1149
1547_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for age and sex)	1547_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for age and sex)	25	179	1	1212	1038	562	4334	179	742	984	4530	1968
4732_Superior longitudinal fasciculus mode of anisotropy	4732_Superior longitudinal fasciculus mode of anisotropy	25	179	1	2791	1790	3478	3368	3151	179	807	2864	2166
3772_Depression - Recent feelings of tiredness or low enery	3772_Depression - Recent feelings of tiredness or low enery	25	179	1	3675	3814	4231	4106	4437	3197	639	3507	179
2669_IL11RA - Interleukin-11 receptor subunit alpha	2669_IL11RA - Interleukin-11 receptor subunit alpha	25	180	1	559	3461	4263	4323	2654	2470	2541	1733	180
73_Total cholesterol	73_Total cholesterol	25	181	1	501	181	1291	182	430	1215	2821	1819	3032
2791_NUDCD3 - NudC domain-containing protein 3	2791_NUDCD3 - NudC domain-containing protein 3	25	181	1	762	1370	181	1925	2546	2495	4565	715	1202
1329_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	1329_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	25	181	1	1538	523	3495	181	1224	2304	4140	2354	3847
1154_Insulin at 30 min	1154_Insulin at 30 min	25	181	1	1640	447	4173	2762	181	3438	3913	911	4078
980_Interferon-gamma	980_Interferon-gamma	25	181	1	3319	424	950	3985	1874	185	181	4594	3618
3344_Age at last live birth (female)	3344_Age at last live birth (female)	25	181	1	1441	3049	3452	844	1604	4640	1329	181	4517
1690_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for age and sex)	1690_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for age and sex)	25	181	1	3415	2639	3198	4406	1761	3253	1727	3702	181
3588_Types of physical activity in last 4 weeks: Light DIY (eg: pruning, watering the lawn)	3588_Types of physical activity in last 4 weeks: Light DIY (eg: pruning, watering the lawn)	25	182	1	182	3288	466	183	2299	1172	1082	453	3838
719_::::X-11537	719_::::X-11537	25	182	1	1646	1797	182	3857	3750	3485	2433	963	2957
540_Lipid::Lysolipid::1-oleoylglycerophosphocholine	540_Lipid::Lysolipid::1-oleoylglycerophosphocholine	25	182	1	1037	3061	3587	3898	530	182	323	3901	3065
2173_IL37 - Interleukin-37	2173_IL37 - Interleukin-37	25	182	1	2116	3191	1815	2020	1193	1363	182	2266	1972
3212_Frequency of walking for pleasure in last 4 weeks	3212_Frequency of walking for pleasure in last 4 weeks	25	183	1	183	4024	629	3436	3264	3121	2290	4487	2052
3442_Impedance measures - Whole body fat mass	3442_Impedance measures - Whole body fat mass	25	183	1	239	3389	183	337	4661	2522	4219	589	2179
4207_Blood urea nitrogen	4207_Blood urea nitrogen	25	183	1	1498	490	644	4347	183	1007	250	1905	1954
4283_FVC	4283_FVC	25	183	1	774	545	2088	335	459	183	291	2923	3805
4436_Herpes simplex virus 1 IgG levels	4436_Herpes simplex virus 1 IgG levels	25	183	1	700	669	2828	3021	1483	651	183	1236	1913
3359_Age high blood pressure diagnosed	3359_Age high blood pressure diagnosed	25	183	1	2247	1436	2679	2286	2681	1892	3382	199	183
2026_Baseline positive affect factor score	2026_Baseline positive affect factor score	25	184	1	583	184	197	334	693	396	313	3317	333
852_Alanine	852_Alanine	25	184	1	286	4728	184	1548	2494	2112	803	2180	1761
2457_RGMB - RGM domain family member B	2457_RGMB - RGM domain family member B	25	184	1	3094	1481	4614	184	4020	3333	1195	1019	2933
1003_Macrophage inflammatory protein-1 (CCL3)	1003_Macrophage inflammatory protein-1 (CCL3)	25	184	1	3056	341	749	414	3849	184	2691	1370	4550
707_Lipid::Sterol/Steroid::X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	707_Lipid::Sterol/Steroid::X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	25	184	1	1068	1866	4744	3073	209	1502	184	300	3750
113_Height	113_Height	25	184	1	4394	566	3418	2211	1822	763	2088	184	1312
3518_How are people in household related to participant: Son and/or daughter (include step-children)	3518_How are people in household related to participant: Son and/or daughter (include step-children)	25	184	1	756	2451	3727	256	3398	647	3403	4663	184
3626_Treatment/medication code: bendroflumethiazide	3626_Treatment/medication code: bendroflumethiazide	25	185	1	185	2476	2280	2580	2380	1139	1242	2030	3270
3833_Basophil count (two-way meta)	3833_Basophil count (two-way meta)	25	185	1	3234	185	3057	3172	622	235	328	4495	2605
2910_PPIB - Peptidyl-prolyl cis-trans isomerase B	2910_PPIB - Peptidyl-prolyl cis-trans isomerase B	25	185	1	2407	1624	185	832	4595	2602	4226	3588	4468
3838_Eosinophil count (two-way meta)	3838_Eosinophil count (two-way meta)	25	185	1	727	661	3249	185	2790	1846	3610	206	3302
3960_Gestational weight gain (maternal, total)	3960_Gestational weight gain (maternal, total)	25	185	1	3855	1986	279	2716	3929	279	185	862	1443
3577_Social support - Leisure/social activities: Pub or social club	3577_Social support - Leisure/social activities: Pub or social club	25	185	1	1205	1096	2327	3957	1275	3086	1728	185	4587
4381_Epithelial ovarian cancer (all invasive)	4381_Epithelial ovarian cancer (all invasive)	25	185	1	4614	1274	4216	1306	4452	324	3314	2025	185
1269_Epworth Sleepiness Scale (GEE)	1269_Epworth Sleepiness Scale (GEE)	25	186	1	186	247	2051	2613	711	3799	4153	1654	2124
2613_CD84 - SLAM family member 5	2613_CD84 - SLAM family member 5	25	186	1	2567	4741	186	4287	4533	2143	1850	4673	3159
2366_EDA2R - Tumor necrosis factor receptor superfamily member 27	2366_EDA2R - Tumor necrosis factor receptor superfamily member 27	25	186	1	1584	4494	1083	186	3902	2553	893	3610	369
3310_Age started wearing glasses or contact lenses	3310_Age started wearing glasses or contact lenses	25	186	1	2166	279	1345	867	953	186	2345	1961	3386
3527_Transport type for commuting to job workplace: Cycle	3527_Transport type for commuting to job workplace: Cycle	25	186	1	2318	1922	3206	825	249	1891	186	3027	4721
1799_High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1799_High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	186	1	613	1188	1220	4348	1757	1407	1708	186	2980
4141_Platelet count	4141_Platelet count	25	187	1	187	4453	2780	2585	1471	1090	1009	746	274
313_CD4nv:%TFH (1)	313_CD4nv:%TFH (1)	25	187	1	1257	3490	187	757	3812	1034	513	2775	2765
2949_COTL1 - Coactosin-like protein	2949_COTL1 - Coactosin-like protein	25	187	1	894	3990	3442	187	849	1276	705	1092	499
1148_AUC insulin	1148_AUC insulin	25	187	1	4708	3370	1948	1012	187	1591	2422	2245	3257
1010_Tumor necrosis factor alpha	1010_Tumor necrosis factor alpha	25	187	1	609	764	1693	1530	3843	187	1867	374	372
2771_ANP32B - Acidic leucine-rich nuclear phosphoprotein 32 family member B	2771_ANP32B - Acidic leucine-rich nuclear phosphoprotein 32 family member B	25	187	1	4052	2621	4637	993	213	4567	187	1242	2540
4109_Serum creatinine	4109_Serum creatinine	25	187	1	2366	280	2426	357	1800	1494	684	4692	187
4745_Genu of corpus callosum radial diusivities	4745_Genu of corpus callosum radial diusivities	25	188	1	188	3634	1622	3046	2898	3638	732	487	1713
966_Concentration of very small VLDL particles	966_Concentration of very small VLDL particles	25	188	1	2902	188	2215	991	1125	2853	4055	1837	3704
3540_Reason for glasses/contact lenses: For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia')	3540_Reason for glasses/contact lenses: For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia')	25	188	1	4502	2503	188	4677	857	1926	3968	699	2606
4279_FVC	4279_FVC	25	188	1	811	593	1615	188	725	406	301	4375	4113
4643_Right vessel	4643_Right vessel	25	188	1	432	2771	3845	1873	397	4078	2777	188	3289
4269_Neuroticism general factor	4269_Neuroticism general factor	25	188	1	482	1137	1830	4171	1331	4364	1994	953	188
3482_Milk type used: Skimmed	3482_Milk type used: Skimmed	25	189	1	4707	189	820	2203	4175	1045	399	2336	2362
3640_Illnesses of mother: Lung cancer	3640_Illnesses of mother: Lung cancer	25	189	1	192	3272	189	1805	4746	1361	1976	2577	2624
2998_GP1BA - Platelet glycoprotein Ib alpha chain	2998_GP1BA - Platelet glycoprotein Ib alpha chain	25	189	1	4070	251	1526	4237	2118	189	4492	3519	2713
1581_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1581_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	189	1	230	287	1028	619	310	1266	189	1997	3074
2823_DHH - Desert hedgehog protein N-product	2823_DHH - Desert hedgehog protein N-product	25	189	1	3864	277	230	1538	4044	4254	3733	4202	189
2682_TLR2 - Toll-like receptor 2	2682_TLR2 - Toll-like receptor 2	25	190	1	190	2369	2806	638	2813	3612	3511	354	3484
2847_PDPK1 - 3-phosphoinositide-dependent protein kinase 1	2847_PDPK1 - 3-phosphoinositide-dependent protein kinase 1	25	190	1	2841	190	4480	3779	4685	3735	1214	1328	368
2882_FUT3 - Galactoside 3(4)-L-fucosyltransferase	2882_FUT3 - Galactoside 3(4)-L-fucosyltransferase	25	190	1	857	1412	190	526	3292	4368	4152	2961	815
1591_Platelet aggregation to ADP (at exam 5, GEE, adjusted for age and sex)	1591_Platelet aggregation to ADP (at exam 5, GEE, adjusted for age and sex)	25	190	1	4377	4069	3626	190	2345	2729	1230	1527	1393
3693_Diagnoses - secondary ICD10: I25 Chronic ischemic heart disease	3693_Diagnoses - secondary ICD10: I25 Chronic ischemic heart disease	25	190	1	2397	1009	4172	3562	190	1715	454	3024	910
1730_Chronic kidney disease (at exam 7, FBAT, adjusted for age and sex)	1730_Chronic kidney disease (at exam 7, FBAT, adjusted for age and sex)	25	190	1	4684	3254	4369	3648	3316	190	794	4162	3185
2251_MAP2K1 - Dual specificity mitogen-activated protein kinase kinase 1	2251_MAP2K1 - Dual specificity mitogen-activated protein kinase kinase 1	25	190	1	3858	3185	4489	3769	1053	2227	190	2745	3888
1250_Percent predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	1250_Percent predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	191	1	191	2684	2418	3334	4146	2882	4578	585	1444
4135_Red blood cell count	4135_Red blood cell count	25	191	1	2578	191	1056	2551	1256	2953	822	1229	4283
2228_IL27 EBI3 - Interleukin-27	2228_IL27 EBI3 - Interleukin-27	25	191	1	4064	3594	1355	191	4390	894	1158	2870	332
3634_Illnesses of father: Diabetes	3634_Illnesses of father: Diabetes	25	191	1	1084	3752	2391	738	278	2893	191	4062	1413
4215_Estimated glomerular filtration rate	4215_Estimated glomerular filtration rate	25	192	1	4242	192	1625	4710	3045	346	2515	1672	2076
3006_JAK2 - Tyrosine-protein kinase JAK2	3006_JAK2 - Tyrosine-protein kinase JAK2	25	192	1	2383	216	192	847	3511	4723	2622	3562	1538
2570_CGA TSHB - Thyroid Stimulating Hormone	2570_CGA TSHB - Thyroid Stimulating Hormone	25	192	1	2718	4392	1938	4212	350	192	324	558	2547
2468_CAMK2A - Calcium/calmodulin-dependent protein kinase type II subunit alpha	2468_CAMK2A - Calcium/calmodulin-dependent protein kinase type II subunit alpha	25	192	1	3670	4700	871	2795	1790	1652	3508	3703	192
3893_Sum neutrophil eosinophil count (three-way meta)	3893_Sum neutrophil eosinophil count (three-way meta)	25	193	2	193	4062	678	421	3038	480	1661	708	640
2384_CA4 - Carbonic anhydrase 4	2384_CA4 - Carbonic anhydrase 4	24	193	1	329	193	293	3904	911	4668	1914	4310	470
3241_Salad / raw vegetable intake	3241_Salad / raw vegetable intake	25	193	1	605	3921	193	3152	1313	4739	4693	302	1556
839_::::X-14473	839_::::X-14473	25	193	1	797	594	2724	193	3987	221	2831	1798	2695
1707_Luteinizing hormone (at exam 3, GEE, adjusted for age and sex)	1707_Luteinizing hormone (at exam 3, GEE, adjusted for age and sex)	25	193	1	3000	3570	1358	652	193	3265	4422	2151	3578
1704_Follicle stimulating hormone (at exam 3, FBAT, adjusted for multivariable)	1704_Follicle stimulating hormone (at exam 3, FBAT, adjusted for multivariable)	25	193	1	554	1296	1104	328	3035	193	4131	2387	4337
1787_QT interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1787_QT interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	193	1	2905	2128	2443	4655	3408	3042	193	387	4638
2093_CCL5 - C-C motif chemokine 5	2093_CCL5 - C-C motif chemokine 5	25	193	1	4478	4534	2506	3138	497	627	3334	193	2988
3667_Diagnoses - main ICD10: H26 Other cataract	3667_Diagnoses - main ICD10: H26 Other cataract	25	193	1	2794	2986	3221	2323	3273	1138	2839	4023	193
1163_Hemoglobin A1C	1163_Hemoglobin A1C	25	194	1	194	2434	1281	1241	1986	2936	3285	4453	1176
1996_MMSE score (at exam 7, FBAT, adjusted for multivariable)	1996_MMSE score (at exam 7, FBAT, adjusted for multivariable)	25	194	1	1725	194	869	2990	817	1109	3401	1880	2137
4396_Menstruation quality of life impact: Agressiveness	4396_Menstruation quality of life impact: Agressiveness	25	194	1	2839	2523	194	4053	1631	2433	4725	4271	1130
851_Acetate	851_Acetate	25	194	1	3450	3096	1227	4028	194	3585	958	2096	3649
3076_NOTCH2 - Neurogenic locus notch homolog protein 2	3076_NOTCH2 - Neurogenic locus notch homolog protein 2	25	194	1	686	2829	815	1390	2942	194	354	3302	4478
1285_Visceral fat by CT (GEE, adjusted for age and sex)	1285_Visceral fat by CT (GEE, adjusted for age and sex)	25	194	1	4595	3712	670	1096	439	792	3244	194	2878
3510_Reason for reducing amount of alcohol drunk: Health precaution	3510_Reason for reducing amount of alcohol drunk: Health precaution	25	195	1	4013	195	2097	3438	3467	3047	3255	1302	930
3668_Diagnoses - main ICD10: I25 Chronic ischemic heart disease	3668_Diagnoses - main ICD10: I25 Chronic ischemic heart disease	25	195	1	4640	2088	4040	2834	195	3223	453	3339	4551
1362_Total cholesterol (at exam 3, FBAT, adjusted for age and sex)	1362_Total cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	195	1	4026	3468	696	1932	877	195	812	817	1903
1615_CD40 Ligand plasma (at exam 7, GEE, adjusted for age and sex)	1615_CD40 Ligand plasma (at exam 7, GEE, adjusted for age and sex)	25	195	1	1851	3245	4729	778	1156	631	195	3628	992
3774_Traumatic events - Been in aconfiding relationship as an adult	3774_Traumatic events - Been in aconfiding relationship as an adult	25	195	1	1375	460	4282	4680	642	4418	1870	3512	195
2877_COL23A1 - Collagen alpha-1(XXIII) chain	2877_COL23A1 - Collagen alpha-1(XXIII) chain	25	196	1	196	4611	2959	975	2788	1747	436	1977	844
432_Amino acid::Valine, leucine and isoleucine metabolism::levulinate (4-oxovalerate)	432_Amino acid::Valine, leucine and isoleucine metabolism::levulinate (4-oxovalerate)	25	196	1	2828	196	3410	3805	1116	4259	4030	660	2699
4550_Left fusiform	4550_Left fusiform	25	196	1	3615	953	3456	196	3503	4159	4227	4666	3648
2917_GSN - Gelsolin	2917_GSN - Gelsolin	25	196	1	392	3437	2534	4622	4659	196	3219	4332	3846
216_NKT:%4-8-	216_NKT:%4-8-	25	196	1	401	2627	3266	1810	1535	313	196	3708	1679
362_1c+mDC:%32+	362_1c+mDC:%32+	25	197	1	197	2293	4170	3809	2054	3065	227	1876	3075
123_Overweight	123_Overweight	25	197	1	664	3194	2533	197	3985	2465	3408	4204	4216
3237_Smoking/smokers in household	3237_Smoking/smokers in household	25	197	1	3920	3446	1020	1127	2680	858	622	3688	197
835_Peptide::Dipeptide::X-14208--phenylalanylserine	835_Peptide::Dipeptide::X-14208--phenylalanylserine	25	198	1	198	3207	2758	3531	4531	1129	3912	3451	1434
1993_Survival past average life expectancy (GEE, adjusted for multivariable)	1993_Survival past average life expectancy (GEE, adjusted for multivariable)	25	198	1	4098	4300	198	3041	4050	896	2394	3413	3513
880_Free cholesterol in IDL	880_Free cholesterol in IDL	25	198	1	3869	3584	2135	198	3309	966	4513	4420	2371
1420_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1420_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	198	1	2093	1392	2417	3582	1687	3273	2319	198	3864
3875_Eosinophil percentage of white cells (three-way meta)	3875_Eosinophil percentage of white cells (three-way meta)	25	199	1	1537	199	2091	770	1467	3285	4726	283	2709
2305_CXCL3 CXCL2 - Gro-beta/gamma	2305_CXCL3 CXCL2 - Gro-beta/gamma	25	199	1	435	636	199	2892	334	1395	1906	2185	1752
3229_Getting up in morning	3229_Getting up in morning	25	199	1	3730	412	3157	1177	199	1321	1581	437	2907
3805_Platelet count	3805_Platelet count	25	199	1	1202	3665	2972	1084	1553	199	607	2564	4405
2309_IL17RA - Interleukin-17 receptor A	2309_IL17RA - Interleukin-17 receptor A	25	199	1	3846	2631	3952	4124	986	713	199	3925	3850
4543_Gray matter	4543_Gray matter	25	199	1	3531	1803	1203	3873	4271	739	2683	2313	199
3720_Frequency of failure to fulfil normal expectations fue to drinking alcohol in last year	3720_Frequency of failure to fulfil normal expectations fue to drinking alcohol in last year	25	200	1	200	1579	3715	4619	2471	459	2932	1362	3715
4525_Left hippocampus	4525_Left hippocampus	25	200	1	4124	200	366	3275	1371	3283	4351	930	1643
2838_ENTPD3 - Ectonucleoside triphosphate diphosphohydrolase 3	2838_ENTPD3 - Ectonucleoside triphosphate diphosphohydrolase 3	25	200	1	4028	1550	200	3542	2062	1122	512	1052	4503
3920_Total cholesterol	3920_Total cholesterol	25	200	1	3125	2164	575	200	2648	3034	2116	4544	1243
3791_Ease of getting up in the morning	3791_Ease of getting up in the morning	25	200	1	3646	481	4190	583	200	2126	3603	1323	4715
3642_Illnesses of mother: Breast cancer	3642_Illnesses of mother: Breast cancer	25	200	1	4633	1944	4455	3131	684	200	2976	954	2489
4461_Left pars orbitalis	4461_Left pars orbitalis	25	200	1	3032	4714	2033	891	2126	2588	200	1585	441
1056_Systemic Lupus Erythematosus	1056_Systemic Lupus Erythematosus	25	200	1	4214	716	2601	1139	2226	3104	562	200	1730
3386_Work/job satisfaction	3386_Work/job satisfaction	25	201	1	4631	201	4298	2721	955	4011	4585	4206	3778
1706_Luteinizing hormone (at exam 3, FBAT, adjusted for age and sex)	1706_Luteinizing hormone (at exam 3, FBAT, adjusted for age and sex)	25	201	1	2750	1245	722	201	3447	1586	2833	1205	3530
4263_Ankylosing spondylitis	4263_Ankylosing spondylitis	25	201	1	4252	4333	448	4652	3322	928	205	201	2510
677_::::X-09026	677_::::X-09026	25	202	1	202	2279	341	2123	4288	2469	3294	1667	2717
4182_Low cholesterol lipoprotein	4182_Low cholesterol lipoprotein	25	202	1	1118	244	202	449	406	1741	4178	1228	1396
215_NK:%Eff	215_NK:%Eff	25	202	1	1194	2797	2924	202	2017	4240	1559	559	2230
1838_Neck width (FBAT, female, adjusted for age)	1838_Neck width (FBAT, female, adjusted for age)	25	202	1	1136	2981	990	3787	623	824	202	1568	1905
2895_SH2D1A - SH2 domain-containing protein 1A	2895_SH2D1A - SH2 domain-containing protein 1A	25	202	1	2341	4597	2359	2992	543	506	828	3365	202
1124_Subcutaneous adipose tissue attenuation (male)	1124_Subcutaneous adipose tissue attenuation (male)	25	203	1	203	2161	645	2206	2102	4332	4353	2225	2219
800_::::X-12749	800_::::X-12749	25	203	1	570	203	3641	1511	4591	1782	1938	2368	770
4240_Latent naming speed	4240_Latent naming speed	25	203	1	4430	2026	3640	203	3302	1629	1802	2094	3430
2667_FCN3 - Ficolin-3	2667_FCN3 - Ficolin-3	25	203	1	3299	1671	4301	2826	203	2781	1740	3786	1558
633_Xenobiotics::Food component, Plant::piperine	633_Xenobiotics::Food component, Plant::piperine	25	203	1	732	3906	1485	4610	3830	203	1763	4646	810
4368_Cannabis use	4368_Cannabis use	25	203	1	1361	1466	2554	378	1592	1621	3725	3056	203
1949_Visuospatial memory and organization (GEE, adjusted for multivariable)	1949_Visuospatial memory and organization (GEE, adjusted for multivariable)	25	204	1	204	4265	1316	3401	4089	4642	740	1515	2832
2394_GAS1 - Growth arrest-specific protein 1	2394_GAS1 - Growth arrest-specific protein 1	25	204	1	457	664	2082	204	3361	4414	1002	3177	1489
3447_Impedance measures - Impedance of whole body	3447_Impedance measures - Impedance of whole body	25	204	1	2542	983	4384	4724	204	2004	839	1633	1197
327_CD4mem:%Th9	327_CD4mem:%Th9	25	204	1	2652	328	4302	571	613	204	4587	1777	1203
1612_von Willebrand Factor (at exam 5, FBAT, adjusted for multivariable)	1612_von Willebrand Factor (at exam 5, FBAT, adjusted for multivariable)	25	204	1	4695	602	2047	1400	1773	4714	4385	204	2762
1672_Bilirubin (at exam 2, FBAT, adjusted for multivariable)	1672_Bilirubin (at exam 2, FBAT, adjusted for multivariable)	25	204	1	1917	2520	2348	4049	2509	2594	4716	612	204
3047_TNFRSF6B - Tumor necrosis factor receptor superfamily member 6B	3047_TNFRSF6B - Tumor necrosis factor receptor superfamily member 6B	25	205	1	205	2776	2291	2906	3422	722	752	2009	2180
2711_HINT1 - Histidine triad nucleotide-binding protein 1	2711_HINT1 - Histidine triad nucleotide-binding protein 1	25	205	1	2316	2000	205	1202	2623	502	3890	3616	4452
3785_Intelligence	3785_Intelligence	25	205	1	1403	2754	2491	205	3529	4458	3706	1411	2470
3727_Anxiety - Ever felt worried, tense, or anxious for most of a month or longer	3727_Anxiety - Ever felt worried, tense, or anxious for most of a month or longer	25	205	1	2218	368	657	2193	205	1987	2745	776	4029
4102_Blood sugar	4102_Blood sugar	25	205	1	901	4478	3581	3314	4721	205	2192	3723	4021
3129_MAP3K7 TAB1 - Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion	3129_MAP3K7 TAB1 - Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion	25	205	1	3796	1567	987	706	2192	4310	431	205	3486
1532_Ankle-brachial index (at exam 6, FBAT, adjusted for multivariable)	1532_Ankle-brachial index (at exam 6, FBAT, adjusted for multivariable)	25	205	1	4141	2995	725	1586	456	3399	965	1933	205
1999_Hip circumference	1999_Hip circumference	25	206	1	3848	206	2660	1386	2198	1537	3931	4190	1863
881_Total lipids in IDL	881_Total lipids in IDL	25	206	1	2511	3500	3619	206	4148	1756	3604	3969	2207
4662_Retrolenticular part of internal capsule fractional anisotropy	4662_Retrolenticular part of internal capsule fractional anisotropy	25	206	1	650	2484	3429	2538	554	1470	206	4164	3471
1183_Sleep duration (female)	1183_Sleep duration (female)	25	207	1	1925	207	3843	4166	1615	2254	2462	327	4701
4441_Epstein Barr Virus antigen EA IgG levels	4441_Epstein Barr Virus antigen EA IgG levels	25	207	1	270	2876	4598	207	4370	3717	3515	3161	2389
1849_Neck Section Modulus (GEE, male, adjusted for age)	1849_Neck Section Modulus (GEE, male, adjusted for age)	25	207	1	504	1401	2086	4544	207	4387	2957	2903	704
669_::::X-06267	669_::::X-06267	25	207	1	4572	2096	4007	1340	978	4462	207	1808	458
41_Educational attainment	41_Educational attainment	25	207	1	823	3553	2941	290	1011	3893	813	207	4203
1125_Subcutaneous adipose tissue attenuation (female)	1125_Subcutaneous adipose tissue attenuation (female)	25	207	1	643	268	4033	2190	1113	2145	3456	506	207
49_Age at first birth (male)	49_Age at first birth (male)	25	208	1	208	4092	3370	1758	4342	1686	2153	2854	2794
3396_Other sociodemographic factors - Private healthcare	3396_Other sociodemographic factors - Private healthcare	25	208	1	4355	525	208	3808	997	1244	3848	1849	1882
4211_Glycine level	4211_Glycine level	25	208	1	941	4299	1190	4223	2733	4265	874	208	3617
85_Femoral Neck BMD	85_Femoral Neck BMD	25	208	1	2406	4565	3321	4160	2302	4678	2106	3975	208
3614_Treatment/medication code: ventolin 100micrograms inhaler	3614_Treatment/medication code: ventolin 100micrograms inhaler	25	209	1	209	2064	4359	3791	2115	2717	439	2766	2718
1934_Temporal brain volume (FBAT, adjusted for age and sex)	1934_Temporal brain volume (FBAT, adjusted for age and sex)	25	209	1	1779	209	1361	4255	2976	2705	881	3349	3191
1629_Interleukin 6 (at exam 7, GEE, adjusted for multivariable)	1629_Interleukin 6 (at exam 7, GEE, adjusted for multivariable)	25	209	1	1009	370	2066	209	3629	768	249	683	440
1540_White matter hyperintensity volume (FBAT, adjusted for multivariable)	1540_White matter hyperintensity volume (FBAT, adjusted for multivariable)	25	209	1	4094	788	1159	4321	3790	209	4515	2976	1582
439_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,5-anhydroglucitol (1,5-AG)	439_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,5-anhydroglucitol (1,5-AG)	25	209	1	2352	684	751	4396	718	3418	2794	209	3044
4305_Trunk-trunk fat ratio (male)	4305_Trunk-trunk fat ratio (male)	25	209	1	3367	4309	3905	806	225	1024	756	753	209
1738_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for age and sex)	1738_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for age and sex)	25	210	1	210	2223	277	463	4150	3946	949	4132	745
606_Peptide::gamma-glutamyl::gamma-glutamylphenylalanine	606_Peptide::gamma-glutamyl::gamma-glutamylphenylalanine	25	210	1	4016	3669	210	517	3919	1640	4255	3368	2528
3080_NRXN1 - Neurexin-1-beta	3080_NRXN1 - Neurexin-1-beta	25	210	1	1692	2139	1635	210	3056	3191	3173	3652	2542
3251_Cheese intake	3251_Cheese intake	25	210	1	1039	1773	2366	1611	210	2509	4039	733	4394
1207_Longevity (>= 85 yrs vs < 65 yrs)	1207_Longevity (>= 85 yrs vs < 65 yrs)	25	210	1	1585	3602	2455	3722	4367	1543	4742	4105	210
1518_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	1518_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	25	211	1	2022	911	3601	211	1141	1157	4323	1422	2425
4012_Probable major dpressive disorder	4012_Probable major dpressive disorder	25	211	1	3683	4125	4689	2991	211	1748	1438	2018	1482
4537_Right pallidum	4537_Right pallidum	25	211	1	2176	3605	4424	3123	3187	211	3249	4501	3136
3663_Cancer register - Behaviour of cancer tumour: Malignant, primary site	3663_Cancer register - Behaviour of cancer tumour: Malignant, primary site	25	211	1	3371	4699	1372	3751	362	1211	211	4080	1551
3072_MICB - MHC class I polypeptide-related sequence B	3072_MICB - MHC class I polypeptide-related sequence B	25	211	1	2171	3844	2350	1859	2507	1994	1386	211	3574
1400_High-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	1400_High-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	211	1	3699	2669	3411	3719	2763	3268	3922	1280	211
4280_FEV1/FVC ratio	4280_FEV1/FVC ratio	25	212	1	212	1157	4113	1789	3584	2205	3204	2224	2888
3277_Maternal smoking around birth	3277_Maternal smoking around birth	25	212	1	1388	212	1082	2153	2037	1383	2344	1509	1188
2749_NTF4 - Neurotrophin-4	2749_NTF4 - Neurotrophin-4	25	212	1	2736	549	212	1371	4277	4074	2099	4349	3361
912_Free cholesterol in medium HDL	912_Free cholesterol in medium HDL	25	212	1	3412	4705	4274	212	3227	3316	3417	2573	3344
3064_JAG2 - Protein jagged-2	3064_JAG2 - Protein jagged-2	25	212	1	3911	4371	3608	4497	212	309	294	278	4396
590_Nucleotide::Pyrimidine metabolism, uracil containing::uridine	590_Nucleotide::Pyrimidine metabolism, uracil containing::uridine	25	212	1	3793	3244	2357	3744	2665	212	459	2934	2544
273_CD8:%SCM	273_CD8:%SCM	25	212	1	374	1192	3524	1978	4143	4395	4281	212	4022
2299_DSG1 - Desmoglein-1	2299_DSG1 - Desmoglein-1	25	213	1	213	315	3757	3551	834	1398	3425	1286	928
1864_Neck cross-sectional moment of inertia (FBAT, male, adjussted for age)	1864_Neck cross-sectional moment of inertia (FBAT, male, adjussted for age)	25	213	1	662	213	4234	2789	2912	4197	612	1614	1828
3536_Mental health - Illness, injury, bereavement, stress in last 2 years: Financial difficulties	3536_Mental health - Illness, injury, bereavement, stress in last 2 years: Financial difficulties	25	213	1	1858	2917	213	593	2704	701	3358	2673	321
883_Phospholipids in IDL	883_Phospholipids in IDL	25	213	1	2603	2518	3751	213	4490	1914	3486	3993	1364
3714_Diagnoses - secondary ICD10: Z90 Acquired absence of organs, not elsewhere classified	3714_Diagnoses - secondary ICD10: Z90 Acquired absence of organs, not elsewhere classified	25	213	1	3201	974	3027	2239	4072	213	4636	3886	4059
1378_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	1378_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	25	213	1	4718	314	1309	1537	1162	2059	1834	1586	213
3520_Current employment status: Retired	3520_Current employment status: Retired	25	214	1	214	3806	610	2278	4032	2119	1384	3040	257
3120_PRKAA2 PRKAB2 PRKAG1 - AMP Kinase (alpha2beta2gamma1)	3120_PRKAA2 PRKAB2 PRKAG1 - AMP Kinase (alpha2beta2gamma1)	25	214	1	2136	214	2069	3365	4412	4484	4143	2482	2642
4672_Body of corpus callosum axial diusivities	4672_Body of corpus callosum axial diusivities	25	214	1	812	2300	214	727	2022	913	2314	1219	522
3913_Cup area	3913_Cup area	25	214	1	1780	949	3180	214	3978	4073	895	4639	3054
3909_Vertical cup-disc ratio	3909_Vertical cup-disc ratio	25	214	1	1638	3639	2292	910	885	214	3713	3867	3343
349_CD8:%TM (2)	349_CD8:%TM (2)	25	214	1	3379	3666	2899	4371	1735	4507	2132	214	1770
2615_TEC - Tyrosine-protein kinase Tec	2615_TEC - Tyrosine-protein kinase Tec	25	214	1	2319	1952	556	3453	792	3133	741	900	214
4110_Estimated glomerular filtration rate	4110_Estimated glomerular filtration rate	25	215	1	3335	215	1847	1126	867	2029	244	1724	567
2105_ROR1 - Tyrosine-protein kinase transmembrane receptor ROR1	2105_ROR1 - Tyrosine-protein kinase transmembrane receptor ROR1	25	215	1	2584	2386	215	1676	2306	451	2689	1663	2454
4455_Left lingual	4455_Left lingual	25	215	1	1547	590	3557	4368	215	1844	723	2859	3303
1129_Ratio of visceral-tosubcutaneous adipose tissue volume	1129_Ratio of visceral-tosubcutaneous adipose tissue volume	25	215	1	2412	2558	2020	4175	4736	215	856	3692	1531
3606_Non-cancer illness code, self-reported: eczema/dermatitis	3606_Non-cancer illness code, self-reported: eczema/dermatitis	25	215	1	978	4085	532	1402	1327	974	215	228	380
2738_HBEGF - Heparin-binding EGF-like growth factor	2738_HBEGF - Heparin-binding EGF-like growth factor	25	215	1	1663	747	4404	4473	611	4526	2357	215	2117
554_Lipid::Medium chain fatty acid::5-dodecenoate (12:1n7)	554_Lipid::Medium chain fatty acid::5-dodecenoate (12:1n7)	25	215	1	3231	2250	3246	3968	4360	2941	488	1857	215
1801_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1801_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	216	1	216	1474	989	1736	664	909	2001	280	3955
1064_Bipolar disorder	1064_Bipolar disorder	25	216	1	4672	4425	216	4648	2485	3394	1715	2888	847
70_Low-density lipoprotein cholesterol	70_Low-density lipoprotein cholesterol	25	216	1	1728	282	1486	216	597	1297	4196	860	3351
37_Loneliness (case/control)	37_Loneliness (case/control)	25	216	1	4128	3112	535	324	216	2201	574	2634	775
2523_GSK3A GSK3B - Glycogen synthase kinase-3 alpha/beta	2523_GSK3A GSK3B - Glycogen synthase kinase-3 alpha/beta	25	216	1	2471	3273	4137	3316	1495	919	3404	216	590
3715_Diagnoses - secondary ICD10: Z92 Personal history of medical treatment	3715_Diagnoses - secondary ICD10: Z92 Personal history of medical treatment	25	216	1	3944	3983	316	4247	3727	2667	903	1050	216
1592_Log ADP platelet aggregation (at exam 5, FBAT, adjusted for multivariable)	1592_Log ADP platelet aggregation (at exam 5, FBAT, adjusted for multivariable)	25	217	1	217	4147	2271	887	4174	4645	786	1482	3160
3266_Average weekly fortified wine intake	3266_Average weekly fortified wine intake	25	217	1	1719	217	1507	489	1142	830	1024	3185	2530
59_Childhood IQ	59_Childhood IQ	25	217	1	3321	4482	4140	217	2829	3822	1939	4208	4253
297_CD4mem:%Th22	297_CD4mem:%Th22	25	217	1	2856	2960	4316	2326	4169	217	652	775	545
3812_CD3+ T cell level	3812_CD3+ T cell level	25	217	1	1119	1458	1403	1678	1321	2194	217	4470	515
2634_CDKN1B - Cyclin-dependent kinase inhibitor 1B	2634_CDKN1B - Cyclin-dependent kinase inhibitor 1B	25	217	1	3538	750	3439	1779	2448	1309	864	217	1996
1946_Visual memory composite score (FBAT, adjusted for multivariable)	1946_Visual memory composite score (FBAT, adjusted for multivariable)	25	218	1	3771	3386	218	2165	2026	2478	4649	2448	1127
1249_Percent predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	1249_Percent predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	25	218	1	561	2447	1359	218	1810	333	3125	240	2914
4656_Fornix (cres) / Stria terminalis fractional anisotropy	4656_Fornix (cres) / Stria terminalis fractional anisotropy	25	218	1	2114	850	4212	2246	218	1538	2368	738	4500
2243_ARG1 - Arginase-1	2243_ARG1 - Arginase-1	25	218	1	2939	3741	3906	540	1235	218	2367	4699	3310
1559_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1559_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	218	1	4689	2842	3995	2881	2596	1423	218	3169	2654
3988_Heart rate recovery at 40 secnds	3988_Heart rate recovery at 40 secnds	25	219	1	219	1774	224	4381	2260	1103	3089	2497	328
260_CD8:%TE	260_CD8:%TE	25	219	1	1279	219	4649	1393	4253	1574	4698	4656	3522
570_Lipid::Sterol, Steroid::5alpha-androstan-3beta,17beta-diol disulfate	570_Lipid::Sterol, Steroid::5alpha-androstan-3beta,17beta-diol disulfate	25	219	1	313	3826	219	4410	1958	4511	3753	2523	1378
879_Total cholesterol in IDL	879_Total cholesterol in IDL	25	219	1	3737	4360	2461	219	2612	1445	3453	4641	2925
3947_11q deletion neuroblastoma	3947_11q deletion neuroblastoma	25	219	1	4253	284	2422	3635	219	689	4567	809	4039
1984_Age at natural menopause (FBAT, adjusted for multivariable)	1984_Age at natural menopause (FBAT, adjusted for multivariable)	25	219	1	743	3819	2502	4194	1500	219	400	3014	2761
1470_Lipoprotein A (at exam 3, FBAT, adjusted for age and sex)	1470_Lipoprotein A (at exam 3, FBAT, adjusted for age and sex)	25	219	1	1374	718	2310	2574	2514	4587	3497	219	700
2609_OCIAD1 - OCIA domain-containing protein 1	2609_OCIAD1 - OCIA domain-containing protein 1	25	219	1	964	1982	3122	1555	227	408	2712	4602	219
58_College completion	58_College completion	25	220	1	220	3016	4599	4454	3688	1298	3822	4660	2943
3554_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Cholesterol lowering medication	3554_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Cholesterol lowering medication	25	220	1	2225	220	1856	814	952	1913	4113	1953	3724
2701_TPT1 - Translationally-controlled tumor protein	2701_TPT1 - Translationally-controlled tumor protein	25	220	1	2764	3057	220	2102	4026	4151	2050	3336	1177
3383_Prospective memory test - Number of attempts	3383_Prospective memory test - Number of attempts	25	220	1	255	4569	812	3947	4608	289	220	948	1090
480_Lipid::Carnitine metabolism::decanoylcarnitine	480_Lipid::Carnitine metabolism::decanoylcarnitine	25	221	1	221	2443	3747	3826	2467	1043	3864	1468	2153
4460_Left pars opercularis	4460_Left pars opercularis	25	221	1	1127	221	1055	2500	414	3050	1370	3497	4664
1723_Serum calcium (at exam 2, GEE, adjusted for age and sex)	1723_Serum calcium (at exam 2, GEE, adjusted for age and sex)	25	221	1	675	3913	221	510	3882	2065	4324	4394	783
4153_Fractional shortening	4153_Fractional shortening	25	221	1	421	2020	2396	221	3506	3056	3473	3289	1154
3440_Impedance measures - Weight	3440_Impedance measures - Weight	25	221	1	4069	758	2851	372	807	2920	221	3143	4443
4264_Ankylosing spondylitis	4264_Ankylosing spondylitis	25	221	1	4494	3721	271	3387	3036	1137	264	221	3755
3067_KIR3DL2 - Killer cell immunoglobulin-like receptor 3DL2	3067_KIR3DL2 - Killer cell immunoglobulin-like receptor 3DL2	25	222	1	222	2421	1879	4482	4438	3842	3205	872	4507
1084_Hemoglobin A1C level	1084_Hemoglobin A1C level	25	222	1	2488	222	1722	1185	1248	3230	4110	3725	3592
3738_Depression - Lifetime number of depressed periods	3738_Depression - Lifetime number of depressed periods	25	222	1	4400	4358	3955	222	3242	2942	4155	4193	3100
3847_Immature fraction of reticulocytes (two-way meta)	3847_Immature fraction of reticulocytes (two-way meta)	25	222	1	3663	1778	2843	293	651	222	1848	890	604
469_Lipid::Bile acid metabolism::hyodeoxycholate	469_Lipid::Bile acid metabolism::hyodeoxycholate	25	222	1	3998	3297	3744	3418	1070	1135	222	3510	1970
4551_Left inferior parietal	4551_Left inferior parietal	25	222	1	2851	4608	679	4013	603	1374	858	3239	222
4504_Right supramarginal	4504_Right supramarginal	25	223	1	223	2900	1918	1370	2814	3053	820	3576	1171
1588_Factor VII (at exam 5, FBAT, adjusted for multivariable)	1588_Factor VII (at exam 5, FBAT, adjusted for multivariable)	25	223	1	3719	223	3766	283	2482	3470	1961	258	2458
126_Height (male)	126_Height (male)	25	223	1	2396	4059	2645	223	2855	3904	3021	435	4163
557_Lipid::Medium chain fatty acid::caprylate (8:0)	557_Lipid::Medium chain fatty acid::caprylate (8:0)	25	223	1	2522	4610	4048	2941	223	1823	4271	2846	1140
4680_Inferior fronto-occipital fasciculus axial diusivities	4680_Inferior fronto-occipital fasciculus axial diusivities	25	224	1	224	1744	1249	2366	1016	4429	4501	2972	1422
354_IgE+B:%27+20-38+	354_IgE+B:%27+20-38+	25	224	1	2951	224	2052	4238	4306	1454	1582	3212	3130
4409_Vaginal discharge: Metrorrhagia	4409_Vaginal discharge: Metrorrhagia	25	224	1	569	859	4120	224	3592	3517	4408	4737	2702
78_Femoral Neck BMD (males)	78_Femoral Neck BMD (males)	25	224	1	3425	1811	1947	3475	224	2282	279	4421	753
293_CD4:%Act(PD1+127+39-73-)	293_CD4:%Act(PD1+127+39-73-)	25	224	1	1987	396	4604	3300	2754	224	315	608	834
3222_Drive faster than motorway speed limit	3222_Drive faster than motorway speed limit	25	224	1	1060	1487	4525	811	388	1054	224	3857	1612
3232_Sleeplessness / insomnia	3232_Sleeplessness / insomnia	25	224	1	1179	2730	3551	1727	3206	3852	4344	224	2680
4052_25-Hydroxyvitamin D level	4052_25-Hydroxyvitamin D level	25	225	1	225	326	4616	1703	1243	4415	4372	1173	901
3488_Cereal type: Bran cereal (e.g. All Bran, Branflakes)	3488_Cereal type: Bran cereal (e.g. All Bran, Branflakes)	25	225	1	3785	225	3806	3755	286	4686	1149	3280	471
1564_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1564_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	225	1	3177	3024	225	3196	341	4514	1819	4113	4182
3865_Red cell distribution width (two-way meta)	3865_Red cell distribution width (two-way meta)	25	225	1	4398	422	1955	225	4539	837	2779	4004	3325
2768_PGD - 6-phosphogluconate dehydrogenase, decarboxylating	2768_PGD - 6-phosphogluconate dehydrogenase, decarboxylating	25	225	1	1803	3834	1870	4266	594	2036	225	3391	871
2191_FAM107A - Protein FAM107A	2191_FAM107A - Protein FAM107A	25	225	1	1670	1246	2238	3844	1813	1589	4147	225	3609
4451_Left inferior temporal	4451_Left inferior temporal	25	225	1	1330	4131	719	2920	936	1595	3531	424	225
2832_ADAM12 - Disintegrin and metalloproteinase domain-containing protein 12	2832_ADAM12 - Disintegrin and metalloproteinase domain-containing protein 12	25	226	1	4036	226	1451	4119	1802	1694	880	1187	3150
2577_AHSG - Alpha-2-HS-glycoprotein	2577_AHSG - Alpha-2-HS-glycoprotein	25	226	1	469	3267	226	3984	2645	2030	2610	944	1338
907_Total cholesterol in LDL	907_Total cholesterol in LDL	25	226	1	2524	3700	4203	226	4732	1813	2237	4671	2011
548_Lipid::Lysolipid::1-stearoylglycerophosphoinositol	548_Lipid::Lysolipid::1-stearoylglycerophosphoinositol	25	226	1	1819	1300	1166	3501	226	2335	1112	2015	3689
1825_Inter-trochanteric buckling ratio (GEE, male, adjussted for age)	1825_Inter-trochanteric buckling ratio (GEE, male, adjussted for age)	25	226	1	3317	3692	1025	2642	4199	226	4586	2631	1599
4213_Glycine level (female)	4213_Glycine level (female)	25	226	1	2012	3443	799	4542	983	3166	420	226	4327
3045_CRTAM - Cytotoxic and regulatory T-cell molecule	3045_CRTAM - Cytotoxic and regulatory T-cell molecule	25	227	1	361	227	4050	711	4519	3784	3291	1571	3432
1661_Alkaline phosphatase (at exam 2, GEE, adjusted for multivariable)	1661_Alkaline phosphatase (at exam 2, GEE, adjusted for multivariable)	25	227	1	3063	4189	261	227	4002	1425	1188	1990	1805
2470_CA6 - Carbonic anhydrase 6	2470_CA6 - Carbonic anhydrase 6	25	227	1	2703	3332	887	1173	1520	227	1133	4721	1118
4450_Left inferior parietal	4450_Left inferior parietal	25	227	1	4573	4154	1134	3597	724	2527	2778	2001	227
3456_Impedance measures - Leg fat percentage (left)	3456_Impedance measures - Leg fat percentage (left)	25	228	1	228	1467	4130	1365	435	4312	3965	3329	4422
968_Triglycerides in very small VLDL	968_Triglycerides in very small VLDL	25	228	1	1237	228	1586	4567	448	4401	4603	1502	4445
701_::::X-11437	701_::::X-11437	25	228	1	3682	1148	228	503	3067	1963	1953	1723	236
2720_PGAM1 - Phosphoglycerate mutase 1	2720_PGAM1 - Phosphoglycerate mutase 1	25	228	1	2761	415	1102	2995	1779	856	228	4255	2142
2266_IL4 - Interleukin-4	2266_IL4 - Interleukin-4	25	228	1	1161	480	560	1851	2667	3857	3675	4536	228
2875_CDON - Cell adhesion molecule-related/down-regulated by oncogenes	2875_CDON - Cell adhesion molecule-related/down-regulated by oncogenes	25	229	1	229	1165	4211	3489	3246	3718	2849	4450	2191
675_::::X-08766	675_::::X-08766	25	229	1	640	229	393	4259	2009	375	550	3384	1768
157_Hip circumference (male)	157_Hip circumference (male)	25	229	1	3995	3229	625	229	4512	1547	3349	1863	3870
665_::::X-05907	665_::::X-05907	25	229	1	2582	4451	2226	3540	1770	259	229	1783	2342
4191_QT interval	4191_QT interval	25	229	1	1705	2612	3135	4600	3362	3254	2138	2105	229
4572_Left superior parietal	4572_Left superior parietal	25	230	1	4586	1368	2991	230	4589	3618	2241	4516	3110
3550_Vascular/heart problems diagnosed by doctor: Angina	3550_Vascular/heart problems diagnosed by doctor: Angina	25	230	1	3760	1598	2311	4495	230	434	297	1714	2256
4645_White matter	4645_White matter	25	230	1	3618	2592	2118	4094	1272	230	1105	4115	3516
2794_PES1 - Pescadillo homolog	2794_PES1 - Pescadillo homolog	25	230	1	1353	2548	355	1421	529	3733	548	230	4298
3170_TNNI2 - Troponin I, fast skeletal muscle	3170_TNNI2 - Troponin I, fast skeletal muscle	25	231	1	231	4609	3169	2412	1861	775	1667	1339	1712
1644_Osteoprotegerin (at exam 7, FBAT, adjusted for multivariable)	1644_Osteoprotegerin (at exam 7, FBAT, adjusted for multivariable)	25	231	1	1236	231	1590	1192	1660	3274	1131	3976	291
97_Height SDS (male at age 12)	97_Height SDS (male at age 12)	25	231	1	1629	1669	231	359	3102	2097	4700	2765	3276
46_Baldness	46_Baldness	25	231	1	1797	2576	324	231	4334	3507	4174	4137	2543
1808_Total power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1808_Total power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	231	1	3501	348	1783	749	1322	231	3985	231	1764
3689_Diagnoses - secondary ICD10: F17 Nicotine dependence	3689_Diagnoses - secondary ICD10: F17 Nicotine dependence	25	232	1	1228	2975	232	3921	4358	2109	3431	2855	1416
2301_CXCL5 - C-X-C motif chemokine 5	2301_CXCL5 - C-X-C motif chemokine 5	25	232	1	940	3448	885	232	3779	1832	1280	1717	2849
3260_Variation in diet	3260_Variation in diet	25	233	1	233	2387	1946	2661	1360	2772	1786	967	4548
3905_Intraocular pressure	3905_Intraocular pressure	25	233	1	4723	233	1029	2068	960	3975	3122	4238	2417
3208_Number of days/week of vigorous physical activity 10+ minutes	3208_Number of days/week of vigorous physical activity 10+ minutes	25	233	1	4050	2630	233	3706	2053	1562	1394	3956	2592
23_Major depressive disorder (females)	23_Major depressive disorder (females)	25	233	1	2297	2798	952	233	1658	2081	3421	426	934
1155_Insulin sensitivity index	1155_Insulin sensitivity index	25	233	1	2130	1760	2273	1398	233	2975	860	1754	3314
1517_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	1517_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	25	233	1	4408	4034	2045	2912	691	427	233	4533	4129
1277_Sabuctaneous fat by CT (GEE, adjusted for age and sex)	1277_Sabuctaneous fat by CT (GEE, adjusted for age and sex)	25	233	1	4431	3575	4559	3408	1186	4210	2168	233	3831
1344_Plasma Apolipoprotein A-I level (FBAT, multivariate adjusted)	1344_Plasma Apolipoprotein A-I level (FBAT, multivariate adjusted)	25	234	1	234	250	4247	4170	1643	3728	2820	2688	576
908_LDL diameter	908_LDL diameter	25	234	1	3653	4460	234	1934	864	3531	1351	2416	1250
3226_Difference in mobile phone use compared to two years previously	3226_Difference in mobile phone use compared to two years previously	25	234	1	3959	486	3912	234	1192	3843	2749	2021	2819
4536_Right putamen	4536_Right putamen	25	234	1	2311	1015	1529	692	234	664	2178	2092	1342
783_::::X-12524	783_::::X-12524	25	234	1	1050	686	3753	2541	1448	1714	814	234	4368
437_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannitol	437_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannitol	25	234	1	4474	505	2641	3741	455	3172	3452	897	234
3630_Illnesses of father: Lung cancer	3630_Illnesses of father: Lung cancer	25	235	1	2181	3040	235	4342	2020	3859	668	1612	2514
3024_UCHL1 - Ubiquitin carboxyl-terminal hydrolase isozyme L1	3024_UCHL1 - Ubiquitin carboxyl-terminal hydrolase isozyme L1	25	235	1	279	2112	1474	235	2762	985	595	3265	2996
55_Neuroticism	55_Neuroticism	24	235	1	2745	630	2098	4585	235	2684	388	1029	652
2321_TSLP - Thymic stromal lymphopoietin	2321_TSLP - Thymic stromal lymphopoietin	25	235	1	1683	1270	1017	2487	297	4680	2705	235	1152
4637_Right putamen	4637_Right putamen	25	235	1	1656	1795	1324	400	1758	257	1175	4556	235
1247_Mean FEV1/FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	1247_Mean FEV1/FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	236	1	236	1601	945	681	2670	1811	4132	548	1572
1136_Parents' age at death	1136_Parents' age at death	25	236	1	2133	236	3443	1249	2240	3977	4142	4391	2062
2769_AKR7A2 - Aflatoxin B1 aldehyde reductase member 2	2769_AKR7A2 - Aflatoxin B1 aldehyde reductase member 2	25	236	1	1419	2913	236	4709	2579	1360	2188	3069	2461
1437_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1437_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	236	1	1909	444	4171	236	561	2569	2470	1377	4598
3792_Daytime napping	3792_Daytime napping	25	236	1	400	308	2797	1316	236	3548	1273	1788	2524
1159_Fasting insulin main effect	1159_Fasting insulin main effect	25	236	1	4188	4142	1323	4005	632	236	1555	2909	1496
3789_Morningness	3789_Morningness	25	236	1	2695	1970	1301	3701	2158	4110	1003	236	2503
2728_HSPA1A - Heat shock 70 kDa protein 1A/1B	2728_HSPA1A - Heat shock 70 kDa protein 1A/1B	25	237	1	237	1571	3039	3348	2134	1938	2730	1858	2048
4374_Free thyroxine (FT4, female)	4374_Free thyroxine (FT4, female)	25	237	1	1774	237	1122	1050	961	3261	3788	605	3676
2254_RAC1 - Ras-related C3 botulinum toxin substrate 1	2254_RAC1 - Ras-related C3 botulinum toxin substrate 1	25	237	1	2433	1066	237	1849	1820	2078	636	1319	2932
981_Interleukin-10	981_Interleukin-10	25	237	1	3058	4622	3220	237	2038	1818	4238	3710	3292
1636_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for multivariable)	1636_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for multivariable)	25	237	1	2131	1604	3305	4326	3833	4613	4496	237	2620
605_Peptide::gamma-glutamyl::gamma-glutamylmethionine*	605_Peptide::gamma-glutamyl::gamma-glutamylmethionine*	25	237	1	1868	1555	2330	495	3774	3233	2320	3472	237
1752_Cystatin C (at exam 7, FBAT, adjusted for multivariable)	1752_Cystatin C (at exam 7, FBAT, adjusted for multivariable)	25	238	1	238	2180	843	893	3291	285	3252	520	2013
27_Neuroticism (NEO-FFI)	27_Neuroticism (NEO-FFI)	25	238	1	3356	253	238	3507	2350	2172	3700	1250	950
340_NKeff:%2+337-R7-	340_NKeff:%2+337-R7-	25	238	1	2408	1537	2842	238	3906	3100	2101	2252	2672
3658_Cancer register - Type of cancer: ICD10: C44 Other and unspecified malignant neoplasm of skin	3658_Cancer register - Type of cancer: ICD10: C44 Other and unspecified malignant neoplasm of skin	25	238	1	1426	4483	1628	2594	4521	238	300	4020	2186
3248_Beef intake	3248_Beef intake	25	238	1	862	265	3034	347	577	1853	238	905	4606
2361_F10 - Coagulation factor Xa	2361_F10 - Coagulation factor Xa	25	238	1	799	4042	3436	3451	2370	4044	1020	2107	238
3770_Depression - Trouble falling or staying asleep. or sleeping too much	3770_Depression - Trouble falling or staying asleep. or sleeping too much	25	239	1	1219	239	2967	2620	3062	3243	2503	2407	3914
3441_Impedance measures - Body fat percentage	3441_Impedance measures - Body fat percentage	25	239	1	843	1924	239	325	1841	4086	3084	3946	3738
1597_Platelet aggregation to collagen (at exam 5, GEE, adjusted for multivariable)	1597_Platelet aggregation to collagen (at exam 5, GEE, adjusted for multivariable)	25	239	1	2386	3704	1019	239	4461	1837	3506	3164	2228
2521_FSTL3 - Follistatin-related protein 3	2521_FSTL3 - Follistatin-related protein 3	25	239	1	1694	1755	3183	3080	3555	1620	2202	239	706
3797_Depressive affect subcluster	3797_Depressive affect subcluster	25	239	1	887	414	1374	817	1048	476	2555	2862	239
3373_Knee pain for 3+ months	3373_Knee pain for 3+ months	25	240	1	240	3000	867	1291	444	4354	2416	1647	1100
1714_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for multivariable)	1714_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for multivariable)	25	240	1	3655	240	4239	1135	1372	2330	3246	373	3025
2438_CST6 - Cystatin-M	2438_CST6 - Cystatin-M	25	240	1	2051	2802	3142	240	2515	1533	545	530	4703
1043_Shaft Width (GEE, adjusted for multivariable)	1043_Shaft Width (GEE, adjusted for multivariable)	25	240	1	1140	3734	2921	1027	436	240	680	1169	358
3317_Falls in the last year	3317_Falls in the last year	25	240	1	563	2934	2313	4545	264	1249	240	349	4418
171_Waist circumference (female)	171_Waist circumference (female)	25	241	1	241	2948	3445	912	4343	2356	2518	2606	4565
936_Total cholesterol in small LDL	936_Total cholesterol in small LDL	25	241	1	2925	2572	4612	241	4206	3263	2019	4217	1329
1754_Cancer (FBAT, adjusted for age and sex)	1754_Cancer (FBAT, adjusted for age and sex)	25	241	1	888	1763	1808	2548	241	3376	1068	367	2173
2775_EPS15L1 - Epidermal growth factor receptor substrate 15-like 1	2775_EPS15L1 - Epidermal growth factor receptor substrate 15-like 1	25	241	1	4057	3313	3646	4446	1783	1192	241	3262	2803
1257_Percent predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	1257_Percent predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	25	241	1	513	3449	2880	3832	2305	3763	2142	241	3635
425_Amino acid::Valine, leucine and isoleucine metabolism::alpha-hydroxyisovalerate	425_Amino acid::Valine, leucine and isoleucine metabolism::alpha-hydroxyisovalerate	25	242	1	242	2998	2285	4169	969	4498	811	3766	2405
946_Serum total triglycerides	946_Serum total triglycerides	25	242	1	1178	242	3149	4151	1027	4302	4531	667	919
421_Amino acid::Valine, leucine and isoleucine metabolism::2-methylbutyroylcarnitine	421_Amino acid::Valine, leucine and isoleucine metabolism::2-methylbutyroylcarnitine	25	242	1	4442	2912	242	3911	477	3765	729	2432	506
3868_White blood cell count (two-way meta)	3868_White blood cell count (two-way meta)	25	242	1	835	2907	440	242	1451	379	245	597	904
1367_Total cholesterol (at exam 5, GEE, adjusted for age and sex)	1367_Total cholesterol (at exam 5, GEE, adjusted for age and sex)	25	242	1	4230	2193	4342	1038	3289	2445	3304	242	1431
1531_Ankle-brachial index (at exam 6, GEE, adjusted for age and sex)	1531_Ankle-brachial index (at exam 6, GEE, adjusted for age and sex)	25	242	1	822	2497	1285	2947	1786	1487	3353	1213	242
3709_Diagnoses - secondary ICD10: Z82 Family history of certain disabilities and chronic diseases (leading to disablement)	3709_Diagnoses - secondary ICD10: Z82 Family history of certain disabilities and chronic diseases (leading to disablement)	25	243	1	243	2785	1827	2177	1040	699	1472	2724	3658
2494_AKT1 AKT2 AKT3 - Protein kinase B alpha/beta/gamma	2494_AKT1 AKT2 AKT3 - Protein kinase B alpha/beta/gamma	25	243	1	1709	2116	243	3112	3494	3604	4570	3307	2285
4127_Lactate dehydrogenase	4127_Lactate dehydrogenase	25	243	1	1696	709	1884	2938	243	672	4561	1293	3311
2499_TBK1 - Serine/threonine-protein kinase TBK1	2499_TBK1 - Serine/threonine-protein kinase TBK1	25	243	1	1182	1849	3859	2258	1484	2348	243	4434	3797
197_Urinary albumin-to-creatinine ratio	197_Urinary albumin-to-creatinine ratio	25	243	1	3426	2345	3962	4113	4301	3687	2635	3739	243
4679_Genu of corpus callosum axial diusivities	4679_Genu of corpus callosum axial diusivities	25	244	1	244	792	335	3666	2130	4454	394	2663	1588
3480_Milk type used: Full cream	3480_Milk type used: Full cream	25	244	1	4694	3328	244	2194	4699	3696	1747	858	1494
44_Household income	44_Household income	25	244	1	1766	1572	4080	244	751	3234	2057	3958	613
473_Lipid::Bile acid metabolism::taurolithocholate 3-sulfate	473_Lipid::Bile acid metabolism::taurolithocholate 3-sulfate	25	245	1	1143	245	1829	3907	3835	900	2830	2016	4388
4529_Left vessel	4529_Left vessel	25	245	1	2358	4521	245	3187	4071	1380	2371	345	642
18_Former versus current smokers	18_Former versus current smokers	25	245	1	3290	4420	2344	245	544	1481	1476	2077	2477
1239_Rate of decline FEF25-75 (GEE, adjusted for multiple covariates)	1239_Rate of decline FEF25-75 (GEE, adjusted for multiple covariates)	25	245	1	3892	1359	4254	2373	245	343	1000	665	3053
3757_Mania - Ever had period extreme irritability	3757_Mania - Ever had period extreme irritability	25	245	1	4375	3847	4063	2189	3236	245	3824	3165	4122
1286_Visceral fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	1286_Visceral fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	245	1	2179	4279	1480	2733	1540	3420	3194	245	1993
373_Amino acid::Cysteine, methionine, SAM, taurine metabolism::methionine	373_Amino acid::Cysteine, methionine, SAM, taurine metabolism::methionine	25	245	1	3953	4184	2983	1289	466	3641	1924	3322	245
67_Inflammatory Bowel Disease	67_Inflammatory Bowel Disease	25	246	1	246	3994	1185	1193	367	1739	458	352	1225
4131_Eosinophil count	4131_Eosinophil count	25	246	1	1048	246	4651	1389	3427	1758	4330	3467	4556
3134_GRAP2 - GRB2-related adapter protein 2	3134_GRAP2 - GRB2-related adapter protein 2	25	246	1	498	3369	4114	246	3500	3957	1963	4081	2950
1841_Neck width (GEE, male, adjusted for age)	1841_Neck width (GEE, male, adjusted for age)	25	246	1	3165	1117	3900	1836	246	3068	1194	303	2172
1354_Plasma Apolipoprotein C3 level (FBAT, adjusted for age and sex)	1354_Plasma Apolipoprotein C3 level (FBAT, adjusted for age and sex)	25	246	1	1890	2711	476	4377	1462	246	4069	4541	1081
994_Interleukin-7	994_Interleukin-7	25	246	1	2912	1084	3898	1737	361	2497	1362	246	4650
3149_CKAP2 - Cytoskeleton-associated protein 2	3149_CKAP2 - Cytoskeleton-associated protein 2	25	246	1	730	1169	4099	4354	1900	4390	1505	2952	246
3220_Time spent using computer	3220_Time spent using computer	25	247	1	3071	627	3575	2443	247	2587	3438	992	2018
3775_Traumatic events - Able to pay rent/morgage as an adult	3775_Traumatic events - Able to pay rent/morgage as an adult	25	247	1	2232	2841	4181	1602	3558	247	3474	1611	490
4373_Free thyroxine (FT4, male)	4373_Free thyroxine (FT4, male)	25	247	1	3033	2875	1312	3047	3107	3775	247	3134	3698
217_NKT:%4+R5-	217_NKT:%4+R5-	25	247	1	2245	3081	3225	3673	2610	4568	4368	247	394
3955_Ankle injury (random effect)	3955_Ankle injury (random effect)	25	247	1	302	780	3014	2056	4157	2475	3815	3982	247
1824_Inter-trochanteric buckling ratio (FBAT, male, adjussted for age)	1824_Inter-trochanteric buckling ratio (FBAT, male, adjussted for age)	25	248	1	248	3048	935	3488	1707	1664	1771	1600	1043
4617_Optic chiasm	4617_Optic chiasm	25	248	1	3128	248	3307	1949	1176	3603	567	1670	4307
90_Body Mass Index - Child	90_Body Mass Index - Child	25	249	1	249	2543	309	3604	3899	2741	1756	3715	2564
4714_Anterior limb of internal capsule mode of anisotropy	4714_Anterior limb of internal capsule mode of anisotropy	25	249	1	3881	249	2576	1463	3282	2671	1688	2769	3556
4685_Splenium of corpus callosum axial diusivities	4685_Splenium of corpus callosum axial diusivities	25	249	1	3802	2512	249	1683	658	855	1498	3675	772
3297_Frequency of depressed mood in last 2 weeks	3297_Frequency of depressed mood in last 2 weeks	25	249	1	4359	2596	3548	249	442	2968	4082	1308	3051
3421_Pairs matching test - Time to complete round	3421_Pairs matching test - Time to complete round	25	249	1	4429	2126	2962	2602	2394	249	1628	3815	468
2693_ACP1 - Low molecular weight phosphotyrosine protein phosphatase	2693_ACP1 - Low molecular weight phosphotyrosine protein phosphatase	25	249	1	4370	1781	4516	2164	3409	1350	3738	3696	249
4166_Body Mass Index	4166_Body Mass Index	25	250	1	250	4241	4219	1099	2652	2627	2747	4294	2922
1454_Low-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	1454_Low-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	250	1	2586	4342	2616	250	974	661	647	3255	2474
716_::::X-11521	716_::::X-11521	25	250	1	2708	3100	4067	482	250	3076	1948	1379	3921
2622_CFHR5 - Complement factor H-related protein 5	2622_CFHR5 - Complement factor H-related protein 5	25	250	1	2884	1416	3451	2604	2066	250	2156	2425	1550
525_Lipid::Long chain fatty acid::palmitate (16:0)	525_Lipid::Long chain fatty acid::palmitate (16:0)	25	251	1	251	1206	3701	1723	2642	4119	1709	4628	634
3164_BRF1 - Transcription factor IIIB 90 kDa subunit	3164_BRF1 - Transcription factor IIIB 90 kDa subunit	25	251	1	454	1517	251	1657	4696	2864	368	3618	2291
4100_Low-density-lipoprotein cholesterol	4100_Low-density-lipoprotein cholesterol	25	251	1	3678	2072	938	4333	251	424	1566	958	651
1634_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for age and sex)	1634_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for age and sex)	25	251	1	3376	2468	2708	4612	3595	4061	4592	251	2106
1775_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for multivariable)	1775_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for multivariable)	25	252	1	2746	252	505	1095	650	3067	1234	4546	4534
1760_Breast cancer (FBAT, adjusted for age and BMI)	1760_Breast cancer (FBAT, adjusted for age and BMI)	25	252	1	3583	2927	252	527	4433	4238	664	2310	4152
2980_C1QBP - Complement component 1 Q subcomponent-binding protein, mitochondrial	2980_C1QBP - Complement component 1 Q subcomponent-binding protein, mitochondrial	25	252	1	3133	976	2615	252	3892	4712	2987	3974	3107
2905_LTA - Lymphotoxin-alpha	2905_LTA - Lymphotoxin-alpha	25	252	1	4258	2643	1009	2161	1521	862	252	2568	1344
3202_Job involves shift work	3202_Job involves shift work	25	252	1	2013	1953	1064	565	321	2332	360	252	4539
2383_ADAMTS13 - A disintegrin and metalloproteinase with thrombospondin motifs 13	2383_ADAMTS13 - A disintegrin and metalloproteinase with thrombospondin motifs 13	25	253	1	253	2192	2077	3602	2844	2123	2989	2749	624
3031_CD163 - Scavenger receptor cysteine-rich type 1 protein M130	3031_CD163 - Scavenger receptor cysteine-rich type 1 protein M130	25	253	1	2788	1958	253	4211	4171	4671	1143	1680	1634
2227_SPINT1 - Kunitz-type protease inhibitor 1	2227_SPINT1 - Kunitz-type protease inhibitor 1	25	253	1	4477	4510	764	3848	4621	253	1666	663	1633
1534_Ankle-brachial index (at exam 7, FBAT, adjusted for age and sex)	1534_Ankle-brachial index (at exam 7, FBAT, adjusted for age and sex)	25	253	1	2852	3585	3408	3795	338	2149	253	1057	2756
1325_Fasting plasma glucose (at exam 7, GEE, adjusted for age, sex and BMI)	1325_Fasting plasma glucose (at exam 7, GEE, adjusted for age, sex and BMI)	24	253	1	4346	1049	3287	4224	1440	1206	1080	253	2682
2773_VTA1 - Vacuolar protein sorting-associated protein VTA1 homolog	2773_VTA1 - Vacuolar protein sorting-associated protein VTA1 homolog	25	253	1	3631	4729	412	3299	2243	2130	1325	1922	253
2111_TNFRSF8 - Tumor necrosis factor receptor superfamily member 8	2111_TNFRSF8 - Tumor necrosis factor receptor superfamily member 8	25	254	1	254	1108	2457	3566	3257	3075	3313	3053	2065
3623_Treatment/medication code: atorvastatin	3623_Treatment/medication code: atorvastatin	25	254	1	943	254	779	983	638	3335	3549	2423	2110
4218_Antithrombotic agents	4218_Antithrombotic agents	25	254	1	1971	1661	1094	2584	4663	254	715	4016	485
457_Cofactors and vitamins::Vitamin B6 metabolism::pyridoxate	457_Cofactors and vitamins::Vitamin B6 metabolism::pyridoxate	25	254	1	3533	504	3760	1248	304	633	254	2388	4374
4658_Inferior fronto-occipital fasciculus fractional anisotropy	4658_Inferior fronto-occipital fasciculus fractional anisotropy	25	254	1	4522	337	3426	4128	572	2980	3667	254	1520
4538_Right hippocampus	4538_Right hippocampus	25	255	1	3708	255	588	2469	929	3296	3443	740	1977
1436_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1436_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	255	1	2126	4183	813	255	3032	954	885	2086	3188
4278_FEV1	4278_FEV1	25	255	1	2870	1248	2634	634	255	492	939	1618	4558
4700_Fornix (cres) / Stria terminalis mean diusivities	4700_Fornix (cres) / Stria terminalis mean diusivities	25	255	1	816	2147	3261	4165	1668	488	255	2100	2796
3533_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault of a close relative	3533_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault of a close relative	25	256	1	3921	256	1922	4479	863	292	538	1836	3455
731_::::X-11799	731_::::X-11799	25	256	1	2591	4166	256	3081	942	4121	2208	4492	329
2286_EHMT2 - Histone-lysine N-methyltransferase EHMT2	2286_EHMT2 - Histone-lysine N-methyltransferase EHMT2	25	256	1	1808	3696	3734	536	2698	643	641	2232	256
1149_Corrected insulin response	1149_Corrected insulin response	25	257	1	2651	4058	1271	257	1570	2605	1353	4182	739
2389_ENTPD1 - Ectonucleoside triphosphate diphosphohydrolase 1	2389_ENTPD1 - Ectonucleoside triphosphate diphosphohydrolase 1	25	257	1	1395	2716	3134	3526	257	4638	1624	4480	2459
2256_TBP - TATA-box-binding protein	2256_TBP - TATA-box-binding protein	25	257	1	2076	4640	782	4059	678	904	257	1193	3005
1443_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	1443_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	24	258	1	3345	1079	258	871	3373	2973	3817	3596	2064
1506_Triglycerides (at exam 5, FBAT, adjusted for age and sex)	1506_Triglycerides (at exam 5, FBAT, adjusted for age and sex)	25	258	1	1616	2169	1782	258	3100	872	2322	1471	905
4546_Left caudal anterior cingulate	4546_Left caudal anterior cingulate	25	258	1	2588	1277	4250	3599	533	258	2595	4106	2344
456_Cofactors and vitamins::Tocopherol metabolism::gamma-tocopherol	456_Cofactors and vitamins::Tocopherol metabolism::gamma-tocopherol	25	258	1	2696	2855	1413	4419	1008	4698	258	4026	2520
1966_MMSE score (at age 65, FBAT, adjusted for multivariable)	1966_MMSE score (at age 65, FBAT, adjusted for multivariable)	25	258	1	1716	1853	829	4121	3837	2917	2615	747	258
3701_Diagnoses - secondary ICD10: M19 Other and unspecified osteoarthritis	3701_Diagnoses - secondary ICD10: M19 Other and unspecified osteoarthritis	25	259	1	4654	259	1045	3738	1481	3195	493	1803	3468
609_Peptide::gamma-glutamyl::gamma-glutamylvaline	609_Peptide::gamma-glutamyl::gamma-glutamylvaline	25	259	1	653	1921	3513	1175	259	4551	1637	4610	3480
3197_Length of working week for main job	3197_Length of working week for main job	25	260	1	3509	260	2157	2809	1625	2100	3750	854	1053
4071_Number of sexual partners	4071_Number of sexual partners	25	260	1	628	1863	260	1563	1160	2982	489	328	674
1430_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1430_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	260	1	2015	1705	1151	260	3805	963	4000	888	859
1023_Neck Cross-Sectional Moment of Inertia (GEE)	1023_Neck Cross-Sectional Moment of Inertia (GEE)	25	260	1	1274	626	3392	2451	260	3109	2894	920	294
60_Educational attainment	60_Educational attainment	25	260	1	4730	4732	908	3389	2678	260	2736	2915	1178
3938_Bisecting GlcNAc	3938_Bisecting GlcNAc	25	260	1	411	1366	2698	610	3170	1689	260	4584	1569
1598_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for age and sex)	1598_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for age and sex)	25	260	1	2635	892	4438	2763	1840	2462	696	260	1540
629_Xenobiotics::Drug::salicyluric glucuronide*	629_Xenobiotics::Drug::salicyluric glucuronide*	25	260	1	307	2979	3689	2700	4211	3033	2440	2282	260
973_Beta nerve growth factor	973_Beta nerve growth factor	25	261	1	261	4029	3566	2910	4104	953	3237	1745	944
4387_Epithelial ovarian cancer (Clear cell)	4387_Epithelial ovarian cancer (Clear cell)	25	261	1	1900	1061	1260	1790	261	4311	805	1619	2033
4235_Adrenergics, inhalants	4235_Adrenergics, inhalants	25	261	1	1560	1283	2595	2197	1983	2898	261	4088	2446
1510_Triglycerides (at exam 7, FBAT, adjusted for age and sex)	1510_Triglycerides (at exam 7, FBAT, adjusted for age and sex)	25	261	1	2234	263	3247	265	3457	2700	4327	261	542
4047_Medial collateral ligament injury	4047_Medial collateral ligament injury	25	262	1	262	4170	1612	2463	1930	1792	4315	4194	742
3821_Celiac disease	3821_Celiac disease	25	262	1	1562	262	2658	2676	1903	2804	890	1393	2936
3672_Diagnoses - main ICD10: K52 Other and unsp noninfective gastroenteritis and colitis	3672_Diagnoses - main ICD10: K52 Other and unsp noninfective gastroenteritis and colitis	25	262	1	1235	4559	262	673	1850	2486	3616	3401	947
1108_Subcutaneous adipose tissue volume	1108_Subcutaneous adipose tissue volume	25	262	1	1335	4317	2896	262	4313	3116	573	1916	672
4027_Alcohol dependency (full discovery samples)	4027_Alcohol dependency (full discovery samples)	25	262	1	2038	3134	1334	2249	878	262	2062	2658	3204
3285_Miserableness	3285_Miserableness	25	263	1	263	291	894	1314	495	1179	2968	1593	1239
1211_Type 2 Diabetes	1211_Type 2 Diabetes	25	263	1	2560	2952	263	2521	525	3761	1267	4715	577
2584_CASP3 - Caspase-3	2584_CASP3 - Caspase-3	25	263	1	2900	4531	2072	1233	314	263	356	3644	3701
1289_Waist circumference by CT (GEE, adjusted for age and sex)	1289_Waist circumference by CT (GEE, adjusted for age and sex)	25	263	1	2272	3119	3406	4011	975	2062	4185	263	319
1514_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	1514_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	25	263	1	1761	4731	1992	1374	3419	3169	2128	1516	263
3366_Age at menopause (last menstrual period) (female)	3366_Age at menopause (last menstrual period) (female)	25	264	1	264	2331	4147	798	891	386	1342	3074	1368
3802_Mean erythrocyte cell volume	3802_Mean erythrocyte cell volume	25	264	1	3036	264	3668	4275	1994	3388	1571	3556	3475
292_CD4:%Act(PD1+)	292_CD4:%Act(PD1+)	25	264	1	2762	1686	1409	4332	4377	264	2078	989	1051
433_Amino acid::Valine, leucine and isoleucine metabolism::valine	433_Amino acid::Valine, leucine and isoleucine metabolism::valine	25	265	1	3587	3395	1651	1554	265	3294	287	995	4186
2516_EPHA1 - Ephrin type-A receptor 1	2516_EPHA1 - Ephrin type-A receptor 1	25	265	1	4413	2617	3259	3889	2916	265	2899	4455	3162
1958_MMSE score (at exam 5, FBAT, adjusted for multivariable)	1958_MMSE score (at exam 5, FBAT, adjusted for multivariable)	25	265	1	2525	1234	4556	3665	830	3636	3722	265	1017
4519_Left cerebellum exterior	4519_Left cerebellum exterior	25	265	1	535	1626	3145	4617	1441	4130	4622	3456	265
3597_Non-cancer illness code, self-reported: hypertension	3597_Non-cancer illness code, self-reported: hypertension	25	266	1	266	1158	3539	1603	800	2255	3362	4379	3563
1847_Neck Section Modulus (GEE, female, adjusted for age)	1847_Neck Section Modulus (GEE, female, adjusted for age)	25	266	1	1169	1799	266	2903	2422	4691	1157	375	1061
3390_Financial situation satisfaction	3390_Financial situation satisfaction	25	266	1	2241	4648	4691	266	4471	4487	2786	937	740
3624_Treatment/medication code: glucosamine product	3624_Treatment/medication code: glucosamine product	25	266	1	2637	451	446	4085	2406	266	2009	2243	2264
4584_Right isthmus cingulate	4584_Right isthmus cingulate	25	266	1	3329	2894	3633	3931	775	3478	1636	3071	266
2722_PSMD7 - 26S proteasome non-ATPase regulatory subunit 7	2722_PSMD7 - 26S proteasome non-ATPase regulatory subunit 7	25	267	1	3746	267	611	2426	4511	3992	3655	4535	3879
1764_Heart failure (free of MI, FBAT, adjusted for age and sex)	1764_Heart failure (free of MI, FBAT, adjusted for age and sex)	25	267	1	2444	4319	686	2722	421	267	1839	1257	3657
2581_C1S - Complement C1s subcomponent	2581_C1S - Complement C1s subcomponent	25	267	1	1226	2492	1600	2259	4643	4472	1111	267	3975
443_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::lactate	443_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::lactate	25	267	1	4227	2184	683	4498	3848	4047	3236	1289	267
1843_Neck Section Modulus (GEE, female, adjusted for multivariable)	1843_Neck Section Modulus (GEE, female, adjusted for multivariable)	25	268	1	2202	4016	268	3001	1747	2824	3948	1505	3540
4526_Left amygdala	4526_Left amygdala	25	268	1	1310	3928	345	268	3106	1670	2270	2794	889
1955_Similarities raw score (GEE, adjusted for multivariable)	1955_Similarities raw score (GEE, adjusted for multivariable)	25	268	1	4290	2388	397	1709	2717	4154	3316	572	268
3700_Diagnoses - secondary ICD10: M13 Other arthritis	3700_Diagnoses - secondary ICD10: M13 Other arthritis	25	269	1	269	1056	1570	2227	4460	2031	2268	2882	1998
2369_MAPK1 - Mitogen-activated protein kinase 1	2369_MAPK1 - Mitogen-activated protein kinase 1	25	269	1	3127	426	269	2526	1576	3547	1710	3864	478
3010_MAPK11 - Mitogen-activated protein kinase 11	3010_MAPK11 - Mitogen-activated protein kinase 11	25	269	1	1651	3790	1259	269	3944	743	3990	2728	379
742_::::X-11859	742_::::X-11859	25	269	1	1940	2571	4349	664	269	935	398	2352	3740
1673_Bilirubin (at exam 2, GEE, adjusted for multivariable)	1673_Bilirubin (at exam 2, GEE, adjusted for multivariable)	25	269	1	2017	2813	2022	2004	4232	269	2042	851	4035
3983_Type 2 Diabetes	3983_Type 2 Diabetes	25	269	1	1328	4634	1727	2300	331	2211	269	4724	828
1442_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	1442_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	269	1	2510	3923	1779	1886	329	1726	765	2167	269
1147_Ratio of AUC insulin to AUC glucose	1147_Ratio of AUC insulin to AUC glucose	25	270	1	1126	4337	270	1073	2196	3902	1102	3478	3615
3388_Family relationship satisfaction	3388_Family relationship satisfaction	25	270	1	2691	4281	2412	270	906	690	926	3959	892
3369_Frequency of other exercises in last 4 weeks	3369_Frequency of other exercises in last 4 weeks	25	270	1	1821	1968	2107	3633	270	353	616	735	2369
4198_Waist-hip ratio (male)	4198_Waist-hip ratio (male)	25	270	1	1501	4745	4643	2109	1623	2380	4236	1818	270
4344_Sleep sedentary (conditioning sex and BMI)	4344_Sleep sedentary (conditioning sex and BMI)	25	271	1	271	2290	1610	3386	574	2378	4301	834	1524
1305_Fasting insulin (at exam 7, GEE, adjusted for age and sex)	1305_Fasting insulin (at exam 7, GEE, adjusted for age and sex)	25	271	1	2532	271	2126	1107	3213	4569	977	1156	4323
982_Interleukin-12p70	982_Interleukin-12p70	25	271	1	1394	3038	3589	271	2825	4653	3664	2829	2246
4367_Coronary artery disease in diabetes	4367_Coronary artery disease in diabetes	25	271	1	1928	3467	1161	4243	3732	271	791	2405	4289
983_Interleukin-13	983_Interleukin-13	25	271	1	487	2866	451	3236	862	1867	271	521	414
1745_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for age and sex)	1745_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for age and sex)	25	271	1	2061	4486	1388	573	3299	596	2397	271	4237
4284_FEV1/FVC ratio	4284_FEV1/FVC ratio	25	272	1	272	2425	4452	3902	3425	2491	4357	4454	1648
2076_CXCL16 - C-X-C motif chemokine 16	2076_CXCL16 - C-X-C motif chemokine 16	25	272	1	3223	272	2142	3986	1731	3024	3526	4122	3210
2287_CFP - Properdin	2287_CFP - Properdin	25	272	1	1358	4626	272	521	4719	1576	3648	3930	2584
3771_Depression - Recent changes in speed/amount of moving or speaking	3771_Depression - Recent changes in speed/amount of moving or speaking	25	272	1	1401	1704	2675	272	1403	1393	2184	2562	3240
2482_FETUB - Fetuin-B	2482_FETUB - Fetuin-B	25	272	1	715	1988	354	4504	285	272	305	3080	1319
2318_PTPN1 - Tyrosine-protein phosphatase non-receptor type 1	2318_PTPN1 - Tyrosine-protein phosphatase non-receptor type 1	25	272	1	2326	3451	2243	1667	731	4136	272	3623	1793
1908_Lateral ventricular volume (FBAT, adjusted for multivariable)	1908_Lateral ventricular volume (FBAT, adjusted for multivariable)	25	272	1	2261	1377	3746	3076	353	2026	3192	272	1231
4097_Colorectal cancer	4097_Colorectal cancer	25	272	1	681	3979	3361	1430	4730	3870	4306	1506	272
939_Total cholesterol in small VLDL	939_Total cholesterol in small VLDL	25	273	1	467	273	585	2016	528	4054	4639	2057	3965
4272_Sleep duration	4272_Sleep duration	25	273	1	2977	3736	273	3807	4090	3400	534	3241	3495
2085_TIMP3 - Metalloproteinase inhibitor 3	2085_TIMP3 - Metalloproteinase inhibitor 3	25	273	1	3047	1766	4183	3068	273	1596	1974	1349	2267
2661_ESM1 - Endothelial cell-specific molecule 1	2661_ESM1 - Endothelial cell-specific molecule 1	25	273	1	2237	1139	4085	376	722	273	525	3965	3387
4660_Posterior limb of internal capsule fractional anisotropy	4660_Posterior limb of internal capsule fractional anisotropy	25	273	1	2019	2118	964	3394	492	863	273	2173	4560
928_MonoLunsaturated fatty acids	928_MonoLunsaturated fatty acids	25	273	1	2898	1943	2549	3036	2437	4746	3505	273	799
1416_High-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	1416_High-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	274	1	274	1190	4184	3022	4060	1144	2793	1154	2856
2574_DDC - Aromatic-L-amino-acid decarboxylase	2574_DDC - Aromatic-L-amino-acid decarboxylase	25	274	1	4459	3154	274	4537	4549	1431	1689	2249	1142
4267_Asthma (adult-onset)	4267_Asthma (adult-onset)	25	274	1	3135	3052	4694	490	1829	1158	274	3205	3172
2050_Periodontal complex trait 5 - Pg trait	2050_Periodontal complex trait 5 - Pg trait	25	275	1	275	1133	1728	3574	1411	1091	1951	4071	4552
1816_Femoral Neck BMD (FBAT, male, adjusted for multivariable)	1816_Femoral Neck BMD (FBAT, male, adjusted for multivariable)	25	275	1	1659	275	1075	3671	1549	1452	2638	1636	1991
467_Lipid::Bile acid metabolism::glycocholate	467_Lipid::Bile acid metabolism::glycocholate	25	275	1	2626	3910	275	3674	483	4467	854	3871	530
4412_Total IgM levels	4412_Total IgM levels	25	275	1	2287	3544	4657	275	4228	4492	3734	1567	3548
3301_Seen doctor (GP) for nerves, anxiety, tension or depression	3301_Seen doctor (GP) for nerves, anxiety, tension or depression	25	275	1	784	981	4127	3725	3132	4624	4139	2937	275
4479_Right entorhinal	4479_Right entorhinal	25	276	1	276	1316	3932	3603	3448	4444	1243	3423	3827
4755_Sagittal stratum radial diusivities	4755_Sagittal stratum radial diusivities	25	276	1	2041	632	276	1649	1442	2746	2436	857	4625
1358_Total cholesterol (at exam 1, FBAT, adjusted for age and sex)	1358_Total cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	276	1	3977	3931	897	276	3563	2851	4557	2740	2201
2519_FN1 - Fibronectin Fragment 4	2519_FN1 - Fibronectin Fragment 4	25	276	1	3209	4297	4030	2419	2811	298	276	2641	2657
3762_Anxiety - Recent inability to stop or control worying	3762_Anxiety - Recent inability to stop or control worying	25	276	1	1490	1823	3574	586	3816	836	1984	276	3220
4178_White blood cells	4178_White blood cells	25	276	1	798	2450	646	4220	1105	4046	1981	4532	276
3231_Nap during day	3231_Nap during day	25	277	1	277	2696	4036	2527	855	3889	708	2808	1928
3933_Galactosylation	3933_Galactosylation	25	277	1	3782	4573	1816	277	2160	3725	3553	4601	2498
1075_Leprosy	1075_Leprosy	25	277	1	1617	2204	1805	2706	277	4271	629	4417	3672
4697_Corticospinal tract mean diusivities	4697_Corticospinal tract mean diusivities	25	277	1	951	687	4204	985	4644	277	2150	650	3137
2670_IL12RB2 - Interleukin-12 receptor subunit beta-2	2670_IL12RB2 - Interleukin-12 receptor subunit beta-2	25	277	1	3523	1140	3296	3730	1417	2012	277	4146	1765
62_Age at menopause	62_Age at menopause	25	278	1	278	1978	2919	2846	3216	2275	3256	4017	1008
2449_IL24 - Interleukin-24	2449_IL24 - Interleukin-24	25	278	1	1002	278	1135	4338	3136	290	288	4285	3722
882_Concentration of IDL particles	882_Concentration of IDL particles	25	278	1	2457	3460	4684	278	3437	2963	2108	4497	1326
2265_CCL14 - C-C motif chemokine 14	2265_CCL14 - C-C motif chemokine 14	25	278	1	2417	612	568	1841	2859	278	1101	1996	3684
2101_CCL2 - C-C motif chemokine 2	2101_CCL2 - C-C motif chemokine 2	25	279	1	4667	3566	1621	279	1002	4282	3268	945	3997
3705_Diagnoses - secondary ICD10: Z51 Encounter for other aftercare	3705_Diagnoses - secondary ICD10: Z51 Encounter for other aftercare	25	279	1	4526	2745	4491	2037	3155	2051	917	279	1192
4112_Sodium	4112_Sodium	25	279	1	3947	1193	4695	3887	2477	1117	2762	2667	279
4575_Left transverse temporal	4575_Left transverse temporal	25	280	1	280	3586	3846	1466	3969	2912	3298	3151	3674
4512_Brain stem	4512_Brain stem	25	280	1	4309	4224	280	3508	1359	2099	2958	2526	1610
2947_PPP3CA PPP3R1 - Calcineurin	2947_PPP3CA PPP3R1 - Calcineurin	25	280	1	3703	3740	1163	3683	280	843	396	3935	2411
3463_Impedance measures - Arm predicted mass (right)	3463_Impedance measures - Arm predicted mass (right)	25	280	2	4594	1887	3020	2519	3397	280	3883	286	1625
2465_AURKB - Aurora kinase B	2465_AURKB - Aurora kinase B	25	281	1	281	514	2188	1477	1502	4109	1544	2546	3015
2518_FN1 - Fibronectin Fragment 3	2518_FN1 - Fibronectin Fragment 3	25	281	1	3992	281	1335	4251	945	1973	590	2441	4389
2153_HGF - Hepatocyte growth factor	2153_HGF - Hepatocyte growth factor	25	281	1	2815	4007	281	667	1622	1195	1654	982	4316
4304_Legs-leg fat ratio (female)	4304_Legs-leg fat ratio (female)	25	281	1	1197	4227	3414	281	1041	911	703	4422	436
2440_FCGR2A FCGR2B - Low affinity immunoglobulin gamma Fc region receptor II-a/b	2440_FCGR2A FCGR2B - Low affinity immunoglobulin gamma Fc region receptor II-a/b	25	281	1	671	1612	2499	4198	2649	3344	281	3431	1640
1468_Lipoprotein A (at exam 3, FBAT, adjusted for multivariable)	1468_Lipoprotein A (at exam 3, FBAT, adjusted for multivariable)	25	281	1	677	1329	4257	1230	1717	3861	2428	281	553
2974_ANXA1 - Annexin A1	2974_ANXA1 - Annexin A1	25	281	1	3465	1554	666	1112	620	3287	2110	1872	281
3250_Pork intake	3250_Pork intake	25	282	1	980	2602	282	882	2886	1939	3852	3132	1645
3363_Age started hormone-replacement therapy (HRT) (female)	3363_Age started hormone-replacement therapy (HRT) (female)	25	282	1	1260	1435	3648	282	4108	3996	2823	3258	2197
2861_FGF7 - Fibroblast growth factor 7	2861_FGF7 - Fibroblast growth factor 7	25	282	1	433	3224	4522	4229	2117	282	988	3049	2557
1618_CD40 Ligand serum (at exam 7, FBAT, adjusted for age and sex)	1618_CD40 Ligand serum (at exam 7, FBAT, adjusted for age and sex)	25	282	1	3252	4351	2640	321	2700	3907	3741	315	282
3452_Impedance measures - Leg fat percentage (right)	3452_Impedance measures - Leg fat percentage (right)	25	283	1	283	3609	3666	834	500	4287	4288	3462	4211
556_Lipid::Medium chain fatty acid::caproate (6:0)	556_Lipid::Medium chain fatty acid::caproate (6:0)	25	283	1	3956	733	283	1482	3222	2353	2434	2289	290
3325_Relative age voice broke (male)	3325_Relative age voice broke (male)	25	283	1	4081	3565	4283	1425	836	283	3374	750	1638
3392_Longest period of depression	3392_Longest period of depression	25	283	1	3792	2183	4546	3660	3294	1444	2978	2311	283
3986_Heart rate recovery at 20 secnds	3986_Heart rate recovery at 20 secnds	25	284	1	284	3035	3880	2085	4083	1373	3908	4059	998
2107_TNFRSF9 - Tumor necrosis factor receptor superfamily member 9	2107_TNFRSF9 - Tumor necrosis factor receptor superfamily member 9	25	284	1	4262	2099	284	1673	912	3303	2111	3526	877
2645_ITGA2B ITGB3 - Integrin alpha-IIb: beta-3 complex	2645_ITGA2B ITGB3 - Integrin alpha-IIb: beta-3 complex	25	284	1	3899	3067	3881	284	2355	3793	3476	4226	3477
17_Anorexia nervosa	17_Anorexia nervosa	25	284	1	1263	2412	1034	465	1393	284	4702	712	4682
3918_High-density lipoprotein cholesterol	3918_High-density lipoprotein cholesterol	25	284	1	2947	1480	1824	747	464	3105	284	1352	2080
3022_PRDX5 - Peroxiredoxin-5, mitochondrial	3022_PRDX5 - Peroxiredoxin-5, mitochondrial	25	284	1	932	1490	1081	3609	4686	3433	4464	284	3153
3804_Mean corpuscular hemoglobin concentration	3804_Mean corpuscular hemoglobin concentration	25	284	1	2795	1931	4336	4306	3638	3892	3558	4704	284
3633_Illnesses of father: High blood pressure	3633_Illnesses of father: High blood pressure	25	285	1	285	2861	3360	4517	999	4179	3491	3433	744
3256_Coffee intake	3256_Coffee intake	25	285	1	2882	4457	3779	698	3070	1624	3969	2395	285
3869_Basophil count (three-way meta)	3869_Basophil count (three-way meta)	25	286	1	2142	1322	1867	1347	2028	286	1298	2958	1324
2420_ACP5 - Tartrate-resistant acid phosphatase type 5	2420_ACP5 - Tartrate-resistant acid phosphatase type 5	25	286	1	2425	1047	364	3586	1391	3663	2939	933	286
1596_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for multivariable)	1596_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for multivariable)	25	287	1	287	3967	1522	566	3482	1106	3174	1957	391
799_::::X-12740	799_::::X-12740	25	287	1	724	1884	287	4687	1957	3833	1484	4672	2301
3195_Average total household income before tax	3195_Average total household income before tax	25	287	1	2389	2678	4462	911	287	2220	1458	2316	1350
4079_Waist-hip ratio (female)	4079_Waist-hip ratio (female)	25	287	1	3788	1265	3059	576	2842	1108	4192	287	1890
2476_CD207 - C-type lectin domain family 4 member K	2476_CD207 - C-type lectin domain family 4 member K	25	288	1	288	2931	4094	3024	1060	1181	372	3655	3478
1312_HOMA-IR (at exam 5, FBAT, adjusted for age and sex)	1312_HOMA-IR (at exam 5, FBAT, adjusted for age and sex)	25	288	1	2827	3582	288	3862	4057	4226	3170	3019	2573
1685_Brain natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	1685_Brain natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	25	288	1	3132	3636	1410	288	3400	4376	3717	3257	459
755_::::X-12094	755_::::X-12094	25	288	1	2132	2275	2892	3245	2865	1781	2236	1974	288
3508_Non-butter spread type details: Other low or reduced fat spread	3508_Non-butter spread type details: Other low or reduced fat spread	25	289	1	289	3172	378	799	1475	2343	2811	1332	4112
3934_Monosialylation	3934_Monosialylation	25	289	1	872	2910	1015	289	1580	2634	3720	3036	3021
4346_Coronary artery disease and triglyceride (bivariate)	4346_Coronary artery disease and triglyceride (bivariate)	25	289	1	688	2243	3748	2730	289	4684	3602	406	2087
1926_Lateral ventricular volume (FBAT, adjusted for age and sex)	1926_Lateral ventricular volume (FBAT, adjusted for age and sex)	25	289	1	4618	515	2061	4225	1344	2502	3851	289	1116
737_::::X-11847	737_::::X-11847	25	289	1	420	4570	3432	1031	3551	4069	4703	4687	289
2551_CAT - Catalase	2551_CAT - Catalase	25	290	1	4060	603	290	2550	3413	3309	4074	1833	2211
4747_Posterior corona radiata radial diusivities	4747_Posterior corona radiata radial diusivities	25	290	1	2777	1309	2246	1856	2622	3766	290	3237	1802
1979_Hand grip (at exam 7, GEE)	1979_Hand grip (at exam 7, GEE)	25	291	1	291	2436	1910	613	3694	797	2171	2053	449
399_Amino acid::Phenylalanine & tyrosine metabolism::phenylalanine	399_Amino acid::Phenylalanine & tyrosine metabolism::phenylalanine	25	291	1	1042	973	291	4112	3548	2432	2598	2440	813
2428_CA10 - Carbonic anhydrase-related protein 10	2428_CA10 - Carbonic anhydrase-related protein 10	25	291	1	2994	2162	359	1535	291	4441	1783	1298	3897
3564_Vitamin and mineral supplements: Vitamin D	3564_Vitamin and mineral supplements: Vitamin D	25	292	1	2817	292	2363	2586	2064	4471	3064	326	4016
2595_EPHB4 - Ephrin type-B receptor 4	2595_EPHB4 - Ephrin type-B receptor 4	25	292	1	3850	2260	292	3272	1289	1171	337	2168	3709
3937_Fucosylation	3937_Fucosylation	25	292	1	375	4429	3216	292	3714	4180	2254	2760	1463
4598_Right precentral	4598_Right precentral	25	292	1	1391	3205	1547	665	1044	972	292	3242	2816
4509_Cerebellar vermal lobules VIII X	4509_Cerebellar vermal lobules VIII X	25	292	1	3541	1030	2171	342	1311	3802	2715	292	2602
1080_Prostate cancer	1080_Prostate cancer	25	292	1	458	3836	3152	2457	1961	541	1477	4446	292
3135_MMP16 - Matrix metalloproteinase-16	3135_MMP16 - Matrix metalloproteinase-16	25	293	1	293	4454	1669	1946	3015	4531	1076	3487	2343
539_Lipid::Lysolipid::1-myristoylglycerophosphocholine	539_Lipid::Lysolipid::1-myristoylglycerophosphocholine	25	293	1	1434	293	3967	1302	2795	1015	2631	3803	3861
2718_MSLN - Mesothelin	2718_MSLN - Mesothelin	25	293	1	4395	3558	3377	3504	1418	293	4632	1137	4570
3268_Alcohol intake versus 10 years previously	3268_Alcohol intake versus 10 years previously	25	293	1	1303	1052	1340	315	377	1959	293	2486	3856
3604_Non-cancer illness code, self-reported: depression	3604_Non-cancer illness code, self-reported: depression	25	293	1	2955	1941	4187	1550	2870	908	3005	1737	293
3872_Sum basophil neutrophil count (three-way meta)	3872_Sum basophil neutrophil count (three-way meta)	25	294	1	294	3536	1568	941	4505	682	2185	1566	1366
1340_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age, sex and BMI)	1340_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age, sex and BMI)	25	294	1	2260	3314	294	1290	3775	853	3571	3846	1912
3839_Eosinophil percentage of white cells (two-way meta)	3839_Eosinophil percentage of white cells (two-way meta)	25	294	1	611	1106	3713	294	3140	3363	1766	672	3076
1757_Cancer (GEE, adjusted for multivariable)	1757_Cancer (GEE, adjusted for multivariable)	25	294	1	1445	2247	876	1080	294	1952	1029	1170	1739
1025_Femoral Neck Length (GEE, adjusted for age and sex)	1025_Femoral Neck Length (GEE, adjusted for age and sex)	25	294	1	4170	3050	2230	3981	4247	294	4198	432	3403
1903_Frontal lobe volume (GEE, adjusted for multivariable)	1903_Frontal lobe volume (GEE, adjusted for multivariable)	25	294	1	2844	1453	2730	3462	3634	1971	3143	294	4656
3246_Processed meat intake	3246_Processed meat intake	25	295	1	295	1741	1564	570	712	4116	699	2139	4406
3200_Job involves mainly walking or standing	3200_Job involves mainly walking or standing	25	295	1	4556	3505	2977	295	3356	1946	2768	2022	1237
136_Weight (male)	136_Weight (male)	25	295	1	4368	2553	428	2468	295	1088	898	1770	891
345_NKearly:%337+	345_NKearly:%337+	25	295	1	1752	2406	709	861	3663	3188	3707	295	3802
4150_Left ventricular mass	4150_Left ventricular mass	25	296	1	296	1005	2299	1669	4564	3224	3650	1446	2419
1140_Type 2 Diabetes (Dominance deviation model)	1140_Type 2 Diabetes (Dominance deviation model)	25	296	1	1271	296	3028	3425	2459	2021	1217	3418	3953
3616_Treatment/medication code: omeprazole	3616_Treatment/medication code: omeprazole	25	296	1	3138	2881	3936	296	3381	1190	1838	4308	867
393_Amino acid::Phenylalanine & tyrosine metabolism::3-methoxytyrosine	393_Amino acid::Phenylalanine & tyrosine metabolism::3-methoxytyrosine	25	296	1	4040	3242	1490	2393	296	1492	4031	3387	3417
3242_Fresh fruit intake	3242_Fresh fruit intake	25	296	1	2194	2794	1193	4089	1970	296	1095	3955	505
2734_FGF6 - Fibroblast growth factor 6	2734_FGF6 - Fibroblast growth factor 6	25	296	1	1189	1337	788	2435	1586	4083	296	1692	982
3611_Treatment/medication code: lisinopril	3611_Treatment/medication code: lisinopril	25	296	1	4343	1493	2519	1442	398	2192	3998	360	296
651_::::X-02249	651_::::X-02249	25	297	1	2398	297	2840	1514	363	2775	1185	1002	4223
1380_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	1380_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	25	297	1	871	2292	3703	297	3510	2702	2379	4234	2906
2954_PLA2G1B - Phospholipase A2	2954_PLA2G1B - Phospholipase A2	25	297	1	2860	4280	3579	3613	2470	297	1869	1333	4349
3108_GCKR - Glucokinase regulatory protein	3108_GCKR - Glucokinase regulatory protein	25	297	1	3104	1837	4419	4548	4284	4018	1742	297	1979
3661_Cancer register - Histology of cancer tumour: Adenocarcinoma, NOS	3661_Cancer register - Histology of cancer tumour: Adenocarcinoma, NOS	25	297	1	820	317	2148	1003	3399	1152	4384	2774	297
4179_Mean corpuscular hemoglobin concentration	4179_Mean corpuscular hemoglobin concentration	25	298	1	298	556	2691	2063	3354	817	4232	459	2859
3579_Social support - Leisure/social activities: Adult education class	3579_Social support - Leisure/social activities: Adult education class	25	298	1	1730	1617	1579	562	1124	2046	3544	298	2128
448_Cofactors and vitamins::Ascorbate and aldarate metabolism::threonate	448_Cofactors and vitamins::Ascorbate and aldarate metabolism::threonate	25	298	1	2987	1634	715	2573	4369	2837	2248	2893	298
3183_SNRPF - Small nuclear ribonucleoprotein F	3183_SNRPF - Small nuclear ribonucleoprotein F	25	299	1	299	1845	3925	1205	4526	2511	1375	423	2399
1576_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1576_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	299	1	2195	2757	299	2951	4106	2599	4115	3854	4025
1138_Mother's age at death	1138_Mother's age at death	25	299	1	2455	469	3868	299	3847	3932	2571	3376	860
778_::::X-12443	778_::::X-12443	25	299	1	999	3758	4732	2861	299	1934	1518	3420	4125
4309_Osteoarthritis of hip	4309_Osteoarthritis of hip	25	299	1	2782	3845	2185	1113	743	299	386	308	2776
3360_Hearing aid user	3360_Hearing aid user	25	299	1	2622	3155	3273	1545	3006	2955	299	4297	3382
3061_LILRB1 - Leukocyte immunoglobulin-like receptor subfamily B member 1	3061_LILRB1 - Leukocyte immunoglobulin-like receptor subfamily B member 1	25	299	1	4326	1841	3035	2953	2939	3639	981	299	1729
2040_Attention function - Excutive function - Child	2040_Attention function - Excutive function - Child	25	299	1	3563	1854	3330	802	966	4077	3639	647	299
2278_ESR1 - Estrogen receptor	2278_ESR1 - Estrogen receptor	25	300	1	300	1647	2565	3961	1944	322	1849	4069	4386
2432_CD5L - CD5 antigen-like	2432_CD5L - CD5 antigen-like	25	300	1	1603	300	526	3820	3497	2312	4495	1472	3939
1718_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for age and sex)	1718_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for age and sex)	25	300	1	1549	4160	1493	300	3008	1659	848	2970	4449
509_Lipid::Glycerolipid metabolism::glycerophosphorylcholine (GPC)	509_Lipid::Glycerolipid metabolism::glycerophosphorylcholine (GPC)	25	300	1	4288	2957	1710	2084	300	2176	1186	3735	4067
830_::::X-14056	830_::::X-14056	25	301	1	791	2814	301	1629	3615	4038	2187	1452	4699
2326_CCL23 - Ck-beta-8-1	2326_CCL23 - Ck-beta-8-1	25	301	1	1874	3988	1611	846	301	2988	1817	3709	2555
672_::::X-06351	672_::::X-06351	25	301	1	3355	2137	410	407	537	301	455	841	4141
1279_Sabuctaneous fat by CT (GEE, adjusted for age, sex, smoking and menopause)	1279_Sabuctaneous fat by CT (GEE, adjusted for age, sex, smoking and menopause)	25	301	1	4420	4491	3756	3249	408	3579	1263	301	3443
4359_Biliary atresia	4359_Biliary atresia	25	301	1	2442	4185	4344	4476	3861	727	2255	4717	301
785_::::X-12556	785_::::X-12556	25	302	1	1151	302	2058	343	662	1645	2179	523	2801
920_Phospholipids in medium LDL	920_Phospholipids in medium LDL	25	302	1	1615	4076	4575	302	4529	1743	2154	3771	2646
3416_Bipolar and major depression status	3416_Bipolar and major depression status	25	302	1	4184	4162	2257	4293	2176	503	302	3648	2234
25_Internalizing	25_Internalizing	25	303	1	2725	303	1554	3483	3626	464	3055	1497	3985
2277_NBL1 - Neuroblastoma suppressor of tumorigenicity 1	2277_NBL1 - Neuroblastoma suppressor of tumorigenicity 1	25	303	1	430	1387	517	3885	875	303	3136	2144	2187
1432_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	1432_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	25	303	1	1525	3089	3203	999	4728	4731	3849	1998	303
3083_PRLR - Prolactin receptor	3083_PRLR - Prolactin receptor	25	304	1	304	3350	2333	3839	2095	1310	4148	4585	1113
3675_Diagnoses - main ICD10: K80 Cholelithiasis	3675_Diagnoses - main ICD10: K80 Cholelithiasis	25	304	1	3647	304	2031	1061	2258	2935	3420	1402	1833
3302_Seen a psychiatrist for nerves, anxiety, tension or depression	3302_Seen a psychiatrist for nerves, anxiety, tension or depression	25	304	1	2086	2701	304	2496	2375	656	1041	4550	1288
2229_KLK11 - Kallikrein-11	2229_KLK11 - Kallikrein-11	25	304	1	711	870	1129	1599	2244	942	4593	304	3274
528_Lipid::Long chain fatty acid::stearate (18:0)	528_Lipid::Long chain fatty acid::stearate (18:0)	25	305	1	305	1635	4509	936	1258	748	331	3547	3908
948_Total fatty acids	948_Total fatty acids	25	305	1	2690	305	1881	2864	438	3306	2774	504	1595
1650_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for age and sex)	1650_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for age and sex)	25	305	1	757	3117	2390	305	2943	4468	4162	2442	3638
1844_Neck Section Modulus (FBAT, male, adjusted for multivariable)	1844_Neck Section Modulus (FBAT, male, adjusted for multivariable)	25	305	1	4022	2768	3741	1132	305	385	4554	330	1518
1263_Residual from predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	1263_Residual from predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	25	305	1	2688	1584	4029	2530	1913	4443	1908	305	3902
2360_IL18BP - Interleukin-18-binding protein	2360_IL18BP - Interleukin-18-binding protein	25	305	1	1094	3590	1408	2713	4075	3779	1647	2692	305
623_Xenobiotics::Drug::4-acetaminophen sulfate	623_Xenobiotics::Drug::4-acetaminophen sulfate	25	306	1	306	2448	4513	3788	4515	3170	2252	1094	1424
3759_Anxiety - Reccent feelings or nervousness or anxiety	3759_Anxiety - Reccent feelings or nervousness or anxiety	25	306	1	3338	3654	306	2667	1439	4339	1107	2445	4605
2401_IDS - Iduronate 2-sulfatase	2401_IDS - Iduronate 2-sulfatase	25	306	1	3623	2363	3372	306	768	4295	3905	3415	2601
1985_Age at natural menopause (GEE, adjusted for multivariable)	1985_Age at natural menopause (GEE, adjusted for multivariable)	25	306	1	2229	2041	4024	3155	306	431	2299	4299	3121
118_Extreme Height	118_Extreme Height	25	306	1	3446	966	3285	3206	4268	670	3121	1149	306
1410_High-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	1410_High-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	307	1	371	1340	891	307	488	1607	326	2619	1508
2274_ARTN - Artemin	2274_ARTN - Artemin	25	307	1	4506	3915	4543	4135	3495	307	395	2260	3499
4686_Superior corona radiata axial diusivities	4686_Superior corona radiata axial diusivities	24	307	1	550	599	4711	2483	3905	2558	307	4168	1446
305_CD4mem:%cFTH (1)	305_CD4mem:%cFTH (1)	25	308	1	308	1814	4520	1879	1878	971	4371	3278	3665
298_CD4mem:%preTh17 (2)	298_CD4mem:%preTh17 (2)	25	308	1	1451	4126	308	3427	4538	1527	443	1790	1737
3431_Fluid intelligence test - Fluid intelligence score	3431_Fluid intelligence test - Fluid intelligence score	25	308	1	4339	4403	2007	308	4133	1735	3904	369	687
2941_INS - Insulin	2941_INS - Insulin	25	308	1	2753	4075	1415	2472	308	826	1916	818	3034
117_Extreme Body Mass Index	117_Extreme Body Mass Index	25	308	1	3350	2738	4165	384	4305	308	1304	3193	1485
771_::::X-12329	771_::::X-12329	25	308	1	1512	2580	1987	3585	1673	1727	308	3693	3641
4096_Open-angle glaucoma	4096_Open-angle glaucoma	25	308	1	3444	4561	4602	3524	4397	4493	3305	1389	308
2671_PRKCQ - Protein kinase C theta type	2671_PRKCQ - Protein kinase C theta type	25	309	1	309	2151	3234	4209	2159	393	3925	2787	4525
1092_Gastric cancer	1092_Gastric cancer	25	309	1	3044	3945	1541	1937	309	708	2990	1143	443
1577_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	1577_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	25	309	1	4270	1464	1442	1025	2273	2889	309	1136	2998
2709_EEF1B2 - Elongation factor 1-beta	2709_EEF1B2 - Elongation factor 1-beta	25	309	1	1259	3535	1425	1523	1632	2603	2209	3682	309
1542_White matter hyperintensity volume (FBAT, adjusted for age and sex)	1542_White matter hyperintensity volume (FBAT, adjusted for age and sex)	25	310	1	2193	3867	3563	2471	1453	310	4739	3671	3561
4375_Hyperthyroidism	4375_Hyperthyroidism	25	310	1	4653	3391	414	3342	756	1679	310	1742	1931
1827_Spine Neck BMD (GEE, female, adjusted for multivariable)	1827_Spine Neck BMD (GEE, female, adjusted for multivariable)	25	310	1	2438	3232	1023	753	443	3509	2177	310	623
307_CD4mem:%cFTH (3)	307_CD4mem:%cFTH (3)	25	310	1	758	364	2194	2391	946	4373	2566	1702	310
4038_Schizophrenia	4038_Schizophrenia	25	311	1	1206	311	2424	1130	3559	4744	3856	4674	4300
1046_Trochanter BMD (FBAT, adjusted for multivariable)	1046_Trochanter BMD (FBAT, adjusted for multivariable)	25	311	1	2594	3850	311	1786	4079	409	947	3667	1190
2685_PPIA - Peptidyl-prolyl cis-trans isomerase A	2685_PPIA - Peptidyl-prolyl cis-trans isomerase A	25	311	1	2917	1509	541	311	2766	3537	3757	3083	4226
2925_SFN - 14-3-3 protein sigma	2925_SFN - 14-3-3 protein sigma	25	311	1	4325	891	4578	4078	311	3686	1109	1517	2452
4104_Total protein	4104_Total protein	25	311	1	885	2659	1048	2291	369	1348	311	1834	879
864_22:6, docosahexaenoic acid (DHA)	864_22:6, docosahexaenoic acid (DHA)	25	311	1	3791	1523	583	4042	920	4328	3803	311	4538
4565_Left postcentral	4565_Left postcentral	25	311	1	2956	3287	4115	1250	1637	494	3091	669	311
1248_Percent predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	1248_Percent predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	25	312	1	312	4742	3301	2238	1510	3952	2464	1555	2450
1888_Shaft Width (FBAT, female, adjussted for age)	1888_Shaft Width (FBAT, female, adjussted for age)	25	312	1	551	312	533	582	1883	4465	2765	365	1719
201_Estimated glomerular filtration rate based on serum creatinine	201_Estimated glomerular filtration rate based on serum creatinine	25	312	1	4716	2729	312	1870	4067	4337	4707	4181	714
1790_QT interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1790_QT interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	312	1	4393	3922	3243	1293	1798	312	4397	2228	3552
3018_CLIC1 - Chloride intracellular channel protein 1	3018_CLIC1 - Chloride intracellular channel protein 1	25	312	1	4041	3748	733	2817	1300	394	878	3374	312
3716_Diagnoses - secondary ICD10: Z95 Presence of cardiac and vascular implants and grafts	3716_Diagnoses - secondary ICD10: Z95 Presence of cardiac and vascular implants and grafts	25	313	1	3091	3516	2440	1417	313	1904	415	3858	3999
334_NKeff:%Kir (1)	334_NKeff:%Kir (1)	25	313	1	1351	1850	4012	4218	482	4563	761	313	3835
3393_Number of depression episodes	3393_Number of depression episodes	25	314	1	314	1876	1308	3708	2359	4358	2278	2611	4060
3556_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Hormone replacement therapy	3556_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Hormone replacement therapy	25	314	1	1480	1305	314	4095	553	1355	959	407	1962
1821_Inter-trochanteric buckling ratio (GEE, male, adjussted for multivariable)	1821_Inter-trochanteric buckling ratio (GEE, male, adjussted for multivariable)	25	314	1	1544	2146	1484	1056	2042	314	4283	4116	4255
1746_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for multivariable)	1746_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for multivariable)	25	314	1	3557	1602	4482	1483	1863	338	314	583	4628
607_Peptide::gamma-glutamyl::gamma-glutamylthreonine*	607_Peptide::gamma-glutamyl::gamma-glutamylthreonine*	25	314	1	750	837	1321	3147	1225	714	746	1132	314
2412_NID1 - Nidogen-1	2412_NID1 - Nidogen-1	25	315	1	315	3181	2838	2616	1517	4209	638	1287	2475
2745_CXCL10 - C-X-C motif chemokine 10	2745_CXCL10 - C-X-C motif chemokine 10	25	315	1	4455	3933	315	488	4100	4309	1823	3288	857
2267_MDK - Midkine	2267_MDK - Midkine	25	315	1	4344	2877	2089	2217	1433	315	2438	1679	4214
4352_Male pattern baldness (BOLT LMM non-infinitesimal mixed model)	4352_Male pattern baldness (BOLT LMM non-infinitesimal mixed model)	25	315	1	4471	708	3856	1189	4256	1223	2986	877	315
985_Interleukin-17	985_Interleukin-17	25	316	1	316	842	4652	1072	1299	1472	2218	1896	1102
3085_ROBO2 - Roundabout homolog 2	3085_ROBO2 - Roundabout homolog 2	25	316	1	3093	4044	3570	316	3110	2083	2485	3340	761
866_Fatty acid length	866_Fatty acid length	25	316	1	3933	3874	4627	2364	4513	2526	316	4599	2183
64_Insulin sensitivity index (adjusted for age, sex)	64_Insulin sensitivity index (adjusted for age, sex)	25	316	1	2422	1371	3100	3737	1537	4399	1132	2082	316
481_Lipid::Carnitine metabolism::hexanoylcarnitine	481_Lipid::Carnitine metabolism::hexanoylcarnitine	25	317	1	317	749	529	1159	1492	1655	2645	1117	1080
3484_Spread type: Butter/spreadable butter	3484_Spread type: Butter/spreadable butter	25	317	1	4249	1505	2740	317	3885	3403	4534	550	4529
3055_IL1RAPL2 - X-linked interleukin-1 receptor accessory protein-like 2	3055_IL1RAPL2 - X-linked interleukin-1 receptor accessory protein-like 2	25	317	1	603	2752	1833	741	460	317	3014	1038	3165
2460_THBS2 - Thrombospondin-2	2460_THBS2 - Thrombospondin-2	25	317	1	2876	4116	4512	4383	3538	2632	317	1009	1637
4201_Body Mass Index	4201_Body Mass Index	25	317	1	3008	3044	559	2828	1126	3807	1113	1982	317
1878_Shaft cross-sectional moment of inertia (FBAT, adjussted for multivariable)	1878_Shaft cross-sectional moment of inertia (FBAT, adjussted for multivariable)	25	318	1	318	3616	2087	2889	919	2960	4130	325	1029
3553_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	3553_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	25	318	1	1981	318	3848	1872	4610	991	2509	947	1468
3562_Vitamin and mineral supplements: Vitamin B	3562_Vitamin and mineral supplements: Vitamin B	25	318	1	1092	3447	2865	318	1015	3601	3318	2083	2495
4230_Opioids	4230_Opioids	25	318	1	409	1198	1674	722	318	3422	2387	881	4124
289_CD4:%Act(25+127+)	289_CD4:%Act(25+127+)	25	318	1	2011	2194	3032	4496	1326	318	737	4022	4175
1508_Triglycerides (at exam 6, FBAT, adjusted for age and sex)	1508_Triglycerides (at exam 6, FBAT, adjusted for age and sex)	25	318	1	3718	903	1878	2058	1999	2349	318	3207	3450
2839_ENTPD5 - Ectonucleoside triphosphate diphosphohydrolase 5	2839_ENTPD5 - Ectonucleoside triphosphate diphosphohydrolase 5	25	318	1	1035	1824	3607	1215	565	1704	2034	318	2167
2746_XCL1 - Lymphotactin	2746_XCL1 - Lymphotactin	25	319	1	319	609	3064	3448	1531	3031	1328	4513	4423
4609_Cerebellar vermal lobules VI VII	4609_Cerebellar vermal lobules VI VII	25	319	1	2404	2435	319	750	4286	2695	2874	4330	330
1079_Prostate cancer	1079_Prostate cancer	25	319	1	2003	2811	2462	319	2089	4181	1191	3109	1603
3723_Frequency of needing morning drink of alcohol after heavy drinking session in last year	3723_Frequency of needing morning drink of alcohol after heavy drinking session in last year	25	319	1	2638	3796	2820	3640	4434	319	3092	3484	1016
3395_Ever highly irritable/argumentative for 2 days	3395_Ever highly irritable/argumentative for 2 days	25	320	1	320	1411	4454	4486	3391	1662	1919	2639	2970
4687_Superior fronto-occipital fasciculus axial diusivities	4687_Superior fronto-occipital fasciculus axial diusivities	25	320	1	1110	320	3629	952	1718	3970	3263	3390	4403
3603_Non-cancer illness code, self-reported: migraine	3603_Non-cancer illness code, self-reported: migraine	25	320	1	3042	2821	320	1557	4678	2067	3161	3943	2143
2082_CCL20 - C-C motif chemokine 20	2082_CCL20 - C-C motif chemokine 20	25	320	1	2891	3861	848	320	2784	3649	2373	3561	1978
2336_CCL3 - C-C motif chemokine 3	2336_CCL3 - C-C motif chemokine 3	25	320	1	2631	623	924	4637	320	337	788	594	1695
504_Lipid::Fatty acid, monohydroxy::2-hydroxypalmitate	504_Lipid::Fatty acid, monohydroxy::2-hydroxypalmitate	25	320	1	4546	2086	2428	1328	1698	3617	320	884	1091
3281_Mother's age	3281_Mother's age	25	320	1	1586	3187	2080	822	2276	3368	3465	320	1797
2283_IGF1 - Insulin-like growth factor I	2283_IGF1 - Insulin-like growth factor I	25	320	1	748	3745	1406	2046	2094	756	1764	1104	320
2184_ULBP3 - NKG2D ligand 3	2184_ULBP3 - NKG2D ligand 3	25	321	1	591	321	1351	1765	3225	4594	3839	936	1609
1216_Alcohol consumption (dichotomous)	1216_Alcohol consumption (dichotomous)	25	321	1	2382	3343	2084	2167	2194	321	598	2967	2893
597_Peptide::Dipeptide::pyroglutamylglycine	597_Peptide::Dipeptide::pyroglutamylglycine	25	322	1	4176	322	1965	4441	3977	2181	3321	4606	1347
19_Ever versus never beeing a regular smoker	19_Ever versus never beeing a regular smoker	25	322	1	1481	4619	322	4400	3382	1428	1617	754	767
1241_Rate of decline of FEV1 (GEE, adjusted for multiple covariates)	1241_Rate of decline of FEV1 (GEE, adjusted for multiple covariates)	25	322	1	4233	592	1869	322	1846	2574	4342	1270	1974
3263_Average weekly champagne plus white wine intake	3263_Average weekly champagne plus white wine intake	25	322	1	2766	881	1452	4436	2029	2297	322	4572	3545
4380_Phltrium width	4380_Phltrium width	25	323	1	323	725	3516	3026	2496	1820	3536	1627	348
3864_Red blood cell count (two-way meta)	3864_Red blood cell count (two-way meta)	25	323	1	1409	323	2325	654	4009	3359	377	2454	3330
2218_ADAMTS4 - A disintegrin and metalloproteinase with thrombospondin motifs 4	2218_ADAMTS4 - A disintegrin and metalloproteinase with thrombospondin motifs 4	25	323	1	3861	2353	323	3567	2869	3723	4289	2047	1217
2961_ITGAV ITGB5 - Integrin alpha-V: beta-5 complex	2961_ITGAV ITGB5 - Integrin alpha-V: beta-5 complex	25	323	1	2380	1525	3420	1458	3903	323	1142	915	4360
2764_H2AFZ - Histone H2A.z	2764_H2AFZ - Histone H2A.z	25	323	1	4746	3498	852	2784	4556	4007	1827	903	323
3860_Neutrophil percentage of white cells (two-way meta)	3860_Neutrophil percentage of white cells (two-way meta)	25	324	1	324	1141	2981	2375	1636	1038	721	3124	439
1314_HOMA-IR (at exam 7, FBAT, adjusted for age and sex)	1314_HOMA-IR (at exam 7, FBAT, adjusted for age and sex)	25	324	1	4261	324	2938	864	2836	3630	1196	1508	836
1223_Mean Pallidum	1223_Mean Pallidum	25	324	1	1344	1960	1128	2542	324	3286	2810	4356	2666
1601_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for multivariable)	1601_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for multivariable)	25	324	1	3642	803	3362	984	1245	4532	2407	324	4633
4086_Type 2 Diabetes (adjusted for BMI)	4086_Type 2 Diabetes (adjusted for BMI)	25	325	1	325	2824	2752	4027	2105	2954	1535	4498	4611
3040_AMHR2 - Anti-Muellerian hormone type-2 receptor	3040_AMHR2 - Anti-Muellerian hormone type-2 receptor	25	325	1	1557	2271	325	1258	1025	3767	2405	3774	1576
2604_MAP2K2 - Dual specificity mitogen-activated protein kinase kinase 2	2604_MAP2K2 - Dual specificity mitogen-activated protein kinase kinase 2	25	325	1	2554	4580	3610	3302	2441	325	389	3333	4090
380_Amino acid::Glycine, serine and threonine metabolism::glycine	380_Amino acid::Glycine, serine and threonine metabolism::glycine	25	325	1	413	1199	3304	3724	3183	2186	325	2163	2861
4273_Long sleep	4273_Long sleep	25	326	1	326	752	636	2330	772	1893	584	1207	2810
3434_Numeric memory test - Maximum digits remembered correctly	3434_Numeric memory test - Maximum digits remembered correctly	25	326	1	639	1681	2687	326	1692	2327	749	3842	489
977_Granulocyte colony-stimulating factor	977_Granulocyte colony-stimulating factor	25	326	1	982	3762	1418	4574	2280	326	4022	2306	3708
901_Total lipids in large VLDL	901_Total lipids in large VLDL	25	326	1	1069	528	2522	4385	689	3262	4176	534	326
619_Xenobiotics::Chemical::glycerol 2-phosphate	619_Xenobiotics::Chemical::glycerol 2-phosphate	25	327	1	2799	3912	327	3412	3024	4423	4488	4575	1310
1488_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for multivariable)	1488_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for multivariable)	25	327	1	1210	2991	2336	327	1940	4403	3107	1234	1665
535_Lipid::Lysolipid::1-eicosatrienoylglycerophosphocholine*	535_Lipid::Lysolipid::1-eicosatrienoylglycerophosphocholine*	25	327	1	1927	2528	4402	1969	327	2508	2355	1792	2742
4651_Cingulum (cingulate gyrus) fractional anisotropy	4651_Cingulum (cingulate gyrus) fractional anisotropy	25	327	1	2069	2653	4107	2702	1559	2104	327	4186	4710
4200_Height	4200_Height	25	328	1	3931	2001	3492	992	2146	328	876	2133	1935
2356_GDF9 - Growth/differentiation factor 9	2356_GDF9 - Growth/differentiation factor 9	25	329	1	3061	329	2563	1881	3287	2214	2998	3914	1675
2112_CRLF1 CLCF1 - Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex	2112_CRLF1 CLCF1 - Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex	25	329	1	3369	4637	329	863	1086	4718	826	4147	3014
2162_PSPN - Persephin	2162_PSPN - Persephin	25	329	1	1763	3291	3381	329	4187	978	3388	2763	4133
3425_Ever smoked	3425_Ever smoked	25	329	1	1906	2555	756	2236	559	3216	329	960	2715
2603_MMEL1 - Membrane metallo-endopeptidase-like 1	2603_MMEL1 - Membrane metallo-endopeptidase-like 1	25	330	1	4536	330	4538	2071	2432	845	3580	3067	2006
4540_Right accumbens area	4540_Right accumbens area	25	330	1	1300	3293	330	413	2668	4392	1461	1646	1788
57_Educational attainment	57_Educational attainment	25	330	1	2083	3865	1215	330	720	2644	4123	1543	2299
738_::::X-11849	738_::::X-11849	25	330	1	3300	2834	3798	4108	330	3782	1437	3850	2685
1666_Aspartate aminotransferase (at exam 2, FBAT, adjusted for age and sex)	1666_Aspartate aminotransferase (at exam 2, FBAT, adjusted for age and sex)	25	330	1	352	1358	2024	4123	1022	886	330	1252	3862
6_Anxiety disorder (case/control)	6_Anxiety disorder (case/control)	25	331	1	331	2291	2331	3656	646	3080	552	645	3890
2626_MFRP - Membrane frizzled-related protein	2626_MFRP - Membrane frizzled-related protein	25	331	1	2967	331	1084	2766	1109	1585	2692	4103	1309
99_Pubertal growth (female)	99_Pubertal growth (female)	25	331	1	502	4547	331	3122	1784	3314	1126	1686	3713
1426_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1426_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	331	1	3668	476	3186	331	2340	4348	2737	1010	4694
3013_MAPK14 - Mitogen-activated protein kinase 14	3013_MAPK14 - Mitogen-activated protein kinase 14	25	331	1	4031	2018	3319	1121	3609	4147	1929	331	781
3337_Years since last breast cancer screening / mammogram (female)	3337_Years since last breast cancer screening / mammogram (female)	25	332	1	332	1737	2846	841	1024	2102	2771	730	3019
1868_Neck-Shaft Angle (FBAT, male, adjussted for multivariable)	1868_Neck-Shaft Angle (FBAT, male, adjussted for multivariable)	25	332	1	2343	332	4097	2615	3516	3961	4057	2073	4245
2724_SNX4 - Sorting nexin-4	2724_SNX4 - Sorting nexin-4	25	332	1	2044	2725	332	2934	1918	4032	3260	2542	1306
583_Nucleotide::Purine metabolism, adenine containing::N1-methyladenosine	583_Nucleotide::Purine metabolism, adenine containing::N1-methyladenosine	25	332	1	3982	3195	834	4434	332	4235	594	1263	4257
804_::::X-12798	804_::::X-12798	25	332	1	3305	390	2395	735	2598	332	3684	586	3253
4072_First PC of the four riskly behaviours	4072_First PC of the four riskly behaviours	25	332	1	767	526	484	3078	713	4221	332	1034	2269
397_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetate	397_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetate	25	332	1	4564	2032	3486	3818	922	2118	1851	332	2317
2359_IL13 - Interleukin-13	2359_IL13 - Interleukin-13	25	333	1	333	3775	4472	3860	4392	2444	334	3913	1404
3269_Breastfed as a baby	3269_Breastfed as a baby	25	333	1	4606	333	1053	534	2991	4542	2134	2560	829
1462_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1462_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	333	1	4481	4315	2610	333	2073	418	3395	711	4426
4321_Neuroticism (univariate)	4321_Neuroticism (univariate)	24	333	1	1106	1324	3046	3685	333	3981	1703	573	675
680_::::X-09789	680_::::X-09789	25	333	1	3704	3264	3230	3510	2618	2225	2593	333	1982
4137_Hematocrit	4137_Hematocrit	25	334	1	2966	334	3782	2175	3698	3914	1305	2376	341
542_Lipid::Lysolipid::1-palmitoleoylglycerophosphocholine*	542_Lipid::Lysolipid::1-palmitoleoylglycerophosphocholine*	25	334	1	3470	1410	483	3905	1459	334	1365	1940	3883
1306_Insulin sensitivity (FBAT, adjusted for age and sex)	1306_Insulin sensitivity (FBAT, adjusted for age and sex)	25	334	1	1231	4682	1720	381	4712	1049	4719	334	1587
4473_Left supramarginal	4473_Left supramarginal	25	335	1	335	3478	4741	2874	2953	3267	1228	3849	587
3710_Diagnoses - secondary ICD10: Z85 Personal history of malignant neoplasm	3710_Diagnoses - secondary ICD10: Z85 Personal history of malignant neoplasm	25	335	1	2312	844	2664	1917	335	4347	2155	1159	1328
3595_Mineral and other dietary supplements: Zinc	3595_Mineral and other dietary supplements: Zinc	25	335	1	1669	1699	3959	1738	4587	335	1723	994	3058
706_::::X-11444	706_::::X-11444	25	335	1	1804	465	1644	2739	549	634	335	1700	1423
3036_TPM1 - Tropomyosin alpha-1 chain	3036_TPM1 - Tropomyosin alpha-1 chain	25	335	1	2793	4511	973	4064	3717	1660	3082	3953	335
3543_Eye problems/disorders: Cataract	3543_Eye problems/disorders: Cataract	25	336	1	336	1544	2978	1861	1067	2663	2500	2815	2898
645_Xenobiotics::Xanthine metabolism::7-methylxanthine	645_Xenobiotics::Xanthine metabolism::7-methylxanthine	25	336	1	2783	336	1897	2901	3755	965	2931	1254	618
1051_Parkinson disease (tier 2b)	1051_Parkinson disease (tier 2b)	25	336	1	4628	1332	336	448	3566	4669	4618	2162	646
1776_Heart failure (censored at interval MI, FBAT, adjusted for age and sex)	1776_Heart failure (censored at interval MI, FBAT, adjusted for age and sex)	25	336	1	3191	3855	1636	336	1303	753	1575	1199	1646
2510_CAMK2D - Calcium/calmodulin-dependent protein kinase type II subunit delta	2510_CAMK2D - Calcium/calmodulin-dependent protein kinase type II subunit delta	25	336	1	4419	1969	3073	4210	1017	336	831	4256	2588
3935_Disialylation	3935_Disialylation	25	336	1	2944	906	1338	3098	1729	1856	3689	336	2926
2506_BMX - Cytoplasmic tyrosine-protein kinase BMX	2506_BMX - Cytoplasmic tyrosine-protein kinase BMX	25	336	1	4277	3595	3475	1051	4117	3341	3113	4425	336
4673_Cingulum (cingulate gyrus) axial diusivities	4673_Cingulum (cingulate gyrus) axial diusivities	25	337	1	2946	828	337	3784	895	3496	1260	1927	3731
4158_Generalised epilepsy	4158_Generalised epilepsy	25	337	1	1360	2010	4112	1383	337	1322	1589	1366	1866
1407_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for multivariable)	1407_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for multivariable)	25	337	1	916	508	767	4203	3810	1548	424	337	2384
4105_Albumin	4105_Albumin	25	338	1	338	1912	2776	2415	1365	4497	1587	1903	2136
449_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,E)*	449_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,E)*	25	338	1	2072	2904	4119	338	4411	2645	1787	4160	3155
1464_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	1464_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	25	338	1	1306	2640	3519	476	1416	628	1163	338	822
2174_LAMA1 LAMB1  LAMC1 - Laminin	2174_LAMA1 LAMB1  LAMC1 - Laminin	25	338	1	1611	4419	1740	2710	3098	1168	4475	3625	338
683_::::X-10429	683_::::X-10429	25	339	1	339	2254	3288	2609	1756	1551	1931	1821	617
1655_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for age and sex)	1655_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for age and sex)	25	339	1	1867	3958	339	3956	3311	2498	2360	831	2391
2696_RPS7 - 40S ribosomal protein S7	2696_RPS7 - 40S ribosomal protein S7	25	339	1	1800	1254	1196	339	854	3282	1954	4537	2491
516_Lipid::Long chain fatty acid::adrenate (22:4n6)	516_Lipid::Long chain fatty acid::adrenate (22:4n6)	25	339	1	4007	3367	2168	2309	339	4325	4455	4744	2641
4297_Extreme obesity (childhood)	4297_Extreme obesity (childhood)	25	339	1	3328	3662	4319	1787	1392	339	3630	4376	4533
769_::::X-12253	769_::::X-12253	25	339	1	2384	3209	2414	3564	2497	2366	339	3370	1020
4613_Brain stem	4613_Brain stem	25	339	1	1146	3033	421	4319	1496	1683	4293	339	2339
666_::::X-06126	666_::::X-06126	25	339	1	2273	1189	954	2510	2909	2476	1529	4333	339
659_::::X-04494	659_::::X-04494	25	340	1	2562	2971	2612	340	3852	3277	3466	3826	3261
2446_SERPIND1 - Heparin cofactor 2	2446_SERPIND1 - Heparin cofactor 2	25	340	1	4336	672	3176	3699	340	1567	3120	2314	4451
3371_Chest pain or discomfort when walking uphill or hurrying	3371_Chest pain or discomfort when walking uphill or hurrying	25	340	1	2957	4423	1288	2229	422	4466	340	3046	2974
230_mDC:%X-Presenting	230_mDC:%X-Presenting	25	340	1	1622	3759	3943	4659	4210	2536	4399	4108	340
4549_Left entorhinal	4549_Left entorhinal	25	341	1	2461	352	1467	3039	365	341	619	791	997
3166_TNFRSF21 - Tumor necrosis factor receptor superfamily member 21	3166_TNFRSF21 - Tumor necrosis factor receptor superfamily member 21	25	341	1	2612	2462	3333	3371	1727	2672	341	4012	3047
874_Glycine	874_Glycine	25	341	1	2109	3347	1336	4528	1568	3384	853	341	3859
758_::::X-12116	758_::::X-12116	25	342	1	342	2187	1640	928	1402	3847	1147	2592	1010
3525_Transport type for commuting to job workplace: Walk	3525_Transport type for commuting to job workplace: Walk	25	342	1	3857	342	2866	4256	3182	4173	4265	1442	555
1322_Fasting plasma glucose (at exam 5, FBAT, adjusted for age, sex and BMI)	1322_Fasting plasma glucose (at exam 5, FBAT, adjusted for age, sex and BMI)	25	342	1	917	3854	342	600	536	3786	816	1060	2329
265_CD8:%RTE	265_CD8:%RTE	25	342	1	2186	2304	2201	2682	1278	342	597	2401	2044
4192_QRS interval	4192_QRS interval	25	342	1	3341	4307	3250	3179	899	1610	342	1440	2636
1297_Adiponectin (GEE, adjusted for age and sex)	1297_Adiponectin (GEE, adjusted for age and sex)	25	342	1	2403	1284	940	1106	2479	1611	4741	342	4636
1898_Troch Neck BMD (FBAT, female, adjussted for multivariable)	1898_Troch Neck BMD (FBAT, female, adjussted for multivariable)	25	342	1	1717	3829	1248	4611	2093	2219	1921	966	342
524_Lipid::Long chain fatty acid::oleate (18:1n9)	524_Lipid::Long chain fatty acid::oleate (18:1n9)	25	343	1	343	3528	1608	836	3540	1961	4011	4509	4151
1127_Visceral adipose tissue sttenutation (male)	1127_Visceral adipose tissue sttenutation (male)	25	343	1	3361	343	1850	3439	1941	3371	3050	3542	4667
2789_NSFL1C - NSFL1 cofactor p47	2789_NSFL1C - NSFL1 cofactor p47	25	343	1	2377	3807	1620	3349	1232	3187	343	3536	2175
370_Amino acid::Creatine metabolism::creatinine	370_Amino acid::Creatine metabolism::creatinine	25	343	1	4148	4352	1528	2067	3492	2716	2606	1904	343
182_Waist-hip ratio (male)	182_Waist-hip ratio (male)	25	344	1	344	3068	1734	1155	3872	2221	4075	4525	3113
813_Lipid::Essential fatty acid::X-12990--docosapentaenoic acid (n6-DPA)	813_Lipid::Essential fatty acid::X-12990--docosapentaenoic acid (n6-DPA)	25	344	1	1551	344	4253	1358	3938	2250	1782	3870	503
1826_Spine Neck BMD (FBAT, female, adjusted for multivariable)	1826_Spine Neck BMD (FBAT, female, adjusted for multivariable)	25	344	1	1071	1232	344	935	3953	2850	4209	653	1277
822_::::X-13548	822_::::X-13548	25	344	1	4591	2586	2642	344	3792	1983	3941	2258	964
3478_Own or rent accommodation lived in: Rent - from local authority, local council, housing association	3478_Own or rent accommodation lived in: Rent - from local authority, local council, housing association	25	344	1	1814	425	743	3045	344	3367	3612	1249	832
2804_SPON1 - Spondin-1	2804_SPON1 - Spondin-1	25	344	1	1057	1344	3571	3915	1704	4453	344	1847	1615
1679_Atrial natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	1679_Atrial natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	25	344	1	4532	990	1689	4443	3440	4424	4195	344	1889
714_::::X-11491	714_::::X-11491	25	344	1	3147	2989	2860	1355	3355	2707	1842	2636	344
823_::::X-13549	823_::::X-13549	25	345	1	345	3241	385	2637	3647	816	3940	4244	2259
3216_Frequency of friend/family visits	3216_Frequency of friend/family visits	25	345	1	4451	345	2808	789	1421	1053	932	584	1457
1941_Hippocampal volume (GEE, adjusted for multivariable with APOE)	1941_Hippocampal volume (GEE, adjusted for multivariable with APOE)	25	345	1	2173	2431	711	345	357	3785	1892	736	1074
935_Triglycerides in small HDL	935_Triglycerides in small HDL	25	345	1	4206	1286	3427	3014	345	2367	2905	508	2204
1879_Shaft cross-sectional moment of inertia (GEE, adjussted for multivariable)	1879_Shaft cross-sectional moment of inertia (GEE, adjussted for multivariable)	25	345	1	4612	781	4350	1975	3883	345	1835	1597	4027
4437_Herpes simplex virus 2 IgG levels	4437_Herpes simplex virus 2 IgG levels	25	345	1	486	4716	4138	3476	560	2902	345	4042	4541
2456_PGLYRP1 - Peptidoglycan recognition protein 1	2456_PGLYRP1 - Peptidoglycan recognition protein 1	25	345	1	3565	472	2304	4395	1131	3326	3853	4334	345
390_Amino acid::Lysine metabolism::pipecolate	390_Amino acid::Lysine metabolism::pipecolate	25	346	1	4584	346	1306	2522	4450	1617	3959	1082	4480
3_Attention deficit hyperactivity disorder	3_Attention deficit hyperactivity disorder	25	346	1	1444	2522	346	4508	764	4029	3361	628	2747
3283_Number of full sisters	3283_Number of full sisters	25	346	1	2091	2748	1311	4643	346	487	1539	376	3694
3585_Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	3585_Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	25	346	1	692	3674	3669	1199	1647	4233	1805	914	346
56_Depressive symptoms	56_Depressive symptoms	25	347	1	347	957	4021	2839	4014	4353	3339	1028	4218
1611_von Willebrand Factor (at exam 5, GEE, adjusted for age and sex)	1611_von Willebrand Factor (at exam 5, GEE, adjusted for age and sex)	25	347	1	824	4587	347	458	2387	1763	2640	609	983
153_Waist-hip ratio (female > 50 yrs, adjusted for BMI)	153_Waist-hip ratio (female > 50 yrs, adjusted for BMI)	25	347	1	3999	1745	3363	2135	347	2881	2382	4682	3920
1333_Fasting HbA1c (at exam 5, GEE, adjusted for age, sex and BMI)	1333_Fasting HbA1c (at exam 5, GEE, adjusted for age, sex and BMI)	25	347	1	2618	1396	4682	1963	3111	347	4507	722	4553
2799_PSMA2 - Proteasome subunit alpha type-2	2799_PSMA2 - Proteasome subunit alpha type-2	25	347	1	3797	2922	3893	1741	1164	3810	347	1485	442
1345_Plasma Apolipoprotein A-I level (GEE, multivariate adjusted)	1345_Plasma Apolipoprotein A-I level (GEE, multivariate adjusted)	25	347	1	3644	3469	3836	1480	3052	4600	4355	2318	347
1057_Major depressive disorder	1057_Major depressive disorder	25	348	1	2401	2608	348	3278	3608	3466	4431	4479	4185
3807_Neutrophil count	3807_Neutrophil count	25	348	1	2200	4275	2990	348	2742	691	2258	2520	4359
3089_ICAM5 - Intercellular adhesion molecule 5	3089_ICAM5 - Intercellular adhesion molecule 5	25	348	1	2504	1980	2000	1899	348	987	414	3538	2890
703_::::X-11440	703_::::X-11440	25	348	1	1979	2384	4324	650	4182	348	2479	3240	2730
3808_Lymphocyte count	3808_Lymphocyte count	25	348	1	429	2657	685	559	2307	3375	348	943	3925
2729_AGER - Advanced glycosylation end product-specific receptor, soluble	2729_AGER - Advanced glycosylation end product-specific receptor, soluble	25	348	1	1623	3718	1391	3350	4229	1876	2493	348	4384
3897_Plateletcrit (three-way meta)	3897_Plateletcrit (three-way meta)	25	349	1	3117	349	4076	1839	3029	3584	779	4228	3000
165_Hip circumference (female, adjusted for BMI)	165_Hip circumference (female, adjusted for BMI)	25	349	1	1643	2104	349	1115	3759	1849	1600	867	862
3925_Coronary artery disease (SOFT definition including angina)	3925_Coronary artery disease (SOFT definition including angina)	25	349	1	2304	4187	660	1286	349	3158	3085	3440	4456
229_mDC:%CD1c+	229_mDC:%CD1c+	25	349	1	3100	1237	4287	2588	3101	349	3663	2649	1851
831_::::X-14057	831_::::X-14057	25	349	1	4367	4168	3902	2624	866	2146	349	1910	1054
4653_Corticospinal tract fractional anisotropy	4653_Corticospinal tract fractional anisotropy	25	349	1	1881	2546	590	2299	4714	641	1349	3759	349
1267_Residual from predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	1267_Residual from predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	25	350	1	350	4660	3364	4097	1584	4248	3007	902	4189
4326_Depressive symptoms (MA GWAMA)	4326_Depressive symptoms (MA GWAMA)	25	350	1	2756	350	4720	3901	2202	829	4468	1540	2659
1456_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1456_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	350	1	3845	847	4041	350	793	1130	700	1300	4462
2045_Primary angle closure glaucoma	2045_Primary angle closure glaucoma	25	350	1	2609	3978	1305	849	2011	350	379	819	4415
2452_LY9 - T-lymphocyte surface antigen Ly-9	2452_LY9 - T-lymphocyte surface antigen Ly-9	25	350	1	3939	541	1683	4185	747	840	350	4077	2691
38_Verbal-numerical reasoning	38_Verbal-numerical reasoning	25	350	1	1243	3408	2989	2257	1130	2132	726	855	350
2721_PDXP - Pyridoxal phosphate phosphatase	2721_PDXP - Pyridoxal phosphate phosphatase	25	351	1	351	2314	4126	3953	2989	367	3833	3566	2184
4626_Left hippocampus	4626_Left hippocampus	25	351	1	4100	735	351	3780	1073	3815	4360	1226	1256
462_Energy::Oxidative phosphorylation::acetylphosphate	462_Energy::Oxidative phosphorylation::acetylphosphate	25	351	1	3370	3124	3403	351	2679	4058	3861	1696	401
475_Lipid::Carnitine metabolism::2-tetradecenoyl carnitine	475_Lipid::Carnitine metabolism::2-tetradecenoyl carnitine	25	351	1	3540	2717	3812	2132	1525	351	2943	1579	3028
1482_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for age and sex)	1482_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for age and sex)	25	351	1	4487	3728	3921	360	608	2713	4416	351	1670
4444_Cytomegalovirus IgG levels	4444_Cytomegalovirus IgG levels	25	351	1	3224	896	3864	3980	1738	1176	2870	1830	351
3607_Non-cancer illness code, self-reported: osteoarthritis	3607_Non-cancer illness code, self-reported: osteoarthritis	25	352	1	2370	535	352	1929	3981	3343	2991	3491	2330
4756_Uncinate fasciculus radial diusivities	4756_Uncinate fasciculus radial diusivities	25	352	1	1532	1974	846	689	352	1248	846	1934	4495
2096_POMC - Beta-endorphin	2096_POMC - Beta-endorphin	25	352	1	2896	2074	1487	3497	2945	352	2181	1160	1635
2990_PI3 - Elafin	2990_PI3 - Elafin	25	352	1	590	3707	3642	2421	1739	976	578	4563	352
3380_Systolic Blood Pressure (automated reading)	3380_Systolic Blood Pressure (automated reading)	25	353	1	353	443	3148	1567	742	3487	3149	3948	1247
1039_Neck-Shaft Angle (GEE, adjusted for multivariable)	1039_Neck-Shaft Angle (GEE, adjusted for multivariable)	25	353	1	2394	353	2329	3027	4716	2518	4261	1373	4081
4384_Epithelial ovarian cancer (low-grade serous and borderline serous)	4384_Epithelial ovarian cancer (low-grade serous and borderline serous)	25	353	1	1564	2408	353	3016	3247	3259	3357	3882	1969
1339_HOMA-IR (at exam 7, GEE, adjusted for age, sex and BMI)	1339_HOMA-IR (at exam 7, GEE, adjusted for age, sex and BMI)	25	353	1	3151	1716	3355	353	3337	4738	2242	3828	3601
1832_Neck length (FBAT, male, adjusted for multivariable)	1832_Neck length (FBAT, male, adjusted for multivariable)	25	353	1	4087	4144	2979	1234	1542	3609	4417	353	3060
409_Amino acid::Tryptophan metabolism::tryptophan	409_Amino acid::Tryptophan metabolism::tryptophan	25	353	1	1145	2059	3047	1819	4641	2710	3826	3082	353
4587_Right lingual	4587_Right lingual	25	354	1	3212	354	2112	2752	2749	2977	4647	990	4481
474_Lipid::Bile acid metabolism::ursodeoxycholate	474_Lipid::Bile acid metabolism::ursodeoxycholate	25	354	1	962	2692	3079	354	3914	4679	3399	3020	1567
2115_EIF5 - Eukaryotic translation initiation factor 5	2115_EIF5 - Eukaryotic translation initiation factor 5	25	354	1	2664	2947	4596	436	1653	2616	4442	3521	354
1537_Ankle-brachial index (at exam 7, GEE, adjusted for multivariable)	1537_Ankle-brachial index (at exam 7, GEE, adjusted for multivariable)	25	355	1	355	1637	444	4511	2114	1808	536	4342	991
4366_Fraction of accelerations	4366_Fraction of accelerations	25	355	1	1248	355	4104	4468	490	1871	1083	2033	1208
2835_CHST6 - Carbohydrate sulfotransferase 6	2835_CHST6 - Carbohydrate sulfotransferase 6	25	355	1	1899	914	3754	3310	2663	355	3811	664	2243
1950_Visual scanning and motor speed (FBAT, adjusted for multivariable)	1950_Visual scanning and motor speed (FBAT, adjusted for multivariable)	25	355	1	3124	4118	2071	3309	4706	2074	836	355	3254
2508_BTK - Tyrosine-protein kinase BTK	2508_BTK - Tyrosine-protein kinase BTK	25	355	1	2923	2807	472	3396	4161	4502	4240	3812	355
3060_IL7R - Interleukin-7 receptor subunit alpha	3060_IL7R - Interleukin-7 receptor subunit alpha	25	356	1	3658	356	1044	4217	4573	1302	997	2718	3636
2585_CTSE - Cathepsin E	2585_CTSE - Cathepsin E	25	356	1	3431	1437	356	3932	1175	918	3860	2919	1477
2145_TNFRSF1A - Tumor necrosis factor receptor superfamily member 1A	2145_TNFRSF1A - Tumor necrosis factor receptor superfamily member 1A	25	356	1	2100	3645	3042	3205	356	1804	1964	957	1697
1529_Remnant lipoprotein cholesterol (at exam 4, GEE)	1529_Remnant lipoprotein cholesterol (at exam 4, GEE)	25	356	1	1556	899	1460	1517	3280	356	3350	3204	3558
2940_GDF2 - Growth/differentiation factor 2	2940_GDF2 - Growth/differentiation factor 2	25	356	1	1836	1498	2765	628	1097	369	4063	356	708
1992_Survival past average life expectancy (FBAT, adjusted for multivariable)	1992_Survival past average life expectancy (FBAT, adjusted for multivariable)	25	356	1	3451	960	3659	1777	3637	4108	3938	463	356
3719_Ever had known person concerned about, or recommended reduction of alcohol consumption	3719_Ever had known person concerned about, or recommended reduction of alcohol consumption	25	357	1	2365	357	1744	1802	3370	3349	1601	1591	3792
3042_ICOSLG - ICOS ligand	3042_ICOSLG - ICOS ligand	25	357	1	4656	2148	357	2337	1205	2908	2512	4275	1831
820_::::X-13477	820_::::X-13477	25	357	1	3113	4032	2064	1847	3614	357	2494	2461	2721
1383_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	1383_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	25	357	1	3073	4702	1769	373	1001	1903	2925	357	2942
42_Self-rated health	42_Self-rated health	25	358	1	895	358	3260	1453	535	3877	3934	3649	1265
4250_L5 timing	4250_L5 timing	25	358	1	2680	1381	3949	2968	358	3836	2827	766	2516
2400_IDE - Insulin-degrading enzyme	2400_IDE - Insulin-degrading enzyme	25	358	1	3152	920	4435	3960	4179	2113	358	1536	3004
1963_Mean MMSE score for exam 5 and 7 (GEE, adjusted for age)	1963_Mean MMSE score for exam 5 and 7 (GEE, adjusted for age)	25	358	1	2903	4005	2191	455	868	1281	4311	358	1395
796_::::X-12728	796_::::X-12728	25	359	1	359	3520	1330	2715	3518	1197	1999	4545	2744
2704_ARID3A - AT-rich interactive domain-containing protein 3A	2704_ARID3A - AT-rich interactive domain-containing protein 3A	25	359	1	1887	359	3526	3012	2268	3163	2679	4620	2428
853_Albumin	853_Albumin	25	359	1	931	2598	4038	2687	909	1273	359	1139	677
3230_Morning/evening person (chronotype)	3230_Morning/evening person (chronotype)	25	359	1	2360	1355	558	3423	2106	1544	1768	359	1800
789_::::X-12680	789_::::X-12680	25	360	1	360	1465	3375	4297	3375	2557	549	3856	3038
4698_External capsule mean diusivities	4698_External capsule mean diusivities	25	360	1	3401	360	1124	1350	3452	3370	3442	639	3490
4391_Dysmenorrhea (quality of life impact)	4391_Dysmenorrhea (quality of life impact)	25	360	1	520	3292	668	839	360	392	2267	3276	2090
1988_Age at death (FBAT, adjusted for multivariable)	1988_Age at death (FBAT, adjusted for multivariable)	25	360	1	1714	2298	2803	4091	2727	360	2164	1364	3653
15_Posttraumatic stress disorder	15_Posttraumatic stress disorder	25	360	1	4443	2326	1299	1422	1347	4063	3862	1625	360
4528_Left ventral DC	4528_Left ventral DC	25	361	1	3809	361	427	762	4649	1147	1475	1915	2083
2199_CCL1 - C-C motif chemokine 1	2199_CCL1 - C-C motif chemokine 1	25	361	1	939	1861	361	1183	2221	4574	1745	4531	1003
2260_SERPINA3 - Alpha-1-antichymotrypsin	2260_SERPINA3 - Alpha-1-antichymotrypsin	25	361	1	4461	4228	4605	361	669	1488	909	2836	3764
4742_External capsule radial diusivities	4742_External capsule radial diusivities	25	362	1	3896	362	3660	3892	1080	2771	3271	1310	4273
2978_ERAP1 - Endoplasmic reticulum aminopeptidase 1	2978_ERAP1 - Endoplasmic reticulum aminopeptidase 1	25	362	1	4280	3660	362	1255	2773	4561	434	552	1484
1569_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for multivariable)	1569_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for multivariable)	25	362	1	2825	4514	430	1686	2227	2266	362	3920	3357
258_CD8mem:%CD31+	258_CD8mem:%CD31+	25	362	1	1860	3687	1071	1846	4426	4034	2016	1879	362
4547_Left caudal middle frontal	4547_Left caudal middle frontal	25	363	1	2346	2698	3749	363	1710	805	710	1017	3347
2308_IL1R1 - Interleukin-1 receptor type 1	2308_IL1R1 - Interleukin-1 receptor type 1	25	363	1	4658	3056	3965	769	1397	2017	363	4388	2462
4494_Right pericalcarine	4494_Right pericalcarine	25	363	1	4590	2860	1738	1803	2310	642	764	3359	363
3997_Worrier / anxious feelings (WORRY)	3997_Worrier / anxious feelings (WORRY)	25	364	1	499	2762	1284	364	1889	2182	1759	1355	1861
1424_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1424_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	364	1	1097	904	4642	3479	3633	364	3606	2111	3427
1242_Mean FEV1 from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1242_Mean FEV1 from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	364	1	2533	2810	3458	2076	1260	3787	364	1083	2808
3015_MSN - Moesin	3015_MSN - Moesin	25	364	1	2492	1723	2910	3819	2201	1697	496	2539	364
4492_Right pars orbitalis	4492_Right pars orbitalis	25	365	1	365	557	571	3804	3084	2285	4530	3933	3356
438_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannose	438_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannose	25	365	1	779	365	3998	2904	2896	2375	1164	811	462
366_Amino acid::Alanine and aspartate metabolism::aspartate	366_Amino acid::Alanine and aspartate metabolism::aspartate	25	365	1	1879	1543	1581	2362	1608	2562	2813	2466	365
4307_Osteoarthritis	4307_Osteoarthritis	25	366	1	366	4254	2600	2139	3976	838	2147	535	3372
4296_Thinness	4296_Thinness	25	366	1	3170	366	2773	4102	1973	931	3250	1521	4246
239_CD24 on IgA+ B	239_CD24 on IgA+ B	25	366	1	2990	1057	3739	366	3955	789	3124	2585	4192
4231_Salicylic acid and derivatives	4231_Salicylic acid and derivatives	25	366	1	3386	2248	4326	3226	366	2857	4251	4030	3079
1174_Extreme chronotype	1174_Extreme chronotype	25	366	1	2729	2493	2656	1305	2292	366	1925	2566	3652
2058_Psoriasis	2058_Psoriasis	25	366	1	4304	1722	3937	1240	1600	3481	3422	366	1273
4155_E/A ratio	4155_E/A ratio	25	366	1	1447	411	2594	721	1144	3576	4008	2714	366
4362_Acceleration average	4362_Acceleration average	25	367	1	699	367	3945	3910	616	1032	1668	874	1901
4398_Menstruation quality of life impact: Bowel movement	4398_Menstruation quality of life impact: Bowel movement	25	367	1	4488	1892	367	2442	1072	937	1303	2345	2921
3259_Major dietary changes in the last 5 years	3259_Major dietary changes in the last 5 years	25	367	1	1596	2563	3518	367	3336	3484	4181	2869	1238
4164_Juvenile Absence Epilepsy (JAE)	4164_Juvenile Absence Epilepsy (JAE)	25	368	1	368	3415	3635	2198	3421	4634	4222	1952	1528
3590_Medication for cholesterol, blood pressure or diabetes: Cholesterol lowering medication	3590_Medication for cholesterol, blood pressure or diabetes: Cholesterol lowering medication	25	368	1	1363	413	368	699	372	892	2895	2281	2263
3787_Insomnia (male)	3787_Insomnia (male)	25	368	1	4180	4247	574	368	1833	4417	2539	4048	1459
4330_Postburn scar pliability	4330_Postburn scar pliability	25	368	1	2663	4675	3612	4407	4664	368	2617	763	1855
1157_Fasting glucose main effect (adjusted for BMI)	1157_Fasting glucose main effect (adjusted for BMI)	25	368	1	2866	1908	1913	2554	1454	2801	2708	368	375
3097_HAVCR2 - Hepatitis A virus cellular receptor 2	3097_HAVCR2 - Hepatitis A virus cellular receptor 2	25	369	1	369	3149	1544	4050	3733	2972	1468	4741	3507
431_Amino acid::Valine, leucine and isoleucine metabolism::leucine	431_Amino acid::Valine, leucine and isoleucine metabolism::leucine	25	369	1	3770	582	1098	3598	615	450	369	2677	937
4681_Posterior corona radiata axial diusivities	4681_Posterior corona radiata axial diusivities	25	370	1	370	4430	3738	2643	3301	717	3363	1387	4282
1254_Percent predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	1254_Percent predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	25	370	1	4229	3556	370	1769	1301	1783	789	380	1474
780_::::X-12456	780_::::X-12456	25	370	1	900	4047	1286	370	2527	2493	2650	2384	3837
2201_IL10 - Interleukin-10	2201_IL10 - Interleukin-10	25	370	1	4675	1149	2117	3982	370	842	1959	4631	736
30_Agreablenes (NEO-FFI)	30_Agreablenes (NEO-FFI)	25	370	1	3636	1275	3167	4607	3926	744	2135	370	1201
4351_Male pattern baldness (BOLT LMM infinitesimal mixed model)	4351_Male pattern baldness (BOLT LMM infinitesimal mixed model)	25	371	1	3082	371	3784	1172	4680	2516	3378	1180	543
3932_Digalactosylation	3932_Digalactosylation	25	371	1	2476	1455	2753	827	371	3147	3228	1401	3729
2001_Height	2001_Height	25	371	1	4306	2482	3125	2129	4683	371	3756	1114	3293
161_Hip circumference (adjusted for BMI)	161_Hip circumference (adjusted for BMI)	25	371	2	3217	1625	1402	942	1234	703	500	371	2909
2044_Severe gingival inflammation	2044_Severe gingival inflammation	25	371	1	989	4723	3444	4120	3318	2793	1397	843	371
4228_Anti-inflammatory and antirheumatic products, non-steroids	4228_Anti-inflammatory and antirheumatic products, non-steroids	25	372	1	372	2231	2335	2467	1247	2906	2351	2500	2519
2527_CXCL8 - Interleukin-8	2527_CXCL8 - Interleukin-8	25	372	1	2918	372	4068	700	3612	1982	736	887	3633
3296_Risk taking	3296_Risk taking	25	372	1	2621	496	372	3934	2443	4126	1296	1073	2897
2680_PTK6 - Protein-tyrosine kinase 6	2680_PTK6 - Protein-tyrosine kinase 6	25	372	1	3516	4165	594	1368	2917	372	1161	1598	2864
3430_Fluid intelligence test - FI8 : chained arithmetic	3430_Fluid intelligence test - FI8 : chained arithmetic	25	373	1	1135	373	4220	1987	675	4268	1492	3991	2146
517_Lipid::Long chain fatty acid::arachidonate (20:4n6)	517_Lipid::Long chain fatty acid::arachidonate (20:4n6)	25	373	1	772	2033	373	1652	1558	903	4469	3385	448
1717_Thyroid stimulation hormone (at exam 4, GEE, adjusted for multivariable)	1717_Thyroid stimulation hormone (at exam 4, GEE, adjusted for multivariable)	25	373	1	503	2226	4006	3114	373	2957	955	3230	616
4312_White matter hyperintensities	4312_White matter hyperintensities	25	373	1	4330	3784	3320	3632	729	373	4734	3832	1734
4402_Menstruation quality of life impact: Joint pina	4402_Menstruation quality of life impact: Joint pina	25	373	1	3866	4329	1841	471	4310	2625	373	4603	4249
3514_Gas or solid-fuel cooking/heating: A gas fire that you use regularly in winter time	3514_Gas or solid-fuel cooking/heating: A gas fire that you use regularly in winter time	25	374	1	1381	374	1424	2077	1832	3143	1620	2811	3024
2678_PDGFC - Platelet-derived growth factor C	2678_PDGFC - Platelet-derived growth factor C	25	374	1	4733	3277	374	620	3268	4174	3414	3411	2042
2029_Crohn's Disease	2029_Crohn's Disease	25	374	1	2499	3744	1380	374	4257	1843	2706	2338	4028
2753_PLG - Plasminogen	2753_PLG - Plasminogen	25	374	1	2170	4572	3318	2761	1101	374	4175	3813	4593
2172_CSF3R - Granulocyte colony-stimulating factor receptor	2172_CSF3R - Granulocyte colony-stimulating factor receptor	25	374	1	4021	4591	822	4664	2508	558	374	2184	517
2976_CDNF - Cerebral dopamine neurotrophic factor	2976_CDNF - Cerebral dopamine neurotrophic factor	25	374	1	2883	1496	2057	3265	2195	4123	3710	1096	374
1320_Adiponectin (FBAT, adjusted for age, sex and BMI)	1320_Adiponectin (FBAT, adjusted for age, sex and BMI)	25	375	1	2709	2783	375	4692	4200	4115	3752	886	1532
1512_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	1512_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	25	375	1	2266	2039	771	375	1194	1468	427	3286	4308
4338_Sleep durataion (conditioning sex and BMI)	4338_Sleep durataion (conditioning sex and BMI)	25	376	1	376	1736	3430	1877	1966	4656	3956	4586	4235
902_Concentration of large VLDL particles	902_Concentration of large VLDL particles	25	376	1	1001	376	2423	4541	940	3840	4328	568	711
1708_Luteinizing hormone (at exam 3, FBAT, adjusted for multivariable)	1708_Luteinizing hormone (at exam 3, FBAT, adjusted for multivariable)	25	376	1	4196	1641	376	684	2211	3299	4249	993	1673
288_CD4:%Treg(39+73+)	288_CD4:%Treg(39+73+)	25	376	1	2308	1391	4035	4490	376	3919	2308	2177	4708
3107_PSME3 - Proteasome activator complex subunit 3	3107_PSME3 - Proteasome activator complex subunit 3	25	376	1	3640	3651	2639	1441	765	376	2608	4120	1557
648_Xenobiotics::Xanthine metabolism::theobromine	648_Xenobiotics::Xanthine metabolism::theobromine	25	376	1	3897	539	1446	2791	3620	2892	928	3430	376
560_Lipid::Medium chain fatty acid::pelargonate (9:0)	560_Lipid::Medium chain fatty acid::pelargonate (9:0)	25	377	1	377	2550	1705	3290	3026	1418	3821	626	4269
4372_Free thyroxine (FT4)	4372_Free thyroxine (FT4)	25	377	1	3873	2283	377	1503	4558	4713	539	4041	3532
3930_N-glycosylation	3930_N-glycosylation	25	378	1	908	1285	4164	830	378	2943	2918	1474	2894
231_mDC (2):%CD1c-	231_mDC (2):%CD1c-	25	378	1	511	1407	1667	1526	3982	378	2435	3669	1944
4162_Focal Epilepsy, other lesion	4162_Focal Epilepsy, other lesion	25	378	1	3011	2109	1354	2898	2901	1826	378	4111	3277
4508_Cerebellar vermal lobules VI VII	4508_Cerebellar vermal lobules VI VII	25	378	1	2254	2536	2312	2268	1754	4062	4524	2227	378
4203_End stage renal disease	4203_End stage renal disease	25	379	1	379	493	1905	4177	2673	4021	4159	796	3286
4457_Left middle temporal	4457_Left middle temporal	25	379	1	712	379	1012	1778	4273	500	3509	974	1471
4055_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	4055_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	379	1	1174	3573	379	1201	3314	2539	4662	2370	3482
2177_NANOG - Homeobox protein NANOG	2177_NANOG - Homeobox protein NANOG	25	379	1	4449	3147	3616	379	3765	2409	2282	4073	4086
2419_SEMA3A - Semaphorin-3A	2419_SEMA3A - Semaphorin-3A	25	380	1	3482	380	4111	3465	4458	4117	1088	1133	3819
3542_Reason for glasses/contact lenses: For 'astigmatism'	3542_Reason for glasses/contact lenses: For 'astigmatism'	25	380	1	522	4579	380	2772	1929	4132	3467	3827	1210
2589_CNDP1 - Beta-Ala-His dipeptidase	2589_CNDP1 - Beta-Ala-His dipeptidase	25	380	1	2551	2313	1619	3600	1585	380	3253	4642	749
1788_QT interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1788_QT interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	381	1	381	3441	2377	1940	1170	4280	3809	4010	3365
3239_Exposure to tobacco smoke outside home	3239_Exposure to tobacco smoke outside home	25	381	1	1959	381	1154	4713	3374	4369	4403	2907	2325
3303_Able to confide	3303_Able to confide	25	381	1	2124	2587	4448	898	4066	381	2000	519	4193
209_Intelligence	209_Intelligence	25	381	1	1724	4003	2973	3997	3061	3129	381	2897	855
3073_CD200R1 - Cell surface glycoprotein CD200 receptor 1	3073_CD200R1 - Cell surface glycoprotein CD200 receptor 1	25	381	1	2042	4215	1723	4493	4203	2300	1874	2986	381
1935_Temporal brain volume (GEE, adjusted for age and sex)	1935_Temporal brain volume (GEE, adjusted for age and sex)	25	382	1	382	1940	1662	1110	4318	3417	3176	1335	3901
4495_Right postcentral	4495_Right postcentral	25	382	1	2765	382	1276	4295	3846	2694	2787	2599	1959
1637_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for multivariable)	1637_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for multivariable)	25	382	1	521	3274	2762	3743	382	2758	3926	883	2420
1458_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1458_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	382	1	1607	887	1250	2007	2048	382	2195	938	3993
763_::::X-12216	763_::::X-12216	25	382	1	1253	3346	1854	2644	709	491	382	4578	4009
4214_Type 2 Diabetes	4214_Type 2 Diabetes	25	382	1	1781	4606	3793	2168	872	1263	1881	1660	382
2959_HBA1 HBB - Hemoglobin	2959_HBA1 HBB - Hemoglobin	25	383	1	3578	383	3212	3974	4274	758	2570	2817	1597
2484_HCK - Tyrosine-protein kinase HCK	2484_HCK - Tyrosine-protein kinase HCK	25	383	1	3001	2695	383	1267	769	2847	1027	3504	906
3342_Birth weight of first child (female)	3342_Birth weight of first child (female)	25	383	1	2472	999	2099	383	1271	1020	2686	3264	1753
48_Age at first birth (female)	48_Age at first birth (female)	25	383	1	2021	611	664	4746	383	3588	4062	4269	3271
4063_Estimated glomerular filtration rate based on serum creatinine	4063_Estimated glomerular filtration rate based on serum creatinine	25	383	1	2996	1593	1395	3099	3799	383	1509	3503	1377
3228_Sleep duration	3228_Sleep duration	25	383	1	4076	1772	2128	3796	3164	413	383	1215	4573
4183_Triglyceride	4183_Triglyceride	25	383	1	3534	439	4277	2945	852	3619	1826	383	1479
1656_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for multivariable)	1656_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for multivariable)	25	384	1	384	389	1441	815	2076	3562	3203	1866	4407
3364_Age last used hormone-replacement therapy (HRT) (female)	3364_Age last used hormone-replacement therapy (HRT) (female)	25	384	1	3352	2202	384	2948	4436	3823	4541	4733	4114
1852_Neck average buckling ratio (FBAT, male, adjussted for multivariable)	1852_Neck average buckling ratio (FBAT, male, adjussted for multivariable)	25	384	1	3372	4063	3388	4645	3048	384	4016	825	3880
1970_MMSE score (at exam 7, FBAT, adjusted for age)	1970_MMSE score (at exam 7, FBAT, adjusted for age)	25	385	1	385	4512	4731	4556	3460	3911	3836	513	566
1446_Low-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	1446_Low-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	385	1	4113	385	1792	3103	2402	3812	1569	2275	4465
3406_Fluid intelligence test - FI8 : chained arithmetic	3406_Fluid intelligence test - FI8 : chained arithmetic	25	385	1	3651	3765	754	385	2315	3680	4657	2028	2357
1850_Neck average buckling ratio (FBAT, female, adjussted for multivariable)	1850_Neck average buckling ratio (FBAT, female, adjussted for multivariable)	25	385	1	670	2023	3139	1047	385	1188	448	1629	3863
2868_NCAM1 - Neural cell adhesion molecule 1, 120 kDa isoform	2868_NCAM1 - Neural cell adhesion molecule 1, 120 kDa isoform	25	385	1	1195	1242	4232	3969	593	2339	385	1419	2722
4539_Right amygdala	4539_Right amygdala	25	385	1	2095	2826	4214	4384	1207	786	3626	1784	385
4016_Central corneal thickness	4016_Central corneal thickness	25	386	1	386	2937	816	987	3171	3214	3054	4449	4543
705_::::X-11442	705_::::X-11442	25	386	1	1693	2662	386	3443	4646	1593	3776	4448	4180
272_CD4:%RTE	272_CD4:%RTE	25	386	1	2961	2399	2384	386	3202	3148	3063	3003	556
3493_Coffee type: Instant coffee	3493_Coffee type: Instant coffee	25	386	1	1565	1439	3556	807	386	2964	1743	1079	2833
2828_IFNL2 - Interferon lambda-2	2828_IFNL2 - Interferon lambda-2	25	386	1	3876	1573	1984	2915	3224	3455	2667	386	1598
3900_Red blood cell count (three-way meta)	3900_Red blood cell count (three-way meta)	25	387	1	1569	387	3483	486	4605	4447	1473	4033	3379
2973_AGR2 - Anterior gradient protein 2 homolog	2973_AGR2 - Anterior gradient protein 2 homolog	25	387	1	1798	4504	387	812	1147	3543	3718	4369	3877
1516_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	1516_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	25	387	1	4550	2944	1753	387	2403	4152	3057	2235	4213
3768_Anxiety - Recent trouble relaxing	3768_Anxiety - Recent trouble relaxing	25	387	1	4216	871	3312	1809	387	3429	2205	1687	2254
951_Urea	951_Urea	25	387	1	2759	704	4118	3088	2341	387	2341	1932	1671
3731_Depression - Difficulty concentrating during worst ddepression	3731_Depression - Difficulty concentrating during worst ddepression	25	387	1	2281	3632	2115	4626	655	1471	587	1175	387
2413_NRP1 - Neuropilin-1	2413_NRP1 - Neuropilin-1	25	388	1	388	4527	2912	662	1655	2621	3559	1309	824
343_NKearly:%337+158b+	343_NKearly:%337+158b+	25	388	1	2754	388	1985	2317	4222	4641	2294	1200	3789
2837_ENPP7 - Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	2837_ENPP7 - Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	25	388	1	1157	4738	388	4360	1765	2817	1036	2705	825
232_mDC (2):%CD1c+	232_mDC (2):%CD1c+	25	388	1	459	2380	2561	1600	4451	388	2926	4163	2741
1709_Luteinizing hormone (at exam 3, GEE, adjusted for multivariable)	1709_Luteinizing hormone (at exam 3, GEE, adjusted for multivariable)	25	388	1	3365	2710	2352	3295	581	2567	1357	3150	388
2143_PLAUR - Urokinase plasminogen activator surface receptor	2143_PLAUR - Urokinase plasminogen activator surface receptor	25	389	1	4410	3747	389	3051	4249	4576	4043	2524	3761
2540_BIRC5 - Baculoviral IAP repeat-containing protein 5	2540_BIRC5 - Baculoviral IAP repeat-containing protein 5	25	389	1	2875	3233	1251	389	2722	3275	4526	1726	3924
2552_CNTF - Ciliary Neurotrophic Factor	2552_CNTF - Ciliary Neurotrophic Factor	25	389	1	813	3679	2663	2672	1523	389	1183	662	1439
2073_FGFR1 - Fibroblast growth factor receptor 1	2073_FGFR1 - Fibroblast growth factor receptor 1	25	389	1	2198	1186	1412	2401	4726	1761	2851	389	2676
282_CD4:%Eff(127-PD1-)	282_CD4:%Eff(127-PD1-)	25	390	1	390	3805	4423	1601	2338	747	476	4529	2438
1923_Hippocampal volume (GEE, adjusted for age and sex)	1923_Hippocampal volume (GEE, adjusted for age and sex)	25	390	1	1371	4018	390	880	4704	2331	1769	1441	541
3145_CD86 - T-lymphocyte activation antigen CD86	3145_CD86 - T-lymphocyte activation antigen CD86	25	390	1	4153	846	3910	2936	494	868	390	610	1688
1719_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for age and sex)	1719_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for age and sex)	25	390	1	596	4383	3267	4186	3297	3079	665	390	1410
223_Mature B:%Memory	223_Mature B:%Memory	25	391	1	391	930	2853	3482	2128	1542	450	3868	463
1484_Mean triglycerides from exam 1-7 (FBAT, adjusted for multivariable)	1484_Mean triglycerides from exam 1-7 (FBAT, adjusted for multivariable)	25	391	1	4521	3738	1416	391	573	3510	2189	4403	1886
4482_Right inferior temporal	4482_Right inferior temporal	25	391	1	4084	3012	2995	3702	3806	391	1408	1235	1682
1694_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for age and sex)	1694_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for age and sex)	25	391	1	4130	2589	2255	1034	2229	1450	2112	391	4434
2193_FGF19 - Fibroblast growth factor 19	2193_FGF19 - Fibroblast growth factor 19	25	392	1	2772	3503	392	1287	649	2139	465	4246	1940
2489_PAK3 - Serine/threonine-protein kinase PAK 3	2489_PAK3 - Serine/threonine-protein kinase PAK 3	25	392	1	3283	3127	826	392	1455	3324	2119	4442	2688
488_Lipid::Essential fatty acid::docosahexaenoate (DHA; 22:6n3)	488_Lipid::Essential fatty acid::docosahexaenoate (DHA; 22:6n3)	25	392	1	1334	2767	2648	4734	1862	3125	392	2024	3442
3409_Education - Qualifications	3409_Education - Qualifications	25	392	1	959	3145	2486	622	1991	3986	4648	392	2205
2873_BST1 - ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	2873_BST1 - ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	25	393	1	393	1878	3336	1008	2734	2278	730	4371	626
3105_PDE9A - High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	3105_PDE9A - High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	25	393	1	472	393	3522	649	1266	4627	974	500	2479
2207_CCL3L1 - C-C motif chemokine 3-like 1	2207_CCL3L1 - C-C motif chemokine 3-like 1	25	393	1	4500	700	3871	1227	393	755	1483	2220	2630
1455_Low-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	1455_Low-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	25	393	1	3582	2188	2430	695	2760	3416	1533	393	931
1736_Serum phosphorus (at exam 2, FBAT, adjusted for multivariable)	1736_Serum phosphorus (at exam 2, FBAT, adjusted for multivariable)	25	393	1	1089	1334	2263	2490	2933	2692	2668	2550	393
1088_Neuroblastoma	1088_Neuroblastoma	25	394	1	394	2699	1237	1434	3922	397	2233	3636	2746
3487_Bread type: Wholemeal or wholegrain	3487_Bread type: Wholemeal or wholegrain	25	394	1	833	394	4536	1666	2152	1264	2751	702	1379
2189_C3 - Complement C3	2189_C3 - Complement C3	25	394	1	2787	463	3196	2811	394	1841	2386	4372	1678
2955_GSTP1 - Glutathione S-transferase P	2955_GSTP1 - Glutathione S-transferase P	25	394	1	875	2525	1813	3963	3748	1700	2506	394	3449
4040_Schizophrenia/Bipolar disorder	4040_Schizophrenia/Bipolar disorder	25	395	1	1453	395	872	4554	2185	2481	2829	4397	4264
4634_Right cerebellum white matter	4634_Right cerebellum white matter	25	395	1	3766	2600	395	3211	695	2053	2661	2084	1415
2833_BCL2L1 - Bcl-2-like protein 1	2833_BCL2L1 - Bcl-2-like protein 1	25	395	1	4490	1662	1008	395	3071	3672	3336	2457	3400
3287_Sensitivity / hurt feelings	3287_Sensitivity / hurt feelings	25	395	1	4273	548	4498	1133	395	2543	672	1874	4491
2790_NME1 - Nucleoside diphosphate kinase A	2790_NME1 - Nucleoside diphosphate kinase A	25	395	1	2980	3004	2106	3692	1396	1750	4516	2483	395
4443_Epstein Barr Virus antigen VCA IgG levels	4443_Epstein Barr Virus antigen VCA IgG levels	25	396	1	396	2081	3707	1521	4415	2243	2012	1551	3780
2061_F11 - Coagulation Factor XI	2061_F11 - Coagulation Factor XI	25	396	1	3886	836	396	2685	1566	2020	2391	1616	972
545_Lipid::Lysolipid::1-palmitoylglycerophosphoinositol*	545_Lipid::Lysolipid::1-palmitoylglycerophosphoinositol*	25	396	1	2262	2569	2262	2148	396	4549	433	2947	900
1165_Fasting glucose	1165_Fasting glucose	25	396	1	1688	569	1399	1449	576	4655	3638	396	1013
295_CD4mem:%Th17	295_CD4mem:%Th17	25	397	1	4520	397	2176	2597	1042	3364	1574	2294	4188
1166_Fasting insulin	1166_Fasting insulin	25	397	1	1450	702	3272	3156	707	3939	397	932	2875
1414_High-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	1414_High-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	397	1	3287	2672	1293	1217	2862	1485	1907	397	3717
2888_KIRREL3 - Kin of IRRE-like protein 3	2888_KIRREL3 - Kin of IRRE-like protein 3	25	397	1	2108	4730	2009	3057	2461	870	3060	1533	397
4117_Total bilirubin	4117_Total bilirubin	25	398	1	398	959	4660	3287	4633	3945	2862	2894	3810
371_Amino acid::Cysteine, methionine, SAM, taurine metabolism::2-hydroxybutyrate (AHB)	371_Amino acid::Cysteine, methionine, SAM, taurine metabolism::2-hydroxybutyrate (AHB)	25	398	1	4499	398	3979	3940	4582	1790	4086	2059	2793
4118_Zinc sulfate turbidity test	4118_Zinc sulfate turbidity test	25	398	1	1036	1024	398	4336	2108	1421	727	4712	3645
1171_Body fat percentage	1171_Body fat percentage	25	399	1	399	3832	971	2515	628	847	1915	2772	1445
4591_Right paracentral	4591_Right paracentral	25	399	1	2381	399	3276	2893	744	2403	3211	1767	3719
1130_Ratio of visceral-tosubcutaneous adipose tissue volume (male)	1130_Ratio of visceral-tosubcutaneous adipose tissue volume (male)	25	399	1	479	2928	399	1418	990	430	1580	3887	1112
3426_Fluid intelligence test - FI3 : word interpolation	3426_Fluid intelligence test - FI3 : word interpolation	25	399	1	3144	3574	1646	399	1165	3405	4133	615	1337
2857_SERPING1 - Plasma protease C1 inhibitor	2857_SERPING1 - Plasma protease C1 inhibitor	25	399	1	1986	1890	1057	4141	4428	399	4230	3661	849
2314_LSAMP - Limbic system-associated membrane protein	2314_LSAMP - Limbic system-associated membrane protein	25	399	1	3519	1345	4180	2926	856	2427	1435	399	1398
546_Lipid::Lysolipid::1-stearoylglycerophosphocholine	546_Lipid::Lysolipid::1-stearoylglycerophosphocholine	25	399	1	3627	1070	443	896	1204	2334	3220	2491	399
194_Estimated glomerular filtration rate based on cystain C	194_Estimated glomerular filtration rate based on cystain C	25	400	1	3910	2310	400	2156	3989	3991	1687	3944	2352
3265_Average weekly spirits intake	3265_Average weekly spirits intake	25	400	1	3343	3795	3213	4076	1257	400	3902	3941	3046
1639_Myeloperoxidase (at exam 7, GEE, adjusted for age and sex)	1639_Myeloperoxidase (at exam 7, GEE, adjusted for age and sex)	25	400	1	4005	3841	3085	1866	2327	4232	2743	400	2884
2772_CFL1 - Cofilin-1	2772_CFL1 - Cofilin-1	25	400	1	4610	895	2876	1410	1528	804	2684	3557	400
579_Lipid::Sterol, Steroid::lathosterol	579_Lipid::Sterol, Steroid::lathosterol	25	401	1	4529	401	1695	1210	4147	3781	3447	3274	3980
3608_Non-cancer illness code, self-reported: high cholesterol	3608_Non-cancer illness code, self-reported: high cholesterol	25	401	1	714	1645	2471	401	1065	808	3953	2984	3826
3400_Noisy workplace	3400_Noisy workplace	25	401	1	1348	805	920	2141	401	594	1063	1691	4622
3333_Frequency of heavy DIY in last 4 weeks	3333_Frequency of heavy DIY in last 4 weeks	25	401	1	3799	4720	1784	1542	3351	401	576	4627	3285
1761_Breast cancer (GEE, adjusted for age and BMI)	1761_Breast cancer (GEE, adjusted for age and BMI)	25	401	1	1369	1243	1180	4484	4144	1917	407	401	4720
3782_Depression - Sleeping too much	3782_Depression - Sleeping too much	25	402	1	3322	402	3986	965	2547	2958	4347	4436	2797
2844_LRRTM3 - Leucine-rich repeat transmembrane neuronal protein 3	2844_LRRTM3 - Leucine-rich repeat transmembrane neuronal protein 3	25	402	1	3199	2263	4167	402	3994	2523	2825	1269	3994
1501_Triglycerides (at exam 2, GEE, adjusted for age and sex)	1501_Triglycerides (at exam 2, GEE, adjusted for age and sex)	25	402	1	1574	1069	4484	2062	2545	402	3888	657	602
3182_SPOCK2 - Testican-2	3182_SPOCK2 - Testican-2	25	402	1	1952	2019	4730	3882	4705	687	402	1669	2085
2472_CDK2 CCNA2 - Cyclin-dependent kinase 2:Cyclin-A2 complex	2472_CDK2 CCNA2 - Cyclin-dependent kinase 2:Cyclin-A2 complex	25	402	1	3768	1438	2253	3622	557	4491	3344	402	3236
3090_SIGLEC14 - Sialic acid-binding Ig-like lectin 14	3090_SIGLEC14 - Sialic acid-binding Ig-like lectin 14	25	402	1	2355	2764	732	2537	2625	1988	2213	2595	402
2673_MAPKAPK5 - MAP kinase-activated protein kinase 5	2673_MAPKAPK5 - MAP kinase-activated protein kinase 5	25	403	1	2410	403	2170	3332	1333	3232	3077	949	1036
1047_Trochanter BMD (GEE, adjusted for multivariable)	1047_Trochanter BMD (GEE, adjusted for multivariable)	25	403	1	4193	4041	403	2862	2984	4694	3653	2702	3677
4024_Excessive hairiness	4024_Excessive hairiness	25	403	1	3552	2647	1919	1890	3274	2530	4128	403	3337
3002_HNRNPK - Heterogeneous nuclear ribonucleoprotein K	3002_HNRNPK - Heterogeneous nuclear ribonucleoprotein K	25	403	1	2451	715	4707	2891	3304	724	657	2851	403
2742_IL20 - Interleukin-20	2742_IL20 - Interleukin-20	25	404	1	404	3780	462	2341	4717	3058	3160	3957	4165
3365_Back pain for 3+ months	3365_Back pain for 3+ months	25	404	1	3076	1682	404	611	4183	1530	3769	1999	676
3644_Illnesses of mother: High blood pressure	3644_Illnesses of mother: High blood pressure	25	404	1	3433	1713	2237	404	4708	1479	3495	3343	2226
3298_Frequency of unenthusiasm / disinterest in last 2 weeks	3298_Frequency of unenthusiasm / disinterest in last 2 weeks	25	404	1	2784	2015	4451	3880	404	2655	1642	1449	1374
710_::::X-11470	710_::::X-11470	25	404	1	2913	562	4595	2013	4486	404	504	652	607
2618_BMPER - BMP-binding endothelial regulator protein	2618_BMPER - BMP-binding endothelial regulator protein	25	404	1	1340	4295	3974	4286	1374	849	404	4124	3832
4212_Glycine level (male)	4212_Glycine level (male)	25	404	1	769	4321	2166	4048	4241	4597	575	404	1511
4696_Cingulum (hippocampus) mean diusivities	4696_Cingulum (hippocampus) mean diusivities	25	405	1	1853	901	405	4689	3709	2424	1750	3167	1795
2304_CXCL1 - Growth-regulated alpha protein	2304_CXCL1 - Growth-regulated alpha protein	25	405	1	3654	2603	841	405	4722	1894	2370	4104	1026
818_Lipid::Carnitine metabolism::X-13431--nonanoylcarnitine*	818_Lipid::Carnitine metabolism::X-13431--nonanoylcarnitine*	25	405	1	2221	2793	2199	3409	779	405	833	4473	977
3656_Alcohol - Alcohol drinker status: Never	3656_Alcohol - Alcohol drinker status: Never	25	405	1	1599	587	757	4096	2608	1389	405	3449	3594
3267_Alcohol usually taken with meals	3267_Alcohol usually taken with meals	25	405	1	3818	1658	3479	4412	440	761	1165	405	3434
3703_Diagnoses - secondary ICD10: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	3703_Diagnoses - secondary ICD10: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	25	405	1	3593	3064	1118	4469	1856	2764	3483	1795	405
3347_Age started oral contraceptive pill (female)	3347_Age started oral contraceptive pill (female)	25	406	1	406	3793	1794	3292	4297	420	1525	1595	1145
3730_Depression - Age at last episode of depression	3730_Depression - Age at last episode of depression	25	406	1	1461	406	4499	3055	617	2629	2850	977	1097
417_Amino acid::Urea cycle; arginine-, proline-, metabolism::proline	417_Amino acid::Urea cycle; arginine-, proline-, metabolism::proline	25	406	1	1164	690	406	4702	3787	3369	810	2517	954
1461_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1461_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	406	1	1884	3589	1721	406	3879	3194	3992	2496	1547
2597_GNS - N-acetylglucosamine-6-sulfatase	2597_GNS - N-acetylglucosamine-6-sulfatase	25	407	1	4012	407	4221	1551	4062	4203	3485	2146	2710
351_gdT:%CM (2)	351_gdT:%CM (2)	25	407	1	4731	1394	1238	4248	407	1365	1955	2202	1953
88_Type 2 Diabetes	88_Type 2 Diabetes	25	407	1	4150	3178	2822	4491	3308	1725	1699	2822	407
3209_Duration of vigorous activity	3209_Duration of vigorous activity	25	408	1	1264	979	408	4547	4609	2887	3742	3995	4528
1393_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for multivariable)	1393_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for multivariable)	25	408	1	3706	3168	3131	408	4432	4053	1322	577	3390
2543_NTRK1 - High affinity nerve growth factor receptor	2543_NTRK1 - High affinity nerve growth factor receptor	25	408	1	2846	2106	3840	4290	898	958	408	4702	2063
2181_SIGLEC7 - Sialic acid-binding Ig-like lectin 7	2181_SIGLEC7 - Sialic acid-binding Ig-like lectin 7	25	408	1	3727	2405	2745	2343	3554	4201	3586	4507	408
3066_KIR2DL4 - Killer cell immunoglobulin-like receptor 2DL4	3066_KIR2DL4 - Killer cell immunoglobulin-like receptor 2DL4	25	409	1	2152	2976	2984	409	673	3302	3152	3175	3348
4652_Cingulum (hippocampus) fractional anisotropy	4652_Cingulum (hippocampus) fractional anisotropy	25	409	1	1996	4506	3271	2696	2919	912	409	2179	562
2104_PRL - Prolactin	2104_PRL - Prolactin	25	409	1	3060	3325	3078	3444	2169	1785	1583	452	409
2638_PYY - Peptide YY	2638_PYY - Peptide YY	25	410	1	2277	410	2450	2222	848	1930	2563	1607	1037
1486_Mean triglycerides from exam 1-7 (FBAT, adjusted for age and sex)	1486_Mean triglycerides from exam 1-7 (FBAT, adjusted for age and sex)	25	410	1	2031	3709	2034	410	4065	3505	4504	4559	3661
1114_Visceral sdipose tissue volume (adjusted for BMI)	1114_Visceral sdipose tissue volume (adjusted for BMI)	25	410	1	3816	2117	4549	3544	4293	410	1824	3077	725
2386_CTSA - Lysosomal protective protein	2386_CTSA - Lysosomal protective protein	25	410	1	2796	2661	1652	2848	901	422	410	2638	2880
1737_Serum phosphorus (at exam 2, GEE, adjusted for multivariable)	1737_Serum phosphorus (at exam 2, GEE, adjusted for multivariable)	25	411	2	4222	3357	411	3142	2074	3651	3522	3486	4077
2231_KLK8 - Kallikrein-8	2231_KLK8 - Kallikrein-8	25	411	1	4514	2360	1347	2625	2278	3878	411	4517	4116
1525_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	1525_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	25	411	1	3882	1821	617	3359	3011	3837	1455	411	1042
4156_Epilepsy	4156_Epilepsy	25	411	1	4537	3062	4218	1462	3099	2011	471	2715	411
3453_Impedance measures - Leg fat mass (right)	3453_Impedance measures - Leg fat mass (right)	25	412	1	412	3647	1157	1593	2295	1992	1847	2062	2545
3181_SPOCK1 - Testican-1	3181_SPOCK1 - Testican-1	25	412	1	2077	3934	857	412	1919	2905	1960	1126	4322
1296_Adiponectin (FBAT, adjusted for age and sex)	1296_Adiponectin (FBAT, adjusted for age and sex)	25	412	1	579	876	2743	2535	3019	412	776	1381	532
1350_Plasma Apolipoprotein B level (FBAT, adjusted for age and sex)	1350_Plasma Apolipoprotein B level (FBAT, adjusted for age and sex)	25	413	1	4166	583	413	2023	1043	2541	4601	1351	1952
1317_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age and sex)	1317_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age and sex)	24	413	1	3747	3083	2667	3670	413	587	1407	1127	2728
1800_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1800_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	413	1	3215	2735	2295	1336	2969	2037	3000	864	413
2175_MICA - MHC class I polypeptide-related sequence A	2175_MICA - MHC class I polypeptide-related sequence A	25	414	1	414	2903	2217	1858	4467	2949	767	603	2992
4448_Left entorhinal	4448_Left entorhinal	25	414	1	1733	1499	888	3530	786	414	769	1546	2662
2629_A2M - Alpha-2-macroglobulin	2629_A2M - Alpha-2-macroglobulin	25	415	1	415	2871	986	3728	859	3179	2599	3531	1578
1595_Platelet aggregation to collagen (at exam 5, GEE, adjusted for age and sex)	1595_Platelet aggregation to collagen (at exam 5, GEE, adjusted for age and sex)	25	415	1	1339	1973	1826	415	1877	2843	1313	3406	1147
3165_LEPR - Leptin receptor	3165_LEPR - Leptin receptor	25	415	1	2592	2490	1182	1456	415	646	2143	1789	662
4175_Heel bone mineral density	4175_Heel bone mineral density	25	415	1	960	4287	426	1991	3276	4662	2396	1434	415
2423_ACAN - Aggrecan core protein	2423_ACAN - Aggrecan core protein	25	416	1	416	787	2581	1367	609	887	1092	3414	2402
3939_Body Mass Index	3939_Body Mass Index	25	416	1	918	416	1934	585	1262	1859	2227	1877	1939
1682_Brain natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	1682_Brain natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	25	416	1	3269	2452	2671	416	3115	1160	2508	1493	2280
3071_SCARB2 - Lysosome membrane protein 2	3071_SCARB2 - Lysosome membrane protein 2	25	416	1	2659	1996	661	2254	416	2435	2120	4154	4674
4282_FEV1	4282_FEV1	25	416	1	725	3204	1252	758	668	454	416	4013	4413
2514_CMA1 - Chymase	2514_CMA1 - Chymase	25	416	1	1703	1813	1266	1471	3715	1883	1927	416	1223
1912_Occipital brain volume (FBAT, adjusted for multivariable)	1912_Occipital brain volume (FBAT, adjusted for multivariable)	25	416	1	2871	654	3750	1226	3585	4149	966	2801	416
1853_Neck average buckling ratio (GEE, male, adjussted for multivariable)	1853_Neck average buckling ratio (GEE, male, adjussted for multivariable)	25	417	1	417	1208	2754	4388	2143	3345	1106	3635	4393
4654_External capsule fractional anisotropy	4654_External capsule fractional anisotropy	25	417	1	452	417	2521	3419	418	3643	3651	814	968
777_Lipid::Long chain fatty acid::X-12442--5,8-tetradecadienoate	777_Lipid::Long chain fatty acid::X-12442--5,8-tetradecadienoate	25	417	1	896	3825	2783	417	4047	3950	728	1174	2118
3424_Symbol digit substitution test - Number of symbol digit matches made correctly	3424_Symbol digit substitution test - Number of symbol digit matches made correctly	25	418	1	2926	3324	4318	418	3756	718	2703	4435	3884
1256_Percent predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	1256_Percent predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	418	1	1038	4438	1079	1364	4181	4657	4512	2414	418
3851_Mean corpuscular hemoglobin (two-way meta)	3851_Mean corpuscular hemoglobin (two-way meta)	25	419	1	419	1025	2643	1763	1716	620	717	1781	1810
4639_Right hippocampus	4639_Right hippocampus	25	419	1	2553	419	550	4618	876	3212	3017	1107	3203
1027_Femoral Neck Length (GEE, adjusted for multivariable)	1027_Femoral Neck Length (GEE, adjusted for multivariable)	25	419	1	4601	3688	3015	2571	4091	419	3265	561	4489
2818_ICAM1 - Intercellular adhesion molecule 1	2818_ICAM1 - Intercellular adhesion molecule 1	25	419	1	446	2078	3886	4577	3746	3938	419	3792	4145
1480_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for multivariable)	1480_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for multivariable)	25	419	1	3440	2070	4091	435	1121	3633	3982	419	3022
389_Amino acid::Lysine metabolism::lysine	389_Amino acid::Lysine metabolism::lysine	25	419	1	3976	1997	4389	3403	2840	1916	835	2580	419
1131_Ratio of visceral-tosubcutaneous adipose tissue volume (female)	1131_Ratio of visceral-tosubcutaneous adipose tissue volume (female)	25	420	1	1250	420	3523	916	1222	2166	2713	4107	1715
4688_Superior longitudinal fasciculus axial diusivities	4688_Superior longitudinal fasciculus axial diusivities	25	420	1	1840	4612	420	4284	2987	2904	750	2902	3889
1792_RR interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1792_RR interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	420	1	3842	2410	3269	1373	2518	981	2863	420	776
2972_RPSA - 40S ribosomal protein SA	2972_RPSA - 40S ribosomal protein SA	25	420	1	1232	3111	2497	4114	4668	2614	867	3263	420
477_Lipid::Carnitine metabolism::acetylcarnitine	477_Lipid::Carnitine metabolism::acetylcarnitine	25	421	1	2935	3664	1785	1408	1304	2238	4203	3285	421
418_Amino acid::Urea cycle; arginine-, proline-, metabolism::trans-4-hydroxyproline	418_Amino acid::Urea cycle; arginine-, proline-, metabolism::trans-4-hydroxyproline	25	422	1	422	2873	4290	1082	3936	4745	4087	3235	2272
1040_Shaft Width (FBAT, adjusted for age and sex)	1040_Shaft Width (FBAT, adjusted for age and sex)	25	422	1	1323	3672	4207	3126	2271	3036	3347	422	3583
1050_Parkinson disease of unrelated individuals (tier 2a)	1050_Parkinson disease of unrelated individuals (tier 2a)	25	422	1	1722	3554	982	3657	3512	4564	3877	3117	422
2547_AGT - Angiotensinogen	2547_AGT - Angiotensinogen	25	423	1	423	1032	1478	2873	3131	4223	770	3010	1341
2802_NAPA - Alpha-soluble NSF attachment protein	2802_NAPA - Alpha-soluble NSF attachment protein	25	423	1	3843	423	3647	3223	3519	4386	2513	815	689
4405_Menstrual quality of life impact: Pressure in the breasts	4405_Menstrual quality of life impact: Pressure in the breasts	25	423	1	2763	4133	423	3516	3627	2376	4708	3098	4267
3507_Non-butter spread type details: Polyunsaturated/sunflower oil based spread (eg: Flora)	3507_Non-butter spread type details: Polyunsaturated/sunflower oil based spread (eg: Flora)	25	423	1	965	4656	1320	423	3583	518	4538	2029	4291
3856_Myeloid white cell count (two-way meta)	3856_Myeloid white cell count (two-way meta)	25	423	1	787	2714	974	1341	3960	423	2519	2272	1063
1575_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	1575_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	25	423	1	4192	1708	1567	869	2947	1985	423	717	2743
1500_Triglycerides (at exam 2, FBAT, adjusted for age and sex)	1500_Triglycerides (at exam 2, FBAT, adjusted for age and sex)	25	423	1	3262	2185	1618	4163	3934	1399	1876	793	423
315_CD8mem:%PD1+R6+	315_CD8mem:%PD1+R6+	25	424	1	424	2133	2613	3922	1197	4523	4206	2522	2586
4465_Left posterior cingulate	4465_Left posterior cingulate	25	424	1	1159	4161	901	424	1569	732	4559	1454	3246
2573_DKK1 - Dickkopf-related protein 1	2573_DKK1 - Dickkopf-related protein 1	25	424	1	4151	4225	3884	3466	424	1061	1478	2682	2995
3906_Intraocular pressure	3906_Intraocular pressure	25	424	1	2466	1524	1198	2701	1859	2138	4435	4373	424
587_Nucleotide::Purine metabolism, urate metabolism::allantoin	587_Nucleotide::Purine metabolism, urate metabolism::allantoin	25	425	1	425	2295	4136	3313	1720	4124	1501	1013	864
2379_APP - Amyloid beta A4 protein	2379_APP - Amyloid beta A4 protein	25	425	1	1326	1945	425	1312	2739	4281	2458	1570	876
2066_PROK1 - Prokineticin-1	2066_PROK1 - Prokineticin-1	25	426	1	426	2340	2993	2982	3699	1830	695	4338	1629
4046_Rotator cuff injury	4046_Rotator cuff injury	25	426	1	4181	4246	4697	426	1328	4290	4675	4690	702
1477_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for multivariable)	1477_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for multivariable)	25	426	1	4014	2454	2720	4628	3144	1258	426	1408	4150
3535_Mental health - Illness, injury, bereavement, stress in last 2 years: Marital separation/divorce	3535_Mental health - Illness, injury, bereavement, stress in last 2 years: Marital separation/divorce	25	426	1	3716	3278	3473	3434	1769	4171	3262	4280	426
4425_Hepatitis B HBc antigen seropositivity	4425_Hepatitis B HBc antigen seropositivity	25	427	1	427	1836	3242	2444	2988	438	3163	3147	2307
3887_Mean corpuscular hemoglobin (three-way meta)	3887_Mean corpuscular hemoglobin (three-way meta)	25	427	1	789	427	2883	1995	2069	683	1660	3835	710
1593_Log ADP platelet aggregation (at exam 5, GEE, adjusted for multivariable)	1593_Log ADP platelet aggregation (at exam 5, GEE, adjusted for multivariable)	25	427	1	3475	3716	3863	630	3927	4346	3801	427	1691
538_Lipid::Lysolipid::1-linoleoylglycerophosphoethanolamine*	538_Lipid::Lysolipid::1-linoleoylglycerophosphoethanolamine*	25	428	1	428	3299	1068	3646	1032	4165	2441	2054	2658
3763_Depression - Recent feelings of depression	3763_Depression - Recent feelings of depression	25	428	1	2879	571	3796	428	3932	1657	4547	3793	3183
1460_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1460_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	428	1	3065	2323	930	1911	4051	765	428	632	3497
4717_Cingulum (cingulate gyrus) mode of anisotropy	4717_Cingulum (cingulate gyrus) mode of anisotropy	25	428	1	867	4688	2274	555	4319	2565	1450	428	1209
4534_Right thalamus proper	4534_Right thalamus proper	25	428	1	3459	1531	1759	1399	1872	2524	1690	913	428
670_::::X-06307	670_::::X-06307	25	429	1	3863	3964	4346	592	429	550	4641	3607	4436
586_Nucleotide::Purine metabolism, guanine containing::N2,N2-dimethylguanosine	586_Nucleotide::Purine metabolism, guanine containing::N2,N2-dimethylguanosine	25	429	1	539	1251	2723	4658	2331	3773	429	445	4613
1473_Mean total cholesterol from exam 1-7 (GEE, adjusted for multivariable)	1473_Mean total cholesterol from exam 1-7 (GEE, adjusted for multivariable)	25	429	1	849	722	748	439	3475	3935	3460	429	3612
3151_CCNB1 - G2/mitotic-specific cyclin-B1	3151_CCNB1 - G2/mitotic-specific cyclin-B1	25	429	1	4531	2856	2974	962	2719	2090	1749	1476	429
4350_Nonischemic cardiomyopathy	4350_Nonischemic cardiomyopathy	25	430	1	923	4332	3820	1990	2162	1339	430	2527	2651
486_Lipid::Carnitine metabolism::stearoylcarnitine	486_Lipid::Carnitine metabolism::stearoylcarnitine	25	430	1	3957	946	1958	3710	1461	1185	1154	2768	430
3769_Anxiety - Recent restlessness	3769_Anxiety - Recent restlessness	25	431	1	431	826	4425	4219	842	3526	4170	3400	2627
779_::::X-12450	779_::::X-12450	25	431	1	2230	431	3596	1718	3502	2422	2354	3745	1620
3158_NLGN4X - Neuroligin-4, X-linked	3158_NLGN4X - Neuroligin-4, X-linked	25	431	1	2556	4739	431	704	4356	3920	2100	4159	3147
2649_PTGS2 - Prostaglandin G/H synthase 2	2649_PTGS2 - Prostaglandin G/H synthase 2	25	431	1	3280	2107	1236	3716	431	3511	1159	2620	3949
2481_ECM1 - Extracellular matrix protein 1	2481_ECM1 - Extracellular matrix protein 1	25	431	1	3836	931	695	2823	648	889	3533	431	2546
386_Amino acid::Histidine metabolism::3-methylhistidine	386_Amino acid::Histidine metabolism::3-methylhistidine	25	431	1	2160	4404	4679	3786	1795	3051	1140	3001	431
4345_Coronary artery disease and total cholesterol (bivariate)	4345_Coronary artery disease and total cholesterol (bivariate)	25	432	1	1631	432	1768	874	1466	4177	3069	2268	4140
455_Cofactors and vitamins::Tocopherol metabolism::alpha-tocopherol	455_Cofactors and vitamins::Tocopherol metabolism::alpha-tocopherol	25	432	1	3826	2605	432	3616	4111	4393	4317	4477	2306
4712_Uncinate fasciculus mean diusivities	4712_Uncinate fasciculus mean diusivities	25	432	1	934	1222	4709	2209	432	1177	2660	4125	2231
4453_Left lateral occipital	4453_Left lateral occipital	25	432	1	1055	1315	507	617	1019	432	2814	3296	540
2477_CHRDL1 - Chordin-like protein 1	2477_CHRDL1 - Chordin-like protein 1	25	432	1	3918	1500	4617	440	1669	499	432	2181	2910
1386_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	1386_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	25	433	1	1778	2691	433	3400	4442	3527	3216	1824	4677
1388_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	1388_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	25	433	1	2336	4385	3654	433	2362	4456	3625	1245	4455
944_Triglycerides in small VLDL	944_Triglycerides in small VLDL	25	433	1	693	753	3694	4641	433	2735	3936	596	2071
931_Phenylalanine	931_Phenylalanine	25	433	1	902	4348	2572	4390	2653	3200	1306	433	2785
3402_Fluid intelligence test - FI3 : word interpolation	3402_Fluid intelligence test - FI3 : word interpolation	25	434	1	434	4406	4667	1721	2551	4485	3672	4635	2949
3379_Diastolic Blood Pressure (automated reading)	3379_Diastolic Blood Pressure (automated reading)	25	434	1	3547	434	1078	3382	1582	612	3340	2324	3320
2146_NTRK3 - NT-3 growth factor receptor	2146_NTRK3 - NT-3 growth factor receptor	25	434	1	2298	4030	434	2233	1168	3758	3045	2844	3200
664_::::X-05426	664_::::X-05426	25	434	1	1810	3429	2093	434	701	4633	1424	3388	4673
1702_Follicle stimulating hormone (at exam 3, FBAT, adjusted for age and sex)	1702_Follicle stimulating hormone (at exam 3, FBAT, adjusted for age and sex)	25	435	1	3184	435	3774	2346	4483	3014	498	441	1718
1478_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	1478_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	25	435	1	2002	2706	1131	671	2702	435	1343	2640	2298
3956_Ankle injury (random effect)	3956_Ankle injury (random effect)	25	435	1	593	1028	3860	2796	3405	2944	2174	1769	435
4390_Dysmenorrhea pain severity	4390_Dysmenorrhea pain severity	25	436	1	1256	3456	436	2312	3091	2134	2693	3714	1989
1942_White matter hyperintensity volume (FBAT, adjusted for multivariable with APOE)	1942_White matter hyperintensity volume (FBAT, adjusted for multivariable with APOE)	25	436	1	2498	1417	2074	2883	4136	436	4335	4688	2416
1698_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for age and sex)	1698_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for age and sex)	25	436	1	2057	991	1050	3305	1012	1459	2496	436	3606
520_Lipid::Long chain fatty acid::margarate (17:0)	520_Lipid::Long chain fatty acid::margarate (17:0)	25	437	1	437	1748	1370	4649	2638	3629	3804	1895	1497
3718_Amount of alcohol drunk on a typical drinking day	3718_Amount of alcohol drunk on a typical drinking day	25	437	1	3402	437	3776	3919	1184	3059	1117	1284	3474
1198_Phosphorylated Tau at position 181	1198_Phosphorylated Tau at position 181	25	437	1	2402	1462	437	865	3349	1057	1700	1188	3018
4067_Cognitive performance	4067_Cognitive performance	25	437	1	2802	1609	1788	437	3137	4306	1116	1799	664
3123_STK17B - Serine/threonine-protein kinase 17B	3123_STK17B - Serine/threonine-protein kinase 17B	25	437	1	4745	4104	1851	1625	437	2665	2406	4117	1194
1700_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for multivariable)	1700_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for multivariable)	25	437	1	2023	3773	2735	2493	2325	4530	1877	1167	437
514_Lipid::Long chain fatty acid::10-heptadecenoate (17:1n7)	514_Lipid::Long chain fatty acid::10-heptadecenoate (17:1n7)	25	438	1	438	1348	3628	3285	2191	1526	2221	2002	1427
3958_Antisocial behavior (male)	3958_Antisocial behavior (male)	25	438	1	4006	495	438	4047	639	1800	1032	1331	2771
2752_PLG - Plasmin	2752_PLG - Plasmin	25	438	1	1802	4239	1659	438	2418	3599	2664	3606	4698
808_::::X-12844	808_::::X-12844	25	439	1	2541	613	439	4562	3077	2691	1990	4180	3001
2378_METAP2 - Methionine aminopeptidase 2	2378_METAP2 - Methionine aminopeptidase 2	25	439	1	4467	2751	4680	4130	3526	439	4613	2349	3562
2761_CFH - Complement factor H	2761_CFH - Complement factor H	25	439	1	3499	2607	4737	3782	2768	2474	2837	439	2582
4474_Left transverse temporal	4474_Left transverse temporal	25	440	1	440	1147	2136	2285	2204	4690	3157	2142	3124
1323_Fasting plasma glucose (at exam 5, GEE, adjusted for age, sex and BMI)	1323_Fasting plasma glucose (at exam 5, GEE, adjusted for age, sex and BMI)	24	440	1	4208	440	1931	3053	674	1156	1204	2946	2392
658_::::X-04357	658_::::X-04357	25	441	1	441	3612	3036	3823	1367	2368	4445	1504	4143
4025_Excessive sweating	4025_Excessive sweating	25	441	1	844	441	3053	3734	4016	3960	4186	3773	4303
1318_Resistin (FBAT, adjusted for age and sex)	1318_Resistin (FBAT, adjusted for age and sex)	25	441	1	2030	4365	441	3611	3079	4350	4544	4457	4724
2168_TNFSF18 - Tumor necrosis factor ligand superfamily member 18	2168_TNFSF18 - Tumor necrosis factor ligand superfamily member 18	25	441	1	1695	1111	4022	918	441	644	1347	1256	3101
109_Coronary artery disease	109_Coronary artery disease	25	441	1	3715	4530	4058	4415	1269	441	3030	4700	3537
692_::::X-11315	692_::::X-11315	25	441	1	1552	464	2968	1735	3676	2233	441	1425	1577
4039_Bipolar disorder	4039_Bipolar disorder	25	442	1	442	1939	3770	3019	4684	3756	4033	2750	4121
2855_RPS27A - Ubiquitin	2855_RPS27A - Ubiquitin	25	442	1	4238	442	2371	2607	3824	4085	1288	2085	631
1891_Shaft Width (GEE, male, adjussted for age)	1891_Shaft Width (GEE, male, adjussted for age)	25	442	1	1485	1589	442	590	3078	3559	4204	4084	2215
3290_Worrier / anxious feelings	3290_Worrier / anxious feelings	25	442	1	572	1804	777	442	1809	1212	1889	925	1153
3378_Number of pregnancy terminations (female)	3378_Number of pregnancy terminations (female)	25	442	1	4209	3491	1585	2532	3489	442	2074	1135	3091
218_T:%NKT	218_T:%NKT	25	442	1	2390	1951	3532	3664	2454	2171	442	2056	4069
3074_NCR1 - Natural cytotoxicity triggering receptor 1	3074_NCR1 - Natural cytotoxicity triggering receptor 1	25	442	1	2678	3215	1095	520	2894	3923	3046	442	1161
3214_Frequency of light DIY in last 4 weeks	3214_Frequency of light DIY in last 4 weeks	25	443	1	2521	3463	1298	443	3568	4251	904	3054	1274
4181_High cholesterol lipoprotein	4181_High cholesterol lipoprotein	25	443	1	2995	4628	4145	2552	2181	443	1816	970	2707
3404_Fluid intelligence test - FI6 : conditional arithmetic	3404_Fluid intelligence test - FI6 : conditional arithmetic	25	443	1	1105	4373	1962	636	2109	4522	4487	443	1747
1395_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for age and sex)	1395_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for age and sex)	25	444	1	2775	4395	1748	444	1879	2930	4461	473	4695
2894_RSPO2 - R-spondin-2	2894_RSPO2 - R-spondin-2	25	445	1	445	2212	1967	797	908	787	3882	721	990
2002_Serum YKL-40 level	2002_Serum YKL-40 level	25	445	1	3245	1768	2835	445	4122	3458	2962	3860	2289
3898_Platelet distribution width (three-way meta)	3898_Platelet distribution width (three-way meta)	25	445	1	4641	4123	1531	1974	445	1434	1271	2422	1367
4323_Life satisfaction (MA GWAMA)	4323_Life satisfaction (MA GWAMA)	25	445	1	3020	1808	1199	1403	3865	1842	716	1797	445
1893_Shaft Section Modulus (GEE, adjussted for multivariable)	1893_Shaft Section Modulus (GEE, adjussted for multivariable)	25	446	1	1458	2057	4661	446	3767	1968	1635	1128	4333
1413_High-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1413_High-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	446	1	1081	4620	4483	3229	446	788	4523	1248	3946
1681_Atrial natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	1681_Atrial natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	25	446	1	3239	1347	3278	3946	4443	446	3352	2357	3309
4701_Genu of corpus callosum mean diusivities	4701_Genu of corpus callosum mean diusivities	25	446	1	464	4489	1924	1228	1996	2871	446	922	1850
275_CD8:%CM	275_CD8:%CM	25	446	1	914	3226	1505	4503	3234	2042	1809	3892	446
2810_PTPN6 - Tyrosine-protein phosphatase non-receptor type 6	2810_PTPN6 - Tyrosine-protein phosphatase non-receptor type 6	25	447	1	447	3106	3356	1989	3738	3204	3524	3178	1960
841_::::X-14588	841_::::X-14588	25	447	1	1282	2521	4238	447	1686	547	1199	2690	678
1840_Neck width (FBAT, male, adjusted for age)	1840_Neck width (FBAT, male, adjusted for age)	25	447	1	2082	746	497	470	447	2372	838	1785	1023
1417_High-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	1417_High-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	25	447	1	2881	4644	2326	4230	2560	543	447	700	1826
2464_SERPINC1 - Antithrombin-III	2464_SERPINC1 - Antithrombin-III	25	447	1	2048	3361	2837	4447	843	4230	4114	1976	447
4088_Paternal history of Alzheimer's disease	4088_Paternal history of Alzheimer's disease	25	448	1	2306	448	2236	1539	4335	1669	2856	3929	1144
993_Interleukin-6	993_Interleukin-6	25	449	1	449	3785	882	1712	3666	457	3118	2170	2163
4149_Left ventricular internal dimension in systole	4149_Left ventricular internal dimension in systole	25	449	1	455	449	1756	966	4517	864	3041	2594	789
2553_EPO - Erythropoietin	2553_EPO - Erythropoietin	25	449	1	1701	3596	449	3061	3854	3951	3666	1203	2443
4206_Estimated glomerular filtration rate	4206_Estimated glomerular filtration rate	25	449	1	2937	1236	1549	3241	3917	449	1292	4266	1869
1586_Factor VII (at exam 5, FBAT, adjusted for age and sex)	1586_Factor VII (at exam 5, FBAT, adjusted for age and sex)	25	450	1	4237	450	2704	485	2906	3956	3233	502	1317
2814_KLK3 - Prostate-specific antigen	2814_KLK3 - Prostate-specific antigen	25	450	1	1133	761	450	3228	2500	2739	4412	4431	1507
2125_Human-virus - Protein E7_HPV18	2125_Human-virus - Protein E7_HPV18	25	450	1	988	3611	3462	450	3040	3702	3761	3783	3291
4556_Left lingual	4556_Left lingual	25	450	1	4266	3969	3852	3753	450	3206	784	3700	1604
1431_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1431_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	450	1	1531	3811	2200	4172	2183	2866	2744	1464	450
3892_Myeloid white cell count (three-way meta)	3892_Myeloid white cell count (three-way meta)	25	451	1	451	3432	1891	473	2921	654	1718	1272	784
10_Schizophrenia	10_Schizophrenia	25	451	1	489	900	3389	451	1926	964	1156	2406	1727
3702_Diagnoses - secondary ICD10: R10 Abdominal and pelvic pain	3702_Diagnoses - secondary ICD10: R10 Abdominal and pelvic pain	25	451	1	4444	4594	4264	3091	451	1966	2865	2629	2607
2103_MPO - Myeloperoxidase	2103_MPO - Myeloperoxidase	25	451	1	2575	2442	861	1883	2272	1909	451	4211	3560
77_Adiponectin level	77_Adiponectin level	25	451	1	1892	4366	1407	1147	4477	1486	4731	2812	451
3101_PDE7A - High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	3101_PDE7A - High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	25	452	1	4527	452	2220	4593	1122	1799	2985	1267	1984
478_Lipid::Carnitine metabolism::carnitine	478_Lipid::Carnitine metabolism::carnitine	25	452	1	3884	4256	452	655	3192	2464	2687	2064	2119
2170_AIMP1 - Endothelial monocyte-activating polypeptide 2	2170_AIMP1 - Endothelial monocyte-activating polypeptide 2	25	452	1	2934	2791	4169	452	1682	2058	2936	2295	3685
2748_NTF3 - Neurotrophin-3	2748_NTF3 - Neurotrophin-3	25	452	1	2024	2309	4733	2270	452	767	925	1707	594
4369_Thyroid-stimulating hormone	4369_Thyroid-stimulating hormone	25	452	1	3594	3247	1310	4636	1316	2623	452	3196	4169
3713_Diagnoses - secondary ICD10: Z88 Allergy status to drug/meds/biol subst	3713_Diagnoses - secondary ICD10: Z88 Allergy status to drug/meds/biol subst	25	453	1	453	4686	2079	1546	1296	1583	685	2390	2656
992_Interleukin-5	992_Interleukin-5	25	453	1	3539	453	4428	2133	1907	1696	4448	1061	1992
4331_Postburn scar height	4331_Postburn scar height	25	453	1	1942	484	1177	2882	453	4389	1314	493	2468
3030_RPS3 - 40S ribosomal protein S3	3030_RPS3 - 40S ribosomal protein S3	25	453	1	1125	3362	648	2180	723	453	658	1695	2060
3490_Cereal type: Oat cereal (e.g. Ready Brek, porridge)	3490_Cereal type: Oat cereal (e.g. Ready Brek, porridge)	25	454	1	3315	454	3759	743	2245	2092	3683	1557	4099
2870_CLEC11A - Stem Cell Growth Factor-alpha	2870_CLEC11A - Stem Cell Growth Factor-alpha	25	454	1	3334	4164	454	2810	1712	2798	3670	3216	1583
3203_Age completed full time education	3203_Age completed full time education	25	454	1	3298	3405	4467	1385	4710	4735	4480	454	589
2985_BIRC3 - Baculoviral IAP repeat-containing protein 3	2985_BIRC3 - Baculoviral IAP repeat-containing protein 3	25	455	1	3930	4114	455	1681	4098	1767	2937	4343	1924
2937_C3 - Complement C3d fragment	2937_C3 - Complement C3d fragment	25	455	1	3701	1482	3245	1986	3665	1708	3287	455	2054
1556_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1556_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	455	1	3422	2723	1331	964	1349	1464	4497	2048	455
910_Total cholesterol in medium HDL	910_Total cholesterol in medium HDL	25	456	1	456	4568	2524	616	1501	2687	4573	3448	3090
2047_Periodontal complex trait 2	2047_Periodontal complex trait 2	25	456	1	2899	456	1770	4741	3572	857	1496	2574	3821
50_Number of children ever born	50_Number of children ever born	25	456	1	4250	4000	3298	456	4543	2814	2079	2335	4348
3103_KRAS - GTPase KRas	3103_KRAS - GTPase KRas	25	456	1	1439	3578	2944	1830	2472	456	3426	2565	2989
1261_Residual from predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	1261_Residual from predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	25	456	1	2283	2357	3736	969	3214	1573	4294	456	1401
1552_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1552_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	456	1	1420	1948	1739	2295	1741	1588	2973	1451	456
427_Amino acid::Valine, leucine and isoleucine metabolism::hydroxyisovaleroyl carnitine	427_Amino acid::Valine, leucine and isoleucine metabolism::hydroxyisovaleroyl carnitine	25	457	1	2837	457	3889	4254	3768	3468	2876	769	3223
1587_Factor VII (at exam 5, GEE, adjusted for age and sex)	1587_Factor VII (at exam 5, GEE, adjusted for age and sex)	25	457	1	2168	4736	457	2361	1726	4704	4746	842	1525
746_::::X-12013	746_::::X-12013	25	457	1	892	1805	4421	457	2242	888	934	4055	4281
1865_Neck cross-sectional moment of inertia (GEE, male, adjussted for age)	1865_Neck cross-sectional moment of inertia (GEE, male, adjussted for age)	25	457	1	1065	2381	1704	4451	457	3925	468	909	2783
2416_FOLH1 - Glutamate carboxypeptidase 2	2416_FOLH1 - Glutamate carboxypeptidase 2	25	457	1	1736	3034	3699	2726	2283	697	2129	4161	457
2598_HGFAC - Hepatocyte growth factor activator	2598_HGFAC - Hepatocyte growth factor activator	25	458	1	1843	458	3147	3624	2098	1251	563	3361	1414
1332_Fasting HbA1c (at exam 5, FBAT, adjusted for age, sex and BMI)	1332_Fasting HbA1c (at exam 5, FBAT, adjusted for age, sex and BMI)	25	458	1	3419	917	458	2395	4583	1578	3226	2821	1336
3172_NPPA - Atrial natriuretic factor	3172_NPPA - Atrial natriuretic factor	25	458	1	3657	2761	3768	1300	2690	2215	3691	458	1232
4554_Left lateral occipital	4554_Left lateral occipital	25	459	1	4543	459	2588	1232	1127	600	2759	4046	1242
2893_PLXNC1 - Plexin-C1	2893_PLXNC1 - Plexin-C1	25	459	1	2479	4331	459	4506	1806	4338	1714	549	4381
2575_ADIPOQ - Adiponectin	2575_ADIPOQ - Adiponectin	25	459	1	4480	2197	3413	459	1817	3089	495	4066	885
1771_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for multivariable)	1771_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for multivariable)	25	460	1	3974	3417	460	3428	2807	3593	936	3273	2614
1553_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1553_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	460	1	2368	1570	1791	460	4675	4578	4490	1415	1565
3467_Impedance measures - Arm predicted mass (left)	3467_Impedance measures - Arm predicted mass (left)	25	460	2	3387	2378	2290	3077	2449	460	3031	562	1408
3916_Disc area	3916_Disc area	25	460	1	531	918	3399	3655	1318	2414	460	1656	4345
4462_Left pars triangularis	4462_Left pars triangularis	25	461	1	2445	3523	461	2786	1794	803	1414	1878	2938
4647_Anterior corona radiata fractional anisotropy	4647_Anterior corona radiata fractional anisotropy	25	461	1	3238	4525	4572	3675	804	3886	461	2473	2619
4676_External capsule axial diusivities	4676_External capsule axial diusivities	25	461	1	3320	621	3602	1457	1908	1183	3302	461	2705
909_Leucine	909_Leucine	25	461	1	4674	1048	597	2645	592	568	3179	2263	461
1218_Alcohol consumption (dichotomous, female)	1218_Alcohol consumption (dichotomous, female)	25	462	1	462	4432	1218	1505	1760	3982	3760	3026	4696
2242_AIF1 - Allograft inflammatory factor 1	2242_AIF1 - Allograft inflammatory factor 1	25	462	1	4349	462	4329	4265	3169	1975	862	533	4649
3382_Prospective memory test - Duration screen displayed	3382_Prospective memory test - Duration screen displayed	25	462	1	877	1540	1907	462	1499	2468	604	1005	2786
2989_DSC3 - Desmocollin-3	2989_DSC3 - Desmocollin-3	25	462	1	4332	1630	4553	3477	1143	1292	462	985	665
2194_FGF20 - Fibroblast growth factor 20	2194_FGF20 - Fibroblast growth factor 20	25	463	1	463	2606	2873	1820	1486	2336	4720	630	4126
4728_Retrolenticular part of internal capsule mode of anisotropy	4728_Retrolenticular part of internal capsule mode of anisotropy	25	463	1	1379	3899	2464	3916	2923	629	463	4456	3383
3368_Chest pain or discomfort walking normally	3368_Chest pain or discomfort walking normally	25	464	1	2475	3546	3865	464	3945	1705	3891	3964	575
622_Xenobiotics::Drug::3-(cystein-S-yl)acetaminophen*	622_Xenobiotics::Drug::3-(cystein-S-yl)acetaminophen*	25	464	1	2566	1935	2948	1021	1661	3845	464	2506	1315
2353_CTSB - Cathepsin B	2353_CTSB - Cathepsin B	25	464	1	1568	778	3737	1878	1055	2674	3419	686	464
3207_Duration of moderate activity	3207_Duration of moderate activity	25	465	1	465	1847	2800	2431	4459	1186	1146	846	2337
4563_Left pars triangularis	4563_Left pars triangularis	25	465	1	1025	3954	465	1512	1766	898	1471	2754	3469
4169_Open-angle glaucoma (random-effect model)	4169_Open-angle glaucoma (random-effect model)	25	465	1	899	4268	1089	1630	3537	465	4296	4680	2997
631_Xenobiotics::Food component, Plant::homostachydrine*	631_Xenobiotics::Food component, Plant::homostachydrine*	25	465	1	3979	1789	3235	3618	4017	1382	4259	2610	465
1481_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for multivariable)	1481_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for multivariable)	25	466	1	466	4624	3716	2764	2282	3451	4392	1011	4062
2902_HIBADH - 3-hydroxyisobutyrate dehydrogenase, mitochondrial	2902_HIBADH - 3-hydroxyisobutyrate dehydrogenase, mitochondrial	25	466	1	2963	466	3695	2815	2837	2971	2797	3192	1915
3411_Interpolated Age of participant when non-cancer illness first diagnosed	3411_Interpolated Age of participant when non-cancer illness first diagnosed	25	466	2	1754	3227	2459	3195	3328	466	1040	3633	3669
976_Basic fibroblast growth factor	976_Basic fibroblast growth factor	25	466	1	2452	1999	1120	1040	2332	4308	3999	4615	466
3697_Diagnoses - secondary ICD10: K29 Gastritis and duodenitis	3697_Diagnoses - secondary ICD10: K29 Gastritis and duodenitis	25	467	1	651	3176	1026	467	2249	1278	3569	2034	3726
3842_Granulocyte percentage of myeloid white cells (two-way meta)	3842_Granulocyte percentage of myeloid white cells (two-way meta)	25	467	1	2589	4595	1665	3075	467	1906	3629	3578	4296
4674_Cingulum (hippocampus) axial diusivities	4674_Cingulum (hippocampus) axial diusivities	25	467	1	1667	471	1396	1187	916	3838	1597	467	1760
1412_High-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1412_High-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	468	1	2836	2859	468	734	4383	3645	4127	2312	3057
2222_CDH5 - Cadherin-5	2222_CDH5 - Cadherin-5	25	468	1	968	1338	1440	4192	468	1378	2883	1480	2708
1115_Visceral sdipose tissue volume (adjusted for BMI, male)	1115_Visceral sdipose tissue volume (adjusted for BMI, male)	25	468	1	574	833	1176	2980	1982	468	3893	4358	3998
4739_Cingulum (cingulate gyrus) radial diusivities	4739_Cingulum (cingulate gyrus) radial diusivities	25	469	1	1984	4073	469	2591	2309	1718	798	1986	2494
3110_CSNK2A2 CSNK2B - Casein kinase II 2-alpha':2-beta heterotetramer	3110_CSNK2A2 CSNK2B - Casein kinase II 2-alpha':2-beta heterotetramer	25	469	1	4247	4191	3018	469	2744	4020	3327	2503	3542
3907_Intraocular pressure	3907_Intraocular pressure	25	469	1	3665	3769	1546	3777	469	489	3155	3712	2115
2606_CADM3 - Cell adhesion molecule 3	2606_CADM3 - Cell adhesion molecule 3	25	469	1	2988	937	4453	2768	1945	469	1610	1823	2961
792_::::X-12712	792_::::X-12712	25	469	1	2014	786	1499	2847	3369	1457	469	771	2279
1657_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for multivariable)	1657_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for multivariable)	25	469	1	4207	894	1315	2870	3197	619	4165	469	3829
979_Hepatocyte growth factor	979_Hepatocyte growth factor	25	470	1	470	2977	2228	2224	4354	957	2852	3966	2088
4139_Mean corpuscular hemoglobin	4139_Mean corpuscular hemoglobin	25	470	1	1162	470	1431	2872	1432	4234	2210	1243	4727
868_OmegaL6 fatty acids	868_OmegaL6 fatty acids	25	470	1	2890	841	1039	1749	470	4457	1338	2443	3620
244_CD32 on mDC	244_CD32 on mDC	25	470	1	2375	4276	3755	3197	1463	662	470	3499	683
2077_FGF10 - Fibroblast growth factor 10	2077_FGF10 - Fibroblast growth factor 10	25	471	1	644	2297	471	4716	3463	1078	1873	829	4036
1848_Neck Section Modulus (FBAT, male, adjusted for age)	1848_Neck Section Modulus (FBAT, male, adjusted for age)	25	471	1	4530	3420	1454	2232	2675	4114	3433	471	1957
717_::::X-11529	717_::::X-11529	25	472	1	2097	1088	3926	472	3384	2520	4671	1706	2952
2414_PIGR - Polymeric immunoglobulin receptor	2414_PIGR - Polymeric immunoglobulin receptor	25	472	1	3313	1654	1414	4361	472	1684	2945	538	2075
96_Height SDS (female at age 10)	96_Height SDS (female at age 10)	25	472	1	4155	3375	3791	4369	1049	472	1150	2593	1801
1493_Remnant lipoprotein triglycerides (at exam 4, GEE, adjusted for age and sex)	1493_Remnant lipoprotein triglycerides (at exam 4, GEE, adjusted for age and sex)	25	472	1	926	2816	3897	1354	1399	3365	472	3559	2053
4385_Epithelial ovarian cancer (Mucinous invasive and borderline mucinous)	4385_Epithelial ovarian cancer (Mucinous invasive and borderline mucinous)	25	472	1	1515	2509	1745	3500	3096	3321	2869	472	610
996_Interleukin-9	996_Interleukin-9	25	472	1	4132	3941	3295	2014	3260	1214	3432	4589	472
819_::::X-13435	819_::::X-13435	25	473	1	556	1351	473	1330	3947	4071	1238	3757	1025
2355_LGALS3 - Galectin-3	2355_LGALS3 - Galectin-3	25	473	1	1352	4065	2015	3491	473	616	3297	2588	1526
1134_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, female)	1134_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, female)	25	473	1	4073	3509	4371	2127	4656	1677	3322	2464	473
3724_Frequency of inability to cease drinking in last year	3724_Frequency of inability to cease drinking in last year	25	474	1	474	2485	1389	2575	2005	3336	1487	850	4263
4608_Cerebellar vermal lobules I V	4608_Cerebellar vermal lobules I V	25	474	1	4615	2803	4141	3707	3042	4318	3634	4368	474
4065_Gait speed	4065_Gait speed	24	475	1	1997	475	2133	1854	4420	3563	2941	2468	4080
2992_ESD - S-formylglutathione hydrolase	2992_ESD - S-formylglutathione hydrolase	25	475	1	2209	2376	4228	475	1341	2983	924	4341	4730
3019_NCK1 - Cytoplasmic protein NCK1	3019_NCK1 - Cytoplasmic protein NCK1	25	475	1	4669	2077	2332	2202	2586	475	2404	4607	3798
4716_Body of corpus callosum mode of anisotropy	4716_Body of corpus callosum mode of anisotropy	25	475	1	1710	679	3829	3248	2446	3615	475	4482	796
4601_Right rostral middle frontal	4601_Right rostral middle frontal	25	476	1	476	1869	1556	3110	3619	2460	1698	724	4460
3963_Gestational weight gain (offspring, total)	3963_Gestational weight gain (offspring, total)	25	476	1	2428	4467	4043	1454	476	2013	3966	3331	2247
3551_Vascular/heart problems diagnosed by doctor: High blood pressure	3551_Vascular/heart problems diagnosed by doctor: High blood pressure	25	477	1	477	2262	3687	1798	1376	2563	1392	3992	2388
434_Carbohydrate::Aminosugars metabolism::erythronate*	434_Carbohydrate::Aminosugars metabolism::erythronate*	25	477	1	4224	477	4740	594	1725	3502	1552	2353	2737
2120_ERBB4 - Receptor tyrosine-protein kinase erbB-4	2120_ERBB4 - Receptor tyrosine-protein kinase erbB-4	25	477	1	3179	3597	477	656	3680	1084	1035	509	3987
3901_Red cell distribution width (three-way meta)	3901_Red cell distribution width (three-way meta)	25	477	1	4548	1715	1114	477	3317	776	4608	2752	2947
4343_Sleep sedentary	4343_Sleep sedentary	25	477	1	1795	1442	1072	596	2184	477	4549	4135	516
1883_Shaft cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	1883_Shaft cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	25	478	1	478	2488	3077	3008	4727	1995	3759	3677	809
3654_Smoking status: Never	3654_Smoking status: Never	25	478	1	947	4229	478	3279	1916	2287	1447	3632	4147
4677_Fornix (column and body of fornix) axial diusivities	4677_Fornix (column and body of fornix) axial diusivities	25	478	1	2760	616	4163	478	2261	3536	1883	3537	4155
4253_Sleep duration (mean)	4253_Sleep duration (mean)	25	478	1	2335	2173	947	1891	478	4285	1203	1690	3258
624_Xenobiotics::Drug::hydroquinone sulfate	624_Xenobiotics::Drug::hydroquinone sulfate	25	478	1	3874	2181	2338	674	4120	1762	478	3090	682
93_Birth length	93_Birth length	25	478	1	2385	2218	3150	4688	1427	4421	692	478	1308
210_Insomnia	210_Insomnia	25	479	1	3669	1058	479	2790	1246	485	1836	4036	2951
1365_Total cholesterol (at exam 4, GEE, adjusted for age and sex)	1365_Total cholesterol (at exam 4, GEE, adjusted for age and sex)	25	479	1	1187	706	4188	479	4502	4320	3911	514	1264
1361_Total cholesterol (at exam 2, GEE, adjusted for age and sex)	1361_Total cholesterol (at exam 2, GEE, adjusted for age and sex)	25	479	1	4553	3977	519	2841	3195	479	2832	1738	1771
3198_Frequency of travelling from home to job workplace	3198_Frequency of travelling from home to job workplace	25	479	1	1357	2994	702	2520	4739	1200	479	3585	3514
2565_PRTN3 - Myeloblastin	2565_PRTN3 - Myeloblastin	25	479	1	4690	4237	2728	1930	2055	4708	2658	4629	479
2624_KLK14 - Kallikrein-14	2624_KLK14 - Kallikrein-14	25	480	1	2045	1272	480	4010	4195	3561	2696	1058	2828
1710_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for age and sex)	1710_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for age and sex)	25	480	1	1440	1001	2256	480	4092	1801	3748	1374	2665
2279_CFD - Complement factor D	2279_CFD - Complement factor D	25	480	1	3097	3131	3907	1339	480	2165	1833	1301	3786
4041_Schizophrenia vs Bipolar disorder	4041_Schizophrenia vs Bipolar disorder	25	480	1	4358	2174	1839	561	3569	915	480	4711	842
422_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxobutyrate	422_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxobutyrate	25	480	1	508	4038	934	3171	2313	1745	4582	2570	480
3591_Medication for cholesterol, blood pressure or diabetes: Blood pressure medication	3591_Medication for cholesterol, blood pressure or diabetes: Blood pressure medication	25	481	1	481	2531	4241	683	2572	2185	1451	2670	1865
4489_Right parahippocampal	4489_Right parahippocampal	25	481	1	4067	2495	481	988	2750	3888	2775	2987	1021
3583_Types of transport used (excluding work): Public transport	3583_Types of transport used (excluding work): Public transport	25	481	1	1026	1449	4745	481	3407	2685	1522	2256	2973
1773_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for age and sex)	1773_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for age and sex)	25	481	1	3693	2985	1264	1939	481	1067	659	4588	4037
3836_Sum basophil neutrophil count (two-way meta)	3836_Sum basophil neutrophil count (two-way meta)	25	481	2	1878	3499	2681	1472	1938	481	2424	1109	4043
243_CXCR3 on CD4n	243_CXCR3 on CD4n	25	482	1	1385	1166	482	4416	2941	3425	1130	1430	3245
1021_Neck Cross-Sectional Moment of Inertia (GEE, adjusted for age and sex)	1021_Neck Cross-Sectional Moment of Inertia (GEE, adjusted for age and sex)	25	482	1	1955	2999	4696	1524	2710	3557	4182	3050	482
2621_COLEC12 - Collectin-12	2621_COLEC12 - Collectin-12	25	483	1	483	782	1074	4281	4654	653	3103	962	3408
2339_SPARC - SPARC	2339_SPARC - SPARC	25	483	1	1859	483	2716	4616	2431	2986	1828	3233	4414
1474_Mean total cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	1474_Mean total cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	25	483	1	2056	1073	1518	483	677	1316	1943	1144	1573
599_Peptide::Fibrinogen cleavage peptide::ADSGEGDFXAEGGGVR*	599_Peptide::Fibrinogen cleavage peptide::ADSGEGDFXAEGGGVR*	25	483	1	876	1012	626	3617	1128	483	1554	3543	2177
2655_CA9 - Carbonic anhydrase 9	2655_CA9 - Carbonic anhydrase 9	25	483	1	1922	1475	3598	3259	1487	4004	483	3372	1375
3021_PARK7 - Protein DJ-1	3021_PARK7 - Protein DJ-1	25	483	1	2559	3475	531	1543	3138	4188	1470	483	811
1399_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for age and sex)	1399_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for age and sex)	25	483	1	1320	4519	2881	3511	2730	3703	2782	4664	483
411_Amino acid::Urea cycle; arginine-, proline-, metabolism::arginine	411_Amino acid::Urea cycle; arginine-, proline-, metabolism::arginine	25	484	1	2919	491	3005	2242	484	1898	1334	4185	1630
1732_Chronic kidney disease (at exam 7, FBAT, adjusted for multivariable)	1732_Chronic kidney disease (at exam 7, FBAT, adjusted for multivariable)	25	484	1	4426	3492	4506	3899	2852	728	484	4177	2026
2912_TFF3 - Trefoil factor 3	2912_TFF3 - Trefoil factor 3	25	484	1	981	3220	2385	3244	2294	2591	3694	4570	484
1635_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for age and sex)	1635_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for age and sex)	25	485	1	485	3411	4367	2955	526	2483	3708	853	841
1497_Triglycerides (at exam 1, GEE, adjusted for multivariable)	1497_Triglycerides (at exam 1, GEE, adjusted for multivariable)	25	485	1	4147	485	3946	3768	4156	1040	3614	655	4340
3088_SEMA6A - Semaphorin-6A	3088_SEMA6A - Semaphorin-6A	25	485	1	1399	521	485	2449	3343	3045	1381	510	3718
1901_Troch Neck BMD (GEE, male, adjussted for multivariable)	1901_Troch Neck BMD (GEE, male, adjussted for multivariable)	25	485	1	3455	1720	4073	4676	485	3360	559	2411	1303
2122_IL6ST - Interleukin-6 receptor subunit beta	2122_IL6ST - Interleukin-6 receptor subunit beta	25	485	1	4129	864	1125	1800	1912	3473	485	794	2802
2056_Rheumatoid Arthritis	2056_Rheumatoid Arthritis	25	485	1	1520	1422	1319	4299	1579	1217	1697	485	3125
501_Lipid::Fatty acid, dicarboxylate::octadecanedioate	501_Lipid::Fatty acid, dicarboxylate::octadecanedioate	25	486	1	3972	3714	4518	1713	486	2855	2447	537	2681
3657_Alcohol - Alcohol drinker status: Previous vs Current	3657_Alcohol - Alcohol drinker status: Previous vs Current	25	486	1	4555	1520	4286	1279	671	1201	486	3859	3527
1033_Neck Section Modulus (GEE, adjusted for age and sex)	1033_Neck Section Modulus (GEE, adjusted for age and sex)	25	486	1	646	2637	553	1262	3631	3393	3355	2679	486
2546_XPNPEP1 - Xaa-Pro aminopeptidase 1	2546_XPNPEP1 - Xaa-Pro aminopeptidase 1	25	487	1	2768	487	2276	3595	2746	681	711	742	3663
1153_Insulin response to glucose duing the first 30 min (adjusted for BMI)	1153_Insulin response to glucose duing the first 30 min (adjusted for BMI)	25	487	1	3949	3058	487	2942	685	3791	2473	4461	2827
2035_Central corneal thickness	2035_Central corneal thickness	25	487	1	2333	3074	763	487	2337	821	1173	4638	1702
2160_OSM - Oncostatin-M	2160_OSM - Oncostatin-M	25	487	1	4223	1425	844	1889	487	735	1905	1887	3757
1128_Visceral adipose tissue sttenutation (female)	1128_Visceral adipose tissue sttenutation (female)	25	487	1	3773	1160	2449	1566	2186	528	487	2236	4521
1266_Residual from predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	1266_Residual from predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	487	1	706	4130	863	1299	3341	4681	4245	3104	487
3825_Osteoarthritis of hip	3825_Osteoarthritis of hip	25	488	1	488	1457	4370	3175	2955	1773	1145	1268	3094
3428_Fluid intelligence test - FI5 : family relationship calculation	3428_Fluid intelligence test - FI5 : family relationship calculation	25	488	1	865	488	1144	2600	679	3301	3597	1989	3424
3936_Sialylation	3936_Sialylation	25	488	1	4137	1151	488	870	1577	4606	3555	4015	2253
776_Lipid::Eicosanoid::X-12441--12-hydroxyeicosatetraenoate (12-HETE)	776_Lipid::Eicosanoid::X-12441--12-hydroxyeicosatetraenoate (12-HETE)	25	489	1	1101	489	4393	1513	1557	1505	3994	1995	1124
3708_Diagnoses - secondary ICD10: Z80 Family history of primary malignant neoplasm	3708_Diagnoses - secondary ICD10: Z80 Family history of primary malignant neoplasm	25	489	1	1278	553	489	877	2366	3978	2380	623	1048
4220_Antihypertensives	4220_Antihypertensives	25	489	1	2654	1547	1607	1222	489	950	2699	1071	1323
4061_Urinary albumin-to-creatinine ratio	4061_Urinary albumin-to-creatinine ratio	25	489	1	1806	1883	4508	3785	4394	4148	4686	489	3640
1907_Hippocampal volume (GEE, adjusted for multivariable)	1907_Hippocampal volume (GEE, adjusted for multivariable)	25	490	1	1930	1937	490	1329	491	4673	4400	1054	1334
3184_Esophageal squamous cell carcinoma	3184_Esophageal squamous cell carcinoma	25	490	1	3175	511	3913	4331	1386	1346	2529	490	2297
1391_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	1391_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	25	491	1	491	1502	4191	3090	2386	3397	930	1492	4061
2674_MAPKAPK3 - MAP kinase-activated protein kinase 3	2674_MAPKAPK3 - MAP kinase-activated protein kinase 3	25	491	1	4469	3946	491	4686	4208	1252	1465	4024	1522
3062_LILRB2 - Leukocyte immunoglobulin-like receptor subfamily B member 2	3062_LILRB2 - Leukocyte immunoglobulin-like receptor subfamily B member 2	25	491	1	2682	2182	3718	3493	3766	2080	2038	491	1812
2607_NID2 - Nidogen-2	2607_NID2 - Nidogen-2	25	491	1	3548	655	3938	3108	3543	2723	1611	2299	491
2829_MST1 - Hepatocyte growth factor-like protein	2829_MST1 - Hepatocyte growth factor-like protein	25	492	1	4598	667	566	492	1425	895	3429	3366	793
3233_Snoring	3233_Snoring	25	492	2	1280	4272	3040	2253	3993	977	790	2672	492
3691_Diagnoses - secondary ICD10: I10 Essential (primary) hypertension	3691_Diagnoses - secondary ICD10: I10 Essential (primary) hypertension	25	493	1	493	1706	2445	3906	3527	4435	1813	4565	538
268_CD4:%TM (1)	268_CD4:%TM (1)	25	493	1	1281	1535	493	4300	3943	1654	2671	3915	1355
1954_Similarities raw score (FBAT, adjusted for multivariable)	1954_Similarities raw score (FBAT, adjusted for multivariable)	25	493	1	1175	1110	3765	3717	1410	493	2045	4384	4092
1889_Shaft Width (GEE, female, adjussted for age)	1889_Shaft Width (GEE, female, adjussted for age)	25	494	1	494	3335	607	2374	3686	514	2719	3942	2045
1819_Inter-trochanteric buckling ratio (GEE, female, adjussted for multivariable)	1819_Inter-trochanteric buckling ratio (GEE, female, adjussted for multivariable)	25	495	1	2984	2134	495	1223	2521	2969	4004	2601	3128
1113_Visceral sdipose tissue volume (female)	1113_Visceral sdipose tissue volume (female)	25	495	1	3228	919	2439	1707	3896	495	3200	3738	2751
4418_Mumps seropositivity	4418_Mumps seropositivity	25	496	1	496	907	3348	2051	2794	3814	2365	2421	3680
3077_NOTCH1 - Neurogenic locus notch homolog protein 1	3077_NOTCH1 - Neurogenic locus notch homolog protein 1	25	496	1	3906	1233	496	1362	1573	2441	4303	1275	2723
1152_Incremental insulin 30 min	1152_Incremental insulin 30 min	25	496	1	2858	1443	4353	2021	496	1900	829	4714	3181
4439_Hepatitis B HBs antigen IgG levels	4439_Hepatitis B HBs antigen IgG levels	25	496	1	1004	1843	1443	3679	3007	496	628	3705	524
4059_Estimated glomerular filtration rate based on cystain C	4059_Estimated glomerular filtration rate based on cystain C	25	496	1	874	2372	790	4743	3878	4608	1504	496	1925
1221_Mean Caudate	1221_Mean Caudate	25	496	1	3116	4726	1559	4526	938	2035	3590	3378	496
3645_Illnesses of mother: Diabetes	3645_Illnesses of mother: Diabetes	25	497	1	1744	497	3481	1263	4015	1232	4553	3847	561
3739_Depression - Ever had prolonged feelings of sadness or depression	3739_Depression - Ever had prolonged feelings of sadness or depression	25	497	1	2877	3772	794	497	607	2626	3598	3575	2953
4751_Splenium of corpus callosum radial diusivities	4751_Splenium of corpus callosum radial diusivities	25	497	1	4703	4141	2398	4613	734	1897	497	1091	2944
850_Acetoacetate	850_Acetoacetate	25	498	1	3043	498	850	3336	570	1324	2070	1907	2759
3038_TYMS - Thymidylate synthase	3038_TYMS - Thymidylate synthase	25	498	1	4456	3201	498	3360	3486	3796	4546	869	1014
1652_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for multivariable)	1652_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for multivariable)	25	498	1	2426	1575	1571	498	3811	2231	3187	1993	4693
3412_Sitting height	3412_Sitting height	25	498	1	3835	3644	4743	2390	3293	498	1221	773	743
1284_Visceral fat by CT (FBAT, adjusted for age and sex)	1284_Visceral fat by CT (FBAT, adjusted for age and sex)	25	498	1	4366	3400	2268	3855	1902	3488	2746	498	1852
828_::::X-13741	828_::::X-13741	25	498	1	4072	3916	3391	4077	4527	2933	3229	3694	498
3690_Diagnoses - secondary ICD10: F32 Major depressive disorder, single episode	3690_Diagnoses - secondary ICD10: F32 Major depressive disorder, single episode	25	499	1	3710	2392	499	3764	2671	4156	3047	2337	4615
2759_F2 - Thrombin	2759_F2 - Thrombin	25	499	1	3764	4106	3083	3883	1867	4129	499	744	757
3538_Attendance/disability/mobility allowance: Blue badge	3538_Attendance/disability/mobility allowance: Blue badge	25	500	1	904	500	700	1335	2097	2878	3100	2833	2245
2224_COMMD7 - COMM domain-containing protein 7	2224_COMMD7 - COMM domain-containing protein 7	25	500	1	2286	755	500	1901	3904	1259	2498	2792	4376
3650_Illnesses of siblings: Breast cancer	3650_Illnesses of siblings: Breast cancer	25	500	1	1474	1372	3284	500	3973	3979	3892	3292	2315
1366_Total cholesterol (at exam 5, FBAT, adjusted for age and sex)	1366_Total cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	500	1	3567	2420	1569	2244	1369	3841	1982	1763	500
691_::::X-11299	691_::::X-11299	25	501	1	3588	501	3824	3995	2344	878	4717	1810	3448
568_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 1*	568_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 1*	25	501	1	1418	1605	501	3118	1776	3529	1815	1602	2333
3027_PSME1 - Proteasome activator complex subunit 1	3027_PSME1 - Proteasome activator complex subunit 1	25	501	1	2648	2098	2018	501	2895	2302	2652	4685	1207
221_T:%Vg9+Vd2-low	221_T:%Vg9+Vd2-low	25	501	1	1061	3158	4261	1722	4702	1318	4045	4347	501
2916_FAM107B - Protein FAM107B	2916_FAM107B - Protein FAM107B	25	502	1	4435	4012	502	1277	4207	2956	3659	4402	1105
1146_Peak insulin response (adjusted for BMI)	1146_Peak insulin response (adjusted for BMI)	25	502	1	1252	3846	1386	502	3041	1749	1299	4157	4746
413_Amino acid::Urea cycle; arginine-, proline-, metabolism::dimethylarginine (SDMA + ADMA)	413_Amino acid::Urea cycle; arginine-, proline-, metabolism::dimethylarginine (SDMA + ADMA)	25	502	1	2916	4291	2897	2666	1206	2546	502	4114	973
1303_Fasting insulin (at exam 5, GEE, adjusted for age and sex)	1303_Fasting insulin (at exam 5, GEE, adjusted for age and sex)	25	502	1	3108	3569	3003	2996	2400	1731	1391	871	502
1726_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for age and sex)	1726_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for age and sex)	25	503	1	3197	503	2202	2684	3279	2463	1430	1822	1040
3503_Male-specific factors - Hair/balding pattern: Pattern 4	3503_Male-specific factors - Hair/balding pattern: Pattern 4	25	503	1	2146	2230	503	939	4240	3704	4722	4296	3212
2970_F3 - Tissue Factor	2970_F3 - Tissue Factor	25	504	1	2443	3413	3934	3713	2729	504	3560	1950	563
1753_Cystatin C (at exam 7, GEE, adjusted for multivariable)	1753_Cystatin C (at exam 7, GEE, adjusted for multivariable)	25	504	1	4412	3959	2650	1578	1610	2093	1949	1015	504
3384_Non-accidental death in close genetic family	3384_Non-accidental death in close genetic family	25	505	1	505	608	1277	2916	2827	3516	1010	2751	2919
2763_TF - Serotransferrin	2763_TF - Serotransferrin	25	505	1	3962	763	3609	927	505	1461	1512	2169	3720
3871_Basophil percentage of granulocytes (three-way meta)	3871_Basophil percentage of granulocytes (three-way meta)	25	505	1	3558	743	1543	2880	1351	505	1171	4573	1360
2733_CFB - Complement factor B	2733_CFB - Complement factor B	25	505	1	1285	4670	787	4474	3937	523	4015	505	2345
412_Amino acid::Urea cycle; arginine-, proline-, metabolism::citrulline	412_Amino acid::Urea cycle; arginine-, proline-, metabolism::citrulline	25	506	1	506	4314	4547	1697	1838	554	3961	2178	3009
192_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	192_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	506	1	3698	506	4210	4373	3602	3573	2732	4413	4161
3304_Age first had sexual intercourse	3304_Age first had sexual intercourse	25	507	1	507	2987	2186	2398	778	3474	4390	3697	1166
1258_Residual from predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	1258_Residual from predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	25	507	1	1976	4662	3300	507	1066	4276	1565	3253	4498
637_Xenobiotics::Food component, Plant::thymol sulfate	637_Xenobiotics::Food component, Plant::thymol sulfate	25	507	1	869	3453	1773	1536	507	2388	1871	2373	595
1452_Low-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	1452_Low-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	507	1	4482	2777	1696	2652	2536	507	1861	2716	1246
2900_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 38	2900_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 38	25	507	1	4163	951	1332	1515	3581	2579	2167	507	874
743_::::X-11876	743_::::X-11876	25	508	1	3544	3258	508	3062	1273	4024	1932	1604	1654
2583_CAMK1 - Calcium/calmodulin-dependent protein kinase type 1	2583_CAMK1 - Calcium/calmodulin-dependent protein kinase type 1	25	508	1	1507	3471	2324	1164	987	4176	508	3038	3359
4151_Left ventricular mass index	4151_Left ventricular mass index	25	509	1	509	818	1244	4101	3677	3712	4310	2983	2877
4138_Mean corpuscular volume	4138_Mean corpuscular volume	25	509	1	4200	509	1038	3207	1244	2783	4678	1893	4294
2417_RET - Proto-oncogene tyrosine-protein kinase receptor Ret	2417_RET - Proto-oncogene tyrosine-protein kinase receptor Ret	25	509	1	2981	1119	509	4608	4674	513	4282	3968	961
3521_Current employment status: Looking after home and/or family	3521_Current employment status: Looking after home and/or family	25	509	1	1758	3678	2732	509	1074	1289	3613	4027	4082
211_Insomnia (male)	211_Insomnia (male)	25	509	1	3690	2052	3158	1309	509	577	3111	4723	1586
2534_PDGFRB - Platelet-derived growth factor receptor beta	2534_PDGFRB - Platelet-derived growth factor receptor beta	25	509	1	2115	2831	3409	3193	1320	509	753	3042	4363
359_mDC:%64-274-	359_mDC:%64-274-	25	509	1	1224	2257	2123	1687	3295	3734	4108	2140	509
4337_Sleep durataion	4337_Sleep durataion	25	510	1	510	2356	2824	2492	3514	3222	3144	3863	2838
1336_HOMA-IR (at exam 5, FBAT, adjusted for age, sex and BMI)	1336_HOMA-IR (at exam 5, FBAT, adjusted for age, sex and BMI)	25	510	1	1478	2973	510	2783	1058	3600	634	3287	4208
3576_Social support - Leisure/social activities: Sports club or gym	3576_Social support - Leisure/social activities: Sports club or gym	25	510	1	1108	2338	4461	2987	510	4012	3139	2885	3752
164_Hip circumference (male, adjusted for BMI)	164_Hip circumference (male, adjusted for BMI)	25	510	1	4104	3379	4372	1958	2439	510	1023	1266	4172
1567_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for age and sex)	1567_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for age and sex)	25	510	1	1658	3358	2196	739	2188	2586	510	3209	1956
4136_Hemoglobin	4136_Hemoglobin	25	510	1	2253	1171	1004	4087	3104	4344	3735	2172	510
649_Xenobiotics::Xanthine metabolism::theophylline	649_Xenobiotics::Xanthine metabolism::theophylline	25	511	1	1400	4084	511	4034	847	4206	1377	1036	4658
1810_Very low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1810_Very low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	511	1	1070	1219	3470	2507	3814	511	3745	574	2608
3725_Frequency of drinking alcohol	3725_Frequency of drinking alcohol	25	511	1	2454	824	1685	514	1107	759	511	4309	2100
3622_Treatment/medication code: cod liver oil capsule	3622_Treatment/medication code: cod liver oil capsule	25	511	1	2153	2984	2662	3481	3924	1788	1452	511	2990
3942_HbA1c	3942_HbA1c	25	512	1	512	2538	1296	2736	2047	655	2197	2507	2096
3711_Diagnoses - secondary ICD10: Z86 Personal history of certain other diseases	3711_Diagnoses - secondary ICD10: Z86 Personal history of certain other diseases	25	512	1	1302	512	4620	4404	2752	3005	3962	2420	1189
2977_ARPP19 - cAMP-regulated phosphoprotein 19	2977_ARPP19 - cAMP-regulated phosphoprotein 19	25	512	1	2803	2830	512	1771	1148	1941	3090	2091	3161
2896_SLITRK5 - SLIT and NTRK-like protein 5	2896_SLITRK5 - SLIT and NTRK-like protein 5	25	512	1	2724	3886	1294	512	3134	1189	4473	2298	1601
3495_Hair colour (natural, before greying): Blonde	3495_Hair colour (natural, before greying): Blonde	25	512	1	2650	2741	3101	4145	2641	512	1286	3034	936
1099_C-reactive protein - Birth cohorts	1099_C-reactive protein - Birth cohorts	25	513	1	1644	513	4529	1395	4287	3117	1884	3383	680
2642_BMP6 - Bone morphogenetic protein 6	2642_BMP6 - Bone morphogenetic protein 6	25	513	1	2174	3813	4576	3095	513	3657	4644	965	780
4363_Strenuous sports or other exercises	4363_Strenuous sports or other exercises	25	514	1	514	998	3194	4603	846	2361	2243	3912	3176
1526_Remnant lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1526_Remnant lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	514	1	3898	804	514	1997	896	4253	4737	1439	4109
2784_LIN7B - Protein lin-7 homolog B	2784_LIN7B - Protein lin-7 homolog B	25	514	1	2477	4008	2092	3145	514	4336	4584	2150	4486
4060_Estimated glomerular filtration rate based on cystain C	4060_Estimated glomerular filtration rate based on cystain C	25	514	1	695	3076	4492	4291	3307	807	3578	1549	514
3841_Granulocyte count (two-way meta)	3841_Granulocyte count (two-way meta)	25	515	2	515	2241	1121	1138	4167	545	2596	1671	2008
367_Amino acid::Alanine and aspartate metabolism::N-acetylalanine	367_Amino acid::Alanine and aspartate metabolism::N-acetylalanine	25	515	1	3072	2441	515	1632	4152	3689	4454	4481	1314
549_Lipid::Lysolipid::2-linoleoylglycerophosphocholine*	549_Lipid::Lysolipid::2-linoleoylglycerophosphocholine*	25	515	1	3597	1981	4278	515	4151	3834	4173	3855	4018
2561_LTA LTB - Lymphotoxin alpha1:beta2	2561_LTA LTB - Lymphotoxin alpha1:beta2	25	516	1	2670	516	3954	3841	4528	1307	4077	3220	2580
3419_Pairs matching test - Number of correct matches in round	3419_Pairs matching test - Number of correct matches in round	25	516	1	3397	2061	516	2078	1744	3806	3825	4009	1335
1228_Parkinson Disease (additive model)	1228_Parkinson Disease (additive model)	25	516	1	3950	3695	2438	516	3986	2094	3939	2043	4156
2407_LYVE1 - Lymphatic vessel endothelial hyaluronic acid receptor 1	2407_LYVE1 - Lymphatic vessel endothelial hyaluronic acid receptor 1	25	516	1	1368	3975	2729	1392	516	4547	591	2671	656
4657_Genu of corpus callosum fractional anisotropy	4657_Genu of corpus callosum fractional anisotropy	25	516	1	1828	2209	2140	2488	2619	3021	1573	516	884
286_CD4:%Treg(39-73+)	286_CD4:%Treg(39-73+)	25	517	1	517	4061	3421	1732	4185	3128	3221	2138	1860
3924_Heart rate variability (pvRSA/HF)	3924_Heart rate variability (pvRSA/HF)	25	517	1	4318	4578	3726	996	2611	517	3279	2342	4162
2486_KLK7 - Kallikrein-7	2486_KLK7 - Kallikrein-7	25	517	1	1173	4447	4567	2130	3752	2566	517	2470	4010
3387_Health satisfaction	3387_Health satisfaction	25	518	1	858	518	1789	4157	1378	3098	1652	859	3264
582_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::xanthine	582_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::xanthine	25	518	1	4616	1690	518	4565	1791	1155	999	4087	3707
2507_IBSP - Bone sialoprotein 2	2507_IBSP - Bone sialoprotein 2	25	518	1	3925	3637	2229	518	4341	4560	787	3116	1460
4735_Anterior corona radiata radial diusivities	4735_Anterior corona radiata radial diusivities	25	518	1	2942	860	1317	2001	1103	2095	518	3996	1887
1090_Alcohol dependence	1090_Alcohol dependence	25	518	1	1185	4496	4045	3340	3122	668	3946	4086	518
47_Age at first birth	47_Age at first birth	25	519	1	519	3169	847	1729	1149	1391	4681	1085	3269
1610_von Willebrand Factor (at exam 5, FBAT, adjusted for age and sex)	1610_von Willebrand Factor (at exam 5, FBAT, adjusted for age and sex)	25	519	1	2517	2681	1940	519	4516	1597	2018	1116	3628
2344_VWF - von Willebrand factor	2344_VWF - von Willebrand factor	25	519	1	622	1872	4515	3005	3466	519	554	980	2987
3605_Non-cancer illness code, self-reported: hayfever/allergic rhinitis	3605_Non-cancer illness code, self-reported: hayfever/allergic rhinitis	25	519	1	2943	832	4650	1304	3788	2610	519	2841	4734
667_::::X-06226	667_::::X-06226	25	519	1	3664	1143	1666	4307	3181	2456	2286	1892	519
1986_Age at natural menopause (FBAT)	1986_Age at natural menopause (FBAT)	25	520	1	1655	520	2105	3144	2052	2749	3345	1090	1783
551_Lipid::Lysolipid::2-palmitoylglycerophosphocholine*	551_Lipid::Lysolipid::2-palmitoylglycerophosphocholine*	25	520	1	864	674	520	3853	771	1615	3067	893	927
2517_EPHA3 - Ephrin type-A receptor 3	2517_EPHA3 - Ephrin type-A receptor 3	25	520	1	3301	4103	1280	2267	924	520	1926	1644	1046
166_Hip circumference (female, adjusted for BMI)	166_Hip circumference (female, adjusted for BMI)	25	521	1	2288	2211	521	768	4018	2874	2122	1035	2047
3568_Why stopped smoking: Health precaution	3568_Why stopped smoking: Health precaution	25	521	1	533	3623	4125	2825	521	2600	3098	3369	2885
2433_CFC1 - Cryptic protein	2433_CFC1 - Cryptic protein	25	521	1	3543	3894	1002	3942	2824	521	2375	3012	3682
3985_Heart rate recovery at 10 secnds	3985_Heart rate recovery at 10 secnds	25	521	1	1421	1403	1532	1369	3603	1685	4278	3270	521
3270_Comparative body size at age 10	3270_Comparative body size at age 10	25	522	1	1032	4706	522	2248	3047	3207	4467	2731	2562
3280_Mother still alive	3280_Mother still alive	25	522	1	4122	4689	3061	522	1722	1759	2647	3967	792
3837_Sum eosinophil basophil count (two-way meta)	3837_Sum eosinophil basophil count (two-way meta)	25	522	1	2192	732	4441	718	4315	3936	3540	522	2407
4388_Epithelial ovarian cancer (Endometrioid)	4388_Epithelial ovarian cancer (Endometrioid)	25	523	1	3101	574	523	3817	1202	2373	1556	4519	4310
1240_Rate of decline of FEV1 (FBAT, adjusted for multiple covariates)	1240_Rate of decline of FEV1 (FBAT, adjusted for multiple covariates)	25	523	1	3829	559	1146	523	2287	3640	4611	986	2120
2663_FGF23 - Fibroblast growth factor 23	2663_FGF23 - Fibroblast growth factor 23	25	523	1	2280	1767	2162	2929	1179	939	4207	3629	523
1960_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for multivariable)	1960_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for multivariable)	25	524	1	2075	1450	524	4735	1548	2862	980	581	648
865_Esterified cholesterol	865_Esterified cholesterol	25	524	1	4567	555	3063	524	2875	2451	4728	2068	3960
2503_UFC1 - Ubiquitin-fold modifier-conjugating enzyme 1	2503_UFC1 - Ubiquitin-fold modifier-conjugating enzyme 1	25	524	1	3164	2611	877	2026	524	2280	3747	3706	3699
4675_Corticospinal tract axial diusivities	4675_Corticospinal tract axial diusivities	25	524	1	4127	2352	2834	1506	1469	4375	524	4056	3728
87_Asthma	87_Asthma	25	525	1	525	3494	3431	2418	1240	2797	3450	964	2066
1925_Hippocampal volume (GEE, adjusted for multivariable)	1925_Hippocampal volume (GEE, adjusted for multivariable)	25	525	1	2714	1955	525	723	582	2688	3980	1043	878
1989_Age at death (GEE, adjusted for multivariable)	1989_Age at death (GEE, adjusted for multivariable)	25	525	1	1298	2733	3743	525	1178	3694	3810	1021	2435
1096_Pulse pressure	1096_Pulse pressure	25	526	1	526	3250	1699	3672	1939	1672	3282	2725	1666
2205_LTF - Lactotransferrin	2205_LTF - Lactotransferrin	25	526	1	566	2261	865	1716	4403	526	892	3100	1710
3671_Diagnoses - main ICD10: K40 Inguinal hernia	3671_Diagnoses - main ICD10: K40 Inguinal hernia	25	526	1	4563	1783	2481	3192	4255	3519	2127	526	1980
4552_Left inferior temporal	4552_Left inferior temporal	25	526	1	2310	3539	1966	4051	1013	2582	3692	1481	526
1886_Shaft Width (FBAT, male, adjussted for multivariable)	1886_Shaft Width (FBAT, male, adjussted for multivariable)	25	527	1	527	644	4000	2969	1513	4506	4405	701	1868
1308_Fasting HbA1c (at exam 5, FBAT, adjusted for age and sex)	1308_Fasting HbA1c (at exam 5, FBAT, adjusted for age and sex)	25	527	1	912	527	2054	3760	3683	3792	2550	3565	638
1359_Total cholesterol (at exam 1, GEE, adjusted for age and sex)	1359_Total cholesterol (at exam 1, GEE, adjusted for age and sex)	25	527	1	946	1320	527	2348	816	828	1144	3924	2775
1466_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	1466_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	25	527	1	1812	3301	3236	2860	1307	527	2618	802	2370
1363_Total cholesterol (at exam 3, GEE, adjusted for age and sex)	1363_Total cholesterol (at exam 3, GEE, adjusted for age and sex)	25	527	1	4298	4629	1383	624	3798	3281	1967	527	771
1711_Thyroid stimulation hormone (at exam 3, GEE, adjusted for age and sex)	1711_Thyroid stimulation hormone (at exam 3, GEE, adjusted for age and sex)	25	527	1	1276	2506	2911	4507	4703	2596	4129	752	527
3600_Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	3600_Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	25	528	1	528	1085	1980	4674	2442	4489	4713	3805	2049
3100_UNC5D - Netrin receptor UNC5D	3100_UNC5D - Netrin receptor UNC5D	25	528	1	3167	4093	3908	1527	1010	1017	528	3802	2043
2999_GPC5 - Glypican-5	2999_GPC5 - Glypican-5	25	528	1	3469	4089	1524	3843	2553	4428	2906	4740	528
4648_Anterior limb of internal capsule fractional anisotropy	4648_Anterior limb of internal capsule fractional anisotropy	25	529	1	529	943	2203	4531	1633	2698	3567	2684	3836
965_Total lipids in very small VLDL	965_Total lipids in very small VLDL	25	529	1	652	529	1825	759	1491	4554	4410	2989	3243
1744_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for age and sex)	1744_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for age and sex)	25	529	1	2518	693	3618	2335	1081	529	553	1447	3077
1748_Urinary albumin excertion (at exam 6, FBAT, adjusted for multivariable)	1748_Urinary albumin excertion (at exam 6, FBAT, adjusted for multivariable)	25	529	1	975	2632	4706	4215	2954	1356	529	1076	1159
1890_Shaft Width (FBAT, male, adjussted for age)	1890_Shaft Width (FBAT, male, adjussted for age)	25	529	1	4742	4074	2540	4634	2570	4000	2455	529	4583
3339_Age when periods started (menarche) (female)	3339_Age when periods started (menarche) (female)	25	530	1	1336	530	2277	4685	3763	1333	3899	4331	3483
4695_Cingulum (cingulate gyrus) mean diusivities	4695_Cingulum (cingulate gyrus) mean diusivities	25	530	1	1229	2953	530	2582	4218	3523	4052	3076	4687
2588_CLEC7A - C-type lectin domain family 7 member A	2588_CLEC7A - C-type lectin domain family 7 member A	25	530	1	534	1029	4331	4216	1880	530	1115	830	3604
855_ApoB	855_ApoB	25	531	1	2880	531	3675	1167	3635	2738	1579	2334	1504
415_Amino acid::Urea cycle; arginine-, proline-, metabolism::N-acetylornithine	415_Amino acid::Urea cycle; arginine-, proline-, metabolism::N-acetylornithine	25	531	1	1255	537	2925	1922	531	2187	3746	3422	3748
2578_ARSA - Arylsulfatase A	2578_ARSA - Arylsulfatase A	25	531	1	893	3251	2406	1837	2552	3968	4432	3552	531
3196_Time employed in main current job	3196_Time employed in main current job	25	532	1	532	3066	3682	3659	1503	1227	3235	3155	3290
3589_Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding, lawn mowing, carpentry, digging)	3589_Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding, lawn mowing, carpentry, digging)	25	532	1	847	4097	3449	532	716	4697	975	2600	2490
3292_Worry too long after embarrassment	3292_Worry too long after embarrassment	25	532	1	1077	4695	1300	1414	532	640	1281	1899	4614
3777_Traumatic events - Diagnosed with life-threatening illness	3777_Traumatic events - Diagnosed with life-threatening illness	25	532	1	2196	2477	2244	2407	3586	532	3104	4418	3700
1112_Visceral sdipose tissue volume (male)	1112_Visceral sdipose tissue volume (male)	25	533	1	4414	783	2945	1476	2771	533	2046	2277	560
523_Lipid::Long chain fatty acid::nonadecanoate (19:0)	523_Lipid::Long chain fatty acid::nonadecanoate (19:0)	25	533	1	4401	3129	2488	2440	2451	3094	533	3344	3991
3567_Why stopped smoking: Illness or ill health	3567_Why stopped smoking: Illness or ill health	25	533	1	1869	2645	4633	2806	1932	2216	4332	1158	533
4185_Cigarettes per day (excluding nonsmokers)	4185_Cigarettes per day (excluding nonsmokers)	25	534	1	3622	534	786	602	641	1986	2303	2842	1015
1952_Boston Naming Test score without cues (FBAT, adjusted for multivariable)	1952_Boston Naming Test score without cues (FBAT, adjusted for multivariable)	25	534	1	3900	726	534	2140	2424	1519	4007	824	1213
2751_PDGFB - Platelet-derived growth factor subunit B	2751_PDGFB - Platelet-derived growth factor subunit B	25	534	1	1857	1962	1883	2508	967	534	2068	2558	1109
632_Xenobiotics::Food component, Plant::N-(2-furoyl)glycine	632_Xenobiotics::Food component, Plant::N-(2-furoyl)glycine	25	535	1	2148	2898	1601	535	1978	1720	3201	3154	4093
728_::::X-11792	728_::::X-11792	25	535	1	2733	2320	3270	4222	2004	1221	535	3839	2028
1048_Type 2 Diabetes	1048_Type 2 Diabetes	25	535	1	4178	3581	3299	3385	1845	2762	537	3634	535
4730_Superior corona radiata mode of anisotropy	4730_Superior corona radiata mode of anisotropy	25	536	1	536	3998	675	3082	1407	2317	1503	3271	2164
2991_ERP29 - Endoplasmic reticulum resident protein 29	2991_ERP29 - Endoplasmic reticulum resident protein 29	25	536	1	3985	536	1641	4620	3003	544	2017	2212	4692
2292_TNFSF15 - Tumor necrosis factor ligand superfamily member 15	2292_TNFSF15 - Tumor necrosis factor ligand superfamily member 15	25	536	1	3934	4127	536	856	3908	2274	1220	3931	3627
953_VLDL diameter	953_VLDL diameter	25	536	1	3712	1217	3069	4679	1968	4715	2343	536	1672
3068_KIR3DS1 - Killer cell immunoglobulin-like receptor 3DS1	3068_KIR3DS1 - Killer cell immunoglobulin-like receptor 3DS1	25	536	1	3353	3110	2014	1960	3650	2515	4037	2891	536
130_Hip circumference (male, adjusted for BMI)	130_Hip circumference (male, adjusted for BMI)	25	537	1	3092	3444	3110	2359	3393	537	642	1588	732
1398_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for age and sex)	1398_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	537	1	1058	3816	825	1671	3975	582	2552	2608	537
2180_SIGLEC6 - Sialic acid-binding Ig-like lectin 6	2180_SIGLEC6 - Sialic acid-binding Ig-like lectin 6	25	538	1	1837	1727	3853	538	1764	2207	624	1051	1262
1301_Fasting plasma glucose (at exam 7, GEE, adjusted for age and sex)	1301_Fasting plasma glucose (at exam 7, GEE, adjusted for age and sex)	24	539	1	4096	4655	539	3852	4132	2086	1127	1025	2378
861_Citrate	861_Citrate	25	539	1	3232	2708	1175	539	3653	2175	4348	3033	1885
1504_Triglycerides (at exam 4, FBAT, adjusted for age and sex)	1504_Triglycerides (at exam 4, FBAT, adjusted for age and sex)	25	540	1	540	854	3527	1014	3139	3751	4258	765	865
2434_CNTN2 - Contactin-2	2434_CNTN2 - Contactin-2	25	540	1	3062	2043	540	821	1477	4616	4485	3899	3723
4077_Waist-hip ratio	4077_Waist-hip ratio	25	540	1	886	1045	4517	3588	3418	540	970	3248	3928
1651_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for age and sex)	1651_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for age and sex)	25	541	1	541	656	3021	4422	4312	2608	3441	917	3511
1392_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for multivariable)	1392_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for multivariable)	25	541	1	4161	2992	3816	541	3360	4356	1724	3838	3132
2335_CXCL11 - C-X-C motif chemokine 11	2335_CXCL11 - C-X-C motif chemokine 11	25	542	1	542	3659	2699	2967	2723	2690	758	2116	3913
1937_Total cerebral brain volume (GEE, adjusted for age and sex)	1937_Total cerebral brain volume (GEE, adjusted for age and sex)	25	542	1	4479	542	3895	2015	2277	2506	3577	2211	4224
4216_Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	4216_Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	25	542	1	2357	4021	542	3035	2728	3225	3311	4021	1943
1427_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1427_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	542	1	1095	4490	2823	542	4622	3137	546	2816	4338
2881_FLRT1 - Leucine-rich repeat transmembrane protein FLRT1	2881_FLRT1 - Leucine-rich repeat transmembrane protein FLRT1	25	542	1	4441	890	1273	4140	3366	542	2567	3798	738
3911_Cup area	3911_Cup area	25	542	1	909	2801	2661	2316	2691	2298	542	1806	2073
1662_Alanine transaminase (at exam 2, FBAT, adjusted for age and sex)	1662_Alanine transaminase (at exam 2, FBAT, adjusted for age and sex)	25	542	1	4561	3764	3823	1074	1281	1012	1843	542	2871
4594_Right pars triangularis	4594_Right pars triangularis	25	543	1	4198	543	3120	4019	4128	3428	3133	3658	912
2650_STX1A - Syntaxin-1A	2650_STX1A - Syntaxin-1A	25	543	1	3374	3306	543	4730	923	4412	1662	3468	4712
3420_Pairs matching test - Number of incorrect matches in round	3420_Pairs matching test - Number of incorrect matches in round	25	543	1	2478	3537	1101	543	1943	2789	1659	870	697
684_::::X-10500	684_::::X-10500	25	543	1	1720	1595	4356	862	1445	1691	543	2221	1418
3843_Hematocrit (two-way meta)	3843_Hematocrit (two-way meta)	25	544	1	544	3599	4581	2226	3740	1954	1808	4227	2733
3765_Anxiety - Recent feelings of foreboding	3765_Anxiety - Recent feelings of foreboding	25	544	1	4019	544	1067	625	2391	2101	1992	1643	2170
4371_Thyroid-stimulating hormone (female)	4371_Thyroid-stimulating hormone (female)	25	544	1	2066	1336	544	1584	1780	3354	744	1729	1093
718_::::X-11530	718_::::X-11530	25	544	1	1865	1123	4291	544	2356	2010	4168	2802	1183
1091_Alcohol dependence	1091_Alcohol dependence	25	545	1	1244	3338	3540	545	3921	1151	1599	3494	3885
2244_C5 - C5a anaphylatoxin	2244_C5 - C5a anaphylatoxin	25	545	1	3018	2997	4196	1635	545	4611	583	3275	2505
1397_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for multivariable)	1397_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for multivariable)	25	545	1	4171	4035	3915	4595	2624	3750	3623	545	4580
3457_Impedance measures - Leg fat mass (left)	3457_Impedance measures - Leg fat mass (left)	25	546	1	546	2883	795	1343	2647	794	4021	1987	3423
2697_RPS6KA5 - Ribosomal protein S6 kinase alpha-5	2697_RPS6KA5 - Ribosomal protein S6 kinase alpha-5	25	546	1	3794	546	1062	1775	4281	3622	3739	714	4726
1232_Usual weekday bedtime (FBAT, adjusted for age, sex and BMI)	1232_Usual weekday bedtime (FBAT, adjusted for age, sex and BMI)	25	546	1	1530	1729	546	3606	4172	4579	3730	2386	3306
1063_Schizophrenia	1063_Schizophrenia	25	546	1	1211	2537	4495	3424	4627	4322	4325	546	3943
1786_QT interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1786_QT interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	546	1	2419	4054	1270	1623	1792	3054	4374	1592	546
3879_Hematocrit (three-way meta)	3879_Hematocrit (three-way meta)	25	547	1	547	1677	3797	3449	3731	1924	3446	3363	2157
2220_AGRP - Agouti-related protein	2220_AGRP - Agouti-related protein	25	547	1	2569	547	3731	3117	4636	791	3924	4577	2711
4334_Asthma	4334_Asthma	25	547	1	1711	631	547	3875	3561	3539	1489	3731	1820
532_Lipid::Lysolipid::1-arachidonoylglycerophosphoinositol*	532_Lipid::Lysolipid::1-arachidonoylglycerophosphoinositol*	25	547	1	2201	2418	3709	547	4574	2597	834	1814	4196
1060_Breast cancer	1060_Breast cancer	25	547	1	2528	2578	1262	4263	3575	4628	2546	547	2496
1186_Triglycerides cholesterol	1186_Triglycerides cholesterol	25	547	1	3460	2067	2340	4654	4160	2987	4346	1345	547
3987_Heart rate recovery at 30 secnds	3987_Heart rate recovery at 30 secnds	25	548	1	548	1010	2901	2339	2175	4693	4006	1561	557
2590_MASP1 - Mannan-binding lectin serine protease 1	2590_MASP1 - Mannan-binding lectin serine protease 1	25	548	1	4575	4431	881	548	4355	3581	1073	2590	4312
927_Triglycerides in medium VLDL	927_Triglycerides in medium VLDL	25	548	1	1846	765	3453	4183	548	3475	4297	840	2855
635_Xenobiotics::Food component, Plant::saccharin	635_Xenobiotics::Food component, Plant::saccharin	25	548	1	3838	2474	760	1401	1921	548	1066	3845	1436
1899_Troch Neck BMD (GEE, female, adjussted for multivariable)	1899_Troch Neck BMD (GEE, female, adjussted for multivariable)	25	549	1	3862	4533	549	3318	3376	4660	4104	3085	2755
2284_CGA LHB - Luteinizing hormone	2284_CGA LHB - Luteinizing hormone	25	549	1	1465	987	2463	549	1405	2136	1572	2587	1767
3498_Hair colour (natural, before greying): Dark brown	3498_Hair colour (natural, before greying): Dark brown	25	549	1	4713	4641	937	1485	2149	549	4672	1453	4428
844_::::X-14632	844_::::X-14632	25	549	1	3495	4435	3129	1242	3012	560	799	1688	549
4254_Sleep duration (SD)	4254_Sleep duration (SD)	25	550	1	4102	550	1926	986	3371	2660	4510	946	4367
3432_Symbol digit substitution test - Number of symbol digit matches attempted	3432_Symbol digit substitution test - Number of symbol digit matches attempted	25	550	1	3705	3059	3175	550	717	3174	4211	2881	4563
111_Coronary artery disease	111_Coronary artery disease	25	551	1	1150	551	1700	2157	3508	994	1845	3760	4536
16_Posttraumatic stress disorder	16_Posttraumatic stress disorder	25	551	1	3156	4349	551	2498	3941	4327	1086	3881	3288
2915_SMPDL3A - Acid sphingomyelinase-like phosphodiesterase 3a	2915_SMPDL3A - Acid sphingomyelinase-like phosphodiesterase 3a	25	551	1	1163	3397	1367	4647	2023	3350	2946	551	3656
4173_Social support - Leisure/social activities: Sports club or gym	4173_Social support - Leisure/social activities: Sports club or gym	25	552	1	552	3166	2525	4500	827	2593	1084	3146	2041
4333_Polycystic ovary syndrome	4333_Polycystic ovary syndrome	25	552	1	1452	552	1112	1280	1936	3560	2141	1526	3463
3473_Reported occurrences of cancer	3473_Reported occurrences of cancer	25	552	1	2596	2634	552	2937	1885	671	1978	4134	4458
2479_CTSV - Cathepsin L2	2479_CTSV - Cathepsin L2	25	552	1	3134	4657	3802	552	3949	1840	4642	2290	4254
1683_Brain natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	1683_Brain natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	25	553	1	553	1511	906	1433	708	2787	4017	3971	914
4724_Inferior fronto-occipital fasciculus mode of anisotropy	4724_Inferior fronto-occipital fasciculus mode of anisotropy	25	553	1	1707	2044	4308	553	2056	2494	2091	2020	1376
1236_Usual weekday sleep duration (FBAT, adjusted for age, sex and BMI)	1236_Usual weekday sleep duration (FBAT, adjusted for age, sex and BMI)	25	553	1	3198	2165	3219	4492	1021	657	3643	553	1705
4744_Fornix (cres) / Stria terminalis radial diusivities	4744_Fornix (cres) / Stria terminalis radial diusivities	25	554	1	949	554	3547	831	787	1440	4591	924	3207
4108_Blood urea nitrogen	4108_Blood urea nitrogen	25	554	1	1792	777	1010	1484	2046	2976	1670	2213	554
1729_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for multivariable)	1729_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for multivariable)	25	555	1	1832	2682	555	3233	1102	823	2121	1978	4641
4042_Obsessive compulsive disorder	4042_Obsessive compulsive disorder	25	555	1	4328	2253	1944	1045	4475	555	2723	2741	4378
512_Lipid::Inositol metabolism::scyllo-inositol	512_Lipid::Inositol metabolism::scyllo-inositol	25	555	1	4571	1161	4505	1619	770	1516	555	3502	2578
4671_Average across all tracts axial diusivities	4671_Average across all tracts axial diusivities	25	556	1	2468	4681	1799	556	1157	4263	1462	2493	1397
2154_HSPD1 - 60 kDa heat shock protein, mitochondrial	2154_HSPD1 - 60 kDa heat shock protein, mitochondrial	25	556	1	4175	1095	2884	2284	2701	960	556	4248	3979
4189_Fasting glucose	4189_Fasting glucose	25	556	1	1504	4205	4704	4133	2885	2559	1379	556	4602
150_Body Mass Index (female <= 50 yrs)	150_Body Mass Index (female <= 50 yrs)	25	557	1	601	2666	3004	2638	2635	557	4663	4348	926
1156_Fasting glucose main effect	1156_Fasting glucose main effect	25	557	1	2786	1793	2322	2622	1626	3554	4247	557	1073
1939_Hippocampal volume (GEE, adjusted for multivariable with APOE)	1939_Hippocampal volume (GEE, adjusted for multivariable with APOE)	25	558	1	558	2374	864	677	3451	1419	1762	644	1359
447_Cofactors and vitamins::Ascorbate and aldarate metabolism::ascorbate (Vitamin C)	447_Cofactors and vitamins::Ascorbate and aldarate metabolism::ascorbate (Vitamin C)	25	558	1	3021	558	2738	2689	3916	586	3798	3334	3898
2083_APCS - Serum amyloid P-component	2083_APCS - Serum amyloid P-component	25	558	1	4018	4744	3663	558	1087	3229	3487	2932	1187
2554_FGF17 - Fibroblast growth factor 17	2554_FGF17 - Fibroblast growth factor 17	25	558	1	2819	660	1217	4344	558	4545	2977	3681	3599
4408_Vaginal discharge: Itching	4408_Vaginal discharge: Itching	25	559	1	713	1873	3265	2598	2588	559	2993	4539	955
3894_Neutrophil percentage of granulocytes (three-way meta)	3894_Neutrophil percentage of granulocytes (three-way meta)	25	560	1	560	879	2206	1322	2096	3192	4040	1312	2093
1511_Triglycerides (at exam 7, GEE, adjusted for age and sex)	1511_Triglycerides (at exam 7, GEE, adjusted for age and sex)	25	560	1	4117	560	2470	2561	4386	3987	2146	1075	1011
3915_Disc area	3915_Disc area	25	560	1	3707	2281	2248	1416	2682	2919	4623	560	2507
4612_Right basal forebrain	4612_Right basal forebrain	25	561	1	2001	561	3062	1751	791	2601	2594	1650	1849
987_Interleukin-1-beta	987_Interleukin-1-beta	25	561	1	3012	3436	561	2877	2713	1545	4651	3070	814
1527_Remnant lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1527_Remnant lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	561	1	635	3818	4018	1123	4476	561	3500	2026	4597
4596_Right postcentral	4596_Right postcentral	25	563	1	4271	563	2719	1885	2374	4505	4066	2666	2769
3331_Other serious medical condition/disability (diagnosed by doctor)	3331_Other serious medical condition/disability (diagnosed by doctor)	25	563	1	4285	3629	1256	563	4713	2222	2271	2113	2664
134_Waist circumference (male, adjusted for BMI)	134_Waist circumference (male, adjusted for BMI)	25	563	1	928	989	1606	792	2881	563	1060	786	978
2238_SPINT2 - Kunitz-type protease inhibitor 2	2238_SPINT2 - Kunitz-type protease inhibitor 2	25	564	1	564	1451	4160	3204	3387	639	2378	4230	1349
4630_Left vessel	4630_Left vessel	25	564	1	3309	3753	564	2656	2633	2110	2560	1353	802
1551_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1551_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	564	1	3330	3864	1594	564	4733	4380	614	4469	2679
4481_Right inferior parietal	4481_Right inferior parietal	25	564	1	2538	2330	2970	2581	1335	3724	564	955	1304
3954_Ankle injury (fixed effect)	3954_Ankle injury (fixed effect)	25	564	1	1214	2040	4583	4081	2285	2999	1779	2155	564
3888_Mean corpuscular volume (three-way meta)	3888_Mean corpuscular volume (three-way meta)	25	565	1	565	834	4400	1947	3200	700	1231	1994	806
1054_Amyotrophic lateral sclerosis	1054_Amyotrophic lateral sclerosis	25	565	1	2789	954	565	2219	2697	781	1561	2186	4095
1126_Visceral adipose tissue sttenutation	1126_Visceral adipose tissue sttenutation	25	565	1	3285	3206	4268	1342	2236	2795	1266	3035	565
761_::::X-12206	761_::::X-12206	25	566	1	4465	4335	4023	929	566	3255	3676	4245	1384
2089_GFRA3 - GDNF family receptor alpha-3	2089_GFRA3 - GDNF family receptor alpha-3	25	566	1	663	2519	1103	1116	610	566	2059	4596	3855
4202_Chronic kidney disease	4202_Chronic kidney disease	25	566	1	4524	789	2721	2008	2626	802	566	3341	3308
725_Cofactors and vitamins::Ascorbate and aldarate metabolism::X-11593--O-methylascorbate*	725_Cofactors and vitamins::Ascorbate and aldarate metabolism::X-11593--O-methylascorbate*	25	566	1	2055	1812	724	2781	704	4125	1026	566	2534
3756_Mental distress - Ever suffered mental distress preventing usual activities	3756_Mental distress - Ever suffered mental distress preventing usual activities	25	567	1	567	3095	3970	1065	1338	2070	3406	2963	1858
4559_Left parahippocampal	4559_Left parahippocampal	25	567	1	4091	567	3558	3183	1346	3312	2766	2147	1680
3153_HNRNPA2B1 - Heterogeneous nuclear ribonucleoproteins A2/B1	3153_HNRNPA2B1 - Heterogeneous nuclear ribonucleoproteins A2/B1	25	567	1	4542	812	567	4708	1237	2116	4009	3445	2303
4022_Eyebrows	4022_Eyebrows	25	567	1	4576	4599	3254	567	4363	3124	2858	1212	3995
461_Energy::Krebs cycle::succinylcarnitine	461_Energy::Krebs cycle::succinylcarnitine	25	567	1	4661	4563	956	3926	567	2120	1751	4090	4467
924_Total lipids in medium VLDL	924_Total lipids in medium VLDL	25	568	1	828	568	2367	4382	1057	2870	4588	1179	2896
1463_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1463_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	568	1	1346	3889	2966	568	4667	2656	962	4172	3279
1767_Heart failure (free of MI, GEE, adjusted for multivariable)	1767_Heart failure (free of MI, GEE, adjusted for multivariable)	25	568	1	1844	4014	2288	3625	1684	592	2758	1971	568
1609_Viscosity I (at exam 5, GEE, adjusted for multivariable)	1609_Viscosity I (at exam 5, GEE, adjusted for multivariable)	25	569	1	1718	1375	3051	2760	4508	1069	569	697	1271
1648_P-selectin (at exam 7, FBAT, adjusted formultivariable)	1648_P-selectin (at exam 7, FBAT, adjusted formultivariable)	25	569	1	2705	2846	3087	1190	3085	2398	4036	4318	569
510_Lipid::Inositol metabolism::chiro-inositol	510_Lipid::Inositol metabolism::chiro-inositol	25	570	1	3492	570	1916	1857	1014	3178	3910	2189	4578
4555_Left lateral orbitofrontal	4555_Left lateral orbitofrontal	25	570	1	3260	3021	570	1479	2165	2490	3159	2101	4544
1077_Attention deficit hyperactivity disorder	1077_Attention deficit hyperactivity disorder	25	570	1	2847	4585	4551	3890	2419	570	4532	2197	2046
3205_Duration of walks	3205_Duration of walks	25	570	1	3963	685	2609	1041	2031	1301	570	2820	2328
601_Peptide::gamma-glutamyl::gamma-glutamylglutamate	601_Peptide::gamma-glutamyl::gamma-glutamylglutamate	25	571	1	4427	3900	3901	3154	571	2571	2340	2508	1488
2249_HDAC8 - Histone deacetylase 8	2249_HDAC8 - Histone deacetylase 8	25	571	1	2020	3009	922	1766	3789	4590	571	1902	2422
470_Lipid::Bile acid metabolism::taurochenodeoxycholate	470_Lipid::Bile acid metabolism::taurochenodeoxycholate	25	571	1	1376	695	2586	1852	1648	731	1355	571	3834
765_::::X-12230	765_::::X-12230	25	571	1	3004	2156	3854	2387	3454	2418	1326	2044	571
3779_Traumatic events - Witnessed sudden violent death	3779_Traumatic events - Witnessed sudden violent death	25	572	1	3734	572	3876	2719	2990	1394	3840	2437	786
424_Amino acid::Valine, leucine and isoleucine metabolism::4-methyl-2-oxopentanoate	424_Amino acid::Valine, leucine and isoleucine metabolism::4-methyl-2-oxopentanoate	25	572	1	1898	928	4477	2679	3939	572	1166	1793	765
1260_Residual from predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	1260_Residual from predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	573	1	573	3393	4096	3607	2223	3009	4032	2041	4655
391_Amino acid::Phenylalanine & tyrosine metabolism::3-(3-hydroxyphenyl)propionate	391_Amino acid::Phenylalanine & tyrosine metabolism::3-(3-hydroxyphenyl)propionate	25	573	1	2493	1504	573	2557	1793	4553	4070	1008	3233
267_CD4:%Exhausted	267_CD4:%Exhausted	25	573	1	3326	4110	3546	3311	1373	573	2148	1064	2931
2715_LDHB - L-lactate dehydrogenase B chain	2715_LDHB - L-lactate dehydrogenase B chain	25	573	1	3389	3743	1823	1717	2820	2025	1923	3718	573
1192_Refractive error	1192_Refractive error	25	574	1	3825	2747	3446	574	4145	4303	4421	4152	1297
2351_TNFSF13B - Tumor necrosis factor ligand superfamily member 13B	2351_TNFSF13B - Tumor necrosis factor ligand superfamily member 13B	25	574	1	2623	3991	3173	1606	1650	1027	824	2578	574
3341_Number of live births (female)	3341_Number of live births (female)	25	575	1	575	677	3686	701	1190	4519	1486	2250	746
4236_Glucocorticoids	4236_Glucocorticoids	25	575	1	4145	575	2221	589	3278	3477	841	3483	4319
4308_Osteoarthritis of hit or knee	4308_Osteoarthritis of hit or knee	25	575	1	3728	1994	4685	2124	575	1396	3697	4322	4714
3532_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault to yourself	3532_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault to yourself	25	576	1	576	1834	3723	1213	4379	4728	1880	1184	4475
163_Hip circumference (male, adjusted for BMI)	163_Hip circumference (male, adjusted for BMI)	25	576	1	4486	2920	4139	1498	2948	576	1441	1477	3544
1265_Residual from predicted FVC for latest exam (GEE, adjusted for multiple covariates)	1265_Residual from predicted FVC for latest exam (GEE, adjusted for multiple covariates)	25	576	1	1729	2335	4315	4477	2395	2246	3523	576	3817
4557_Left medial orbitofrontal	4557_Left medial orbitofrontal	25	577	1	1816	577	2198	2371	4497	4183	3147	4719	4038
4459_Left paracentral	4459_Left paracentral	25	577	1	2172	2517	3577	3546	1145	2715	577	2678	4404
1229_Parkinson Disease	1229_Parkinson Disease	25	578	1	3686	1027	578	2930	3802	4065	2971	593	4275
4493_Right pars triangularis	4493_Right pars triangularis	25	578	1	2607	4481	4262	1470	578	3419	4478	3685	3392
4032_Alcohol dependency (unrelated individuals)	4032_Alcohol dependency (unrelated individuals)	25	578	1	4705	1794	3387	3343	2178	1984	1510	4121	578
446_Carbohydrate::Nucleotide sugars, pentose metabolism::threitol	446_Carbohydrate::Nucleotide sugars, pentose metabolism::threitol	25	579	1	4283	2179	1709	579	3368	4139	3693	3139	1129
2699_SEZ6L2 - Seizure 6-like protein 2	2699_SEZ6L2 - Seizure 6-like protein 2	25	579	1	3270	4199	2114	1807	2304	579	1950	725	3353
3353_Number of cigarettes previously smoked daily	3353_Number of cigarettes previously smoked daily	25	579	1	3589	2638	1596	2831	3646	1295	579	4057	660
51_Number of children ever born (female)	51_Number of children ever born (female)	25	579	1	2779	3888	4544	2290	4598	3772	3678	2490	579
2268_CCL23 - C-C motif chemokine 23	2268_CCL23 - C-C motif chemokine 23	25	580	1	2257	580	2955	4660	853	4208	2114	3352	3040
485_Lipid::Carnitine metabolism::palmitoylcarnitine	485_Lipid::Carnitine metabolism::palmitoylcarnitine	25	580	1	4201	4306	2857	1238	3617	580	3427	1544	1432
2213_ALPL - Alkaline phosphatase, tissue-nonspecific isozyme	2213_ALPL - Alkaline phosphatase, tissue-nonspecific isozyme	25	580	1	1103	1461	1921	3838	4298	1025	580	1095	3422
1093_Glioma	1093_Glioma	25	581	1	581	3435	1863	1831	976	3762	2315	4240	1331
2376_ADAMTS5 - A disintegrin and metalloproteinase with thrombospondin motifs 5	2376_ADAMTS5 - A disintegrin and metalloproteinase with thrombospondin motifs 5	25	581	1	1820	1228	581	3505	4262	4459	1893	4003	960
4544_White matter	4544_White matter	25	581	1	4645	2127	2169	3331	3054	581	2881	4267	1830
3544_Mouth/teeth dental problems: Mouth ulcers	3544_Mouth/teeth dental problems: Mouth ulcers	25	581	1	2653	1239	1436	4111	4292	4293	581	1484	1696
511_Lipid::Inositol metabolism::myo-inositol	511_Lipid::Inositol metabolism::myo-inositol	25	582	1	582	691	2187	4629	3912	4036	600	2419	2587
3128_PDE5A - cGMP-specific 3',5'-cyclic phosphodiesterase	3128_PDE5A - cGMP-specific 3',5'-cyclic phosphodiesterase	25	582	1	2215	3853	582	1704	4113	2782	3831	1820	2051
3636_Illnesses of father: Severe depression	3636_Illnesses of father: Severe depression	25	583	1	4406	2215	1503	3321	1211	2290	1695	3249	583
3852_Mean corpuscular volume (two-way meta)	3852_Mean corpuscular volume (two-way meta)	25	584	1	584	814	4042	1015	3560	623	1602	1059	966
4101_Triglyceride	4101_Triglyceride	25	584	1	3926	584	3958	2812	1624	4192	4619	1320	1902
4705_Posterior thalamic radiation (include optic radiation) mean diusivities	4705_Posterior thalamic radiation (include optic radiation) mean diusivities	25	584	1	2509	1007	3882	584	2199	1134	743	3481	2904
3632_Illnesses of father: Chronic bronchitis/emphysema	3632_Illnesses of father: Chronic bronchitis/emphysema	25	584	1	3378	3279	3457	2671	584	1855	2332	4616	4167
3065_AMICA1 - Junctional adhesion molecule-like	3065_AMICA1 - Junctional adhesion molecule-like	25	584	1	3178	3957	714	2476	3679	2485	861	783	584
4245_Left handed	4245_Left handed	25	585	1	585	1895	4654	3630	730	4581	2848	4521	1429
2075_CTSG - Cathepsin G	2075_CTSG - Cathepsin G	25	585	1	4340	585	4463	2979	1452	4028	3869	2993	3567
4205_Estimated glomerular filtration rate	4205_Estimated glomerular filtration rate	25	585	1	3150	1927	1405	2757	3378	585	1205	4259	2356
1076_Pancreatic cancer	1076_Pancreatic cancer	25	585	1	2739	4616	3514	3837	2810	2679	585	2879	4051
3537_Attendance/disability/mobility allowance: Disability living allowance	3537_Attendance/disability/mobility allowance: Disability living allowance	25	586	1	586	4113	2210	3289	3207	3698	4073	4354	3307
2130_IL13RA1 - Interleukin-13 receptor subunit alpha-1	2130_IL13RA1 - Interleukin-13 receptor subunit alpha-1	25	586	1	4417	924	1957	2406	586	3856	4667	4346	4030
311_CD4nv:%R6+R4-	311_CD4nv:%R6+R4-	25	587	1	3248	3719	774	587	3910	2291	3981	2999	1108
3136_SHC1 - SHC-transforming protein 1	3136_SHC1 - SHC-transforming protein 1	25	587	1	2644	3348	3515	4310	587	3269	1276	3251	3961
1983_Walking speed (at exam 7, GEE)	1983_Walking speed (at exam 7, GEE)	25	587	1	3908	2709	3165	2769	2503	1247	1252	587	881
3327_Had major operations	3327_Had major operations	25	588	1	2997	588	3316	4214	4387	3653	3230	2662	2844
4315_Cigarettes per day	4315_Cigarettes per day	25	588	1	2741	4685	1464	4706	4697	945	1618	3436	588
1041_Shaft Width (GEE, adjusted for age and sex)	1041_Shaft Width (GEE, adjusted for age and sex)	25	589	1	3168	589	3379	2657	3562	1438	2505	1703	2845
2530_KLK6 - Kallikrein-6	2530_KLK6 - Kallikrein-6	25	589	1	4338	3133	589	4459	845	2190	3621	2309	2843
922_Cholesterol esters in medium VLDL	922_Cholesterol esters in medium VLDL	25	589	1	936	795	1192	3487	589	2006	2481	1216	2554
744_::::X-11905	744_::::X-11905	25	590	1	3472	2963	3862	4138	590	3627	1995	1354	729
1334_Fasting HbA1c (at exam 7, FBAT, adjusted for age, sex and BMI)	1334_Fasting HbA1c (at exam 7, FBAT, adjusted for age, sex and BMI)	25	591	1	3172	3430	4433	591	4501	750	4646	1437	4301
1855_Neck average buckling ratio (GEE, female, adjussted for age)	1855_Neck average buckling ratio (GEE, female, adjussted for age)	25	591	1	3778	1333	3681	3914	1772	591	4067	1244	797
3264_Average weekly beer plus cider intake	3264_Average weekly beer plus cider intake	25	591	1	3867	2224	3179	1356	2848	4703	4234	591	1677
3555_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Blood pressure medication	3555_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Blood pressure medication	25	592	1	592	3531	2782	3813	2664	4080	3955	2645	4447
3381_Prospective memory test - Time to answer	3381_Prospective memory test - Time to answer	25	592	1	1824	2514	592	1976	1089	4216	4694	2575	3650
1018_Lumbar Spine BMD (FBAT, adjusted for multivariable)	1018_Lumbar Spine BMD (FBAT, adjusted for multivariable)	25	592	1	1154	1414	3677	959	1329	1955	3875	592	1955
212_Insomnia (female)	212_Insomnia (female)	25	593	1	4173	1210	3407	2824	3829	593	2392	3313	1146
4292_Asthma	4292_Asthma	25	593	1	2362	3507	2958	1092	2319	754	593	3095	608
4222_Beta blocking agents	4222_Beta blocking agents	25	595	1	604	595	4134	2562	2445	3111	4407	4136	2571
222_B:%Mature	222_B:%Mature	25	595	1	777	897	595	1522	1092	1964	3566	2981	1926
274_CD8:%TEM	274_CD8:%TEM	25	595	1	2614	1129	3286	595	1705	2641	1713	1324	620
3398_Leg pain on walking	3398_Leg pain on walking	25	595	1	2850	3122	713	899	595	2921	747	2011	1394
2134_MRC1 - Macrophage mannose receptor 1	2134_MRC1 - Macrophage mannose receptor 1	25	595	1	2781	1037	3788	2069	939	3352	3400	595	3446
4456_Left medial orbitofrontal	4456_Left medial orbitofrontal	25	596	1	786	596	1993	2988	3453	3860	2641	2521	2148
2127_IL1RAP - Interleukin-1 Receptor accessory protein	2127_IL1RAP - Interleukin-1 Receptor accessory protein	25	596	1	1561	1900	1140	2389	956	1957	596	3663	2512
2592_DKK3 - Dickkopf-related protein 3	2592_DKK3 - Dickkopf-related protein 3	25	597	1	597	1507	3170	2875	4588	1884	3168	3096	4026
1695_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for age and sex)	1695_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for age and sex)	25	597	1	1788	3838	1840	597	1663	1504	4602	1605	1421
1133_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, male)	1133_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, male)	25	597	1	1362	1105	1278	2853	2961	597	2843	3660	3555
3982_Schizophrenia	3982_Schizophrenia	25	598	1	598	1826	2378	4387	3962	2158	2095	675	3250
1275_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	1275_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	25	598	1	1011	598	3044	3896	780	4445	2461	1574	4138
3515_Gas or solid-fuel cooking/heating: An open solid fuel fire that you use regularly in winter time	3515_Gas or solid-fuel cooking/heating: An open solid fuel fire that you use regularly in winter time	25	598	1	3937	647	838	3184	1497	598	2460	4695	1976
3641_Illnesses of mother: Bowel cancer	3641_Illnesses of mother: Bowel cancer	25	598	1	2376	994	3772	4232	4238	4695	2923	2867	598
4715_Average across all tracts mode of anisotropy	4715_Average across all tracts mode of anisotropy	25	599	1	4316	2449	599	4109	1305	3903	1570	1024	3138
3858_Neutrophil percentage of granulocytes (two-way meta)	3858_Neutrophil percentage of granulocytes (two-way meta)	25	599	1	785	800	1599	599	2139	4381	2558	935	1589
4625_Left pallidum	4625_Left pallidum	25	599	1	4651	4589	4526	3535	3991	599	2613	3495	4561
1712_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for age and sex)	1712_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for age and sex)	25	599	1	2151	3907	3914	1562	4701	3506	599	3281	1348
1837_Neck width (GEE, male, adjusted for multivariable)	1837_Neck width (GEE, male, adjusted for multivariable)	25	599	1	4525	1293	835	3945	1009	2542	3584	599	917
775_::::X-12435	775_::::X-12435	25	599	1	795	3257	2792	2714	2001	4343	4161	2830	599
2072_BDNF - Brain-derived neurotrophic factor	2072_BDNF - Brain-derived neurotrophic factor	25	600	1	600	3591	4666	1780	3815	2742	2525	3947	805
4170_Loneliness (MTAG)	4170_Loneliness (MTAG)	25	600	1	4221	4479	4001	2176	3244	2223	1739	600	2674
603_Peptide::gamma-glutamyl::gamma-glutamylisoleucine*	603_Peptide::gamma-glutamyl::gamma-glutamylisoleucine*	25	601	1	1645	601	4535	2670	3449	3123	1463	4474	2876
2744_IL7 - Interleukin-7	2744_IL7 - Interleukin-7	25	601	1	1977	3730	601	3552	1075	943	654	1294	3459
1691_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for age and sex)	1691_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for age and sex)	25	601	1	3740	3177	3811	601	4205	1822	4339	1165	2738
565_Lipid::Monoacylglycerol::1-stearoylglycerol (1-monostearin)	565_Lipid::Monoacylglycerol::1-stearoylglycerol (1-monostearin)	25	601	1	3272	3263	4636	4069	601	3662	1532	3137	2727
1872_Shaft average buckling ratio (FBAT, male, adjussted for multivariable)	1872_Shaft average buckling ratio (FBAT, male, adjussted for multivariable)	25	601	1	3143	1907	1037	2010	2542	3942	4367	810	601
1213_Alcohol consumption	1213_Alcohol consumption	25	602	1	602	1765	1476	4578	2632	4031	971	1498	2482
2354_FGF5 - Fibroblast growth factor 5	2354_FGF5 - Fibroblast growth factor 5	25	602	1	3742	4418	1455	2381	3049	602	3079	3876	2969
2237_ICAM2 - Intercellular adhesion molecule 2	2237_ICAM2 - Intercellular adhesion molecule 2	25	602	1	4354	2945	1363	1191	3499	2865	602	3381	835
3455_Impedance measures - Leg predicted mass (right)	3455_Impedance measures - Leg predicted mass (right)	25	602	2	2595	886	3346	3693	1400	673	2417	602	2155
3539_Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia')	3539_Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia')	25	603	1	1579	3732	1054	603	4043	4170	2532	1380	4473
770_::::X-12261	770_::::X-12261	25	603	1	1460	798	1108	693	1172	603	3859	1197	794
3599_Non-cancer illness code, self-reported: asthma	3599_Non-cancer illness code, self-reported: asthma	25	603	2	1505	809	4025	2255	4492	1613	603	3747	4355
4260_Facial attractiveness (female-coder)	4260_Facial attractiveness (female-coder)	25	603	1	2969	3488	4376	2782	2918	1496	1622	4082	603
4682_Posterior limb of internal capsule axial diusivities	4682_Posterior limb of internal capsule axial diusivities	25	604	1	2820	2176	604	805	4572	1345	1528	4302	1896
451_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (Z,Z)	451_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (Z,Z)	25	604	1	3574	4010	2512	604	3221	3739	2480	2849	3746
1815_Femoral Neck BMD (GEE, female, adjusted for multivariable)	1815_Femoral Neck BMD (GEE, female, adjusted for multivariable)	25	604	1	1624	4725	2920	4273	2002	604	2587	2689	1235
4560_Left paracentral	4560_Left paracentral	25	605	1	1698	605	2768	2041	3961	1074	2872	2072	826
3627_Treatment/medication code: paracetamol	3627_Treatment/medication code: paracetamol	25	605	1	2239	1020	3775	2158	605	2809	649	3611	4420
2196_GDF11 - Growth/differentiation factor 11	2196_GDF11 - Growth/differentiation factor 11	25	605	1	2032	947	1360	3522	2661	1511	605	2951	2377
4611_Left basal forebrain	4611_Left basal forebrain	25	606	1	3457	606	2888	3366	694	3803	1901	1145	1744
105_Tanner scale (female)	105_Tanner scale (female)	25	606	1	4624	4415	606	2322	4033	621	3633	3188	1449
3619_Treatment/medication code: ibuprofen	3619_Treatment/medication code: ibuprofen	25	606	1	1171	3351	4061	2459	2138	1198	2459	606	4668
1304_Fasting insulin (at exam 7, FBAT, adjusted for age and sex)	1304_Fasting insulin (at exam 7, FBAT, adjusted for age and sex)	25	606	1	4592	1675	2960	958	1154	4362	4511	3015	606
1189_Aortic-valve calcification	1189_Aortic-valve calcification	25	607	1	607	1196	1046	2780	1082	975	4149	2856	2295
1533_Ankle-brachial index (at exam 6, GEE, adjusted for multivariable)	1533_Ankle-brachial index (at exam 6, GEE, adjusted for multivariable)	25	607	1	741	2491	1356	1565	4445	607	4003	1869	3050
1628_Interleukin 6 (at exam 7, FBAT, adjusted for multivariable)	1628_Interleukin 6 (at exam 7, FBAT, adjusted for multivariable)	25	607	1	3240	4129	2701	3854	1967	4425	4710	607	1879
1423_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1423_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	608	1	608	3778	2375	1360	3659	4654	3196	2182	3224
3748_Traumatic events - Felt loved as child	3748_Traumatic events - Felt loved as child	25	608	1	1873	1044	608	3721	4149	1515	2305	1432	4660
3352_Age started smoking in former smokers	3352_Age started smoking in former smokers	25	608	1	2356	3549	4415	608	4567	2439	2600	1641	4584
1795_RR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1795_RR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	608	1	4516	3442	4230	3903	3850	608	1061	2269	1151
3349_Ever used hormone-replacement therapy (HRT) (female)	3349_Ever used hormone-replacement therapy (HRT) (female)	25	608	1	1649	2228	948	1914	4309	1570	608	4353	2240
2899_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 27	2899_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 27	25	609	1	2345	848	609	4449	2397	1554	2377	3875	3521
4242_Rapid automised naming of letters	4242_Rapid automised naming of letters	25	609	1	2685	720	4443	609	3940	740	2452	4142	1782
2863_IL5RA - Interleukin-5 receptor subunit alpha	2863_IL5RA - Interleukin-5 receptor subunit alpha	25	609	1	2162	3104	1170	2802	3157	609	2901	2988	2872
2259_YES1 - Tyrosine-protein kinase Yes	2259_YES1 - Tyrosine-protein kinase Yes	25	609	1	3630	4070	3365	1540	3844	1501	609	1423	3747
3752_Traumatic events - Felt distant from other people in past month	3752_Traumatic events - Felt distant from other people in past month	25	609	1	1735	3667	4297	3044	2111	3875	3410	3377	609
526_Lipid::Long chain fatty acid::palmitoleate (16:1n7)	526_Lipid::Long chain fatty acid::palmitoleate (16:1n7)	25	610	1	610	3483	4659	2384	3995	4103	1675	1198	3790
1622_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for age and sex)	1622_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for age and sex)	25	611	1	3901	1562	3940	4241	4409	875	2372	611	853
248_CD337 on NK early	248_CD337 on NK early	25	611	1	3442	1594	2547	2890	4038	790	1902	3480	611
2683_UFM1 - Ubiquitin-fold modifier 1	2683_UFM1 - Ubiquitin-fold modifier 1	25	612	1	612	2510	4410	2360	3021	2607	3516	2090	1877
1085_Behcet disease	1085_Behcet disease	25	612	1	3875	4614	612	3534	1935	3755	4453	1541	1333
2731_C6 - Complement component C6	2731_C6 - Complement component C6	25	612	1	2748	3924	721	1154	1746	3141	3855	3328	612
1560_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1560_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	613	1	2585	4310	613	645	913	2188	1547	3389	4362
1806_SDNN HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1806_SDNN HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	613	1	4600	2427	4281	1163	4566	1658	613	2452	3553
4336_Overall activity (conditioning sex and BMI)	4336_Overall activity (conditioning sex and BMI)	25	614	1	614	2782	2318	4667	1956	1786	1395	1510	3041
1739_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for age and sex)	1739_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for age and sex)	25	614	1	4696	3815	614	3793	4688	1037	3880	2563	1823
3257_Hot drink temperature	3257_Hot drink temperature	25	614	1	2904	1093	4143	614	2368	2264	1056	2803	948
4252_Number of sleep episodes	4252_Number of sleep episodes	25	614	1	4685	2246	3448	1239	614	4402	1265	2124	4417
4640_Right amygdala	4640_Right amygdala	25	614	1	1944	3757	1168	4732	3119	614	3095	1623	1400
1696_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for multivariable)	1696_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for multivariable)	25	614	1	1809	3515	3649	1252	972	1965	4241	614	1804
3306_Ever had same-sex intercourse	3306_Ever had same-sex intercourse	25	615	1	615	1600	3371	3106	3791	2052	3657	1531	768
1522_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	1522_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	25	615	1	2180	615	3400	2665	1925	2277	1694	1800	1412
444_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::pyruvate	444_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::pyruvate	25	615	1	759	4250	2750	615	4040	4469	3010	4523	4547
4353_Tuberculosis	4353_Tuberculosis	25	615	1	4112	4743	994	3404	4252	615	3066	2706	1825
2490_PAK7 - Serine/threonine-protein kinase PAK 7	2490_PAK7 - Serine/threonine-protein kinase PAK 7	25	615	1	2018	799	4375	3264	3390	2540	615	2087	2745
1535_Ankle-brachial index (at exam 7, GEE, adjusted for age and sex)	1535_Ankle-brachial index (at exam 7, GEE, adjusted for age and sex)	25	616	1	616	3525	1232	2758	1036	2648	964	4095	1544
4199_Waist-hip ratio (female)	4199_Waist-hip ratio (female)	25	616	1	2842	4638	616	2505	2525	3674	3464	4485	1287
4251_M10 timing	4251_M10 timing	25	616	1	4001	2111	3161	3731	3068	1996	693	616	4076
1834_Neck width (FBAT, female, adjusted for multivariable)	1834_Neck width (FBAT, female, adjusted for multivariable)	25	617	1	617	2463	2829	1108	2420	3846	4103	2832	1922
2406_LTA4H - Leukotriene A-4 hydrolase	2406_LTA4H - Leukotriene A-4 hydrolase	25	617	1	997	617	1036	4357	1004	1107	1212	1956	1318
4049_Achilles tendon injury	4049_Achilles tendon injury	25	617	1	2697	3001	2011	4558	2569	1733	617	3131	845
2282_IGFBP4 - Insulin-like growth factor-binding protein 4	2282_IGFBP4 - Insulin-like growth factor-binding protein 4	25	617	1	1680	2689	2831	1816	4351	876	1275	617	2983
3530_Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	3530_Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	25	618	1	4074	1666	2189	618	4653	2872	3154	4409	1229
2525_IL15RA - Interleukin-15 receptor subunit alpha	2525_IL15RA - Interleukin-15 receptor subunit alpha	25	619	1	2344	619	2528	4339	801	4451	4451	1722	3084
1692_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for multivariable)	1692_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for multivariable)	25	619	1	636	663	619	4023	2999	3483	4338	3598	929
4403_Menstruation quality of life impact: Loss of concentration	4403_Menstruation quality of life impact: Loss of concentration	25	619	1	1366	1585	2213	3726	619	3668	1767	839	1749
834_Peptide::Dipeptide::X-14205--alpha-glutamyltyrosine	834_Peptide::Dipeptide::X-14205--alpha-glutamyltyrosine	25	619	1	2593	1881	4388	1641	2041	2272	3909	2238	619
2167_SERPINA7 - Thyroxine-Binding Globulin	2167_SERPINA7 - Thyroxine-Binding Globulin	25	620	1	2597	620	4523	4365	2809	2346	3583	2904	3675
4750_Retrolenticular part of internal capsule radial diusivities	4750_Retrolenticular part of internal capsule radial diusivities	25	620	1	1000	3427	1807	2576	996	2265	620	4317	2852
2520_FLT3 - Receptor-type tyrosine-protein kinase FLT3	2520_FLT3 - Receptor-type tyrosine-protein kinase FLT3	25	621	1	621	4308	902	4465	1104	3052	851	3023	3061
562_Lipid::Monoacylglycerol::1-linoleoylglycerol (1-monolinolein)	562_Lipid::Monoacylglycerol::1-linoleoylglycerol (1-monolinolein)	25	621	1	3487	4713	621	1898	2539	2805	3596	3534	3534
614_Xenobiotics::Benzoate metabolism::4-hydroxyhippurate	614_Xenobiotics::Benzoate metabolism::4-hydroxyhippurate	25	621	1	2121	3364	2139	1583	1119	2732	621	3927	762
1550_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1550_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	621	1	2892	2534	1272	3492	3565	941	2538	656	621
3876_Eosinophil percentage of granulocytes (three-way meta)	3876_Eosinophil percentage of granulocytes (three-way meta)	25	622	1	1091	622	4055	944	1709	3670	2408	696	883
294_CD4mem:%Th1* (1)	294_CD4mem:%Th1* (1)	25	622	1	2270	1033	622	2989	1180	1370	1586	2681	2811
2694_PSMA1 - Proteasome subunit alpha type-1	2694_PSMA1 - Proteasome subunit alpha type-1	25	622	1	3081	4387	1211	2618	3201	622	3770	3217	3608
2106_VEGFA - Vascular endothelial growth factor A	2106_VEGFA - Vascular endothelial growth factor A	25	623	1	623	2690	2934	3274	3487	2461	3721	3676	2690
620_Xenobiotics::Drug::2-hydroxyacetaminophen sulfate*	620_Xenobiotics::Drug::2-hydroxyacetaminophen sulfate*	25	623	1	3196	2150	623	3851	1691	2228	2889	3222	3420
1371_Total cholesterol (at exam 7, GEE, adjusted for age and sex)	1371_Total cholesterol (at exam 7, GEE, adjusted for age and sex)	25	623	1	4146	1341	3696	623	3509	3012	2021	2555	1132
181_Waist-hip ratio (male)	181_Waist-hip ratio (male)	25	624	1	624	1000	712	1000	3237	1828	3564	2756	2484
2987_DBNL - Drebrin-like protein	2987_DBNL - Drebrin-like protein	25	624	1	2564	2432	624	3216	1406	3242	1577	4386	2818
4567_Left precentral	4567_Left precentral	25	624	1	1225	893	1672	3335	624	1392	1198	1462	1731
2864_IL11 - Interleukin-11	2864_IL11 - Interleukin-11	25	624	1	2713	2874	1690	2865	2346	2823	2904	624	2478
3405_Fluid intelligence test - FI7 : synonym	3405_Fluid intelligence test - FI7 : synonym	25	625	1	625	4274	2250	675	1183	3407	3546	3148	4722
1105_Systolic Blood Pressure - Birth cohorts	1105_Systolic Blood Pressure - Birth cohorts	25	625	1	3381	3023	3994	2420	625	925	817	3458	4520
2831_SFTPD - Pulmonary surfactant-associated protein D	2831_SFTPD - Pulmonary surfactant-associated protein D	25	625	1	1141	4671	831	2577	1091	2423	1248	625	3282
4058_Estimated glomerular filtration rate based on serum creatinine	4058_Estimated glomerular filtration rate based on serum creatinine	25	625	1	729	4226	3160	1691	1005	1150	3049	3843	625
995_Interleukin-8 (CXCL8)	995_Interleukin-8 (CXCL8)	25	626	1	4194	2736	3758	626	4184	663	4463	2889	1517
1645_Osteoprotegerin (at exam 7, GEE, adjusted for multivariable	1645_Osteoprotegerin (at exam 7, GEE, adjusted for multivariable	25	626	1	3055	3161	3595	1431	626	3322	2952	1093	3367
2706_CAMKK1 - Calcium/calmodulin-dependent protein kinase kinase 1	2706_CAMKK1 - Calcium/calmodulin-dependent protein kinase kinase 1	25	626	1	3828	4484	2903	717	2826	626	2048	4569	3795
952_Valine	952_Valine	25	626	1	3970	1406	3981	1519	2938	1497	626	1285	2229
2871_ADAMTS15 - A disintegrin and metalloproteinase with thrombospondin motifs 15	2871_ADAMTS15 - A disintegrin and metalloproteinase with thrombospondin motifs 15	25	627	1	2361	3105	627	4414	3761	3771	2951	4175	4431
750_::::X-12040	750_::::X-12040	25	627	1	1582	2712	1325	1642	3588	3890	627	4706	3598
489_Lipid::Essential fatty acid::docosapentaenoate (n3 DPA; 22:5n3)	489_Lipid::Essential fatty acid::docosapentaenoate (n3 DPA; 22:5n3)	25	627	1	3146	2080	717	840	4302	3887	4318	1390	627
3726_Frequency of consuming six or more units of alcohol	3726_Frequency of consuming six or more units of alcohol	25	628	1	1241	628	2791	4597	950	2107	1122	852	1659
3612_Treatment/medication code: ramipril	3612_Treatment/medication code: ramipril	25	628	1	4002	2930	628	4673	1974	2899	1416	3459	837
2988_DPT - Dermatopontin	2988_DPT - Dermatopontin	25	628	1	3526	1933	2604	4029	2279	1692	3231	4075	628
1781_Artial fibrillation (GEE, adjusted for age and sex)	1781_Artial fibrillation (GEE, adjusted for age and sex)	25	629	1	3783	629	3810	3515	3972	3064	4194	2576	1096
3215_Duration of light DIY	3215_Duration of light DIY	25	629	1	3307	1402	3561	646	629	2714	1339	2156	1910
1235_Usual weekday sleep duration (GEE)	1235_Usual weekday sleep duration (GEE)	25	629	1	1876	1335	1582	1352	3556	2115	1546	629	2161
3104_NMT1 - Glycylpeptide N-tetradecanoyltransferase 1	3104_NMT1 - Glycylpeptide N-tetradecanoyltransferase 1	25	629	1	4110	3980	3693	3457	3701	1719	2755	3142	629
4580_Right entorhinal	4580_Right entorhinal	25	630	1	1998	2153	630	1278	965	4317	3673	2762	3959
3928_Total-body less head BMD and total body lean mass (bivariate meta-analysis)	3928_Total-body less head BMD and total body lean mass (bivariate meta-analysis)	25	630	1	974	3534	3275	2070	3456	4237	630	4270	1818
1073_Parkinson disease	1073_Parkinson disease	25	630	1	3149	2892	2987	2592	1875	2002	2126	2695	630
558_Lipid::Medium chain fatty acid::heptanoate (7:0)	558_Lipid::Medium chain fatty acid::heptanoate (7:0)	25	631	1	631	4320	3006	2142	1198	3801	2383	3299	3173
2208_CCL8 - C-C motif chemokine 8	2208_CCL8 - C-C motif chemokine 8	25	631	1	778	1176	631	4460	710	1254	1401	2158	2282
1697_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for multivariable)	1697_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for multivariable)	25	631	1	2971	4200	4065	1168	2373	2137	3301	631	3119
3126_PDE3A - cGMP-inhibited 3',5'-cyclic phosphodiesterase A	3126_PDE3A - cGMP-inhibited 3',5'-cyclic phosphodiesterase A	25	632	1	632	2002	2231	2000	3549	4455	2882	3997	1963
2599_IL22RA1 - Interleukin-22 receptor subunit alpha-1	2599_IL22RA1 - Interleukin-22 receptor subunit alpha-1	25	632	1	2240	2317	632	4437	3946	2471	4098	2791	4635
4478_Right cuneus	4478_Right cuneus	25	632	1	1757	1633	1328	632	1954	1013	1422	3476	920
2723_SKP1 - S-phase kinase-associated protein 1	2723_SKP1 - S-phase kinase-associated protein 1	25	632	1	3185	1301	1963	2481	2721	632	795	2843	4292
2860_C5 C6 - Complement C5b-C6 complex	2860_C5 C6 - Complement C5b-C6 complex	25	632	1	819	2895	1868	4246	3523	3440	3083	4153	632
355_IgG+B:%27+	355_IgG+B:%27+	25	633	1	633	4532	2493	3840	3838	659	3581	1776	3666
1568_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for multivariable)	1568_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for multivariable)	25	633	1	4725	2707	633	4532	2133	1536	1180	4079	1437
2754_KLKB1 - Plasma kallikrein	2754_KLKB1 - Plasma kallikrein	25	633	1	3016	955	2943	746	761	707	3765	633	4012
1331_Insulin sensitivity (GEE, adjusted for age, sex and BMI)	1331_Insulin sensitivity (GEE, adjusted for age, sex and BMI)	25	634	1	634	4158	2994	3381	1753	1886	3715	689	2941
1022_Neck Cross-Sectional Moment of Inertia (FBAT)	1022_Neck Cross-Sectional Moment of Inertia (FBAT)	25	634	1	1389	634	4279	2372	1868	4244	2997	3765	778
3377_Number of spontaneous miscarriages (female)	3377_Number of spontaneous miscarriages (female)	25	634	1	2092	2031	634	2447	2498	4088	3423	4278	2451
1715_Thyroid stimulation hormone (at exam 3, GEE, adjusted for multivariable)	1715_Thyroid stimulation hormone (at exam 3, GEE, adjusted for multivariable)	25	634	1	728	4380	2178	3426	2666	4172	4097	634	3673
2796_GPI - Glucose-6-phosphate isomerase	2796_GPI - Glucose-6-phosphate isomerase	25	635	1	3725	2370	635	3000	4580	3096	1840	1630	907
1119_Pericardial adipose tissue volume (female)	1119_Pericardial adipose tissue volume (female)	25	635	1	1291	4639	1725	635	2805	2180	941	2509	2007
2779_HSPA8 - Heat shock cognate 71 kDa protein	2779_HSPA8 - Heat shock cognate 71 kDa protein	25	635	1	1553	1614	1085	3756	635	3190	4081	2582	827
3729_Depression - Age at first episode of depression	3729_Depression - Age at first episode of depression	25	635	1	1738	4051	3586	4587	2010	635	942	2922	637
4483_Right isthmus cingulate	4483_Right isthmus cingulate	25	636	1	3357	4195	4237	4456	636	3205	927	2036	2427
1751_Cystatin C (at exam 7, GEE, adjusted for age and sex)	1751_Cystatin C (at exam 7, GEE, adjusted for age and sex)	25	636	1	4611	2660	2689	3238	3109	636	3631	706	2736
1444_Low-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	1444_Low-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	636	1	4109	4223	3553	760	2032	1751	1691	636	3936
1224_Mean Putamen	1224_Mean Putamen	25	637	1	3844	637	4725	1968	2920	1175	1078	4119	696
2942_CCL7 - C-C motif chemokine 7	2942_CCL7 - C-C motif chemokine 7	25	637	1	3414	4171	1964	990	637	3549	4556	2975	3512
1678_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	1678_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	25	637	1	1982	2972	900	3461	2720	3934	1376	637	3580
1867_Neck-Shaft Angle (GEE, female, adjussted for multivariable)	1867_Neck-Shaft Angle (GEE, female, adjussted for multivariable)	25	638	1	2565	831	638	4720	774	4593	689	3179	3381
3069_KLRF1 - Killer cell lectin-like receptor subfamily F member 1	3069_KLRF1 - Killer cell lectin-like receptor subfamily F member 1	25	639	1	3717	940	639	702	3365	3918	2292	1772	1220
3973_Total body BMD (45-60 years old)	3973_Total body BMD (45-60 years old)	25	639	1	4305	1734	1639	639	3266	4330	2284	3581	3117
578_Lipid::Sterol, Steroid::estrone 3-sulfate	578_Lipid::Sterol, Steroid::estrone 3-sulfate	25	640	1	3373	4325	3578	640	3396	2060	1799	4094	820
4727_Posterior thalamic radiation (include optic radiation) mode of anisotropy	4727_Posterior thalamic radiation (include optic radiation) mode of anisotropy	25	640	1	4468	3749	4728	2583	640	674	1534	4553	3858
2856_ZAP70 - Tyrosine-protein kinase ZAP-70	2856_ZAP70 - Tyrosine-protein kinase ZAP-70	25	640	1	4142	2465	1253	3746	2180	1565	1244	640	1339
3127_PDE4D - cAMP-specific 3',5'-cyclic phosphodiesterase 4D	3127_PDE4D - cAMP-specific 3',5'-cyclic phosphodiesterase 4D	25	641	1	3473	711	641	3547	1811	1006	2411	1708	3857
4329_Fractures	4329_Fractures	25	641	1	1413	875	3251	641	1952	2731	3552	1728	4008
1313_HOMA-IR (at exam 5, GEE, adjusted for age and sex)	1313_HOMA-IR (at exam 5, GEE, adjusted for age and sex)	25	641	1	1849	865	783	754	4096	1387	754	641	3242
2952_ENG - Endoglin	2952_ENG - Endoglin	25	641	1	2570	4330	975	2703	2504	2383	2704	1924	641
2842_HNRNPAB - Heterogeneous nuclear ribonucleoprotein A/B	2842_HNRNPAB - Heterogeneous nuclear ribonucleoprotein A/B	25	642	1	642	4277	1996	3149	755	3310	1363	3252	1179
3995_Fed-up feelings (FED_UP)	3995_Fed-up feelings (FED_UP)	25	643	1	3434	643	1339	4605	1061	1080	3396	4433	3447
2478_CSK - Tyrosine-protein kinase CSK	2478_CSK - Tyrosine-protein kinase CSK	25	643	1	4519	4197	643	714	1628	3522	1360	2254	1790
4600_Right rostral anterior cingulate	4600_Right rostral anterior cingulate	25	643	1	2580	4384	1397	1169	643	3157	4520	4085	1361
1796_RR interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1796_RR interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	643	1	2314	3077	2620	3861	2520	2517	2783	643	4623
2198_Human-virus - Protein Rev_HV2BE	2198_Human-virus - Protein Rev_HV2BE	25	644	1	972	2021	4352	644	2643	1140	3365	2012	1388
1421_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1421_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	645	1	645	1092	1928	1547	1701	1646	1316	2013	1214
1820_Inter-trochanteric buckling ratio (FBAT, male, adjussted for multivariable)	1820_Inter-trochanteric buckling ratio (FBAT, male, adjussted for multivariable)	25	645	1	1805	645	1268	2587	3730	3659	4714	2393	2203
1161_Fasting insulin interaction (adjusted for BMI)	1161_Fasting insulin interaction (adjusted for BMI)	25	645	1	2149	2389	3590	2294	2772	645	2336	2529	939
3091_SLAMF6 - SLAM family member 6	3091_SLAMF6 - SLAM family member 6	25	645	1	4390	2102	798	3168	1020	1385	1568	2955	645
3629_Illnesses of father: Stroke	3629_Illnesses of father: Stroke	25	646	1	3997	3885	2021	2962	3080	1062	646	3291	2637
2778_SYNCRIP - Heterogeneous nuclear ribonucleoprotein Q	2778_SYNCRIP - Heterogeneous nuclear ribonucleoprotein Q	25	647	1	754	1534	1047	3043	647	3025	780	4390	1554
3692_Diagnoses - secondary ICD10: I20 Angina pectoris	3692_Diagnoses - secondary ICD10: I20 Angina pectoris	25	648	1	4086	648	4368	3859	829	2909	3712	3656	3195
2421_CCDC80 - Coiled-coil domain-containing protein 80	2421_CCDC80 - Coiled-coil domain-containing protein 80	25	648	1	4562	2479	3785	1206	3855	648	3208	4221	4153
142_Height	142_Height	25	648	1	4403	3047	3366	1577	2050	940	1988	648	2824
642_Xenobiotics::Xanthine metabolism::1-methylurate	642_Xenobiotics::Xanthine metabolism::1-methylurate	25	649	1	649	2515	4481	2819	4745	3944	2756	4746	2712
3660_Cancer register - Histology of cancer tumour: Basal cell carcinoma, NOS	3660_Cancer register - Histology of cancer tumour: Basal cell carcinoma, NOS	25	649	1	1484	3506	2425	733	3258	649	1526	2604	2185
1485_Mean triglycerides from exam 1-7 (GEE, adjusted for multivariable)	1485_Mean triglycerides from exam 1-7 (GEE, adjusted for multivariable)	25	649	1	1370	2082	4256	1720	3241	3512	2840	649	4589
3971_Total body BMD	3971_Total body BMD	25	649	1	4629	3884	3098	1375	1602	822	2892	2827	649
1870_Shaft average buckling ratio (FBAT, female, adjussted for multivariable)	1870_Shaft average buckling ratio (FBAT, female, adjussted for multivariable)	25	650	1	1558	650	3537	1124	4586	1023	4677	3353	2697
344_NKearly:%335+314-	344_NKearly:%335+314-	25	650	1	2630	3803	650	1235	3639	3361	2086	3554	4530
4288_FEV1/FVC ratio	4288_FEV1/FVC ratio	25	650	1	3784	1072	3282	2424	1319	1093	674	1304	650
4031_Alcohol dependency (discovery)	4031_Alcohol dependency (discovery)	25	651	1	4049	651	3533	2514	2589	2352	3392	1535	2098
2234_MMP17 - Matrix metalloproteinase-17	2234_MMP17 - Matrix metalloproteinase-17	25	651	1	3601	3630	651	3170	2057	3947	916	2699	3716
402_Amino acid::Tryptophan metabolism::3-indoxyl sulfate	402_Amino acid::Tryptophan metabolism::3-indoxyl sulfate	25	651	1	2217	3160	1588	651	3485	3035	3469	2971	1663
2957_CCL16 - C-C motif chemokine 16	2957_CCL16 - C-C motif chemokine 16	25	652	1	2291	4412	652	1087	4168	2260	1190	4393	3086
791_::::X-12704	791_::::X-12704	25	652	1	4619	2891	3643	1171	652	4167	771	3203	4432
2654_CDH2 - Cadherin-2	2654_CDH2 - Cadherin-2	25	652	1	3584	2400	4334	1150	4023	652	4625	2530	1455
1797_RR interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1797_RR interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	653	1	749	653	2587	1083	3803	3851	1008	3890	3958
1008_Stem cell growth factor beta	1008_Stem cell growth factor beta	25	654	1	654	4203	2637	1541	4263	2529	3001	1856	2653
3648_Illnesses of siblings: Heart disease	3648_Illnesses of siblings: Heart disease	25	654	1	3912	3541	654	3373	1532	1882	1043	2148	4372
1742_Urinary albumin excertion (at exam 6, FBAT, adjusted for age and sex)	1742_Urinary albumin excertion (at exam 6, FBAT, adjusted for age and sex)	25	654	1	1993	3371	3849	2690	4021	1703	1399	654	969
3476_Own or rent accommodation lived in: Own outright (by you or someone in your household)	3476_Own or rent accommodation lived in: Own outright (by you or someone in your household)	25	654	1	1431	2533	2839	713	1187	3081	2165	3599	654
3776_Traumatic events - Been in serious accident believed to be life-threatening	3776_Traumatic events - Been in serious accident believed to be life-threatening	25	655	1	655	4719	2559	801	1664	712	4059	2031	1613
676_::::X-08988	676_::::X-08988	25	655	1	4538	2004	655	2057	1598	4614	3615	4258	2850
4268_Atrial Fibrillation	4268_Atrial Fibrillation	25	655	1	4577	4248	4162	4427	2867	4363	3542	2398	655
256_CD32 on 11c+123+DC	256_CD32 on 11c+123+DC	25	656	1	656	2890	3536	4670	3220	1359	2175	3463	2102
3547_Mouth/teeth dental problems: Loose teeth	3547_Mouth/teeth dental problems: Loose teeth	25	656	1	1080	2256	656	2383	2364	4190	3974	1736	4146
1288_Waist circumference by CT (FBAT, adjusted for age and sex)	1288_Waist circumference by CT (FBAT, adjusted for age and sex)	25	656	1	2242	3694	3560	1834	1267	1178	656	4380	4135
1206_Longevity (>= 90 yrs vs < 65 yrs)	1206_Longevity (>= 90 yrs vs < 65 yrs)	25	657	1	657	4596	2197	3467	3851	3867	3873	4590	3509
3976_Total body BMD (15 or younger)	3976_Total body BMD (15 or younger)	25	657	1	2731	657	2003	4705	4665	2740	2611	4451	2853
94_Birth weight	94_Birth weight	25	657	1	1995	3842	2283	657	2908	3715	3292	3545	1167
3093_SCARF2 - Scavenger receptor class F member 2	3093_SCARF2 - Scavenger receptor class F member 2	25	657	1	4372	2125	3977	2120	2789	2799	849	4506	657
2333_IL19 - Interleukin-19	2333_IL19 - Interleukin-19	25	658	1	658	4112	2669	3189	3948	3586	4208	3007	2782
4704_Posterior limb of internal capsule mean diusivities	4704_Posterior limb of internal capsule mean diusivities	25	658	1	971	1244	1329	658	3664	1771	3731	4650	2406
1727_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for age and sex)	1727_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for age and sex)	25	659	1	3674	4735	659	1174	2247	1291	1482	1375	3929
2533_POSTN - Periostin	2533_POSTN - Periostin	25	659	1	790	2236	962	1793	659	2217	2412	1906	1750
339_NKeff:%Kir+ (4)	339_NKeff:%Kir+ (4)	25	659	1	2865	3182	4081	2152	831	4559	3132	659	2277
4510_Left basal forebrain	4510_Left basal forebrain	25	659	1	1902	1556	1872	2868	982	1435	1466	1313	659
3389_Friendships satisfaction	3389_Friendships satisfaction	25	660	1	3777	2208	694	4701	3578	660	1315	3201	3037
723_::::X-11550	723_::::X-11550	25	661	1	661	1389	4466	3384	2986	2839	2374	1638	1383
3330_Fractured/broken bones in last 5 years	3330_Fractured/broken bones in last 5 years	25	661	1	2855	2239	3222	661	3641	3646	1269	2372	2585
2568_CCL17 - C-C motif chemokine 17	2568_CCL17 - C-C motif chemokine 17	25	661	1	3383	3098	4178	1612	661	2820	3015	1291	1946
3150_CPNE1 - Copine-1	3150_CPNE1 - Copine-1	25	661	1	2120	1089	2192	4631	1029	666	661	1966	4205
3526_Transport type for commuting to job workplace: Public transport	3526_Transport type for commuting to job workplace: Public transport	25	662	1	836	2623	3155	1650	1473	2822	662	1985	2767
3980_Offspring birthweight (maternal)	3980_Offspring birthweight (maternal)	25	663	1	3024	2344	663	2935	3685	4191	3449	4514	1087
3334_Duration of heavy DIY	3334_Duration of heavy DIY	25	663	1	1555	3962	1419	4039	663	2845	2740	1894	3485
2836_COLEC11 - Collectin-11	2836_COLEC11 - Collectin-11	25	663	1	2854	986	4146	1450	918	3069	2602	4327	663
2206_CCL4L1 - C-C motif chemokine 4-like	2206_CCL4L1 - C-C motif chemokine 4-like	25	665	1	4662	1993	1982	4197	1858	665	2085	2884	690
4447_Left cuneus	4447_Left cuneus	25	666	1	3206	666	1576	2950	3198	3632	3182	3022	4297
4650_Body of corpus callosum fractional anisotropy	4650_Body of corpus callosum fractional anisotropy	25	666	1	3406	2685	2760	666	3710	2237	4050	873	3917
2948_CASP2 - Caspase-2	2948_CASP2 - Caspase-2	25	666	1	818	1214	4611	4420	2966	3459	666	1816	1537
4132_Basophil count	4132_Basophil count	25	666	1	3130	4497	4233	775	4125	3101	3997	666	2336
4709_Superior fronto-occipital fasciculus mean diusivities	4709_Superior fronto-occipital fasciculus mean diusivities	25	667	1	667	2024	1718	4352	752	946	1947	1757	728
1311_Fasting HbA1c (at exam 7, GEE, adjusted for age and sex)	1311_Fasting HbA1c (at exam 7, GEE, adjusted for age and sex)	25	667	1	1936	835	667	980	1721	4258	4486	1416	1101
4229_Drugs affecting bone structure and mineralization	4229_Drugs affecting bone structure and mineralization	25	667	1	2456	4493	3111	2750	4063	3406	667	4652	2867
4699_Fornix (column and body of fornix) mean diusivities	4699_Fornix (column and body of fornix) mean diusivities	25	668	1	668	1828	2965	1560	4584	3915	3775	4149	2192
3874_Eosinophil count (three-way meta)	3874_Eosinophil count (three-way meta)	25	668	1	3129	1235	1961	668	4380	2620	2665	1307	3415
1069_Diabetic Nephropathy in Type 1 Diabetes	1069_Diabetic Nephropathy in Type 1 Diabetes	25	669	1	669	1731	3292	3227	3868	1766	1531	1463	2561
277_CD8:%Act(25+)	277_CD8:%Act(25+)	25	669	1	3904	3593	669	1573	980	1535	2316	1603	4662
1725_Serum calcium (at exam 2, GEE, adjusted for age, sex and serum creatinine)	1725_Serum calcium (at exam 2, GEE, adjusted for age, sex and serum creatinine)	25	669	1	1288	3809	923	669	4058	1819	4309	4385	953
3945_HbA1c	3945_HbA1c	25	669	1	3823	3103	3903	3031	2289	669	2043	4416	4042
1549_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for multivariable)	1549_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for multivariable)	25	670	1	3806	670	3869	1332	1609	3199	3975	4735	4137
61_Age at menarche	61_Age at menarche	25	670	1	2645	4052	2483	2650	670	2585	3519	4694	2480
291_CD4:%Act(DR+38+)	291_CD4:%Act(DR+38+)	25	670	1	1755	4381	755	3991	2683	4075	2163	1740	670
4098_Total cholesterol	4098_Total cholesterol	25	671	1	1990	2760	671	1833	1639	2209	2306	1542	2274
4099_High-density-lipoprotein cholesterol	4099_High-density-lipoprotein cholesterol	25	671	1	1588	938	1778	3478	828	1119	671	1908	3937
2156_IGFBP5 - Insulin-like growth factor-binding protein 5	2156_IGFBP5 - Insulin-like growth factor-binding protein 5	25	671	1	3029	1476	2893	1310	4116	3550	2854	671	2305
3831_Amyotrophic lateral sclerosis (linear mixed model)	3831_Amyotrophic lateral sclerosis (linear mixed model)	25	672	1	672	1170	2030	1950	1231	3423	1972	3821	4421
2922_COL8A1 - Collagen alpha-1(VIII) chain	2922_COL8A1 - Collagen alpha-1(VIII) chain	25	672	1	721	2863	672	2497	1836	4672	3272	1334	3397
2571_VIP - Vasoactive Intestinal Peptide	2571_VIP - Vasoactive Intestinal Peptide	25	673	1	673	1373	4723	868	2544	1812	1830	4658	1694
4355_IL-1beta in gingival crevicular	4355_IL-1beta in gingival crevicular	25	673	1	2267	1290	673	2154	3305	1265	1500	2720	3371
4573_Left superior temporal	4573_Left superior temporal	25	673	1	2613	3982	898	4271	954	2635	673	2134	3143
1245_Mean FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	1245_Mean FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	673	1	2910	2845	3725	2470	3386	3567	4333	673	2686
4502_Right superior parietal	4502_Right superior parietal	25	674	1	674	2195	1658	3966	4069	2974	4525	1753	3178
2996_FGFR4 - Fibroblast growth factor receptor 4	2996_FGFR4 - Fibroblast growth factor receptor 4	25	674	1	3154	1213	674	4092	2058	4066	3023	2488	1391
3446_Impedance measures - Basal metabolic rate	3446_Impedance measures - Basal metabolic rate	25	674	1	3827	2832	3684	2949	4264	1231	4001	674	2296
154_Waist-hip ratio (female <= 50 yrs, adjusted for BMI)	154_Waist-hip ratio (female <= 50 yrs, adjusted for BMI)	25	675	1	3932	675	2397	2994	814	4582	4224	3290	698
4008_Osteoarthritis of knee (hospital diagnosed)	4008_Osteoarthritis of knee (hospital diagnosed)	25	675	1	1393	1874	1623	1326	1285	2421	675	2733	1035
1783_Artial fibrillation (GEE, adjusted for multivariable)	1783_Artial fibrillation (GEE, adjusted for multivariable)	25	676	1	3162	1231	676	765	3616	4023	2842	2099	4535
1381_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	1381_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	25	676	1	3883	2186	3502	676	3347	4040	3679	1572	3643
3044_CD300C - CMRF35-like molecule 6	3044_CD300C - CMRF35-like molecule 6	25	676	1	3188	1424	2764	2108	676	4610	1335	1007	2565
702_::::X-11438	702_::::X-11438	25	676	1	3247	2529	1929	3470	4692	3569	676	3987	3205
1921_Frontal lobe volume (GEE, adjusted for age and sex)	1921_Frontal lobe volume (GEE, adjusted for age and sex)	25	676	1	3331	2055	2523	1137	1137	4262	3628	676	1079
2788_NME2 - Nucleoside diphosphate kinase B	2788_NME2 - Nucleoside diphosphate kinase B	25	677	1	4015	3723	677	4453	4008	4416	2792	1391	1191
1098_Body Mass Index - Birth cohorts	1098_Body Mass Index - Birth cohorts	25	677	1	3244	3407	2793	3577	1807	1746	3791	677	959
4045_Type 2 Diabetes	4045_Type 2 Diabetes	25	678	1	2740	1825	3324	1575	1063	3883	678	4273	3102
1896_Shaft Section Modulus (FBAT, male, adjussted for multivariable)	1896_Shaft Section Modulus (FBAT, male, adjussted for multivariable)	25	679	1	679	3735	1972	1797	3379	4631	3346	2899	4371
493_Lipid::Fatty acid metabolism::isovalerate	493_Lipid::Fatty acid metabolism::isovalerate	25	679	1	3106	2394	4444	679	1997	1734	3854	2241	4659
4358_Diverticular disease	4358_Diverticular disease	25	679	1	1258	4249	1609	4561	3606	679	1920	3194	3350
250_CD39 on CD4 T	250_CD39 on CD4 T	25	679	1	4549	4072	3909	4640	4427	1257	679	3351	4271
4314_Ever smoked regulary	4314_Ever smoked regulary	25	679	1	2393	961	1141	1708	788	3288	1290	679	4390
1789_QT interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1789_QT interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	680	1	3804	3184	2427	1468	680	4010	1067	4489	4665
1829_Spine Neck BMD (GEE, male, adjusted for multivariable)	1829_Spine Neck BMD (GEE, male, adjusted for multivariable)	25	680	1	4649	2815	2404	3102	3238	680	1225	3267	3938
3854_Monocyte percentage of white cells (two-way meta)	3854_Monocyte percentage of white cells (two-way meta)	25	681	1	2074	2655	4201	3243	681	1369	3138	3355	3180
4069_Drinks per week	4069_Drinks per week	25	681	1	3613	1911	1680	3224	2329	1630	1412	681	3256
2531_LCK - Tyrosine-protein kinase Lck	2531_LCK - Tyrosine-protein kinase Lck	25	682	1	1571	682	2950	3920	2963	4716	3189	2132	4234
2944_POMC - Corticotropin	2944_POMC - Corticotropin	25	682	1	1989	4444	682	4693	1078	3864	1888	2010	3339
1641_Myeloperoxidase (at exam 7, GEE, adjusted for multivariable)	1641_Myeloperoxidase (at exam 7, GEE, adjusted for multivariable)	25	682	1	3286	3777	4195	682	2212	3245	2015	803	3808
3218_Time spent outdoors in winter	3218_Time spent outdoors in winter	25	682	1	3002	2085	1449	2547	682	1128	2003	2921	899
2444_GFRA1 - GDNF family receptor alpha-1	2444_GFRA1 - GDNF family receptor alpha-1	25	682	1	3940	1215	3814	3015	1214	2613	682	2729	3992
1434_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	1434_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	25	683	1	683	3761	4059	3835	4744	3849	2232	875	2074
3011_MAPK12 - Mitogen-activated protein kinase 12	3011_MAPK12 - Mitogen-activated protein kinase 12	25	683	1	840	2470	2665	2277	683	3759	4471	2905	3394
3681_Diagnoses - main ICD10: R07 Pain in throat and chest	3681_Diagnoses - main ICD10: R07 Pain in throat and chest	25	683	1	2087	4650	3545	902	1864	3744	683	4560	2313
3563_Vitamin and mineral supplements: Vitamin C	3563_Vitamin and mineral supplements: Vitamin C	25	684	1	1969	4328	684	2195	1743	2447	1550	4242	1291
1998_Body Mass Index	1998_Body Mass Index	25	684	1	1894	1204	3093	804	1428	2267	1162	2693	684
3609_Treatment/medication code: omega-3/fish oil supplement	3609_Treatment/medication code: omega-3/fish oil supplement	25	685	1	685	4529	1852	3689	1884	2811	4329	2552	3900
4365_Moderate to vigorous physical activity levels	4365_Moderate to vigorous physical activity levels	25	685	1	2391	843	3795	685	3159	4500	1050	3560	1561
4014_Major depressive disorder	4014_Major depressive disorder	25	685	1	1268	785	4363	3770	3599	685	3545	2214	1687
2020_Adenocarcinoma (adjusted for age)	2020_Adenocarcinoma (adjusted for age)	25	685	1	1590	3319	886	3970	1436	1149	1609	685	1005
2320_TGFBR3 - Transforming growth factor beta receptor type 3	2320_TGFBR3 - Transforming growth factor beta receptor type 3	25	686	1	3564	4386	4265	686	4295	2210	2662	3471	4191
4532_Right cerebellum exterior	4532_Right cerebellum exterior	25	686	1	1130	1011	2017	3397	686	3953	2601	1628	3284
4360_Biliary atresia	4360_Biliary atresia	25	686	1	3781	1135	2733	4521	879	686	4736	3470	2268
1750_Cystatin C (at exam 7, FBAT, adjusted for age and sex)	1750_Cystatin C (at exam 7, FBAT, adjusted for age and sex)	25	686	1	2683	4399	4051	3280	2024	1401	686	1394	4219
106_Tanner scale (male)	106_Tanner scale (male)	25	686	1	3190	909	1634	3888	1253	3337	4406	1796	686
3673_Diagnoses - main ICD10: K57 Diverticular disease of intestine	3673_Diagnoses - main ICD10: K57 Diverticular disease of intestine	25	687	1	4321	1216	687	2388	883	2590	1070	1529	1662
3862_Platelet distribution width (two-way meta)	3862_Platelet distribution width (two-way meta)	25	687	1	3447	4067	797	1502	687	1299	1155	3127	1068
3832_Vitiligo	3832_Vitiligo	25	687	1	717	3952	1575	892	3329	2257	4676	687	1343
36_Loneliness (multivariate)	36_Loneliness (multivariate)	25	688	1	4199	2601	688	4376	2741	1315	2073	3243	1135
1495_Remnant lipoprotein triglycerides (at exam 4, GEE)	1495_Remnant lipoprotein triglycerides (at exam 4, GEE)	25	688	1	3266	4096	2736	688	2706	3764	4398	1259	3260
3472_Age at cancer diagnosis	3472_Age at cancer diagnosis	25	688	1	1349	1503	1771	2207	688	1784	1151	1926	3613
4718_Cingulum (hippocampus) mode of anisotropy	4718_Cingulum (hippocampus) mode of anisotropy	25	688	1	3173	3455	3985	1639	3270	3568	688	4502	4314
4746_Inferior fronto-occipital fasciculus radial diusivities	4746_Inferior fronto-occipital fasciculus radial diusivities	25	689	1	870	689	3830	2340	1409	1293	1758	1659	3011
4177_C-reactive protein	4177_C-reactive protein	25	689	1	2878	4649	689	1518	1948	2076	4362	1130	3679
152_Waist-hip ratio (male <= 50 yrs, adjusted for BMI)	152_Waist-hip ratio (male <= 50 yrs, adjusted for BMI)	25	690	1	690	1913	1011	1773	3152	1848	852	2341	4705
991_Interleukin-4	991_Interleukin-4	25	690	1	4348	840	3573	967	3771	1644	690	4155	2346
657_::::X-03094	657_::::X-03094	25	691	1	961	3703	3679	1822	2533	4288	691	1946	3342
4317_Drinks per day	4317_Drinks per day	25	691	1	1304	1109	3116	2692	1387	1159	1237	3829	691
585_Nucleotide::Purine metabolism, guanine containing::guanosine	585_Nucleotide::Purine metabolism, guanine containing::guanosine	25	692	1	3226	692	4662	4366	3573	3099	3702	2742	3177
906_Lactate	906_Lactate	25	692	1	4588	1898	1506	1596	3769	692	1454	2157	2227
1205_Serum Thyroid-stimulating hormone level	1205_Serum Thyroid-stimulating hormone level	25	692	1	2888	1311	3622	2143	3350	4274	2582	692	3126
2091_GFRA2 - GDNF family receptor alpha-2	2091_GFRA2 - GDNF family receptor alpha-2	25	692	1	3411	2232	3771	1794	3116	3430	1380	2757	692
2906_EPB41 - Protein 4.1	2906_EPB41 - Protein 4.1	25	693	1	3311	4549	693	4317	1694	3499	963	1554	2760
65_Insulin sensitivity index (adjusted for age, sex. Bmi)	65_Insulin sensitivity index (adjusted for age, sex. Bmi)	25	693	1	720	1343	770	4208	1787	3556	4102	2895	693
1158_Fasting glucose interaction (adjusted for BMI)	1158_Fasting glucose interaction (adjusted for BMI)	25	694	1	694	2428	2954	3929	4221	1944	725	1942	967
2257_TOP1 - DNA topoisomerase 1	2257_TOP1 - DNA topoisomerase 1	25	694	1	744	694	4328	1351	2529	4160	4683	3922	2354
4432_Rubella IgG levels	4432_Rubella IgG levels	25	694	1	4243	4323	4017	694	3254	3181	3451	910	3082
3048_DSG2 - Desmoglein-2	3048_DSG2 - Desmoglein-2	25	694	1	3968	3156	3218	1419	1052	694	2984	4039	817
1032_Neck Section Modulus (FBAT, adjusted for age and sex)	1032_Neck Section Modulus (FBAT, adjusted for age and sex)	25	694	1	3508	4472	3717	1207	1596	1205	694	2069	1134
3169_TNFRSF11A - Tumor necrosis factor receptor superfamily member 11A	3169_TNFRSF11A - Tumor necrosis factor receptor superfamily member 11A	25	694	1	2824	3635	3302	4632	2562	3183	3034	3911	694
1415_High-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	1415_High-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	25	695	1	3724	714	1886	2367	1241	695	775	1413	3912
242_PD1 on CD4mem	242_PD1 on CD4mem	25	695	1	1543	3445	4511	2289	2712	3731	3517	4091	695
3981_25-Hydroxyvitamin D level	3981_25-Hydroxyvitamin D level	25	696	1	4636	2430	1555	3474	696	4732	2172	2605	4057
3335_Light smokers, at least 100 smokes in lifetime	3335_Light smokers, at least 100 smokes in lifetime	25	696	1	4737	4261	1724	2022	2473	696	2113	1980	3008
2702_TPO - Thyroid peroxidase	2702_TPO - Thyroid peroxidase	25	697	1	1639	697	4072	1702	2156	4250	1891	868	1428
600_Peptide::Fibrinogen cleavage peptide::DSGEGDFXAEGGGVR*	600_Peptide::Fibrinogen cleavage peptide::DSGEGDFXAEGGGVR*	25	697	1	1915	4600	3327	697	2745	4305	1007	2102	4194
679_::::X-09706	679_::::X-09706	25	698	1	2027	698	4527	2306	4140	3794	2680	3025	3595
739_::::X-11850	739_::::X-11850	25	698	1	3297	1694	4669	2717	2597	698	1396	4662	1002
3294_Loneliness, isolation	3294_Loneliness, isolation	25	698	1	3733	4071	2726	4723	3711	4291	2961	698	2431
3211_Frequency of stair climbing in last 4 weeks	3211_Frequency of stair climbing in last 4 weeks	25	699	1	4369	1386	699	3119	3550	3304	4135	2814	2574
2372_CD4 - T-cell surface glycoprotein CD4	2372_CD4 - T-cell surface glycoprotein CD4	25	700	1	3031	2445	2465	1170	700	1161	1903	3814	3742
4468_Left rostral anterior cingulate	4468_Left rostral anterior cingulate	25	701	1	3366	701	4700	2218	3819	2038	1653	3772	2734
2169_CNTFR - Ciliary neurotrophic factor receptor subunit alpha	2169_CNTFR - Ciliary neurotrophic factor receptor subunit alpha	25	701	1	1947	2511	1132	2738	2891	3606	2607	3820	701
3767_Depression - Recent lack of interenst of pleasure in doing things	3767_Depression - Recent lack of interenst of pleasure in doing things	25	702	1	2155	1328	2874	1699	702	3706	4138	1725	3029
193_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	193_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	702	1	2527	2809	1392	3560	4389	702	2301	2351	956
2092_CCL21 - C-C motif chemokine 21	2092_CCL21 - C-C motif chemokine 21	25	702	1	807	2073	2811	773	1228	4092	702	4726	1553
4440_Hepatitis B HBc antigen IgG levels	4440_Hepatitis B HBc antigen IgG levels	25	703	1	703	2792	2446	3748	2922	2531	3102	2498	3566
2451_LRP8 - Low-density lipoprotein receptor-related protein 8	2451_LRP8 - Low-density lipoprotein receptor-related protein 8	25	703	1	2604	703	1668	3356	2669	746	2266	1558	3156
4248_Parkinson's disease age at onset	4248_Parkinson's disease age at onset	25	703	1	1428	1753	4586	2647	703	3521	957	3088	2735
2659_CST5 - Cystatin-D	2659_CST5 - Cystatin-D	25	704	1	704	3223	2890	4513	2297	3795	4267	2945	2814
4076_Body Mass Index (female)	4076_Body Mass Index (female)	25	704	1	3204	2739	2355	1251	4346	704	2855	3990	4117
4516_Optic chiasm	4516_Optic chiasm	25	704	1	3112	2573	2862	3758	2110	4496	704	3679	994
1590_Platelet aggregation to ADP (at exam 5, FBAT, adjusted for age and sex)	1590_Platelet aggregation to ADP (at exam 5, FBAT, adjusted for age and sex)	25	704	1	1446	4026	1509	1478	3017	869	1663	704	3206
1078_Serum Iron concentration	1078_Serum Iron concentration	25	705	1	705	2939	750	1325	1805	2262	1707	3934	945
133_Waist circumference (female)	133_Waist circumference (female)	25	705	1	2088	1226	1348	705	802	3578	2757	4178	1467
392_Amino acid::Phenylalanine & tyrosine metabolism::3-(4-hydroxyphenyl)lactate	392_Amino acid::Phenylalanine & tyrosine metabolism::3-(4-hydroxyphenyl)lactate	25	705	1	2269	1420	814	2305	705	2151	3165	1479	2445
4295_Morning person (binary)	4295_Morning person (binary)	25	706	1	4143	3619	706	2718	4571	1925	2230	2118	3736
249_CD27 on CD4 T	249_CD27 on CD4 T	25	707	1	707	4446	2495	2297	2929	4658	1233	4555	3198
1231_Usual weekday bedtime (GEE)	1231_Usual weekday bedtime (GEE)	25	707	1	1675	1769	3804	2975	3357	4437	707	1122	4599
2054_Percentage improvement after 12 weeks of antidepressant treatment in MDD	2054_Percentage improvement after 12 weeks of antidepressant treatment in MDD	25	707	1	848	4121	4401	4235	1775	992	877	3181	707
2545_DUSP3 - Dual specificity protein phosphatase 3	2545_DUSP3 - Dual specificity protein phosphatase 3	25	708	1	1499	4022	708	4569	3777	2895	3682	2665	2887
151_Waist-hip ratio (male > 50 yrs, adjusted for BMI)	151_Waist-hip ratio (male > 50 yrs, adjusted for BMI)	25	709	1	709	3337	2044	1910	2526	3924	3295	2685	735
2139_PRKCA - Protein kinase C alpha type	2139_PRKCA - Protein kinase C alpha type	25	709	1	2549	2446	766	709	1578	1948	4336	3620	1491
559_Lipid::Medium chain fatty acid::laurate (12:0)	559_Lipid::Medium chain fatty acid::laurate (12:0)	25	709	1	4121	1875	1800	3390	2708	709	940	3093	4448
3721_Frequency of memory loss due to drinking alcohol in last year	3721_Frequency of memory loss due to drinking alcohol in last year	25	709	1	1587	1751	3124	1345	2087	3776	4370	4659	709
4476_Right caudal anterior cingulate	4476_Right caudal anterior cingulate	25	710	1	710	867	904	2725	1056	2402	4493	2534	4732
1197_Cerebrospinal fluid levels of amyloid-beta 1-42	1197_Cerebrospinal fluid levels of amyloid-beta 1-42	25	710	1	4634	3870	710	4583	1478	3248	3671	1861	940
1948_Visuospatial memory and organization (FBAT, adjusted for multivariable)	1948_Visuospatial memory and organization (FBAT, adjusted for multivariable)	25	710	1	3859	1851	3290	710	925	798	4576	1044	2841
566_Lipid::Short chain fatty acid::valerate	566_Lipid::Short chain fatty acid::valerate	25	712	1	1870	712	3832	4260	2517	3558	3051	2322	1425
3491_Cereal type: Muesli	3491_Cereal type: Muesli	25	712	1	1337	2334	1909	712	2587	3472	1250	795	2448
3023_PRDX6 - Peroxiredoxin-6	3023_PRDX6 - Peroxiredoxin-6	25	712	1	3279	1916	4249	1983	1355	873	712	4743	1596
811_::::X-12851	811_::::X-12851	25	713	1	4291	3208	1843	3301	973	4196	713	4209	3660
759_::::X-12188	759_::::X-12188	25	713	1	1783	4213	4615	2188	3353	4391	1627	713	3131
2142_ICAM3 - Intercellular adhesion molecule 3	2142_ICAM3 - Intercellular adhesion molecule 3	25	714	1	3445	2516	1394	2639	3593	1495	714	4031	851
4258_Facial attractiveness (male-coder, male samples)	4258_Facial attractiveness (male-coder, male samples)	25	715	1	2105	2827	3128	715	3210	2431	4624	4223	3479
4520_Left cerebellum white matter	4520_Left cerebellum white matter	25	715	1	1382	4025	821	3433	715	3077	4568	3266	1019
2717_MED1 - Mediator of RNA polymerase II transcription subunit 1	2717_MED1 - Mediator of RNA polymerase II transcription subunit 1	25	715	1	2065	3794	4177	3271	4155	715	1490	4037	3378
3162_SET - Protein SET	3162_SET - Protein SET	25	715	1	2701	4551	4590	4249	4577	4099	3409	2383	715
2011_Remission following treatment of MDD subjects	2011_Remission following treatment of MDD subjects	25	716	1	716	3646	1302	2629	2944	3624	2628	4052	1584
1758_Breast cancer (FBAT, adjusted for age)	1758_Breast cancer (FBAT, adjusted for age)	25	716	1	4219	3163	716	1979	4535	4664	1051	2795	3092
1572_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable\)	1572_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable\)	25	716	1	2064	4673	2163	716	4094	2995	1895	827	2265
1199_Epilepsy	1199_Epilepsy	25	716	1	1502	738	3153	1179	784	3695	2133	716	2766
374_Amino acid::Glutamate metabolism::glutamate	374_Amino acid::Glutamate metabolism::glutamate	25	717	1	4729	3860	3678	3006	1825	1381	2929	3546	717
2887_IL34 - Interleukin-34	2887_IL34 - Interleukin-34	25	718	1	718	4374	4601	3525	3112	2560	973	1490	3978
998_Monocyte chemotactic protein-1 (CCL2)	998_Monocyte chemotactic protein-1 (CCL2)	25	718	1	3211	3092	3071	3518	2466	2552	718	2655	1241
1911_Temporal horn volume (GEE, adjusted for multivariable)	1911_Temporal horn volume (GEE, adjusted for multivariable)	25	718	1	921	858	1557	3642	1987	921	3177	718	4089
403_Amino acid::Tryptophan metabolism::C-glycosyltryptophan*	403_Amino acid::Tryptophan metabolism::C-glycosyltryptophan*	25	719	1	719	4592	3719	2216	2582	3320	4239	2391	766
4464_Left postcentral	4464_Left postcentral	25	719	1	1941	3125	4229	3140	2605	719	4361	2051	1448
1451_Low-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	1451_Low-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	25	719	1	1618	3093	4665	2856	4353	3808	1792	908	719
254_CD3 on DN T	254_CD3 on DN T	25	720	1	2716	3995	720	3495	2631	2609	3360	4729	2497
2427_C1R - Complement C1r subcomponent	2427_C1R - Complement C1r subcomponent	25	720	1	2806	2489	1164	878	818	1443	2956	4214	720
1866_Neck-Shaft Angle (FBAT, female, adjussted for multivariable)	1866_Neck-Shaft Angle (FBAT, female, adjussted for multivariable)	25	721	1	2073	3434	4294	4305	721	3431	808	1655	1669
4524_Left pallidum	4524_Left pallidum	25	721	1	1888	3708	4309	3952	3577	721	3277	4361	2643
410_Amino acid::Tryptophan metabolism::tryptophan betaine	410_Amino acid::Tryptophan metabolism::tryptophan betaine	25	722	1	722	3211	2685	3867	3208	1636	2056	1963	3072
1494_Remnant lipoprotein triglycerides (at exam 4, FBAT)	1494_Remnant lipoprotein triglycerides (at exam 4, FBAT)	25	722	1	2459	1963	1912	1372	763	3714	2767	3778	722
2155_C3 - Complement C3b, inactivated	2155_C3 - Complement C3b, inactivated	25	723	1	2197	3739	723	3529	3542	2994	1639	3226	2826
4021_Double eyelid	4021_Double eyelid	25	723	1	3614	1469	4168	3925	2786	2415	2329	1545	723
870_Free cholesterol	870_Free cholesterol	25	724	1	3692	921	2885	724	2224	1632	1977	1720	3721
3793_Sleep duration	3793_Sleep duration	25	725	1	4310	741	1150	1840	3178	725	907	1569	3444
2644_CSF1 - Macrophage colony-stimulating factor 1	2644_CSF1 - Macrophage colony-stimulating factor 1	25	726	1	726	3643	4430	4022	3574	4623	2401	1410	1509
3007_LGALS3BP - Galectin-3-binding protein	3007_LGALS3BP - Galectin-3-binding protein	25	726	1	2699	2159	1999	726	3114	893	1348	2892	2918
4423_Helicobacter pylori seropositivity	4423_Helicobacter pylori seropositivity	25	726	1	814	4470	3405	3749	726	2294	4029	3202	4398
1433_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	1433_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	25	726	1	4423	1278	4248	1097	4534	3346	4508	726	933
2965_AMH - Muellerian-inhibiting factor	2965_AMH - Muellerian-inhibiting factor	25	727	1	3235	727	2380	3865	3243	3816	4019	2621	1647
2760_PLAU - Urokinase-type plasminogen activator	2760_PLAU - Urokinase-type plasminogen activator	25	727	1	1165	3973	727	1294	1755	3332	4744	4127	2374
2931_IL1A - Interleukin-1 alpha	2931_IL1A - Interleukin-1 alpha	25	727	1	1188	821	4690	2601	727	2023	2999	1766	1880
1252_Percent predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	1252_Percent predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	25	727	1	3174	1202	4580	2792	4395	2662	4154	727	803
2447_HTRA2 - Serine protease HTRA2, mitochondrial	2447_HTRA2 - Serine protease HTRA2, mitochondrial	25	728	1	2886	728	2151	837	3784	2852	3744	3736	4399
1914_Parietal brain volume (FBAT, adjusted for multivariable)	1914_Parietal brain volume (FBAT, adjusted for multivariable)	25	728	1	3650	3715	728	4298	1789	4352	2136	2819	4427
871_Glucose	871_Glucose	25	728	1	4376	2835	2095	4401	728	1552	1094	4205	3766
1190_Mitral annular calcification	1190_Mitral annular calcification	25	729	1	2547	3222	729	917	3158	4422	982	3825	2213
308_CD4nv:%Th0	308_CD4nv:%Th0	25	729	1	4484	3992	3104	729	4615	2761	773	2344	2376
4713_Anterior corona radiata mode of anisotropy	4713_Anterior corona radiata mode of anisotropy	25	729	1	3759	3787	1477	3124	3121	729	1456	4437	1693
1668_Aspartate aminotransferase (at exam 2, FBAT, adjusted for multivariable)	1668_Aspartate aminotransferase (at exam 2, FBAT, adjusted for multivariable)	25	729	1	740	1785	3517	2954	2396	850	1530	729	4064
806_::::X-12830	806_::::X-12830	25	730	1	2548	1961	730	2027	4599	2990	3366	3408	1270
1185_Low-density lipoprotein cholesterol	1185_Low-density lipoprotein cholesterol	25	730	1	3941	3947	1952	730	3438	861	4264	3158	3239
3728_Anxiety - Ever worried more than most people would in similar situation	3728_Anxiety - Ever worried more than most people would in similar situation	25	730	1	4062	3438	1550	2944	2972	730	968	892	1033
752_::::X-12063	752_::::X-12063	25	730	1	945	1740	919	4571	3517	4646	4160	2462	730
3082_CD200 - OX-2 membrane glycoprotein	3082_CD200 - OX-2 membrane glycoprotein	25	731	1	731	2668	1598	2182	1887	3611	2819	1666	875
3653_Illnesses of siblings: Severe depression	3653_Illnesses of siblings: Severe depression	25	731	1	1856	731	832	1075	1595	4433	871	2019	1936
3566_Vitamin and mineral supplements: Multivitamins +/- minerals	3566_Vitamin and mineral supplements: Multivitamins +/- minerals	25	731	1	1875	2780	731	2121	1153	809	1047	4484	1874
2074_C8A C8B C8G - Complement component C8	2074_C8A C8B C8G - Complement component C8	25	731	1	3938	3189	1592	731	3708	4367	3415	1705	2332
1759_Breast cancer (GEE, adjusted for age)	1759_Breast cancer (GEE, adjusted for age)	25	731	1	1919	2839	1673	4524	2440	2084	731	940	4725
1006_Regulated on Activation, Normal T Cell Expressed and Secreted (CCL5)	1006_Regulated on Activation, Normal T Cell Expressed and Secreted (CCL5)	25	731	1	4158	3457	1539	957	4391	737	3270	731	2347
1684_Brain natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	1684_Brain natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	25	732	1	3980	4445	3988	732	3335	2309	2621	1230	1796
377_Amino acid::Glutathione metabolism::5-oxoproline	377_Amino acid::Glutathione metabolism::5-oxoproline	25	732	1	2523	1179	4593	971	1515	2819	3654	732	3071
2118_ERBB2 - Receptor tyrosine-protein kinase erbB-2	2118_ERBB2 - Receptor tyrosine-protein kinase erbB-2	25	733	1	733	2896	2659	4278	3826	879	2457	2097	4350
4620_Left cerebellum exterior	4620_Left cerebellum exterior	25	733	1	1040	1613	3549	2534	733	4396	2725	3396	3651
1897_Shaft Section Modulus (GEE, male, adjussted for multivariable)	1897_Shaft Section Modulus (GEE, male, adjussted for multivariable)	25	733	1	1813	4557	3762	2370	2815	733	2035	4176	830
2385_CTSC - Dipeptidyl peptidase 1	2385_CTSC - Dipeptidyl peptidase 1	25	733	1	2204	1349	3980	4353	3184	835	2053	1864	733
2576_SERPINA1 - Alpha-1-antitrypsin	2576_SERPINA1 - Alpha-1-antitrypsin	25	734	1	4038	734	3623	3715	2974	2747	3093	4300	2959
2261_C7 - Complement component C7	2261_C7 - Complement component C7	25	734	1	4226	4588	734	3663	2959	1831	2490	2117	2421
527_Lipid::Long chain fatty acid::pentadecanoate (15:0)	527_Lipid::Long chain fatty acid::pentadecanoate (15:0)	25	734	1	1115	3285	2393	2923	4482	734	4396	2809	3464
2241_WIF1 - Wnt inhibitory factor 1	2241_WIF1 - Wnt inhibitory factor 1	25	734	1	2325	1655	3192	4288	4729	2153	734	2137	4629
730_::::X-11795	730_::::X-11795	25	734	1	3700	877	1901	3375	2973	3607	2776	734	2027
233_Lymph:%T	233_Lymph:%T	25	735	1	3493	4186	735	1843	2113	1406	1432	2492	2009
2562_LTA LTB - Lymphotoxin alpha2:beta1	2562_LTA LTB - Lymphotoxin alpha2:beta1	25	735	1	3462	3812	1030	2533	735	2420	3520	4222	3437
3361_Neck/shoulder pain for 3+ months	3361_Neck/shoulder pain for 3+ months	25	736	1	1980	1672	3892	736	3442	2504	3967	3490	1756
4566_Left posterior cingulate	4566_Left posterior cingulate	25	736	1	2668	2407	1735	3268	736	1072	4242	2067	4318
4157_Focal Epilepsy	4157_Focal Epilepsy	25	737	1	4664	737	2520	3647	1946	926	2410	2796	4444
3890_Monocyte percentage of white cells (three-way meta)	3890_Monocyte percentage of white cells (three-way meta)	25	737	1	1144	2564	3538	2842	737	1953	3331	2738	3401
3407_Number of older siblings	3407_Number of older siblings	25	737	1	3327	4509	1871	1742	3470	1775	2260	737	3426
1846_Neck Section Modulus (FBAT, female, adjusted for age)	1846_Neck Section Modulus (FBAT, female, adjusted for age)	25	737	1	1753	1271	1379	2939	4485	1233	1803	2198	737
827_::::X-13671	827_::::X-13671	25	738	1	3591	3798	1677	3096	3065	738	3470	3668	3407
2429_CD109 - CD109 antigen	2429_CD109 - CD109 antigen	25	739	1	739	3676	949	4435	2716	1522	2516	2789	804
2090_EFNB3 - Ephrin-B3	2090_EFNB3 - Ephrin-B3	25	739	1	1343	739	2289	3678	2743	3655	777	2703	3971
627_Xenobiotics::Drug::p-acetamidophenylglucuronide	627_Xenobiotics::Drug::p-acetamidophenylglucuronide	25	739	1	2642	4654	739	3798	4711	1376	3889	2510	2632
3001_GSTA3 - Glutathione S-transferase A3	3001_GSTA3 - Glutathione S-transferase A3	25	739	1	2175	4672	2786	2900	962	4571	739	1973	2129
2641_TNFRSF4 - Tumor necrosis factor receptor superfamily member 4	2641_TNFRSF4 - Tumor necrosis factor receptor superfamily member 4	25	740	1	4317	740	1545	3180	1886	3711	4529	4548	1933
4168_Open-angle glaucoma (fixed-effect model)	4168_Open-angle glaucoma (fixed-effect model)	25	740	1	1614	2848	941	740	2427	2121	2979	4667	2834
3499_Hair colour (natural, before greying): Black	3499_Hair colour (natural, before greying): Black	25	740	1	2327	3869	2713	3459	740	3722	1323	2273	4619
1210_FEV1/FCV	1210_FEV1/FCV	25	741	1	4470	4502	741	4285	2187	1789	1527	4329	3634
1447_Low-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	1447_Low-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	25	741	1	2350	4666	1643	2997	4635	1169	4035	741	868
2071_APOE - Apolipoprotein E	2071_APOE - Apolipoprotein E	25	741	1	1199	4182	1697	4462	4225	2329	1626	4197	741
2950_F5 - Coagulation Factor V	2950_F5 - Coagulation Factor V	25	742	1	3233	742	4382	4487	3831	1005	2297	1123	4669
550_Lipid::Lysolipid::2-oleoylglycerophosphocholine*	550_Lipid::Lysolipid::2-oleoylglycerophosphocholine*	25	742	1	1272	1551	742	1714	2301	2505	2521	2518	2413
4484_Right lateral occipital	4484_Right lateral occipital	25	742	1	3602	2333	3239	4178	3002	2725	742	4196	3391
4255_Sleep efficiency	4255_Sleep efficiency	25	744	1	1074	3617	914	744	812	2263	3319	3191	1481
3816_CD19+ B cell level	3816_CD19+ B cell level	25	745	1	745	4437	2964	1429	3420	1304	4020	4199	3793
1528_Remnant lipoprotein cholesterol (at exam 4, FBAT)	1528_Remnant lipoprotein cholesterol (at exam 4, FBAT)	25	745	1	4709	745	1960	4606	1993	2657	3328	2307	3498
220_T:%Vd1	220_T:%Vd1	25	745	1	3023	1591	745	4314	819	3446	3607	2642	2398
414_Amino acid::Urea cycle; arginine-, proline-, metabolism::homocitrulline	414_Amino acid::Urea cycle; arginine-, proline-, metabolism::homocitrulline	25	745	1	3713	2319	1831	745	3684	961	1293	807	2444
2226_CX3CL1 - Fractalkine	2226_CX3CL1 - Fractalkine	25	745	1	3324	1926	2002	3554	2433	745	3131	3741	4031
101_Pubertal growth	101_Pubertal growth	25	745	1	2798	2825	4245	2818	2775	1136	745	1265	4299
2664_FGFR2 - Fibroblast growth factor receptor 2	2664_FGFR2 - Fibroblast growth factor receptor 2	25	745	1	1665	2311	3037	748	3611	3003	1912	745	2883
3972_Total body BMD (60 or older)	3972_Total body BMD (60 or older)	25	746	1	3107	4369	746	2611	2528	1972	1564	4253	3763
2466_ADRBK1 - beta-adrenergic receptor kinase 1	2466_ADRBK1 - beta-adrenergic receptor kinase 1	25	746	1	3382	2844	2682	2456	746	2868	1364	4235	4119
408_Amino acid::Tryptophan metabolism::serotonin (5HT)	408_Amino acid::Tryptophan metabolism::serotonin (5HT)	25	747	1	747	4455	2603	3668	4638	2068	2238	1689	2613
1089_Alcohol dependence	1089_Alcohol dependence	25	747	1	984	869	2906	2409	3073	2239	1993	4608	747
3737_Depression - Ever had prolonged loss of interest in normal activities	3737_Depression - Ever had prolonged loss of interest in normal activities	25	748	1	800	748	2882	2091	1909	1857	3390	2192	756
2453_MATN2 - Matrilin-2	2453_MATN2 - Matrilin-2	25	748	1	2628	3863	1456	3060	4491	819	3479	748	4154
1465_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	1465_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	25	749	1	4399	3041	2553	1580	2043	749	2915	1920	3187
1558_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1558_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	750	1	4515	3932	851	2654	2081	3871	2933	1698	750
4500_Right rostral middle frontal	4500_Right rostral middle frontal	25	751	1	751	3555	2102	4142	4590	3460	4389	835	3518
3682_Diagnoses - main ICD10: R10 Abdominal and pelvic pain	3682_Diagnoses - main ICD10: R10 Abdominal and pelvic pain	25	751	1	2409	751	2019	3414	4025	2712	3528	2199	2739
726_Amino acid::Cysteine, methionine, SAM, taurine metabolism::X-11786--methylcysteine	726_Amino acid::Cysteine, methionine, SAM, taurine metabolism::X-11786--methylcysteine	25	751	1	4020	4153	4032	4188	2949	3594	1936	984	751
810_::::X-12850	810_::::X-12850	25	752	1	752	2833	4500	1938	2475	3824	2445	1483	4356
276_CD4:%RTE	276_CD4:%RTE	25	752	1	4248	3702	752	909	2067	4111	4257	3651	4600
945_Serum total cholesterol	945_Serum total cholesterol	25	752	1	3349	1830	4639	752	3822	3976	1761	4734	1133
2345_FASLG - Tumor necrosis factor ligand superfamily member 6, soluble form	2345_FASLG - Tumor necrosis factor ligand superfamily member 6, soluble form	25	752	1	3739	1197	909	1759	4316	752	1352	3419	1819
2078_FGF8 - Fibroblast growth factor 8 isoform B	2078_FGF8 - Fibroblast growth factor 8 isoform B	25	752	1	2550	4091	2153	3636	3722	3159	2077	3699	752
4303_Legs-leg fat ratio (male)	4303_Legs-leg fat ratio (male)	25	753	1	4066	4286	2211	2779	753	1558	1744	1396	2032
3122_PPIF - Peptidyl-prolyl cis-trans isomerase F, mitochondrial	3122_PPIF - Peptidyl-prolyl cis-trans isomerase F, mitochondrial	25	754	1	4345	754	2475	1848	3807	1531	1053	4006	4545
499_Lipid::Fatty acid, dicarboxylate::dodecanedioate	499_Lipid::Fatty acid, dicarboxylate::dodecanedioate	25	755	1	4055	2393	2416	755	2782	2156	2847	3597	3377
1290_Waist circumference by CT (FBAT, adjusted for age, sex, smoking and menopause)	1290_Waist circumference by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	755	1	1350	3879	2877	2240	2956	884	755	2732	4532
2840_FCRL3 - Fc receptor-like protein 3	2840_FCRL3 - Fc receptor-like protein 3	25	756	1	1609	756	3193	1631	4267	4537	1878	968	1476
2903_FABP3 - Fatty acid-binding protein, heart	2903_FABP3 - Fatty acid-binding protein, heart	25	756	1	2292	3944	2546	756	2270	3278	4569	4392	3800
1962_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for age)	1962_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for age)	25	757	1	3721	3481	3496	2952	3016	3017	757	1405	2908
2774_DCTN2 - Dynactin subunit 2	2774_DCTN2 - Dynactin subunit 2	25	757	1	2927	2642	2063	2434	4055	3383	3458	757	779
613_Xenobiotics::Benzoate metabolism::4-ethylphenylsulfate	613_Xenobiotics::Benzoate metabolism::4-ethylphenylsulfate	25	758	1	2838	4368	1417	4154	758	1549	3896	2861	2144
1139_Body Mass Index (Dominance deviation model)	1139_Body Mass Index (Dominance deviation model)	25	759	1	3503	759	4288	2956	3954	1311	2067	4216	3623
2_Attention deficit hyperactivity disorder	2_Attention deficit hyperactivity disorder	25	759	1	1575	2967	759	2961	2317	2631	4376	1070	4400
454_Cofactors and vitamins::Pantothenate and CoA metabolism::pantothenate	454_Cofactors and vitamins::Pantothenate and CoA metabolism::pantothenate	25	759	1	1791	964	3025	2018	759	3513	3732	2669	2862
1440_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	1440_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	25	759	1	3336	3891	1138	1059	1251	967	759	1066	1872
2069_FLT4 - Vascular endothelial growth factor receptor 3	2069_FLT4 - Vascular endothelial growth factor receptor 3	25	759	1	2359	2635	3354	788	4325	2618	1753	2614	759
1215_Alcohol consumption (female)	1215_Alcohol consumption (female)	25	760	1	3679	2415	3712	3121	4474	760	1469	3977	2568
2330_CGA FSHB - Follicle stimulating hormone	2330_CGA FSHB - Follicle stimulating hormone	25	760	1	2973	3203	2678	3996	1045	4067	760	3921	3062
1300_Fasting plasma glucose (at exam 7, FBAT, adjusted for age and sex)	1300_Fasting plasma glucose (at exam 7, FBAT, adjusted for age and sex)	25	760	1	3611	4636	1136	1474	1249	773	4533	760	1462
463_Energy::Oxidative phosphorylation::phosphate	463_Energy::Oxidative phosphorylation::phosphate	25	761	1	761	2938	4587	2928	3037	3830	2510	1177	4450
1895_Shaft Section Modulus (GEE, female, adjussted for multivariable)	1895_Shaft Section Modulus (GEE, female, adjussted for multivariable)	25	761	1	4138	3508	1875	761	1354	1648	3550	2876	2319
4290_Frequent insomnia symptoms	4290_Frequent insomnia symptoms	25	761	1	1765	3881	2769	2958	4493	2283	1879	761	3860
1074_Serum levels of soluble E-selectin with T1D	1074_Serum levels of soluble E-selectin with T1D	25	762	1	1731	910	1822	2436	1937	762	2495	4730	1088
3438_Doctor diagnosed asthma	3438_Doctor diagnosed asthma	25	762	1	2778	2687	3966	1049	3557	1602	762	4552	2312
1643_Osteoprotegerin (at exam 7, GEE, adjusted for age and sex)	1643_Osteoprotegerin (at exam 7, GEE, adjusted for age and sex)	25	762	1	4011	4452	1953	2636	2931	4617	4121	762	1773
3037_PRSS2 - Trypsin-2	3037_PRSS2 - Trypsin-2	25	763	1	763	4088	2717	1860	3298	4060	1567	2835	3969
2730_BPI - Bactericidal permeability-increasing protein	2730_BPI - Bactericidal permeability-increasing protein	25	763	1	3550	2970	2345	763	4372	4400	2710	4483	2199
2819_DAPK2 - Death-associated protein kinase 2	2819_DAPK2 - Death-associated protein kinase 2	25	763	1	3929	3607	892	3965	4176	2890	763	3672	3196
1669_Aspartate aminotransferase (at exam 2, GEE, adjusted for multivariable)	1669_Aspartate aminotransferase (at exam 2, GEE, adjusted for multivariable)	25	763	1	1626	2339	3386	4696	4061	3106	4500	1211	763
4356_Menstrual cycle length	4356_Menstrual cycle length	25	765	1	765	3685	4185	829	3493	1626	1207	3516	4608
4669_Anterior corona radiata axial diusivities	4669_Anterior corona radiata axial diusivities	25	765	1	1217	1596	765	1782	2832	4205	4505	1218	4158
1225_Mean Thalamus	1225_Mean Thalamus	25	766	1	766	3648	3347	2336	1099	4371	2948	1276	2016
2165_TNFRSF13B - Tumor necrosis factor receptor superfamily member 13B	2165_TNFRSF13B - Tumor necrosis factor receptor superfamily member 13B	25	766	1	2274	766	3611	1813	3217	4420	4580	2973	2874
3217_Time spend outdoors in summer	3217_Time spend outdoors in summer	25	766	1	3607	2935	4133	766	3290	4370	2585	3141	1938
2692_PRDX1 - Peroxiredoxin-1	2692_PRDX1 - Peroxiredoxin-1	25	766	1	815	1082	2181	1270	766	2142	1274	3215	4453
4159_Childhood Absence Epilepsy	4159_Childhood Absence Epilepsy	25	767	1	1132	1758	1422	767	1385	2183	802	1704	2935
4592_Right pars opercularis	4592_Right pars opercularis	25	767	1	3478	3799	2802	835	767	1618	1045	4412	3056
3695_Diagnoses - secondary ICD10: J45 Asthma	3695_Diagnoses - secondary ICD10: J45 Asthma	25	768	1	4498	768	4176	2628	3348	4548	2176	3603	2985
1817_Femoral Neck BMD (GEE, male, adjusted for multivariable)	1817_Femoral Neck BMD (GEE, male, adjusted for multivariable)	25	768	1	2129	4382	768	3682	2040	3967	2884	941	2086
2408_MATN3 - Matrilin-3	2408_MATN3 - Matrilin-3	25	768	1	4387	4196	4092	2621	1706	1094	768	1559	3671
2303_LGALS4 - Galectin-4	2303_LGALS4 - Galectin-4	25	769	1	2189	1541	967	1871	2850	814	4581	3000	769
4010_Amyotrophic lateral sclerosis	4010_Amyotrophic lateral sclerosis	25	770	1	3555	770	4460	940	3782	2989	3032	2925	1986
4722_Fornix (cres) / Stria terminalis mode of anisotropy	4722_Fornix (cres) / Stria terminalis mode of anisotropy	25	770	1	3497	4566	3029	1533	3424	770	1354	4289	2870
491_Lipid::Essential fatty acid::linoleate (18:2n6)	491_Lipid::Essential fatty acid::linoleate (18:2n6)	25	772	1	1929	4571	772	2474	3473	4247	2245	3256	3710
1675_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for age and sex)	1675_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for age and sex)	25	772	1	1293	4055	3916	3070	2694	3592	772	1023	1555
1330_Insulin sensitivity (FBAT, adjusted for age, sex and BMI)	1330_Insulin sensitivity (FBAT, adjusted for age, sex and BMI)	25	772	1	4097	1369	3248	1622	1801	3266	996	772	2976
3025_PGK1 - Phosphoglycerate kinase 1	3025_PGK1 - Phosphoglycerate kinase 1	25	773	1	2029	773	2452	1186	3931	3831	1059	3734	2308
321_CD8mem:%R6+PD1+161-	321_CD8mem:%R6+PD1+161-	25	773	1	3517	1560	773	4062	3622	1060	2890	4562	1566
3194_Number of vehicles in household	3194_Number of vehicles in household	25	774	1	1975	774	3498	2271	1112	1845	2483	3960	3376
3560_Medication for pain relief, constipation, heartburn: Omeprazole (e.g. Zanprol)	3560_Medication for pain relief, constipation, heartburn: Omeprazole (e.g. Zanprol)	25	774	1	1043	1777	4485	774	1362	3855	1460	1867	2704
1632_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for multivariable)	1632_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for multivariable)	25	774	1	3641	2060	4562	3437	4324	2195	3728	774	777
2374_TNFRSF1B - Tumor necrosis factor receptor superfamily member 1B	2374_TNFRSF1B - Tumor necrosis factor receptor superfamily member 1B	25	774	1	1397	4697	2714	1520	2208	3450	1097	2860	774
2064_TIMP1 - Metalloproteinase inhibitor 1	2064_TIMP1 - Metalloproteinase inhibitor 1	25	775	1	775	2471	3508	2723	3656	4118	3042	1711	840
2012_Remission following 8-week treatment of MDD subjects	2012_Remission following 8-week treatment of MDD subjects	25	776	1	776	3622	942	4742	4013	1991	3329	2265	1932
3313_Hearing difficulty/problems	3313_Hearing difficulty/problems	25	776	1	1796	1979	776	4099	1571	1974	1345	2240	2034
3157_MIF - Macrophage migration inhibitory factor	3157_MIF - Macrophage migration inhibitory factor	25	777	1	2415	4347	1838	777	4597	1525	4607	3356	3227
3477_Own or rent accommodation lived in: Own with a mortgage	3477_Own or rent accommodation lived in: Own with a mortgage	25	777	1	4587	1733	2774	3684	777	1523	3141	1346	4574
4406_Menstrual quality of life impact: Sleepiness	4406_Menstrual quality of life impact: Sleepiness	25	778	1	1592	3269	1450	4378	4107	778	2427	4128	2576
3497_Hair colour (natural, before greying): Light brown	3497_Hair colour (natural, before greying): Light brown	25	779	1	2845	3470	3504	2473	1504	779	781	2694	3345
1875_Shaft average buckling ratio (GEE, female, adjussted for age)	1875_Shaft average buckling ratio (GEE, female, adjussted for age)	25	779	1	2723	2840	4365	1903	1077	1949	2055	779	2616
1780_Artial fibrillation (FBAT, adjusted for age and sex)	1780_Artial fibrillation (FBAT, adjusted for age and sex)	25	780	1	780	2368	955	4213	2621	3865	2064	1791	2504
615_Xenobiotics::Benzoate metabolism::4-vinylphenol sulfate	615_Xenobiotics::Benzoate metabolism::4-vinylphenol sulfate	25	780	1	1308	1904	780	3893	1064	1507	3535	2119	2078
1068_Bipolar disorder	1068_Bipolar disorder	25	781	1	2212	2568	781	3186	4645	1564	4452	2463	3194
4196_Hypertension	4196_Hypertension	25	781	1	2487	4676	1692	781	4559	4213	3881	4174	4238
668_::::X-06246	668_::::X-06246	25	781	1	1845	1578	858	3537	781	1208	1562	2262	3811
3750_Traumatic events - Felt irritable or had angry outbursts in past month	3750_Traumatic events - Felt irritable or had angry outbursts in past month	25	782	1	782	3776	3729	1967	2714	3872	2861	3923	4201
1971_MMSE score (at exam 7, GEE, adjusted for age)	1971_MMSE score (at exam 7, GEE, adjusted for age)	25	782	1	3037	2737	2946	2985	3430	1933	782	4410	3771
843_::::X-14626	843_::::X-14626	25	783	1	783	1665	4053	2174	2510	1791	4730	2478	791
1502_Triglycerides (at exam 3, FBAT, adjusted for age and sex)	1502_Triglycerides (at exam 3, FBAT, adjusted for age and sex)	25	783	1	2167	4334	1429	783	3716	1509	3223	1225	2149
682_::::X-10395	682_::::X-10395	25	783	1	2992	3175	3662	2524	3884	783	2716	3797	2506
1324_Fasting plasma glucose (at exam 7, FBAT, adjusted for age, sex and BMI)	1324_Fasting plasma glucose (at exam 7, FBAT, adjusted for age, sex and BMI)	25	784	1	1075	3540	1804	2693	837	784	3786	2427	4618
1459_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1459_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	784	1	1500	4302	4592	2321	2995	1833	1989	784	4463
2436_CNTN5 - Contactin-5	2436_CNTN5 - Contactin-5	25	785	1	3510	2119	785	2243	2997	1414	1928	1712	2260
4574_Left supramarginal	4574_Left supramarginal	25	785	1	2177	1134	3396	2095	2937	2273	785	2379	1085
4569_Left rostral anterior cingulate	4569_Left rostral anterior cingulate	25	786	1	4551	1905	3350	786	3005	4215	1378	4494	2150
2967_MMP13 - Collagenase 3	2967_MMP13 - Collagenase 3	25	787	1	2634	1810	2281	787	4472	916	2900	1003	2022
3801_Hematocrit	3801_Hematocrit	25	787	1	2785	1563	1117	4035	2222	1352	4484	787	1433
2488_LYN - Tyrosine-protein kinase Lyn, isoform B	2488_LYN - Tyrosine-protein kinase Lyn, isoform B	25	787	1	1417	2124	4563	3040	4506	4701	3002	1590	787
4501_Right superior frontal	4501_Right superior frontal	25	788	1	788	2724	2914	1842	3667	4202	4701	3454	1660
661_::::X-04498	661_::::X-04498	25	789	1	2894	2787	789	2347	1306	4637	2844	3051	2271
4421_Herpes simplex virus 1 seropositivity	4421_Herpes simplex virus 1 seropositivity	25	789	1	1822	2820	1279	2208	789	2978	2204	4511	4311
4286_FEV1	4286_FEV1	25	790	1	4126	3011	1577	790	1777	3318	3385	3762	2892
673_::::X-07765	673_::::X-07765	25	790	1	1121	1303	3422	3850	790	3295	972	2219	1450
2003_Plasma Lipoprotein A level	2003_Plasma Lipoprotein A level	25	790	1	2625	3073	1595	1409	2910	1236	1997	2251	790
3115_PCSK9 - Proprotein convertase subtilisin/kexin type 9	3115_PCSK9 - Proprotein convertase subtilisin/kexin type 9	25	791	1	1829	2719	791	3369	3642	934	4248	3724	1257
2620_PPP3R1 - Calcineurin subunit B type 1	2620_PPP3R1 - Calcineurin subunit B type 1	25	791	1	1907	3252	3992	791	3652	1320	1359	3261	2804
1887_Shaft Width (GEE, male, adjussted for multivariable)	1887_Shaft Width (GEE, male, adjussted for multivariable)	25	792	1	792	3502	2926	1757	2975	4405	2471	3039	3931
2485_IL17RD - Interleukin-17 receptor D	2485_IL17RD - Interleukin-17 receptor D	25	792	1	3837	3608	792	2458	1522	2856	1209	1315	4700
2221_BCAM - Basal Cell Adhesion Molecule	2221_BCAM - Basal Cell Adhesion Molecule	25	793	1	4491	793	3397	2097	3267	3135	4270	1105	1987
617_Xenobiotics::Benzoate metabolism::catechol sulfate	617_Xenobiotics::Benzoate metabolism::catechol sulfate	25	793	1	2135	4206	2555	4596	4715	793	4038	1608	3528
3799_Red blood cell count	3799_Red blood cell count	25	793	1	3841	4538	1504	800	3520	1064	793	3460	1280
1515_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	1515_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	24	794	1	3277	794	2145	3398	3190	2184	4668	1466	1104
2811_AMN - Protein amnionless	2811_AMN - Protein amnionless	25	794	1	2147	2796	2381	794	2696	1807	911	3282	3262
2909_IL3 - Interleukin-3	2909_IL3 - Interleukin-3	25	795	1	2464	3214	3773	795	4388	4577	4345	2995	1594
3827_Osteoarthritis of hip and/or knee	3827_Osteoarthritis of hip and/or knee	25	796	1	3916	4134	3620	796	2393	1098	3915	4613	1570
1916_Temporal brain volume (FBAT, adjusted for multivariable)	1916_Temporal brain volume (FBAT, adjusted for multivariable)	25	797	1	2568	856	972	3435	3231	3697	797	3186	4187
1994_Survival past average life expectancy (FBAT, adjusted for birth-cohort)	1994_Survival past average life expectancy (FBAT, adjusted for birth-cohort)	25	797	1	3346	1014	4446	2003	2286	3153	3797	797	2123
3598_Non-cancer illness code, self-reported: angina	3598_Non-cancer illness code, self-reported: angina	25	798	1	2700	2049	3455	3766	798	2279	2835	2108	1000
3049_TNFRSF25 - Tumor necrosis factor receptor superfamily member 25	3049_TNFRSF25 - Tumor necrosis factor receptor superfamily member 25	25	798	1	1768	968	1604	2720	2505	1063	2666	798	3152
3878_Granulocyte percentage of myeloid white cells (three-way meta)	3878_Granulocyte percentage of myeloid white cells (three-way meta)	25	799	1	3813	2276	913	3499	799	1824	3359	4250	3536
1029_Neck Width (GEE, adjusted for age and sex)	1029_Neck Width (GEE, adjusted for age and sex)	25	799	1	2482	3649	3874	1323	2288	799	3257	1299	3301
3223_Length of mobile phone use	3223_Length of mobile phone use	25	799	1	1539	1497	2583	3129	1252	2858	3554	799	1198
3109_CSNK2A1 CSNK2B - Casein kinase II 2-alpha:2-beta heterotetramer	3109_CSNK2A1 CSNK2B - Casein kinase II 2-alpha:2-beta heterotetramer	25	800	1	1494	4424	800	3590	1587	1555	2568	4143	2361
4281_PEF	4281_PEF	25	800	1	2053	2954	4584	2855	1018	800	2051	3824	3581
3252_Bread intake	3252_Bread intake	25	800	1	2545	2473	802	4457	3251	1364	4610	800	3163
4123_Activated partial thromboplastin time	4123_Activated partial thromboplastin time	25	801	1	801	4324	2108	2869	2318	2652	3418	1047	1884
1401_High-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	1401_High-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	25	801	1	4267	4039	3828	1862	1526	801	1735	2244	3967
4313_Age of initiation of regular smoking	4313_Age of initiation of regular smoking	25	802	1	802	1068	4157	2566	3377	2760	1538	2004	3388
1246_Mean FEV1/FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1246_Mean FEV1/FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	802	1	1855	802	3520	1748	4724	2467	2478	2504	3129
3830_Amyotrophic lateral sclerosis (meta-analysis)	3830_Amyotrophic lateral sclerosis (meta-analysis)	25	803	1	803	1564	4434	2983	3963	4710	3371	2271	2108
878_Histidine	878_Histidine	25	803	1	2068	3937	803	2333	1412	1858	1656	1771	2154
4370_Thyroid-stimulating hormone (male)	4370_Thyroid-stimulating hormone (male)	25	803	1	1345	4536	2266	2822	803	1760	951	3711	2266
4472_Left superior temporal	4472_Left superior temporal	25	804	1	804	2190	2570	4129	917	1056	2476	3017	4250
1922_Hippocampal volume (FBAT, adjusted for age and sex)	1922_Hippocampal volume (FBAT, adjusted for age and sex)	25	804	1	2526	1542	804	4602	2436	1910	4424	1665	1726
310_CD4nv:%preTh17	310_CD4nv:%preTh17	25	806	1	806	4712	4116	2410	3340	2826	3477	1813	981
328_CD4mem:%preTh17 (3)	328_CD4mem:%preTh17 (3)	25	806	1	2627	806	3722	3446	2281	4383	1855	1473	1269
2640_SST - Somatostatin-28	2640_SST - Somatostatin-28	25	806	1	850	2349	1510	1301	2489	806	2244	2535	3824
2467_BMP1 - Bone morphogenetic protein 1	2467_BMP1 - Bone morphogenetic protein 1	25	807	1	3368	3280	807	2329	4413	1008	3300	2818	1245
826_::::X-13658	826_::::X-13658	25	808	1	808	1306	3511	3277	4226	1104	3198	2278	2429
1438_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1438_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	808	1	1953	1478	1390	808	1581	883	1179	3532	3429
1589_Factor VII (at exam 5, GEE, adjusted for multivariable)	1589_Factor VII (at exam 5, GEE, adjusted for multivariable)	25	808	1	3274	2034	1043	3452	3175	2840	1366	808	4097
2675_MATK - Megakaryocyte-associated tyrosine-protein kinase	2675_MATK - Megakaryocyte-associated tyrosine-protein kinase	25	808	1	1784	4698	2795	820	1785	3774	3197	1232	808
4291_Asthma	4291_Asthma	25	809	1	809	2402	1896	2509	1740	2400	2974	3972	4634
1505_Triglycerides (at exam 4, GEE, adjusted for age and sex)	1505_Triglycerides (at exam 4, GEE, adjusted for age and sex)	25	809	1	1830	2277	809	3569	4278	2056	3012	921	4661
269_CD4:%TM (2)	269_CD4:%TM (2)	25	809	1	2537	3139	2458	809	3735	2997	2907	4478	890
4633_Right cerebellum exterior	4633_Right cerebellum exterior	25	809	1	1006	1553	1923	4438	809	4252	1986	2014	3602
1881_Shaft cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	1881_Shaft cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	25	810	1	2084	810	3745	2570	4575	4357	3561	1131	1386
2732_CCL24 - C-C motif chemokine 24	2732_CCL24 - C-C motif chemokine 24	25	811	1	2577	1651	811	3128	3564	2589	2089	4534	4672
3020_PLA2G7 - Platelet-activating factor acetylhydrolase	3020_PLA2G7 - Platelet-activating factor acetylhydrolase	25	811	1	2715	2949	2706	1754	811	1453	1091	3452	1160
699_Nucleotide::Purine metabolism, (hypo)xanthine/inosine containing::X-11422--xanthine	699_Nucleotide::Purine metabolism, (hypo)xanthine/inosine containing::X-11422--xanthine	25	811	1	2289	2220	2635	1461	4418	811	3565	3269	894
2927_TNFRSF10A - Tumor necrosis factor receptor superfamily member 10A	2927_TNFRSF10A - Tumor necrosis factor receptor superfamily member 10A	25	812	1	983	1971	3969	4105	2777	812	1720	3527	4502
2689_DNAJB1 - DnaJ homolog subfamily B member 1	2689_DNAJB1 - DnaJ homolog subfamily B member 1	25	812	1	4466	3239	951	3900	2879	2091	4704	1404	812
3177_PRKCG - Protein kinase C gamma type	3177_PRKCG - Protein kinase C gamma type	25	813	1	3098	3072	3033	813	3380	2638	4691	1450	2116
656_::::X-03088	656_::::X-03088	25	813	1	1536	4607	1565	3422	813	1379	1310	4722	1215
2853_TGM3 - Protein-glutamine gamma-glutamyltransferase E	2853_TGM3 - Protein-glutamine gamma-glutamyltransferase E	25	813	1	4225	3378	2830	3218	4123	813	4466	2320	2483
1369_Total cholesterol (at exam 6, GEE, adjusted for age and sex)	1369_Total cholesterol (at exam 6, GEE, adjusted for age and sex)	25	813	1	1497	1074	3076	1897	2484	1809	875	813	4225
821_::::X-13496	821_::::X-13496	25	815	1	2572	4079	2386	4164	2190	815	2130	4232	3007
2904_CSF2 - Granulocyte-macrophage colony-stimulating factor	2904_CSF2 - Granulocyte-macrophage colony-stimulating factor	25	815	1	834	3545	3562	1598	2808	3027	815	4598	3209
1756_Cancer (FBAT, adjusted for multivariable)	1756_Cancer (FBAT, adjusted for multivariable)	25	817	1	817	3315	860	4666	1259	3151	3180	2571	1574
352_NKT:%TM	352_NKT:%TM	25	817	1	991	1122	817	2185	3219	3854	3112	4089	1777
1037_Neck-Shaft Angle (GEE, adjusted for age and sex)	1037_Neck-Shaft Angle (GEE, adjusted for age and sex)	25	818	1	2608	1317	2460	1971	4617	818	1946	901	3734
2780_EIF4G2 - Eukaryotic translation initiation factor 4 gamma 2	2780_EIF4G2 - Eukaryotic translation initiation factor 4 gamma 2	25	819	1	3159	819	3109	1359	4510	2252	1251	1581	2594
2493_PIK3CG - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	2493_PIK3CG - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	25	820	1	3928	4746	1289	3304	3918	820	2161	1673	1249
1374_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for age and sex)	1374_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for age and sex)	25	821	1	3840	2268	1846	1689	3687	3048	821	3539	1281
2993_FABP5 - Fatty acid-binding protein, epidermal	2993_FABP5 - Fatty acid-binding protein, epidermal	25	821	1	2328	4553	4609	3136	2778	1280	2020	821	2471
1107_Blond hair in Solomon Islanders	1107_Blond hair in Solomon Islanders	25	821	1	1524	1279	4364	2694	3834	1650	1560	1951	821
364_Amino acid::Alanine and aspartate metabolism::alanine	364_Amino acid::Alanine and aspartate metabolism::alanine	25	822	1	1785	822	1989	1496	3693	4228	4669	1247	2820
3148_CPE - Carboxypeptidase E	3148_CPE - Carboxypeptidase E	25	823	1	3039	823	4069	4586	4336	3876	1176	823	3702
1005_Platelet derived growth factor BB	1005_Platelet derived growth factor BB	25	823	1	1309	1936	823	3771	4188	2245	3209	3144	3045
1390_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	1390_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	823	1	2211	2670	3767	823	3411	1717	2217	2502	2779
3570_Pain type(s) experienced in last month: Headache	3570_Pain type(s) experienced in last month: Headache	25	823	1	3596	2249	2511	1005	1894	4097	823	3732	3848
1874_Shaft average buckling ratio (FBAT, female, adjussted for age)	1874_Shaft average buckling ratio (FBAT, female, adjussted for age)	25	824	1	4547	2094	3801	824	3414	2248	4477	1891	4676
3944_HbA1c	3944_HbA1c	25	825	1	825	1441	2125	2851	3668	2199	4433	1805	2821
2787_L1CAM - Neural cell adhesion molecule L1	2787_L1CAM - Neural cell adhesion molecule L1	25	825	1	1223	3583	1951	4282	825	988	3609	3940	1261
2068_TGFB1 - Transforming growth factor beta-1	2068_TGFB1 - Transforming growth factor beta-1	25	825	1	2656	977	2059	1376	3951	825	4320	1255	2050
734_::::X-11820	734_::::X-11820	25	827	1	827	4301	2569	4167	2600	1082	3978	1053	1813
2232_XRCC6 - X-ray repair cross-complementing protein 6	2232_XRCC6 - X-ray repair cross-complementing protein 6	25	827	1	2070	3320	2247	4536	3001	827	2911	3210	3193
4007_Osteoarthritis of hip (hospital diagnosed)	4007_Osteoarthritis of hip (hospital diagnosed)	25	828	1	970	3097	828	2512	3193	4198	2788	2071	2984
149_Body Mass Index (female > 50 yrs)	149_Body Mass Index (female > 50 yrs)	25	828	1	2611	3710	2816	828	4393	3150	1210	2953	3774
4342_Moderate intesity (conditioning sex and BMI)	4342_Moderate intesity (conditioning sex and BMI)	25	828	1	4473	4623	4280	2380	2104	2355	2443	828	2835
3320_Chest pain or discomfort	3320_Chest pain or discomfort	25	829	1	2506	829	3138	3190	3749	1575	2545	1421	2314
784_::::X-12544	784_::::X-12544	25	830	1	3656	2140	4645	3399	2594	4162	830	4583	4284
191_Estimated glomerular filtration rate based on serum creatinine	191_Estimated glomerular filtration rate based on serum creatinine	25	831	1	3432	1287	1373	1980	4162	831	1685	2343	1623
2135_CSF1R - Macrophage colony-stimulating factor 1 receptor	2135_CSF1R - Macrophage colony-stimulating factor 1 receptor	25	832	1	832	4711	3332	3163	3433	2521	1398	2887	4058
4310_Osteoarthritis of knee	4310_Osteoarthritis of knee	25	832	1	2933	880	2545	1029	832	2072	2559	2572	3251
190_Waist-hip ratio (female, adjusted for BMI)	190_Waist-hip ratio (female, adjusted for BMI)	25	832	2	3798	4632	2315	2626	1556	832	3278	3102	3760
2187_GDF5 - Growth/differentiation factor 5	2187_GDF5 - Growth/differentiation factor 5	25	832	1	1943	2778	3464	4549	4429	1722	3273	832	4003
3824_Celiac disease	3824_Celiac disease	25	833	1	3463	2095	3156	833	2408	3900	4460	2480	1717
1384_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	1384_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	25	834	1	2248	1700	2628	1379	904	834	883	2746	4471
3338_Years since last cervical smear test (female)	3338_Years since last cervical smear test (female)	25	835	1	1442	3234	4692	1679	835	3501	1858	2513	2358
2725_UBE2N - Ubiquitin-conjugating enzyme E2 N	2725_UBE2N - Ubiquitin-conjugating enzyme E2 N	25	836	1	2497	2964	836	2002	2892	1021	3947	3777	1642
4249_Diurnal inactivity duration	4249_Diurnal inactivity duration	25	836	1	4541	1268	3471	3584	3167	4068	992	836	3515
395_Amino acid::Phenylalanine & tyrosine metabolism::p-cresol sulfate	395_Amino acid::Phenylalanine & tyrosine metabolism::p-cresol sulfate	25	837	1	837	4488	2490	4147	4314	2249	1028	3246	2232
1582_D-dimer (at exam 6, FBAT, adjusted for age and sex)	1582_D-dimer (at exam 6, FBAT, adjusted for age and sex)	25	837	1	2268	915	837	1058	4738	2769	1616	1001	946
4128_C-reactive protein	4128_C-reactive protein	25	838	1	1168	838	2154	4445	2120	3279	2144	2839	2593
4564_Left pericalcarine	4564_Left pericalcarine	25	838	1	2874	4057	4311	838	2354	3839	4350	1626	3983
4383_Epithelial ovarian cancer (high-grade serous)	4383_Epithelial ovarian cancer (high-grade serous)	25	839	1	2863	3949	4470	1348	3842	839	1890	882	2537
4146_Interventricular septum thickness	4146_Interventricular septum thickness	25	839	1	4623	1159	1614	3649	2384	4349	3348	1851	839
279_CD8:%39+	279_CD8:%39+	25	841	1	4738	3377	1247	2119	841	1286	3324	3979	2882
4659_Posterior corona radiata fractional anisotropy	4659_Posterior corona radiata fractional anisotropy	25	842	1	2950	1566	842	1046	2985	2841	1536	2283	1807
544_Lipid::Lysolipid::1-palmitoylglycerophosphoethanolamine	544_Lipid::Lysolipid::1-palmitoylglycerophosphoethanolamine	25	843	1	852	2622	926	1688	2463	3331	843	1189	2548
363_Mono:%11c-16-274+	363_Mono:%11c-16-274+	25	844	1	2752	3070	3987	2986	844	2900	1425	2697	3510
4057_Estimated glomerular filtration rate based on serum creatinine	4057_Estimated glomerular filtration rate based on serum creatinine	25	844	1	973	1817	918	1692	2659	844	2474	2505	3451
2445_GPC2 - Glypican-2	2445_GPC2 - Glypican-2	25	845	1	845	2244	3818	1420	4487	3208	2868	2781	2598
2975_ANXA2 - Annexin A2	2975_ANXA2 - Annexin A2	25	845	1	3236	845	3132	1443	2994	2818	2023	3791	2611
2296_CD36 - Platelet glycoprotein 4	2296_CD36 - Platelet glycoprotein 4	25	845	1	2686	1603	845	1136	4349	3452	3424	4002	2603
975_Eotaxin (CCL11)	975_Eotaxin (CCL11)	25	846	1	3702	2101	4468	2742	2107	2743	4307	2968	846
2502_TPSG1 - Tryptase gamma	2502_TPSG1 - Tryptase gamma	25	847	1	2276	4630	3055	1253	3218	4618	847	4637	3218
484_Lipid::Carnitine metabolism::oleoylcarnitine	484_Lipid::Carnitine metabolism::oleoylcarnitine	25	848	1	3871	1526	4721	848	3874	2598	2346	1552	1327
2801_RBM39 - RNA-binding protein 39	2801_RBM39 - RNA-binding protein 39	25	848	1	3810	2245	1917	4519	4545	3037	2468	848	3873
3354_Age stopped smoking	3354_Age stopped smoking	25	850	1	1921	1207	4726	4126	2228	1011	850	3184	4483
845_::::X-14658	845_::::X-14658	25	851	1	851	3782	1708	1592	2167	3682	943	3434	3414
925_Concentration of medium VLDL particles	925_Concentration of medium VLDL particles	25	851	1	1318	851	3569	4202	1062	2708	4543	1084	2079
4349_Heart failure	4349_Heart failure	25	851	1	4231	1914	1864	873	851	4166	1781	3447	1259
3004_HRG - Histidine-rich glycoprotein	3004_HRG - Histidine-rich glycoprotein	25	851	1	4287	1569	2420	3407	1377	851	2603	1141	3418
3403_Fluid intelligence test - FI5 : family relationship calculation	3403_Fluid intelligence test - FI5 : family relationship calculation	25	852	1	2872	852	2624	3030	4029	4439	2965	3041	1908
296_CD4mem:%preTh17 (1)	296_CD4mem:%preTh17 (1)	25	853	1	853	2299	3503	1694	3535	2473	2087	1760	2731
2313_JAM3 - Junctional adhesion molecule C	2313_JAM3 - Junctional adhesion molecule C	25	853	1	3680	4340	853	2569	4399	3093	3704	1360	1649
781_::::X-12465	781_::::X-12465	25	854	1	3556	4318	854	1715	2321	2649	1098	3637	2513
4683_Posterior thalamic radiation (include optic radiation) axial diusivities	4683_Posterior thalamic radiation (include optic radiation) axial diusivities	25	854	1	3242	1113	2590	854	3669	1047	3114	1640	2135
2713_ING1 - Inhibitor of growth protein 1	2713_ING1 - Inhibitor of growth protein 1	25	854	1	2079	1263	2349	4694	1294	1821	2564	1947	854
3273_Skin colour	3273_Skin colour	25	855	1	4676	3517	4151	855	3233	1716	3976	1101	4251
3448_Impedance measures - Impedance of leg (right)	3448_Impedance measures - Impedance of leg (right)	25	855	1	1247	1607	3878	2397	1888	3713	855	2000	861
2569_TGFB3 - Transforming growth factor beta-3	2569_TGFB3 - Transforming growth factor beta-3	25	856	1	856	1865	4396	2093	3326	2733	2014	1358	2639
464_Lipid::Bile acid metabolism::cholate	464_Lipid::Bile acid metabolism::cholate	25	857	1	2717	857	1981	3520	1534	1702	2004	1262	4306
3781_Depression - Trouble falling asleep	3781_Depression - Trouble falling asleep	25	857	1	4454	1771	1979	857	2571	3908	4112	4040	3891
3953_Amyotrophic lateral sclerosis (LMM)	3953_Amyotrophic lateral sclerosis (LMM)	25	857	1	2853	1539	4431	4656	1507	2069	857	2045	2955
224_B Mem:%IgA	224_B Mem:%IgA	25	858	1	3474	3482	4056	858	1111	922	1443	4669	2750
1545_White matter hyperintensity volume (GEE, adjusted for multivariable)	1545_White matter hyperintensity volume (GEE, adjusted for multivariable)	25	859	1	859	4526	3208	4367	4131	4659	3838	1261	3582
616_Xenobiotics::Benzoate metabolism::benzoate	616_Xenobiotics::Benzoate metabolism::benzoate	25	859	1	4544	2016	859	4117	1719	1210	1738	1067	3962
2100_LEP - Leptin	2100_LEP - Leptin	25	859	1	2161	4180	2775	3085	3747	859	3457	3200	4170
1377_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	1377_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	25	859	1	4048	3929	3326	3351	3166	3780	859	2515	4131
833_Peptide::Dipeptide::X-14189--leucylalanine	833_Peptide::Dipeptide::X-14189--leucylalanine	25	860	1	860	2282	1733	4421	1666	3238	1911	2853	1689
2757_TNC - Tenascin	2757_TNC - Tenascin	25	860	1	969	4176	3308	2631	3462	860	3315	1112	3557
1905_Hippocampal volume (GEE, adjusted for multivariable)	1905_Hippocampal volume (GEE, adjusted for multivariable)	25	861	1	861	3298	939	883	2296	996	1021	898	2029
3921_Triglycerides cholesterol	3921_Triglycerides cholesterol	25	861	1	4559	861	2627	1984	874	2537	1975	1444	1686
3449_Impedance measures - Impedance of leg (left)	3449_Impedance measures - Impedance of leg (left)	25	861	1	1708	2539	4343	2112	861	2754	1970	1811	1608
2919_CMPK1 - UMP-CMP kinase	2919_CMPK1 - UMP-CMP kinase	25	861	1	3490	2527	4703	4515	2021	2940	953	861	4603
3926_Total-body less head BMD	3926_Total-body less head BMD	25	862	1	3007	2822	862	4529	4357	2179	1258	3130	3120
1931_Occipital brain volume (GEE, adjusted for age and sex)	1931_Occipital brain volume (GEE, adjusted for age and sex)	25	863	1	4698	2556	4530	2485	2015	2064	863	2255	2600
805_::::X-12816	805_::::X-12816	25	863	1	1610	2437	2507	4071	3813	2507	1114	4029	863
63_Age at menarche	63_Age at menarche	25	865	1	2324	1221	1915	1661	2078	865	2467	2804	4052
3029_RB1 - Retinoblastoma-associated protein	3029_RB1 - Retinoblastoma-associated protein	25	866	1	2843	2152	866	2083	1617	4272	2347	2380	3840
2158_MIA - Melanoma-derived growth regulatory protein	2158_MIA - Melanoma-derived growth regulatory protein	25	866	1	3750	1711	925	2029	4441	866	3130	3466	974
1490_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for age and sex)	1490_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for age and sex)	25	866	1	1148	1529	2852	922	1677	3476	4727	866	3370
3749_Traumatic events - Someone to take to doctor when needed as a child	3749_Traumatic events - Someone to take to doctor when needed as a child	25	867	1	3193	2734	1241	3344	3025	867	4025	3145	4199
1894_Shaft Section Modulus (FBAT, female, adjussted for multivariable)	1894_Shaft Section Modulus (FBAT, female, adjussted for multivariable)	25	868	1	1396	868	3255	1534	1641	1202	4202	2410	1030
2051_Periodontal complex trait 5	2051_Periodontal complex trait 5	25	868	1	929	2327	868	4432	1430	4278	3338	1392	2286
1479_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for age and sex)	1479_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for age and sex)	25	869	1	1762	4151	3084	3056	2298	2763	869	2501	2865
3853_Monocyte count (two-way meta)	3853_Monocyte count (two-way meta)	25	870	1	1147	4428	4149	1964	870	2584	2430	4581	4612
3519_Current employment status: In paid employment or self-employed	3519_Current employment status: In paid employment or self-employed	25	871	1	4711	1501	2794	1243	871	4143	1940	1065	1122
2572_CD40LG - CD40 ligand	2572_CD40LG - CD40 ligand	25	871	1	2776	3020	2617	1654	4134	871	4621	2050	4006
4597_Right posterior cingulate	4597_Right posterior cingulate	25	872	1	1384	872	1657	4560	2761	3074	4228	4014	1829
3131_ABL2 - Abelson tyrosine-protein kinase 2	3131_ABL2 - Abelson tyrosine-protein kinase 2	25	873	1	3800	873	3159	1188	2967	4042	4094	2935	3944
4121_Alkaline phosphatase	4121_Alkaline phosphatase	25	873	1	1415	1288	873	4518	3478	1081	3575	4593	3541
3014_SOD2 - Superoxide dismutase [Mn], mitochondrial	3014_SOD2 - Superoxide dismutase [Mn], mitochondrial	25	873	1	3096	2626	2761	4196	4068	4193	873	3283	2837
3255_Tea intake	3255_Tea intake	25	873	1	3824	3236	3238	1102	4509	3390	4535	2412	873
2148_DCN - Decorin	2148_DCN - Decorin	25	874	1	1015	1308	2712	4683	2411	874	1806	1617	1871
2971_EREG - Epiregulin	2971_EREG - Epiregulin	25	875	1	3986	1452	2435	875	963	2479	3484	1081	2913
3635_Illnesses of father: Alzheimer's disease/dementia	3635_Illnesses of father: Alzheimer's disease/dementia	25	876	1	4523	2703	3195	876	4064	1901	4609	3810	2509
2365_ULBP2 - NKG2D ligand 2	2365_ULBP2 - NKG2D ligand 2	25	876	1	3155	2769	1706	1307	4660	3969	3898	876	2978
4593_Right pars orbitalis	4593_Right pars orbitalis	25	878	1	1541	878	3942	2943	2756	2189	1882	3631	1606
4752_Superior corona radiata radial diusivities	4752_Superior corona radiata radial diusivities	25	878	1	4265	1508	878	3421	4223	3805	2302	2418	3217
2288_PROC - Vitamin K-dependent protein C	2288_PROC - Vitamin K-dependent protein C	25	879	1	3711	4581	2065	1915	1685	3182	879	3889	3317
3309_Wears glasses or contact lenses	3309_Wears glasses or contact lenses	25	880	1	880	2051	2891	4110	992	1046	3181	2377	2661
346_NKearly:%337+335+2-	346_NKearly:%337+335+2-	25	880	1	4637	982	880	2675	1642	2003	3868	1142	1674
3312_Electronic device use - Plays computer games	3312_Electronic device use - Plays computer games	25	880	1	1674	1473	3790	3886	880	3553	2620	2650	4401
4616_4th ventricle	4616_4th ventricle	25	880	1	4513	2862	2654	1001	1947	880	1904	3866	3773
2317_PDCD1LG2 - Programmed cell death 1 ligand 2	2317_PDCD1LG2 - Programmed cell death 1 ligand 2	25	882	1	2213	882	3024	3377	3443	1277	3513	2315	1009
3780_Depression - Did your sleep change?	3780_Depression - Did your sleep change?	25	882	1	1533	2610	1349	1811	1665	882	4724	1014	4130
3201_Job involves heavy manual or physical work	3201_Job involves heavy manual or physical work	25	883	1	4489	3930	883	1028	2290	1634	3829	1140	2692
4074_Body Mass Index	4074_Body Mass Index	25	884	1	884	4019	3815	1892	1984	1164	3217	3590	2977
2252_KAT6A - Histone acetyltransferase KAT6A	2252_KAT6A - Histone acetyltransferase KAT6A	25	884	1	1934	4137	3631	884	3531	4643	4548	2112	3458
3345_Ever had stillbirth, spontaneous miscarriage or termination (female)	3345_Ever had stillbirth, spontaneous miscarriage or termination (female)	25	884	1	2427	2170	3705	1795	884	3685	1898	1097	1723
4382_Epithelial ovarian cancer (high -grade and low-grade serous)	4382_Epithelial ovarian cancer (high -grade and low-grade serous)	25	885	1	4119	3729	4390	1893	3204	885	3658	2625	1058
1647_P-selectin (at exam 7, GEE, adjusted for age and sex)	1647_P-selectin (at exam 7, GEE, adjusted for age and sex)	25	885	1	2414	3914	2935	3225	3988	3798	900	885	2501
1137_Father's age at death	1137_Father's age at death	25	886	1	4061	3559	1445	886	3319	1131	3758	3055	2261
4748_Posterior limb of internal capsule radial diusivities	4748_Posterior limb of internal capsule radial diusivities	25	886	1	4424	1894	4426	4543	2293	4525	886	2317	3788
4044_Body Mass Index	4044_Body Mass Index	25	886	1	4704	2219	2429	1119	4299	1303	2960	2761	886
3914_Disc area	3914_Disc area	25	888	1	3635	3283	1661	888	3046	1890	3599	2190	4681
2815_CLEC1B - C-type lectin domain family 1 member B	2815_CLEC1B - C-type lectin domain family 1 member B	25	888	1	2293	3641	1313	2913	2027	2034	4337	4257	888
4721_Fornix (column and body of fornix) mode of anisotropy	4721_Fornix (column and body of fornix) mode of anisotropy	25	889	1	3068	1663	889	1935	4414	905	4276	4184	1212
2088_CDH1 - Cadherin-1	2088_CDH1 - Cadherin-1	25	889	1	1313	1404	2929	2128	889	3637	2277	4364	1985
4210_Chronic kidney disease	4210_Chronic kidney disease	25	889	1	4125	2036	2870	4080	2928	930	889	2203	3784
1476_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	1476_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	25	890	1	890	3418	2695	3083	4053	2147	3299	1499	1454
2929_CSF3 - Granulocyte colony-stimulating factor	2929_CSF3 - Granulocyte colony-stimulating factor	25	890	1	4570	2929	890	1493	4119	4182	3137	1417	4704
1083_Hemoglobin A1C level in intensive treatment group	1083_Hemoglobin A1C level in intensive treatment group	25	890	1	3789	1323	2711	2681	2831	890	1979	4224	3882
2841_GREM1 - Gremlin-1	2841_GREM1 - Gremlin-1	25	891	1	891	3786	1877	4179	1599	2203	2504	1068	4074
1538_White matter hyperintensity volume (FBAT, adjusted for age and sex)	1538_White matter hyperintensity volume (FBAT, adjusted for age and sex)	25	891	1	4282	1893	4106	2332	2490	891	2675	4554	3190
2487_PRKCI - Protein kinase C iota type	2487_PRKCI - Protein kinase C iota type	25	893	1	3991	3625	893	2727	1676	3338	2734	3819	2652
1009_Stromal cell-derived factor-1 alpha (CXCL12)	1009_Stromal cell-derived factor-1 alpha (CXCL12)	25	894	1	4043	3902	4640	894	1334	2163	4051	1774	3986
2623_IGF2R - Cation-independent mannose-6-phosphate receptor	2623_IGF2R - Cation-independent mannose-6-phosphate receptor	25	894	1	2220	3532	1438	1570	894	2014	1516	1621	1099
4294_Chronotype	4294_Chronotype	25	894	1	2034	2348	2399	2836	4578	2532	894	1382	3867
3288_Fed-up feelings	3288_Fed-up feelings	25	895	1	4511	1067	895	4661	1752	1491	4096	4678	4512
4467_Left precuneus	4467_Left precuneus	25	895	1	2677	3601	2184	2136	1745	3408	1346	895	2945
1653_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for multivariable)	1653_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for multivariable)	25	896	1	992	1636	1691	4642	4499	1290	1860	896	2784
2080_PLA2G5 - Calcium-dependent phospholipase A2	2080_PLA2G5 - Calcium-dependent phospholipase A2	25	896	1	2004	3519	1058	3736	4217	3525	4661	1227	896
2705_ASGR1 - Asialoglycoprotein receptor 1	2705_ASGR1 - Asialoglycoprotein receptor 1	25	897	1	4324	4198	2602	2079	897	2918	3921	1750	3070
1693_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for multivariable)	1693_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for multivariable)	25	897	1	2814	3454	2111	1459	1881	897	3202	2476	4329
4586_Right lateral orbitofrontal	4586_Right lateral orbitofrontal	25	897	1	4204	4173	3933	4615	3705	3138	4205	1371	897
2532_LYN - Tyrosine-protein kinase Lyn	2532_LYN - Tyrosine-protein kinase Lyn	25	898	1	2033	2366	3851	4200	3363	1729	2909	3493	898
2087_ANGPT4 - Angiopoietin-4	2087_ANGPT4 - Angiopoietin-4	25	899	1	2938	4503	899	3198	3075	3127	2331	2840	1370
2962_LIFR - Leukemia inhibitory factor receptor	2962_LIFR - Leukemia inhibitory factor receptor	25	901	1	1239	2008	1956	1151	3306	901	3608	1329	3905
3439_Tobacco smoking	3439_Tobacco smoking	25	902	1	1690	912	3463	4002	3625	902	4629	4323	1568
674_::::X-08402	674_::::X-08402	25	903	1	903	1687	4153	1411	1831	3185	2388	1239	1808
2880_EMR2 - EGF-like module-containing mucin-like hormone receptor-like 2	2880_EMR2 - EGF-like module-containing mucin-like hormone receptor-like 2	25	903	1	1099	3028	903	4244	2075	4539	2637	3092	3332
3435_Body Mass Index	3435_Body Mass Index	25	903	2	1177	3526	2655	2251	903	2535	2065	4247	2145
2686_DYNLRB1 - Dynein light chain roadblock-type 1	2686_DYNLRB1 - Dynein light chain roadblock-type 1	25	903	1	4260	2582	4475	1564	3515	3426	2724	1356	903
3051_EPHB2 - Ephrin type-B receptor 2	3051_EPHB2 - Ephrin type-B receptor 2	25	904	1	1883	3380	3382	904	2008	3720	994	1746	2647
2164_PROS1 - Vitamin K-dependent protein S	2164_PROS1 - Vitamin K-dependent protein S	25	905	1	2693	905	3482	3773	4676	2321	3543	3279	4354
840_::::X-14541	840_::::X-14541	25	905	1	2558	4105	905	1068	1583	993	4590	3983	2141
715_::::X-11497	715_::::X-11497	25	906	1	906	2035	2535	2627	2936	3534	3823	2691	2635
1013_Vascular endothelial growth factor	1013_Vascular endothelial growth factor	25	906	1	2921	4152	2902	906	1518	4059	3793	2918	4713
2310_IL18RAP - Interleukin-18 receptor accessory protein	2310_IL18RAP - Interleukin-18 receptor accessory protein	25	907	1	2922	3587	907	2753	1068	1377	2634	3306	1150
1439_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1439_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	907	1	3652	1835	3368	907	3383	3897	4298	3121	3097
2657_CKB - Creatine kinase B-type	2657_CKB - Creatine kinase B-type	25	908	1	3530	2413	1461	3941	4300	2576	2334	2444	908
736_::::X-11845	736_::::X-11845	25	910	1	910	3355	4179	3322	4554	2019	1731	1457	4397
3889_Monocyte count (three-way meta)	3889_Monocyte count (three-way meta)	25	910	1	1924	3304	2982	2151	910	1836	1549	2965	4395
3016_NAMPT - Nicotinamide phosphoribosyltransferase	3016_NAMPT - Nicotinamide phosphoribosyltransferase	25	910	1	3732	1102	2734	1156	1286	3140	910	2914	4440
375_Amino acid::Glutamate metabolism::glutamine	375_Amino acid::Glutamate metabolism::glutamine	25	911	1	4279	939	911	2699	2071	929	1629	1494	1967
350_gdT:%CM (1)	350_gdT:%CM (1)	25	911	1	3605	3383	4746	3337	4709	2570	2928	4072	911
4570_Left rostral middle frontal	4570_Left rostral middle frontal	25	912	1	1608	3336	912	1013	4616	1409	1201	3315	3524
3357_Likelihood of resuming smoking	3357_Likelihood of resuming smoking	25	913	1	913	3592	4676	2740	3162	3297	3022	4156	3083
644_Xenobiotics::Xanthine metabolism::3-methylxanthine	644_Xenobiotics::Xanthine metabolism::3-methylxanthine	25	913	1	4574	4487	2898	4481	1420	3161	913	1524	2903
875_Glycoprotein acetyls, mainly a1Lacid glycoprotein	875_Glycoprotein acetyls, mainly a1Lacid glycoprotein	25	914	1	4183	3966	2339	914	2558	4211	3436	1807	1199
2247_NR3C1 - Glucocorticoid receptor	2247_NR3C1 - Glucocorticoid receptor	25	914	1	4625	2676	2419	1178	914	1675	1875	4378	1279
4163_Generalized epilepsy with tonic-clonic seizures	4163_Generalized epilepsy with tonic-clonic seizures	25	914	1	1912	1754	3917	1236	4202	914	1017	2954	3505
2053_Advanced adenoma	2053_Advanced adenoma	25	915	1	915	2722	3873	4277	2148	4055	2081	3874	3502
4404_Menstrual quality of life impact: Nervousness	4404_Menstrual quality of life impact: Nervousness	25	915	1	1914	1107	915	2296	2964	999	2118	4061	2618
4621_Left cerebellum white matter	4621_Left cerebellum white matter	25	915	1	4428	4238	1200	3789	915	3102	2125	1443	1929
4056_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	4056_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	915	1	1968	3162	2605	4458	2060	3334	4065	2753	915
3132_BCAR3 - Breast cancer anti-estrogen resistance protein 3	3132_BCAR3 - Breast cancer anti-estrogen resistance protein 3	25	916	1	3222	916	2294	2066	4400	2066	3705	3604	3845
3054_GPNMB - Transmembrane glycoprotein NMB	3054_GPNMB - Transmembrane glycoprotein NMB	25	916	1	4437	3486	1939	2885	4368	2998	2805	916	3023
4691_Anterior corona radiata mean diusivities	4691_Anterior corona radiata mean diusivities	25	918	1	3554	1643	2626	1093	2030	4430	918	3195	2798
4486_Right lingual	4486_Right lingual	25	918	1	2157	1696	3655	3556	4269	2807	2318	1939	918
3112_KIF23 - Kinesin-like protein KIF23	3112_KIF23 - Kinesin-like protein KIF23	25	919	1	919	4633	958	1961	4503	2996	3052	3482	3352
2311_IL1RL2 - Interleukin-1 receptor-like 2	2311_IL1RL2 - Interleukin-1 receptor-like 2	25	920	1	920	3698	1508	2724	4542	2162	1796	4676	1878
2398_GNLY - Granulysin	2398_GNLY - Granulysin	25	920	1	3780	4202	3877	2318	1821	4702	920	4316	2338
1785_PR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1785_PR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	921	1	4404	1379	921	2678	3909	3436	3617	1030	2400
440_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,6-anhydroglucose	440_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,6-anhydroglucose	25	922	1	922	1998	2160	3132	1138	4025	2235	1282	2059
2046_Periodontal complex trait 1 - Socransky trait	2046_Periodontal complex trait 1 - Socransky trait	25	922	1	3738	922	2618	2437	4317	3700	1899	3638	2787
342_NKearly:%337+335+R7-	342_NKearly:%337+335+R7-	25	922	1	2646	950	4209	1764	4087	2854	922	2358	1244
2783_LCMT1 - Leucine carboxyl methyltransferase 1	2783_LCMT1 - Leucine carboxyl methyltransferase 1	25	923	1	1429	923	1149	4625	1728	3552	2653	1486	1914
356_IgG+B:%20+24+27+	356_IgG+B:%20+24+27+	25	923	1	927	1710	3454	923	3800	3347	3128	4098	3646
4515_4th ventricle	4515_4th ventricle	25	923	1	3865	3271	4739	1613	1151	923	948	3804	4321
2302_ESAM - Endothelial cell-selective adhesion molecule	2302_ESAM - Endothelial cell-selective adhesion molecule	25	923	1	3137	3548	4716	1264	3432	4090	923	2969	3696
4628_Left accumbens area	4628_Left accumbens area	25	924	1	3872	2306	2267	1318	2206	1838	2275	3909	924
3669_Diagnoses - main ICD10: K21 Gastro-esophageal reflux disease	3669_Diagnoses - main ICD10: K21 Gastro-esophageal reflux disease	25	925	1	3776	925	2415	2282	2501	2959	2098	3424	1758
4256_Sleep midpoint	4256_Sleep midpoint	25	925	1	1137	4181	3067	925	2876	2374	3164	3187	1893
1625_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for multivariable)	1625_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for multivariable)	25	926	1	3755	4343	3258	926	1350	1815	1863	1295	1617
4585_Right lateral occipital	4585_Right lateral occipital	25	927	1	4402	927	3097	3283	3630	4050	4604	2458	3135
522_Lipid::Long chain fatty acid::myristoleate (14:1n5)	522_Lipid::Long chain fatty acid::myristoleate (14:1n5)	25	927	1	1041	2046	2812	3141	927	4239	1287	2549	2740
2727_FGF4 - Fibroblast growth factor 4	2727_FGF4 - Fibroblast growth factor 4	25	927	1	1767	4631	4566	3601	2818	927	3146	2730	4470
4174_Social support - Leisure/social activities: Religious group	4174_Social support - Leisure/social activities: Religious group	25	928	1	1910	4694	928	3572	3786	4473	1578	2545	2304
533_Lipid::Lysolipid::1-docosahexaenoylglycerophosphocholine*	533_Lipid::Lysolipid::1-docosahexaenoylglycerophosphocholine*	25	928	1	990	4128	1624	1996	928	1651	2094	1773	2121
4319_Life satisfaction (univariate)	4319_Life satisfaction (univariate)	25	929	1	1198	929	2383	1855	2872	2480	3214	1012	4402
2095_TNFRSF11B - Tumor necrosis factor receptor superfamily member 11B	2095_TNFRSF11B - Tumor necrosis factor receptor superfamily member 11B	25	929	1	4009	3857	929	4707	4118	1676	2845	4351	3149
3305_Lifetime number of sexual partners	3305_Lifetime number of sexual partners	25	929	1	1519	1223	4166	3104	2543	3339	1152	929	2521
2396_CNDP2 - Cytosolic non-specific dipeptidase	2396_CNDP2 - Cytosolic non-specific dipeptidase	25	930	1	930	4450	1178	2634	3388	1002	1887	4337	2460
2596_FCN1 - Ficolin-1	2596_FCN1 - Ficolin-1	25	930	1	1721	2003	3393	2178	930	4589	4284	2361	4624
753_::::X-12092	753_::::X-12092	25	931	1	1550	1062	931	989	2934	4229	4254	4512	2375
2422_WFIKKN2 - WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2	2422_WFIKKN2 - WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2	25	931	1	3295	2837	1060	1077	1574	3305	931	2400	2529
3219_Time spent watching television (TV)	3219_Time spent watching television (TV)	25	931	1	1354	4474	2046	1900	2320	4072	2507	931	1283
497_Lipid::Fatty acid, dicarboxylate::2-hydroxyglutarate	497_Lipid::Fatty acid, dicarboxylate::2-hydroxyglutarate	25	932	1	3757	2312	932	1876	2256	3319	2444	3837	2122
3234_Daytime dozing / sleeping (narcolepsy)	3234_Daytime dozing / sleeping (narcolepsy)	25	932	1	1190	1447	1542	4728	932	1736	1211	1119	1562
774_::::X-12428	774_::::X-12428	25	933	1	2486	2252	1333	933	2063	1667	2477	1518	4197
3698_Diagnoses - secondary ICD10: K44 Diaphragmatic hernia	3698_Diagnoses - secondary ICD10: K44 Diaphragmatic hernia	25	933	1	2555	1770	4381	2707	2100	933	4071	1026	1038
2660_DMP1 - Dentin matrix acidic phosphoprotein 1	2660_DMP1 - Dentin matrix acidic phosphoprotein 1	25	933	1	2982	4691	3317	955	2189	4236	933	1844	3157
3575_Pain type(s) experienced in last month: Knee pain	3575_Pain type(s) experienced in last month: Knee pain	25	934	1	2210	934	1638	1698	3839	1744	3514	3386	2729
2357_IGHM IGJ IGK@ IGL@ - Immunoglobulin M	2357_IGHM IGJ IGK@ IGL@ - Immunoglobulin M	25	934	1	4509	2216	1287	2595	934	3879	3140	2878	3322
4246_Right handed	4246_Right handed	25	935	1	935	3896	4406	1387	4440	3257	1548	3664	1420
602_Peptide::gamma-glutamyl::gamma-glutamylglutamine	602_Peptide::gamma-glutamyl::gamma-glutamylglutamine	25	935	1	2222	4409	2833	1719	2780	3307	935	3811	3436
4053_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	4053_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	936	1	4485	936	2684	1638	1000	3577	4085	2931	3940
1766_Heart failure (free of MI, FBAT, adjusted for multivariable)	1766_Heart failure (free of MI, FBAT, adjusted for multivariable)	25	936	1	3066	3801	3672	2144	2871	936	3058	1077	1402
3053_TNFRSF18 - Tumor necrosis factor receptor superfamily member 18	3053_TNFRSF18 - Tumor necrosis factor receptor superfamily member 18	25	937	1	3243	2806	2373	4014	937	4377	3227	2872	2070
1201_Focal epilepsy	1201_Focal epilepsy	25	937	1	4174	1008	1274	3159	4740	1827	937	1556	3315
741_::::X-11858	741_::::X-11858	25	938	1	3741	1380	2813	938	3859	3152	2289	2790	2842
4589_Right middle temporal	4589_Right middle temporal	25	938	1	2103	984	3599	3863	3364	938	2082	3937	2806
1917_Temporal brain volume (GEE, adjusted for multivariable)	1917_Temporal brain volume (GEE, adjusted for multivariable)	25	942	1	942	4108	1560	1269	3094	2386	2249	997	2095
4048_Plantar fasciitis	4048_Plantar fasciitis	25	942	1	3984	942	1366	2358	1589	1641	950	3062	1290
4339_Walking	4339_Walking	25	942	1	2062	3416	4631	2546	2769	1797	4340	942	4488
2564_CCL15 - C-C motif chemokine 15	2564_CCL15 - C-C motif chemokine 15	25	943	1	2434	2347	4307	943	2065	1873	4600	1040	3631
4085_Type 2 Diabetes	4085_Type 2 Diabetes	25	943	1	1463	4260	2577	3059	943	3605	1054	4231	2886
531_Lipid::Lysolipid::1-arachidonoylglycerophosphoethanolamine*	531_Lipid::Lysolipid::1-arachidonoylglycerophosphoethanolamine*	25	944	1	944	4136	2076	3700	3952	2859	3538	2332	2195
2179_NOV - Protein NOV homolog	2179_NOV - Protein NOV homolog	25	944	1	4646	2315	1752	951	4378	944	1641	3952	3413
329_CD4Nv:%TFH (3)	329_CD4Nv:%TFH (3)	25	946	1	1139	3724	946	3052	3066	3664	3668	3788	3632
4301_Arms-arm fat ratio (male)	4301_Arms-arm fat ratio (male)	25	946	1	1045	3514	3009	946	2914	3753	2773	2261	1248
1346_Plasma Apolipoprotein A-I level (FBAT, adjusted for age and sex)	1346_Plasma Apolipoprotein A-I level (FBAT, adjusted for age and sex)	25	946	1	3961	3202	3352	2878	3321	1052	946	3717	1848
2062_CCL27 - C-C motif chemokine 27	2062_CCL27 - C-C motif chemokine 27	25	947	1	3363	4583	1534	947	3907	1560	3737	2939	3621
636_Xenobiotics::Food component, Plant::stachydrine	636_Xenobiotics::Food component, Plant::stachydrine	25	947	1	3302	3143	1908	2770	1860	947	4295	4241	2401
450_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,Z or Z,E)*	450_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,Z or Z,E)*	25	948	1	1872	948	4456	4226	2567	3112	1222	2553	2324
974_Cutaneous T-cell attracting (CCL27)	974_Cutaneous T-cell attracting (CCL27)	25	948	1	3924	3513	3835	3429	948	1777	978	2430	4651
639_Xenobiotics::Tobacco metabolite::cotinine	639_Xenobiotics::Tobacco metabolite::cotinine	25	948	1	3476	1128	3127	3165	2925	948	1318	2940	2815
2679_PTEN - Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	2679_PTEN - Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	25	949	1	3009	2888	4174	949	3654	2903	2790	1918	2467
2712_KPNB1 - Importin subunit beta-1	2712_KPNB1 - Importin subunit beta-1	25	949	1	4342	4292	3781	3549	949	2152	4111	1575	4477
3643_Illnesses of mother: Chronic bronchitis/emphysema	3643_Illnesses of mother: Chronic bronchitis/emphysema	25	949	1	3145	1471	1290	3370	1591	2413	2573	4739	949
1961_Mean MMSE score for exam 5 and 7 (GEE, adjusted for multivariable)	1961_Mean MMSE score for exam 5 and 7 (GEE, adjusted for multivariable)	25	950	1	3903	2686	4712	950	2168	2750	4093	2602	2248
1713_Thyroid stimulation hormone (at exam 4, GEE, adjusted for age and sex)	1713_Thyroid stimulation hormone (at exam 4, GEE, adjusted for age and sex)	25	950	1	1158	2123	3685	4084	2435	4087	2649	950	2956
2803_SPHK1 - Sphingosine kinase 1	2803_SPHK1 - Sphingosine kinase 1	25	951	1	3420	1809	3438	4030	4001	1563	2967	2279	951
4233_Antimigraine preparations	4233_Antimigraine preparations	25	952	1	2998	952	3204	1500	2792	1794	3033	4515	3815
3541_Reason for glasses/contact lenses: For just reading/near work as you are getting older (called 'presbyopia')	3541_Reason for glasses/contact lenses: For just reading/near work as you are getting older (called 'presbyopia')	25	953	1	953	2240	2940	2298	2512	2703	4117	4011	3399
745_::::X-12007	745_::::X-12007	25	953	1	1559	1266	953	1114	2861	4219	4457	1420	4644
2349_KLRK1 - NKG2-D type II integral membrane protein	2349_KLRK1 - NKG2-D type II integral membrane protein	25	953	1	4284	4233	4039	953	2219	2226	3240	4490	2763
4649_Average across all tracts fractional anisotropy	4649_Average across all tracts fractional anisotropy	25	954	1	954	4150	2703	1303	4734	3328	1262	3613	2433
1214_Alcohol consumption (male)	1214_Alcohol consumption (male)	25	954	1	3520	4148	4469	954	3461	2519	4220	3081	3520
612_Xenobiotics::Benzoate metabolism::2-hydroxyhippurate (salicylurate)	612_Xenobiotics::Benzoate metabolism::2-hydroxyhippurate (salicylurate)	25	954	1	4131	1738	4501	3454	1505	1279	954	2798	2273
4618_Left lateral ventricle	4618_Left lateral ventricle	25	956	1	956	4679	4049	2858	1218	3300	1729	3047	2625
3707_Diagnoses - secondary ICD10: Z72 Problems related to lifestyle	3707_Diagnoses - secondary ICD10: Z72 Problems related to lifestyle	25	956	1	3259	956	4533	4045	4099	3800	3951	972	3787
4407_Menstrual quality of life impact: Stiff neck	4407_Menstrual quality of life impact: Stiff neck	25	956	1	4275	3808	2505	956	2802	2946	4285	1055	1521
787_::::X-12644	787_::::X-12644	25	957	1	957	1155	2847	2462	3256	3362	3368	4018	2644
1779_Heart failure (censored at interval MI, GEE, adjusted for multivariable)	1779_Heart failure (censored at interval MI, GEE, adjusted for multivariable)	25	958	1	958	2214	1552	2086	2549	1723	2084	2381	3027
646_Xenobiotics::Xanthine metabolism::caffeine	646_Xenobiotics::Xanthine metabolism::caffeine	25	958	1	3830	2853	3325	972	3594	3340	2738	3938	958
2538_SELE - E-Selectin	2538_SELE - E-Selectin	25	959	1	4691	3392	959	3775	2421	1115	3003	4053	2418
593_Peptide::Dipeptide::glycylvaline	593_Peptide::Dipeptide::glycylvaline	25	959	1	4396	3968	2657	1808	959	4450	1804	3136	2687
2886_HDGFRP2 - Hepatoma-derived growth factor-related protein 2	2886_HDGFRP2 - Hepatoma-derived growth factor-related protein 2	25	959	1	4314	1016	2550	4440	2932	959	3929	2392	4328
1945_Total cerebral brain volume (GEE, adjusted for multivariable with APOE)	1945_Total cerebral brain volume (GEE, adjusted for multivariable with APOE)	25	961	1	2470	3871	961	1605	4637	1911	1736	4362	3355
3374_Headaches for 3+ months	3374_Headaches for 3+ months	25	961	1	1412	3238	2413	4450	3303	1412	961	3949	4351
3315_Use of sun/uv protection	3315_Use of sun/uv protection	25	962	1	3722	3618	3572	1244	1437	962	3248	2644	4648
505_Lipid::Fatty acid, monohydroxy::2-hydroxystearate	505_Lipid::Fatty acid, monohydroxy::2-hydroxystearate	25	962	1	1405	3571	1932	2924	1675	1071	2313	2130	962
238_CD27 on IgA+B	238_CD27 on IgA+B	25	963	1	963	2870	2932	2159	3597	4515	2224	2637	3529
5_Bipolar disorder	5_Bipolar disorder	25	963	1	4463	963	4624	2907	1963	4667	2947	3579	1658
621_Xenobiotics::Drug::2-methoxyacetaminophen sulfate*	621_Xenobiotics::Drug::2-methoxyacetaminophen sulfate*	25	965	1	3468	1087	2755	3591	2019	3049	995	3851	965
4702_Inferior fronto-occipital fasciculus mean diusivities	4702_Inferior fronto-occipital fasciculus mean diusivities	25	966	1	1839	3256	966	1007	4276	3060	4256	2123	3321
3610_Treatment/medication code: multivitamins	3610_Treatment/medication code: multivitamins	25	967	1	967	2616	2473	4609	2378	2129	1692	4564	4272
3912_Cup area	3912_Cup area	25	969	1	1580	4462	1540	2450	1674	969	3018	3392	3503
2480_DKK4 - Dickkopf-related protein 4	2480_DKK4 - Dickkopf-related protein 4	25	969	1	2392	2014	2127	1446	4742	2296	969	3781	3807
494_Lipid::Fatty acid metabolism (also BCAA metabolism)::butyrylcarnitine	494_Lipid::Fatty acid metabolism (also BCAA metabolism)::butyrylcarnitine	25	970	1	2734	2728	970	2922	3324	1430	4299	2865	2293
4287_FVC	4287_FVC	25	971	1	3860	971	1226	4104	1363	2916	2528	1959	3340
2246_MAPK3 - Mitogen-activated protein kinase 3	2246_MAPK3 - Mitogen-activated protein kinase 3	25	971	1	4077	4417	2275	1801	3895	3737	4638	3208	971
773_::::X-12407	773_::::X-12407	25	972	1	4232	972	2727	1321	3445	1721	4083	2274	2911
33_Extraversion (IRT)	33_Extraversion (IRT)	25	975	1	4299	975	1024	3918	1446	2897	3364	4034	3148
2126_HSP90AA1 HSP90AB1 - Heat shock protein HSP 90-alpha/beta	2126_HSP90AA1 HSP90AB1 - Heat shock protein HSP 90-alpha/beta	25	975	1	4172	3401	1812	3977	1308	1066	1969	975	4494
2777_FER - Tyrosine-protein kinase Fer	2777_FER - Tyrosine-protein kinase Fer	25	975	1	2823	3334	2279	2368	3696	1420	4213	4447	975
4505_Right transverse temporal	4505_Right transverse temporal	25	976	1	976	4143	2980	2438	4260	4144	3778	3895	2316
1658_Alkaline phosphatase (at exam 2, FBAT, adjusted for age and sex)	1658_Alkaline phosphatase (at exam 2, FBAT, adjusted for age and sex)	25	976	1	4079	2278	976	1039	3228	2669	3087	1883	2202
1053_Neuroblastoma	1053_Neuroblastoma	25	976	1	4371	4615	1749	3431	2367	3007	976	4363	1077
2392_CRISP3 - Cysteine-rich secretory protein 3	2392_CRISP3 - Cysteine-rich secretory protein 3	25	976	1	1496	4405	4341	2103	4028	4033	3917	976	2372
3761_Depression - Recent trouble concentrating on things	3761_Depression - Recent trouble concentrating on things	25	976	1	1602	2342	3174	2466	3741	3669	1607	4626	976
2338_MB - Myoglobin	2338_MB - Myoglobin	25	977	1	977	2025	2361	3720	3513	2611	2300	4727	3776
1555_Mean common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1555_Mean common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	977	1	4322	4544	977	4221	2086	4365	1760	3089	2323
3087_RTN4 - Reticulon-4	3087_RTN4 - Reticulon-4	25	978	1	1516	2358	2514	978	4290	2407	4545	1909	2189
104_Late pubertal growth	104_Late pubertal growth	25	979	1	979	1423	3202	4205	3496	1411	1249	3755	3438
1546_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for age and sex)	1546_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for age and sex)	25	979	1	2503	2201	979	3105	3539	4324	4380	3305	2040
2522_GZMA - Granzyme A	2522_GZMA - Granzyme A	25	979	1	1973	2289	3920	979	3797	2125	2908	3052	4332
2204_IL22 - Interleukin-22	2204_IL22 - Interleukin-22	25	979	1	2676	4396	3821	2413	1268	4398	979	3160	3915
2114_TYRO3 - Tyrosine-protein kinase receptor TYRO3	2114_TYRO3 - Tyrosine-protein kinase receptor TYRO3	25	980	1	1251	1352	2306	3792	2487	980	1508	3410	3973
2043_Bipolar disorder	2043_Bipolar disorder	25	980	1	1170	4285	3277	1048	3999	2676	1894	3426	980
3664_External causes: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	3664_External causes: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	25	984	1	1427	1510	2489	1298	984	3276	3369	1400	3441
1012_TNF-related apoptosis inducing ligand	1012_TNF-related apoptosis inducing ligand	25	984	1	2118	3002	3154	2261	4266	984	4125	4657	3907
3138_CCL11 - Eotaxin	3138_CCL11 - Eotaxin	25	984	1	3833	1162	1937	2400	2888	2877	2052	3272	984
1857_Neck average buckling ratio (GEE, male, adjussted for age)	1857_Neck average buckling ratio (GEE, male, adjussted for age)	25	985	1	985	2524	2245	2192	4027	3545	2215	3653	1458
4193_PR interval	4193_PR interval	25	986	1	2975	4400	2904	3543	4480	1408	986	2288	1316
1120_Pericardial adipose tissue volume (adjusted for height and weight)	1120_Pericardial adipose tissue volume (adjusted for height and weight)	25	987	1	987	1034	2999	3994	4550	2583	2231	4203	2217
2605_CDC42BPB - Serine/threonine-protein kinase MRCK beta	2605_CDC42BPB - Serine/threonine-protein kinase MRCK beta	25	987	1	2531	1173	2623	3362	3426	3966	1446	4328	987
1812_Biologic age by osseographic scoring system (FBAT, adjusted for multivariable)	1812_Biologic age by osseographic scoring system (FBAT, adjusted for multivariable)	25	988	1	4374	4177	988	1504	4074	1776	1193	2948	2390
3167_CDH15 - Cadherin-15	3167_CDH15 - Cadherin-15	25	989	1	1249	2702	1605	4386	989	3486	2102	2297	3393
1774_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for multivariable)	1774_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for multivariable)	25	989	1	4334	1152	3667	2353	3966	989	1595	3335	4513
2471_CA7 - Carbonic anhydrase 7	2471_CA7 - Carbonic anhydrase 7	25	989	1	1999	3153	3651	1509	4652	3292	1752	4064	989
2805_TK1 - Thymidine kinase, cytosolic	2805_TK1 - Thymidine kinase, cytosolic	25	991	1	3268	4577	1654	4038	991	4626	3222	1178	1740
3784_Depression - Weight change during worst episode of depression	3784_Depression - Weight change during worst episode of depression	25	991	1	2540	2296	1472	1962	1094	1000	991	3548	4070
122_Obesity class 3	122_Obesity class 3	25	991	1	3163	2155	3656	4008	2379	1213	2817	991	3338
4129_White blood cell count	4129_White blood cell count	25	992	1	3064	992	2101	4604	2851	1754	2625	2586	3977
786_::::X-12627	786_::::X-12627	25	992	1	1540	2746	992	2748	4192	1590	3325	3438	1536
2435_CNTN4 - Contactin-4	2435_CNTN4 - Contactin-4	25	993	1	4663	1099	993	2767	4280	4508	3086	1649	2404
2994_PTK2 - Focal adhesion kinase 1	2994_PTK2 - Focal adhesion kinase 1	25	994	1	3337	4339	1983	994	1696	1587	1049	4698	2716
3329_Cancer (diagnosed by doctor)	3329_Cancer (diagnosed by doctor)	25	995	1	3078	3167	995	4697	4291	3445	3649	3630	1895
4289_PEF	4289_PEF	25	995	1	3914	1456	1432	4173	4170	4341	3398	3951	995
3350_Bilateral oophorectomy (both ovaries removed) (female)	3350_Bilateral oophorectomy (both ovaries removed) (female)	25	996	1	996	3927	3593	2863	3126	2326	3842	3776	2597
1276_Sabuctaneous fat by CT (FBAT, adjusted for age and sex)	1276_Sabuctaneous fat by CT (FBAT, adjusted for age and sex)	25	996	1	3360	996	4267	3232	4430	3061	2549	1731	1169
2411_ASAH2 - Neutral ceramidase	2411_ASAH2 - Neutral ceramidase	25	996	1	1448	2847	996	1700	3262	3280	1551	3232	3111
1184_High-density lipoprotein cholesterol	1184_High-density lipoprotein cholesterol	25	997	1	3756	997	1369	2034	2905	4225	3056	1841	3421
2647_MMP10 - Stromelysin-2	2647_MMP10 - Stromelysin-2	25	997	1	1662	2105	2411	997	3173	4521	1897	4440	2091
1842_Neck Section Modulus (FBAT, female, adjusted for multivariable)	1842_Neck Section Modulus (FBAT, female, adjusted for multivariable)	25	998	1	3118	3030	4213	4325	2164	998	1971	1342	1883
3998_Tense / 'highly strung' (TENSE)	3998_Tense / 'highly strung' (TENSE)	25	998	1	2661	2921	1100	4592	2248	3882	2482	998	2134
1342_Resistin (FBAT, adjusted for age, sex and BMI)	1342_Resistin (FBAT, adjusted for age, sex and BMI)	25	999	1	1511	3848	999	3346	2263	2314	4352	3231	2158
416_Amino acid::Urea cycle; arginine-, proline-, metabolism::ornithine	416_Amino acid::Urea cycle; arginine-, proline-, metabolism::ornithine	25	1001	1	3744	3340	1001	2804	4642	2148	4044	4464	4733
2885_HS6ST1 - Heparan-sulfate 6-O-sulfotransferase 1	2885_HS6ST1 - Heparan-sulfate 6-O-sulfotransferase 1	25	1001	1	3271	2365	3476	3018	3894	1862	1001	1039	3211
4219_Vasodilators used in cardiac diseases	4219_Vasodilators used in cardiac diseases	25	1001	1	1030	2581	1447	3924	1828	2637	4014	4591	1001
2809_DCTPP1 - dCTP pyrophosphatase 1	2809_DCTPP1 - dCTP pyrophosphatase 1	25	1002	1	1117	1002	3592	3829	2253	3665	2044	4313	2112
1563_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1563_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	1003	1	1003	3725	3534	4721	3673	4510	1385	3862	2581
2461_THBS4 - Thrombospondin-4	2461_THBS4 - Thrombospondin-4	25	1003	1	2747	1003	2785	4139	2781	3164	3991	2982	3089
2117_EFNA5 - Ephrin-A5	2117_EFNA5 - Ephrin-A5	25	1004	1	1238	1801	1857	1004	2573	2907	4393	3111	2694
2102_MMP9 - Matrix metalloproteinase-9	2102_MMP9 - Matrix metalloproteinase-9	25	1004	1	2145	1680	1105	3135	2978	1854	1004	2852	1514
285_CD4:%Treg(39+)	285_CD4:%Treg(39+)	25	1004	1	3621	4060	4718	1912	4522	1268	4088	2321	1004
4209_Chronic kidney disease	4209_Chronic kidney disease	25	1005	1	3481	2071	2887	3989	2841	1275	1005	2514	4557
2271_SERPINE1 - Plasminogen activator inhibitor 1	2271_SERPINE1 - Plasminogen activator inhibitor 1	25	1006	1	2423	1006	2083	1750	2904	1371	3539	3500	1293
4411_Total IgG levels	4411_Total IgG levels	25	1006	1	2458	2924	1297	1006	2200	4556	3397	4683	3886
2166_CCL25 - C-C motif chemokine 25	2166_CCL25 - C-C motif chemokine 25	25	1006	1	2662	4458	1475	1149	2401	1673	1440	3642	1006
2136_MST1R - Macrophage-stimulating protein receptor	2136_MST1R - Macrophage-stimulating protein receptor	25	1009	1	3292	4190	1563	1009	4261	3943	4179	4264	1363
4632_Right inferior lateral ventricle	4632_Right inferior lateral ventricle	25	1010	1	3955	3781	3777	1010	1479	4599	1012	2374	3783
4332_Erectile dysfunction	4332_Erectile dysfunction	25	1011	1	3377	2213	4303	4711	1910	2224	1011	2434	3104
3615_Treatment/medication code: lansoprazole	3615_Treatment/medication code: lansoprazole	25	1012	1	1012	4584	4088	3208	1640	4438	3681	2913	3565
4160_Focal Epilepsy, hippocampal sclerosis (HS)	4160_Focal Epilepsy, hippocampal sclerosis (HS)	25	1013	1	2317	1276	1013	3219	2523	3850	1791	1645	3759
3594_Mineral and other dietary supplements: Calcium	3594_Mineral and other dietary supplements: Calcium	25	1014	1	1014	4707	3576	2183	4024	1608	4402	3437	3887
2402_KLK12 - Kallikrein-12	2402_KLK12 - Kallikrein-12	25	1014	1	1433	1852	1014	2744	4039	4620	2859	1166	3267
1856_Neck average buckling ratio (FBAT, male, adjussted for age)	1856_Neck average buckling ratio (FBAT, male, adjussted for age)	25	1015	1	1301	4661	4194	3517	2084	3022	1015	1674	4085
4511_Right basal forebrain	4511_Right basal forebrain	25	1016	1	2437	1782	2788	3420	2674	1016	4183	4428	2649
1104_Low-density lipoprotein - Birth cohorts	1104_Low-density lipoprotein - Birth cohorts	25	1017	1	1017	3493	2562	2886	2535	2525	2327	3006	3105
3578_Social support - Leisure/social activities: Religious group	3578_Social support - Leisure/social activities: Religious group	25	1017	1	1491	1017	4161	3643	3163	4476	2801	2495	3775
4030_Alcohol dependency (bayesian effect  for unrelated genotyped individuals)	4030_Alcohol dependency (bayesian effect  for unrelated genotyped individuals)	25	1017	1	4580	4001	2585	1017	1083	1234	1937	4547	3932
3141_APOE - Apolipoprotein E (isoform E2)	3141_APOE - Apolipoprotein E (isoform E2)	25	1018	1	3659	1018	4439	2970	4628	1070	3232	4219	3487
503_Lipid::Fatty acid, ester::n-Butyl Oleate	503_Lipid::Fatty acid, ester::n-Butyl Oleate	25	1018	1	3822	2171	1018	1675	4419	2786	3928	2985	4164
1335_Fasting HbA1c (at exam 7, GEE, adjusted for age, sex and BMI)	1335_Fasting HbA1c (at exam 7, GEE, adjusted for age, sex and BMI)	25	1018	1	4432	4219	2205	1018	2136	2791	3430	4382	3816
1428_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1428_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	1018	1	1299	1145	2598	2430	2516	1018	2465	1209	4266
837_::::X-14374	837_::::X-14374	25	1018	1	1807	3086	1802	4116	2662	3491	1018	1336	2058
1253_Percent predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	1253_Percent predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	25	1018	1	3779	2129	3264	1812	2383	2442	1669	1018	2061
3946_HbA1c	3946_HbA1c	25	1018	1	3115	3019	4701	1413	2035	3203	3435	2525	1018
2248_HAT1 - Histone acetyltransferase type B catalytic subunit	2248_HAT1 - Histone acetyltransferase type B catalytic subunit	25	1019	1	1019	2650	4217	2225	4236	4677	1485	2023	2341
873_Glycerol	873_Glycerol	25	1019	1	2742	1240	3283	2408	4555	1474	1019	2615	3452
3193_Number in household	3193_Number in household	25	1020	1	4327	3385	4478	2429	2854	2630	4286	1020	1505
2703_UBE2L3 - Ubiquitin-conjugating enzyme E2 L3	2703_UBE2L3 - Ubiquitin-conjugating enzyme E2 L3	25	1021	1	1021	3352	2028	2293	3700	3635	1182	3005	4430
301_CD4mem:%PD1-R6+	301_CD4mem:%PD1-R6+	25	1022	1	3086	1022	3189	4402	2426	2001	3696	3834	2194
2195_FGF9 - Fibroblast growth factor 9	2195_FGF9 - Fibroblast growth factor 9	25	1022	1	4545	3174	1022	2260	4594	3410	3830	4306	1125
1450_Low-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	1450_Low-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	1022	1	1621	1200	3899	1022	4384	1979	1415	2323	3575
3666_Diagnoses - main ICD10: D12 Benign neoplasm of colon, rectum, anus and anal canal	3666_Diagnoses - main ICD10: D12 Benign neoplasm of colon, rectum, anus and anal canal	25	1024	1	1024	2274	3241	2605	3724	3574	1797	1378	3093
4180_Platelets	4180_Platelets	25	1026	1	3333	3877	2466	1026	1667	1757	4711	2785	1602
3534_Mental health - Illness, injury, bereavement, stress in last 2 years: Death of a close relative	3534_Mental health - Illness, injury, bereavement, stress in last 2 years: Death of a close relative	25	1027	1	2235	2849	1027	3895	3785	3040	1679	1111	1899
1964_MMSE score (at exam 5, FBAT, adjusted for age)	1964_MMSE score (at exam 5, FBAT, adjusted for age)	25	1027	1	2353	2409	2953	3923	3770	2777	3405	1829	1027
3121_PDE2A - cGMP-dependent 3',5'-cyclic phosphodiesterase	3121_PDE2A - cGMP-dependent 3',5'-cyclic phosphodiesterase	25	1028	1	1028	2583	3555	4599	1381	1180	1673	3877	3942
3751_Traumatic events - Avoided activities or situations because of previous stressful experience in past month	3751_Traumatic events - Avoided activities or situations because of previous stressful experience in past month	25	1028	1	2979	1036	1859	4738	1028	4096	1403	2188	2869
2700_SGTA - Small glutamine-rich tetratricopeptide repeat-containing protein alpha	2700_SGTA - Small glutamine-rich tetratricopeptide repeat-containing protein alpha	25	1030	1	4642	4552	1225	1030	1949	1814	3039	1162	2966
3618_Treatment/medication code: aspirin	3618_Treatment/medication code: aspirin	25	1030	1	3723	1040	1327	2281	1030	4178	3463	2797	4559
2209_MMP3 - Stromelysin-1	2209_MMP3 - Stromelysin-1	25	1031	1	1031	1289	1188	2478	2835	4586	2353	2200	2252
9_Schizophrenia	9_Schizophrenia	25	1031	1	4300	1031	1679	4358	2127	2910	4200	4265	1193
2291_VCAM1 - Vascular cell adhesion protein 1	2291_VCAM1 - Vascular cell adhesion protein 1	25	1031	1	3139	1405	3528	3846	1051	1031	4685	2436	4735
1835_Neck width (GEE, female, adjusted for multivariable)	1835_Neck width (GEE, female, adjusted for multivariable)	25	1031	1	4164	1815	1160	4431	2311	1556	2152	1031	1714
757_Amino acid::Tryptophan metabolism::X-12100--hydroxytryptophan*	757_Amino acid::Tryptophan metabolism::X-12100--hydroxytryptophan*	25	1032	1	4508	3404	1032	1792	3780	4604	2486	2104	2415
3670_Diagnoses - main ICD10: K29 Gastritis and duodenitis	3670_Diagnoses - main ICD10: K29 Gastritis and duodenitis	25	1032	1	2535	2113	1209	2857	1849	4536	1676	3277	1032
732_::::X-11805	732_::::X-11805	25	1033	1	2807	2557	1681	1588	3628	1033	1404	4325	3851
2513_CDC2 CCNB1 - Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex	2513_CDC2 CCNB1 - Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex	25	1033	1	4383	3316	3973	4392	4231	1600	3076	1033	4741
264_CD4:%SCM	264_CD4:%SCM	25	1035	1	2605	1035	4577	4349	3117	3032	1795	2066	2068
1212_Type 2 Diabetes	1212_Type 2 Diabetes	25	1035	1	3811	1060	1035	4061	1375	2458	2216	3393	1322
1007_Stem cell factor	1007_Stem cell factor	25	1036	1	3645	4618	1995	1036	3436	3272	4696	3350	2840
2557_IL17A - Interleukin-17A	2557_IL17A - Interleukin-17A	25	1037	1	2158	1484	3049	1037	2577	2966	3258	3316	1916
724_::::X-11552	724_::::X-11552	25	1037	1	3498	2836	1861	1740	4361	4015	1037	2331	4645
4754_Superior longitudinal fasciculus radial diusivities	4754_Superior longitudinal fasciculus radial diusivities	25	1039	1	2050	1039	1580	2272	2179	3000	1481	3740	2320
634_Xenobiotics::Food component, Plant::quinate	634_Xenobiotics::Food component, Plant::quinate	25	1039	1	4082	3731	2207	2452	1039	3749	3841	3795	1325
2342_RETN - Resistin	2342_RETN - Resistin	25	1039	1	2098	3878	2952	3802	4311	2063	3472	2767	1039
713_::::X-11485	713_::::X-11485	25	1040	1	2964	3022	1040	3320	4553	3004	2229	3312	1827
466_Lipid::Bile acid metabolism::glycochenodeoxycholate	466_Lipid::Bile acid metabolism::glycochenodeoxycholate	25	1041	1	2536	3722	1041	2867	3417	2161	4615	4401	1390
4420_Influenza A seropositivity	4420_Influenza A seropositivity	25	1041	1	3661	2916	1116	2697	2177	1041	1327	4277	1354
1543_White matter hyperintensity volume (GEE, adjusted for age and sex)	1543_White matter hyperintensity volume (GEE, adjusted for age and sex)	25	1041	1	2989	3613	4293	3987	2088	2288	3184	1041	3215
3826_Osteoarthritis of knee	3826_Osteoarthritis of knee	25	1042	1	1327	3085	4224	3714	4365	4538	2632	1042	2836
2851_SPHK2 - Sphingosine kinase 2	2851_SPHK2 - Sphingosine kinase 2	25	1043	1	2122	1043	3231	3115	2787	2385	4692	4407	3154
2928_EPHA2 - Ephrin type-A receptor 2	2928_EPHA2 - Ephrin type-A receptor 2	25	1044	1	1160	1623	2614	3645	2455	1044	4537	1103	2927
4114_Chloride	4114_Chloride	25	1044	1	4360	1075	3311	2590	3261	4397	2325	1838	1044
3817_CD56+ NK cell level	3817_CD56+ NK cell level	25	1045	1	2689	3823	2010	3812	2606	1706	2520	1045	2768
1403_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for multivariable)	1403_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for multivariable)	25	1046	1	2233	1046	3861	3191	4088	4289	1965	4279	1759
2343_PRSS1 - Trypsin-1	2343_PRSS1 - Trypsin-1	25	1047	1	4496	3192	4362	2170	1047	3480	3490	3978	4685
748_::::X-12038	748_::::X-12038	25	1048	1	1402	4518	1774	2998	4073	1432	3296	1048	3576
84_Forearm BMD	84_Forearm BMD	25	1049	1	1049	1521	2372	1295	3967	3131	3688	1944	2349
3106_PPID - Peptidyl-prolyl cis-trans isomerase D	3106_PPID - Peptidyl-prolyl cis-trans isomerase D	25	1050	1	3258	1050	1458	2816	1339	2191	2395	3769	1627
302_CD4mem:R6+	302_CD4mem:R6+	25	1050	1	3484	4421	3217	3778	1050	4153	3699	4612	3777
3240_Cooked vegetable intake	3240_Cooked vegetable intake	25	1050	1	4721	4155	3103	4276	4690	1050	2107	2106	2449
3810_Eosinphil count	3810_Eosinphil count	25	1051	1	1051	2753	1494	3881	1174	1931	4217	4619	2678
574_Lipid::Sterol, Steroid::cortisol	574_Lipid::Sterol, Steroid::cortisol	25	1051	1	3878	1051	2646	2565	2250	2965	3306	3367	2502
4725_Posterior corona radiata mode of anisotropy	4725_Posterior corona radiata mode of anisotropy	25	1051	1	3598	4635	1051	2808	3832	4639	2553	1826	1406
3999_Worry too long after embarrassment (WORR-EMB)	3999_Worry too long after embarrassment (WORR-EMB)	25	1051	1	1961	4443	1350	1166	1140	1051	1279	2078	4719
241_CD161 on CD4mem	241_CD161 on CD4mem	25	1052	1	2928	2941	3140	3181	4049	4301	1052	4630	1117
515_Lipid::Long chain fatty acid::10-nonadecenoate (19:1n9)	515_Lipid::Long chain fatty acid::10-nonadecenoate (19:1n9)	25	1053	1	1053	1649	1927	1951	3758	4486	3013	4452	4132
337_NKeff:%Kir+ (2)	337_NKeff:%Kir+ (2)	25	1054	1	1054	1967	2401	2646	3281	3817	3574	4303	3839
4013_Major depressive disorder (ICD-coded)	4013_Major depressive disorder (ICD-coded)	25	1055	1	4307	1055	3625	3254	2907	3019	4674	1897	2092
4186_Coffee cups per day	4186_Coffee cups per day	25	1055	1	4599	2438	1224	1752	2265	2200	1922	3439	1055
2913_AFM - Afamin	2913_AFM - Afamin	25	1056	1	3131	2663	3322	2648	3023	4379	2149	1056	4293
1143_Acute insulin response (adjusted for BMI)	1143_Acute insulin response (adjusted for BMI)	25	1057	1	2378	3381	4437	1057	4431	3325	3711	4076	4653
846_::::X-14662	846_::::X-14662	25	1057	1	2959	2577	4121	1423	3146	3885	1057	3284	2645
3433_Symbol digit substitution test - Duration to entering value	3433_Symbol digit substitution test - Duration to entering value	25	1057	1	2252	1581	2697	2024	1552	1312	1754	2848	1057
2328_CLEC4M - C-type lectin domain family 4 member M	2328_CLEC4M - C-type lectin domain family 4 member M	25	1058	1	2649	1071	4258	2338	2036	1127	1058	3326	4011
711_::::X-11478	711_::::X-11478	25	1059	1	2805	1314	1059	1982	3141	3625	4514	1564	2125
4583_Right inferior temporal	4583_Right inferior temporal	25	1059	1	2495	1257	3351	2897	2776	3412	3188	1534	1059
2008_Dapsone hypersensitivity syndrome	2008_Dapsone hypersensitivity syndrome	25	1060	1	2617	1175	3280	1060	1976	1656	1320	4141	3741
3778_Traumatic events - Victim of physically violent crime	3778_Traumatic events - Victim of physically violent crime	25	1062	1	3423	4244	3867	3973	3235	2057	1062	3072	3922
3639_Illnesses of mother: Stroke	3639_Illnesses of mother: Stroke	25	1062	1	1120	3953	3383	3927	3863	2032	3863	1923	1062
2212_SOD1 - Superoxide dismutase [Cu-Zn]	2212_SOD1 - Superoxide dismutase [Cu-Zn]	25	1063	1	3148	1174	1063	1814	2416	3819	3061	1682	4157
1169_Leptin	1169_Leptin	25	1063	1	1116	4240	2930	1063	4374	3503	3376	2771	2487
4001_Loneliness, isolation (LONE)	4001_Loneliness, isolation (LONE)	25	1063	1	3282	3830	4105	3833	2913	3167	3872	1063	4742
4389_Bust size	4389_Bust size	25	1064	1	1085	1064	3786	2854	2893	3087	3428	2857	3654
2897_SORCS2 - VPS10 domain-containing receptor SorCS2	2897_SORCS2 - VPS10 domain-containing receptor SorCS2	25	1064	1	2474	1749	2094	2630	1853	3813	1064	3060	1362
2492_PIK3CA PIK3R1 - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform:Phosphatidylinositol 3-kinase regulatory subunit alpha complex	2492_PIK3CA PIK3R1 - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform:Phosphatidylinositol 3-kinase regulatory subunit alpha complex	25	1065	1	3666	1065	4442	3587	1551	2744	3582	2128	4666
2639_SCT - Secretin	2639_SCT - Secretin	25	1066	1	2123	3333	1066	4316	1123	2810	1480	2532	2693
333_NKeff:%337+	333_NKeff:%337+	25	1066	1	1847	3137	4458	1066	4347	4175	4145	3801	3142
2812_CST2 - Cystatin-SA	2812_CST2 - Cystatin-SA	25	1066	1	2302	4441	2173	4152	3315	4200	3020	4283	1066
1055_Inflammatory Bowel Disease	1055_Inflammatory Bowel Disease	25	1067	1	1067	4232	1234	3042	1697	4727	4218	2007	4120
4145_Pulse pressure	4145_Pulse pressure	25	1069	1	3772	3037	1069	3939	3441	1803	2537	1341	1164
630_Xenobiotics::Food component, Plant::ergothioneine	630_Xenobiotics::Food component, Plant::ergothioneine	25	1069	1	3358	3327	2282	1069	1358	1580	3413	2208	3374
1368_Total cholesterol (at exam 6, FBAT, adjusted for age and sex)	1368_Total cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	1069	1	2751	2288	1479	1148	1969	2514	2140	3602	1069
3948_1p deletion neuroblastoma	3948_1p deletion neuroblastoma	25	1070	1	4289	3827	2868	2096	1529	2299	4382	2736	1070
490_Lipid::Essential fatty acid::eicosapentaenoate (EPA; 20:5n3)	490_Lipid::Essential fatty acid::eicosapentaenoate (EPA; 20:5n3)	25	1071	1	3528	2551	2784	1071	2930	1253	4042	2287	1816
114_Waist-hip ratio (adjusted for BMI)	114_Waist-hip ratio (adjusted for BMI)	25	1071	1	1373	4242	3011	2106	1071	3186	2828	2557	3488
2614_DKKL1 - Dickkopf-like protein 1	2614_DKKL1 - Dickkopf-like protein 1	25	1071	1	3488	1844	1810	3727	4362	2229	1071	3441	2396
3596_Mineral and other dietary supplements: Iron	3596_Mineral and other dietary supplements: Iron	25	1071	1	4063	4078	3199	1626	4455	3494	1282	3435	1071
4604_Right superior temporal	4604_Right superior temporal	25	1072	1	3050	2843	1776	3325	2049	3980	1866	1072	3106
4393_Menstrual fever	4393_Menstrual fever	25	1072	1	4712	2786	2480	1701	1808	4384	1957	1495	1072
1293_Diabetes incidence (GEE, adjusted for age and sex)	1293_Diabetes incidence (GEE, adjusted for age and sex)	25	1073	1	3057	3423	1073	4274	2593	2577	3812	2547	1708
400_Amino acid::Phenylalanine & tyrosine metabolism::phenyllactate (PLA)	400_Amino acid::Phenylalanine & tyrosine metabolism::phenyllactate (PLA)	25	1074	1	1823	3479	2421	4340	2478	2838	1074	2959	2799
2140_PRKCZ - Protein kinase C zeta type	2140_PRKCZ - Protein kinase C zeta type	25	1074	1	1408	1972	1844	4580	4398	2234	2201	1074	4546
3096_TGFBR2 - TGF-beta receptor type-2	3096_TGFBR2 - TGF-beta receptor type-2	25	1075	1	4447	1946	1169	2966	3570	1075	4695	1273	2663
2719_NAGK - N-acetyl-D-glucosamine kinase	2719_NAGK - N-acetyl-D-glucosamine kinase	25	1075	1	1365	4603	2756	3831	1150	2876	4574	2359	1075
1782_Artial fibrillation (FBAT, adjusted for multivariable)	1782_Artial fibrillation (FBAT, adjusted for multivariable)	25	1076	1	1076	3302	2748	3634	2486	3119	2076	1911	4033
4082_Waist-hip ratio (adjusted for BMI, female)	4082_Waist-hip ratio (adjusted for BMI, female)	25	1076	1	2467	1532	2073	1076	3135	2459	3876	1129	3098
1997_MMSE score (at exam 7, GEE, adjusted for multivariable)	1997_MMSE score (at exam 7, GEE, adjusted for multivariable)	25	1077	1	1787	4100	3484	3619	3567	1077	2182	3872	4302
102_Late pubertal growth (female)	102_Late pubertal growth (female)	25	1077	1	3496	1298	2469	2993	1897	4185	1077	4520	1961
252_CD3 on CD8 T	252_CD3 on CD8 T	25	1078	1	2243	1486	3885	1078	2817	4214	4599	1606	1313
200_Microalbuminuria	200_Microalbuminuria	25	1078	1	3393	4208	3847	3592	1732	2883	1138	4441	1078
2619_CDH12 - Cadherin-12	2619_CDH12 - Cadherin-12	25	1079	1	1096	1818	1483	2149	1079	2241	2071	2065	3781
899_Cholesterol esters in large VLDL	899_Cholesterol esters in large VLDL	25	1080	1	1668	1080	1235	4264	1120	3358	3529	1110	1722
4619_Left inferior lateral ventricle	4619_Left inferior lateral ventricle	25	1081	1	2610	1081	3614	3825	1613	3013	3183	3294	1942
2495_PLK1 - Serine/threonine-protein kinase PLK1	2495_PLK1 - Serine/threonine-protein kinase PLK1	25	1082	1	1082	1434	2848	3202	2830	2208	3983	4458	4604
816_::::X-13215	816_::::X-13215	25	1083	1	1487	1083	3617	1952	1644	2788	1246	4696	1834
2766_YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,SFN - 14-3-3 protein family	2766_YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,SFN - 14-3-3 protein family	25	1084	1	2187	3890	1760	1894	1084	3443	2784	3533	1373
1741_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for multivariable)	1741_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for multivariable)	25	1085	1	2901	1515	2652	3161	3661	1085	4423	2516	3809
3580_Social support - Leisure/social activities: Other group activity	3580_Social support - Leisure/social activities: Other group activity	25	1086	1	3303	1659	3395	3049	1443	2177	2240	3627	1086
2176_POR - NADPH--cytochrome P450 reductase	2176_POR - NADPH--cytochrome P450 reductase	25	1087	1	2643	3522	1087	4393	2014	4649	1418	1901	3501
3919_Low-density lipoprotein cholesterol	3919_Low-density lipoprotein cholesterol	25	1088	1	2436	1397	1469	1088	1588	3396	4064	4411	3312
4161_Focal Epilepsy, lesion negative	4161_Focal Epilepsy, lesion negative	25	1089	1	1954	2390	2894	1089	3123	2396	2921	3601	4464
3736_Depression - Impact of normal roles during worst period of depression	3736_Depression - Impact of normal roles during worst period of depression	25	1090	1	1090	1354	2113	3333	1390	2382	4316	3293	1631
1798_High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1798_High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	1090	1	3919	1513	3494	1663	1090	4520	3972	2284	2082
2346_FLT3LG - Fms-related tyrosine kinase 3 ligand	2346_FLT3LG - Fms-related tyrosine kinase 3 ligand	25	1091	1	3214	1091	1888	3532	2252	3595	2033	1732	3410
2190_C3 - C3a anaphylatoxin des Arginine	2190_C3 - C3a anaphylatoxin des Arginine	25	1092	1	2911	4717	2062	3222	3209	1092	2466	2800	1738
1876_Shaft average buckling ratio (FBAT, male, adjussted for age)	1876_Shaft average buckling ratio (FBAT, male, adjussted for age)	25	1092	1	4492	4473	1500	4153	1607	1678	2450	2936	1092
3745_Happiness and subjective well-being - General happiness	3745_Happiness and subjective well-being - General happiness	25	1093	1	1093	2869	1113	4564	1388	4585	2888	4131	1389
3236_Past tobacco smoking	3236_Past tobacco smoking	25	1093	1	2465	1319	1093	1198	1533	2271	2162	1424	4387
3116_NR1D1 - Nuclear receptor subfamily 1 group D member 1	3116_NR1D1 - Nuclear receptor subfamily 1 group D member 1	25	1093	1	2071	2500	4083	4553	1093	2846	1253	2339	1345
1794_RR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1794_RR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	1095	1	1620	2341	1809	3614	2216	1095	1837	3461	4178
496_Lipid::Fatty acid, branched::15-methylpalmitate (isobar with 2-methylpalmitate)	496_Lipid::Fatty acid, branched::15-methylpalmitate (isobar with 2-methylpalmitate)	25	1095	1	1153	4541	4377	3811	3695	2945	4277	3657	1095
4627_Left amygdala	4627_Left amygdala	25	1096	1	1966	3691	1096	1762	3034	3149	1991	2465	1700
2225_EDA - Ectodysplasin-A, secreted form	2225_EDA - Ectodysplasin-A, secreted form	25	1097	1	4152	3159	2358	2115	1855	1097	3105	1577	1611
729_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::X-11793--oxidized bilirubin*	729_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::X-11793--oxidized bilirubin*	25	1098	1	1098	3390	4333	2173	3415	4625	2834	4571	4100
1164_Glucose levels 2 h after an oral glucose challenge	1164_Glucose levels 2 h after an oral glucose challenge	25	1098	1	1628	1619	2141	4550	3272	2178	1283	3108	1098
4340_Walking (conditioning sex and BMI)	4340_Walking (conditioning sex and BMI)	25	1099	1	2143	2951	1099	3641	2689	4300	3389	2770	4542
2132_LAYN - Layilin	2132_LAYN - Layilin	25	1099	1	3697	2594	3531	3288	2764	1099	1178	4423	1632
1188_Tetralogy of Fallot	1188_Tetralogy of Fallot	25	1099	1	2993	3345	3499	2832	1657	1947	1099	1937	2216
762_::::X-12212	762_::::X-12212	25	1100	1	3685	1444	3359	1653	3191	1100	1350	3936	1791
4666_Superior longitudinal fasciculus fractional anisotropy	4666_Superior longitudinal fasciculus fractional anisotropy	25	1100	1	3662	1991	3066	1818	4031	2401	1100	3998	1111
3786_Insomnia	3786_Insomnia	25	1100	1	2543	2968	4532	3583	2731	3401	2381	1100	3849
687_::::X-10810	687_::::X-10810	25	1101	1	1218	3260	1525	1101	2493	4374	4172	4623	3976
1680_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	1680_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	25	1102	1	2601	3082	3844	3379	4671	3827	3459	1102	1512
2233_MET - Hepatocyte growth factor receptor	2233_MET - Hepatocyte growth factor receptor	25	1103	1	4626	1103	2038	1288	3108	1477	2492	2609	4526
4693_Average across all tracts mean diusivities	4693_Average across all tracts mean diusivities	25	1104	1	1104	1730	1702	2033	3339	2434	3367	4005	4646
814_::::X-13069	814_::::X-13069	25	1104	1	2864	1104	2568	3330	1480	3311	1406	3245	1725
4034_Alcohol dependency (discovery)	4034_Alcohol dependency (discovery)	25	1105	1	1871	1776	2956	3007	1498	1105	3158	3498	2532
1356_Total cholesterol (at exam 1, FBAT, multivariate adjusted)	1356_Total cholesterol (at exam 1, FBAT, multivariate adjusted)	25	1106	1	1988	4178	2067	1672	3149	3504	4459	1106	3189
801_::::X-12771	801_::::X-12771	25	1107	1	1416	1427	1152	4242	3795	3990	2626	1900	1107
3279_Father's age at death	3279_Father's age at death	25	1108	1	3429	4252	3353	2688	1108	3353	4395	3994	1780
4568_Left precuneus	4568_Left precuneus	25	1108	1	4053	4083	3114	2771	1555	2135	1108	1409	3814
4743_Fornix (column and body of fornix) radial diusivities	4743_Fornix (column and body of fornix) radial diusivities	25	1109	1	1109	2731	4675	3028	2082	2131	3213	3066	3249
2504_BCL2 - Apoptosis regulator Bcl-2	2504_BCL2 - Apoptosis regulator Bcl-2	25	1110	1	3390	1703	1110	2186	3044	2337	3043	4587	3603
460_Energy::Krebs cycle::malate	460_Energy::Krebs cycle::malate	25	1110	1	4197	1360	4537	3260	3465	1143	1110	2475	1516
1880_Shaft cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	1880_Shaft cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	25	1112	1	1112	3606	2456	1761	3613	4434	4670	1357	2792
571_Lipid::Sterol, Steroid::7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca)	571_Lipid::Sterol, Steroid::7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca)	25	1112	1	1591	1112	3961	3877	4629	2831	2514	4415	4562
2968_SHBG - Sex hormone-binding globulin	2968_SHBG - Sex hormone-binding globulin	25	1113	1	3960	1477	2777	2025	3226	1113	4233	1314	1683
1877_Shaft average buckling ratio (GEE, male, adjussted for age)	1877_Shaft average buckling ratio (GEE, male, adjussted for age)	25	1113	1	1275	3099	2536	3750	3142	3411	2007	1113	3637
1405_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for age and sex)	1405_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for age and sex)	25	1114	1	1114	2667	3240	3654	3160	3095	3920	3626	2020
1280_Sagittal diameter by CT (FBAT, adjusted for age and sex)	1280_Sagittal diameter by CT (FBAT, adjusted for age and sex)	25	1114	1	4071	1339	4003	3856	4282	1114	1502	3347	3116
4590_Right parahippocampal	4590_Right parahippocampal	25	1115	1	3375	2199	1115	4150	3020	2492	1257	2737	1233
4488_Right middle temporal	4488_Right middle temporal	25	1116	1	1124	2005	3982	4283	3450	1116	1968	2755	3139
3243_Dried fruit intake	3243_Dried fruit intake	25	1117	1	2698	3866	2529	1117	1288	4596	2980	3475	2127
2869_PDGFA - Platelet-derived growth factor subunit A	2869_PDGFA - Platelet-derived growth factor subunit A	25	1117	1	2432	3193	4102	3319	1117	1737	3175	3822	4343
2049_Periodontal complex trait 4	2049_Periodontal complex trait 4	25	1118	1	3504	1118	4208	2315	2101	3327	2800	3954	3683
2653_ANGPTL4 - Angiopoietin-related protein 4	2653_ANGPTL4 - Angiopoietin-related protein 4	25	1118	1	2949	3543	1437	1118	4639	4388	2311	2652	2395
2368_DDX19B - ATP-dependent RNA helicase DDX19B	2368_DDX19B - ATP-dependent RNA helicase DDX19B	25	1118	1	3464	1870	4606	2345	1118	4706	2026	4707	3963
2240_RPS27A - Ubiquitin+1, truncated mutation for UbB	2240_RPS27A - Ubiquitin+1, truncated mutation for UbB	25	1118	1	1203	3359	2530	2245	3027	2776	2795	1118	3547
1319_Resistin (GEE, adjusted for age and sex)	1319_Resistin (GEE, adjusted for age and sex)	25	1119	1	4385	4722	1119	4330	2398	4696	3661	2916	4265
4503_Right superior temporal	4503_Right superior temporal	25	1119	1	1689	1806	3088	3891	4707	3120	1493	3984	1119
1913_Occipital brain volume (GEE, adjusted for multivariable)	1913_Occipital brain volume (GEE, adjusted for multivariable)	25	1120	1	3403	1120	4545	3732	2371	3896	1224	1988	2021
3722_Frequency of feeling guilt or remorse after drinking alcohol in last year	3722_Frequency of feeling guilt or remorse after drinking alcohol in last year	25	1120	1	1315	2065	2544	3176	4408	1120	1853	1678	4482
3291_Tense / 'highly strung'	3291_Tense / 'highly strung'	25	1120	1	4024	2595	1206	1574	2358	3315	1120	1941	3349
2138_CDH3 - Cadherin-3	2138_CDH3 - Cadherin-3	25	1121	1	3189	1121	2818	1739	3406	3705	1910	2285	1973
369_Amino acid::Creatine metabolism::creatine	369_Amino acid::Creatine metabolism::creatine	25	1121	1	2755	4263	3070	2504	2751	1622	1121	3831	3589
3213_Duration walking for pleasure	3213_Duration walking for pleasure	25	1121	1	4692	2083	1295	2166	4139	2861	2352	3844	1121
647_Xenobiotics::Xanthine metabolism::paraxanthine	647_Xenobiotics::Xanthine metabolism::paraxanthine	25	1123	1	4220	1759	3369	4289	2246	3515	1612	2938	1123
3346_Ever taken oral contraceptive pill (female)	3346_Ever taken oral contraceptive pill (female)	25	1124	1	3194	1124	1632	3691	1797	4314	3502	1296	2720
4571_Left superior frontal	4571_Left superior frontal	25	1124	1	4457	4507	3585	3794	4479	1124	2069	4399	2968
1111_Visceral sdipose tissue volume	1111_Visceral sdipose tissue volume	25	1124	1	3879	3699	4403	3688	3840	2913	1124	1948	3692
553_Lipid::Medium chain fatty acid::10-undecenoate (11:1n1)	553_Lipid::Medium chain fatty acid::10-undecenoate (11:1n1)	25	1125	1	3812	3235	3337	1125	4153	4717	2676	3250	4632
1580_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	1580_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	25	1125	1	4472	3032	1208	4695	2877	2736	1125	2683	3935
3117_PPIE - Peptidyl-prolyl cis-trans isomerase E	3117_PPIE - Peptidyl-prolyl cis-trans isomerase E	25	1125	1	2985	4393	1243	4729	1992	3691	4659	1125	2366
303_CD4mem:%Th1* (4)	303_CD4mem:%Th1* (4)	25	1126	1	3856	1126	4011	2324	3890	3621	2317	3999	3169
1282_Sagittal diameter by CT (FBAT, adjusted for age, sex, smoking and menopause)	1282_Sagittal diameter by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	1126	1	4251	1949	4570	3158	3086	1126	1918	3048	2860
2550_CXCL13 - C-X-C motif chemokine 13	2550_CXCL13 - C-X-C motif chemokine 13	25	1126	1	3284	1536	2916	4727	2342	2240	2361	1512	1126
2612_RBP4 - Retinol-binding protein 4	2612_RBP4 - Retinol-binding protein 4	25	1128	1	1854	3113	3922	3347	1803	1429	1128	3416	3068
2280_GHR - Growth hormone receptor	2280_GHR - Growth hormone receptor	25	1129	1	1129	1688	1165	2214	2003	4164	4738	1794	2103
426_Amino acid::Valine, leucine and isoleucine metabolism::beta-hydroxyisovalerate	426_Amino acid::Valine, leucine and isoleucine metabolism::beta-hydroxyisovalerate	25	1129	1	2502	2983	4215	1129	2846	1541	2220	2646	4004
3483_Milk type used: Soya	3483_Milk type used: Soya	25	1131	1	1131	4169	2442	2568	4011	1238	2663	4035	2671
2852_CHST15 - Carbohydrate sulfotransferase 15	2852_CHST15 - Carbohydrate sulfotransferase 15	25	1131	1	3763	2651	4471	1131	3097	4692	4620	4459	4588
3651_Illnesses of siblings: High blood pressure	3651_Illnesses of siblings: High blood pressure	25	1132	1	2936	1977	2917	1604	1132	2018	2006	2782	1918
686_::::X-10510	686_::::X-10510	25	1133	1	2587	3547	1133	1875	3743	2455	4506	2159	2440
2593_DPP7 - Dipeptidyl peptidase 2	2593_DPP7 - Dipeptidyl peptidase 2	25	1133	1	1138	1761	1631	1895	2262	1133	2702	2329	3281
429_Amino acid::Valine, leucine and isoleucine metabolism::isoleucine	429_Amino acid::Valine, leucine and isoleucine metabolism::isoleucine	25	1134	1	2284	2940	3554	1134	3265	3937	4246	3107	3175
4005_Osteoarthritis (self reported)	4005_Osteoarthritis (self reported)	25	1134	1	4650	3221	2374	1260	2980	1203	1134	3898	3892
1703_Follicle stimulating hormone (at exam 3, GEE, adjusted for age and sex)	1703_Follicle stimulating hormone (at exam 3, GEE, adjusted for age and sex)	25	1134	1	4448	2480	2845	1648	2237	3330	3101	1134	1853
2726_DDR1 - Epithelial discoidin domain-containing receptor 1	2726_DDR1 - Epithelial discoidin domain-containing receptor 1	25	1135	1	2303	2167	3419	4075	1135	2993	3808	3488	4435
2710_EIF5A - Eukaryotic translation initiation factor 5A-1	2710_EIF5A - Eukaryotic translation initiation factor 5A-1	25	1137	1	4075	4043	1137	4391	1922	3290	2530	1428	4048
419_Amino acid::Urea cycle; arginine-, proline-, metabolism::urea	419_Amino acid::Urea cycle; arginine-, proline-, metabolism::urea	25	1137	1	3099	1428	3291	4552	4439	2934	1137	3346	4313
3035_SSRP1 - FACT complex subunit SSRP1	3035_SSRP1 - FACT complex subunit SSRP1	25	1137	1	3585	4590	4635	2803	3532	1980	4268	2362	1137
1101_Glucose - Birth cohorts	1101_Glucose - Birth cohorts	25	1139	1	3427	4064	1352	4681	2873	2340	3074	4065	1139
1071_Diabetic Nephropathy in Type 1 Diabetes	1071_Diabetic Nephropathy in Type 1 Diabetes	25	1142	1	2986	4172	1142	2563	4371	3667	3510	3065	4123
2529_SERPINA4 - Kallistatin	2529_SERPINA4 - Kallistatin	25	1142	1	4655	2461	4646	3072	2703	1142	1202	4568	4688
270_CD4:%Naive	270_CD4:%Naive	25	1144	1	2954	1144	1649	1165	3253	2193	3040	2204	4383
3565_Vitamin and mineral supplements: Vitamin E	3565_Vitamin and mineral supplements: Vitamin E	25	1145	1	3890	3270	2036	3143	4725	1145	4595	3128	2355
3249_Lamb/mutton intake	3249_Lamb/mutton intake	25	1146	1	1410	4099	1994	1146	4173	2985	3701	4438	3591
3125_PDE11A - Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	3125_PDE11A - Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	25	1146	1	3814	2713	2043	4370	3188	1146	2920	3171	2772
1769_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for age and sex)	1769_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for age and sex)	25	1148	1	4719	1611	1148	3315	2150	2721	1741	2455	3966
3326_Number of children fathered (male)	3326_Number of children fathered (male)	25	1149	1	1149	4037	3721	3950	2163	1242	4190	2719	4149
2281_PLA2G10 - Group 10 secretory phospholipase A2	2281_PLA2G10 - Group 10 secretory phospholipase A2	25	1150	1	4217	1313	2204	1579	2122	3988	4120	1150	1478
2556_IFNA2 - Interferon alpha-2	2556_IFNA2 - Interferon alpha-2	25	1151	1	3111	3231	2821	3917	3649	3995	2955	1151	2409
2437_CST7 - Cystatin-F	2437_CST7 - Cystatin-F	25	1152	1	1152	3849	1893	2946	3580	2295	3239	3918	1757
4740_Cingulum (hippocampus) radial diusivities	4740_Cingulum (hippocampus) radial diusivities	25	1153	1	2561	1153	2242	4389	1538	3447	1420	4486	4433
383_Amino acid::Glycine, serine and threonine metabolism::serine	383_Amino acid::Glycine, serine and threonine metabolism::serine	25	1153	1	2462	4516	4131	1909	2103	1153	1388	3986	4366
436_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::fructose	436_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::fructose	25	1154	1	1425	1154	3941	3667	4042	3899	3341	3577	1841
3385_Happiness	3385_Happiness	25	1156	1	1678	1156	3106	3869	1348	3804	3794	2325	2854
240_CD27 on IgG+B	240_CD27 on IgG+B	25	1156	1	1220	3080	3990	3252	2748	3250	3501	1853	1156
2387_CTSD - Cathepsin D	2387_CTSD - Cathepsin D	25	1157	1	2307	1829	4440	2111	3498	1627	3059	1157	2353
3628_Illnesses of father: Heart disease	3628_Illnesses of father: Heart disease	25	1158	1	3186	1393	2436	4461	1158	1639	1821	3469	4346
4413_Total IgE levels	4413_Total IgE levels	25	1158	1	1908	2207	4378	2163	1280	1907	3261	4381	1158
2327_CD209 - CD209 antigen	2327_CD209 - CD209 antigen	25	1160	1	4497	1989	4734	1160	1203	4134	2199	1448	2753
1132_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI)	1132_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI)	25	1160	1	4416	2385	1755	3329	3446	4488	1160	1185	2539
2399_HAPLN1 - Hyaluronan and proteoglycan link protein 1	2399_HAPLN1 - Hyaluronan and proteoglycan link protein 1	25	1162	1	3436	3510	1162	3576	3332	4275	1933	4580	3039
3908_Vertical cup-disc ratio	3908_Vertical cup-disc ratio	25	1162	1	2205	2379	4409	1162	2259	4140	2109	1935	4686
847_::::X-14745	847_::::X-14745	25	1162	1	3648	3308	4299	1571	4547	1162	4718	3425	2789
4062_Urinary albumin-to-creatinine ratio	4062_Urinary albumin-to-creatinine ratio	25	1164	1	1746	1764	3931	4180	2197	1367	3942	1164	3225
1195_Asthma (male)	1195_Asthma (male)	25	1166	1	1166	3266	4348	1357	2215	3520	3785	4254	2024
569_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 2*	569_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 2*	25	1166	1	2006	2773	2394	1319	2385	1166	2982	2487	2436
1106_Triglycerides - Birth cohorts	1106_Triglycerides - Birth cohorts	25	1167	1	1570	1702	2402	3450	1167	4408	3885	1601	3186
2740_IL17D - Interleukin-17D	2740_IL17D - Interleukin-17D	25	1167	1	3774	1583	1221	2909	4682	1167	3878	1326	3268
1869_Neck-Shaft Angle (GEE, male, adjussted for multivariable)	1869_Neck-Shaft Angle (GEE, male, adjussted for multivariable)	25	1168	1	2119	2914	3665	1888	3330	4163	2857	1168	2553
237_CD32 on pDC	237_CD32 on pDC	25	1170	1	3396	1886	4074	2169	3060	1170	3646	3591	2379
2582_CDH6 - Cadherin-6	2582_CDH6 - Cadherin-6	25	1170	1	2732	4704	4034	4712	4339	3044	1170	2896	2014
2876_CLU - Clusterin	2876_CLU - Clusterin	25	1170	1	3160	4542	2050	4375	2209	1730	2875	4745	1170
1118_Pericardial adipose tissue volume (male)	1118_Pericardial adipose tissue volume (male)	25	1172	1	1172	4422	3310	4057	2692	3532	4394	3861	3878
1315_HOMA-IR (at exam 7, GEE, adjusted for age and sex)	1315_HOMA-IR (at exam 7, GEE, adjusted for age and sex)	25	1172	1	4168	1172	3550	1569	1597	4446	3259	1172	4260
1217_Alcohol consumption (dichotomous, male)	1217_Alcohol consumption (dichotomous, male)	25	1172	1	3575	3880	3050	3376	3476	3380	1172	3609	4144
3523_Current employment status: Doing unpaid or voluntary work	3523_Current employment status: Doing unpaid or voluntary work	25	1173	1	2529	2332	1975	4675	1649	4630	3308	4251	1173
385_Amino acid::Guanidino and acetamido metabolism::4-acetamidobutanoate	385_Amino acid::Guanidino and acetamido metabolism::4-acetamidobutanoate	25	1174	1	2127	3552	3799	3107	4544	3634	1174	4158	3192
610_Peptide::Polypeptide::bradykinin, des-arg(9)	610_Peptide::Polypeptide::bradykinin, des-arg(9)	25	1174	1	1992	4361	4411	1525	3886	2548	1785	1765	1174
4480_Right fusiform	4480_Right fusiform	25	1175	1	4080	3961	2737	1494	4446	4204	2754	2713	1175
1906_Hippocampal volume (FBAT, adjusted for multivariable)	1906_Hippocampal volume (FBAT, adjusted for multivariable)	25	1176	1	1176	4558	1911	3079	3249	4101	3440	3206	3904
795_::::X-12726	795_::::X-12726	25	1176	1	1454	3078	1239	1176	2557	3748	3247	3464	4684
1243_Mean FEV1 from exam 3 and 5 (GEE, adjusted for multiple covariates)	1243_Mean FEV1 from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	1176	1	4644	1209	2233	4228	3702	3453	2633	1176	4555
999_Monocyte specific chemokine 3 (CCL7)	999_Monocyte specific chemokine 3 (CCL7)	25	1179	1	4627	1648	1179	3200	3817	2624	3562	2039	1409
2405_KREMEN2 - Kremen protein 2	2405_KREMEN2 - Kremen protein 2	25	1181	1	1522	1181	1344	1845	3793	1207	4334	3926	1778
1987_Age at natural menopause (GEE)	1987_Age at natural menopause (GEE)	25	1181	1	3817	1299	3226	1655	1181	4557	3178	2356	2847
4124_Prothrombin time	4124_Prothrombin time	25	1181	1	3893	1468	1828	2213	3490	3555	3827	3726	1181
3401_Loud music exposure frequency	3401_Loud music exposure frequency	25	1182	1	2920	2053	4159	2567	1182	3329	1382	2346	4111
3968_Asthma (fixed effect model)	3968_Asthma (fixed effect model)	25	1182	1	1506	2683	3752	2635	3524	1182	2115	4430	4568
4299_Vitiligo (late onset)	4299_Vitiligo (late onset)	25	1182	1	2792	2906	1853	1491	4137	4528	1254	1182	2383
1920_Frontal lobe volume (FBAT, adjusted for age and sex)	1920_Frontal lobe volume (FBAT, adjusted for age and sex)	24	1183	1	1466	1183	1761	4691	3069	4460	1872	2823	3517
1209_FVC	1209_FVC	25	1183	1	1548	2943	1183	2610	1923	1199	4409	2135	2924
2850_SPARCL1 - SPARC-like protein 1	2850_SPARCL1 - SPARC-like protein 1	25	1184	1	1184	2784	4600	3074	2971	2545	4061	2246	3112
4154_Ejection fraction	4154_Ejection fraction	25	1184	1	2508	1184	4019	2555	4303	4246	2763	2589	1751
2535_BCAN - Brevican core protein	2535_BCAN - Brevican core protein	25	1184	1	2238	1546	2032	1184	3333	3768	4331	2748	2673
2108_TNFSF9 - Tumor necrosis factor ligand superfamily member 9	2108_TNFSF9 - Tumor necrosis factor ligand superfamily member 9	25	1184	1	3527	2029	4010	4698	1336	1868	1184	4019	4247
704_::::X-11441	704_::::X-11441	25	1185	1	2184	1185	2109	3937	1866	3821	2414	4110	4391
1953_Boston Naming Test score without cues (GEE, adjusted for multivariable)	1953_Boston Naming Test score without cues (GEE, adjusted for multivariable)	25	1186	1	3293	2800	1186	2263	3968	3439	2729	1525	2209
2849_SIGLEC1 - Sialoadhesin	2849_SIGLEC1 - Sialoadhesin	25	1187	1	3902	3690	1187	2658	1905	3565	2487	2544	3577
4708_Superior corona radiata mean diusivities	4708_Superior corona radiata mean diusivities	25	1187	1	2909	1728	3065	2031	3464	4682	1187	2125	3336
4195_Diastolic Blood Pressure	4195_Diastolic Blood Pressure	25	1189	1	2249	3210	1189	3388	2072	4501	3195	4543	1937
1519_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	1519_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	25	1189	1	4534	3075	3016	4066	1189	4513	1841	4419	4572
4694_Body of corpus callosum mean diusivities	4694_Body of corpus callosum mean diusivities	25	1192	1	1192	4354	2552	4292	2614	1284	1696	4467	2426
2662_EPHA5 - Ephrin type-A receptor 5	2662_EPHA5 - Ephrin type-A receptor 5	25	1192	1	1956	4053	4117	4466	3455	2050	1192	1637	1240
4678_Fornix (cres) / Stria terminalis axial diusivities	4678_Fornix (cres) / Stria terminalis axial diusivities	25	1193	1	1193	1548	3107	2668	2376	4709	1730	4426	3585
24_Attention deficit hyperactivity disorder	24_Attention deficit hyperactivity disorder	25	1194	1	2563	1194	4677	3581	4473	4426	3923	4339	1591
2496_REN - Renin	2496_REN - Renin	25	1194	1	1704	3200	1194	4086	3533	2404	1259	1676	2469
1343_Resistin (GEE, adjusted for age, sex and BMI)	1343_Resistin (GEE, adjusted for age, sex and BMI)	25	1195	1	3946	2633	1195	2663	4620	3760	4349	4293	1870
990_Interleukin-2 receptor, alpha subunit	990_Interleukin-2 receptor, alpha subunit	25	1195	1	4278	3804	4255	2287	1195	1603	4191	4078	3063
1418_High-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	1418_High-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	1195	1	2893	3560	2551	1916	1404	1362	2103	1195	4065
1411_High-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	1411_High-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	25	1196	1	1534	2069	1616	1196	4407	3381	3289	2784	4690
824_::::X-13553	824_::::X-13553	25	1196	1	4319	1255	2619	3858	4546	1196	1702	3654	3794
2004_Primary biliary cirrhosis	2004_Primary biliary cirrhosis	25	1197	1	4313	4355	1517	1197	1474	3931	2809	2042	4347
1326_Fasting insulin (at exam 5, FBAT, adjusted for age, sex and BMI)	1326_Fasting insulin (at exam 5, FBAT, adjusted for age, sex and BMI)	25	1200	1	1200	3225	4736	2531	2092	1864	3151	4179	4210
4397_Menstruation quality of life impact: Increased appetite	4397_Menstruation quality of life impact: Increased appetite	25	1200	1	1332	3152	4621	4470	1200	4440	1426	1885	2114
4020_Freckles	4020_Freckles	25	1201	1	1811	3008	1375	2850	1201	3247	3337	3528	2572
4438_Helicobacter pylori IgG levels	4438_Helicobacter pylori IgG levels	25	1201	1	2106	4179	4289	1490	2524	4277	3935	1201	4429
4130_Neutrophil count	4130_Neutrophil count	25	1202	1	3625	1586	4095	4350	4720	2371	2295	1202	2000
2688_GAPDH - Glyceraldehyde-3-phosphate dehydrogenase	2688_GAPDH - Glyceraldehyde-3-phosphate dehydrogenase	25	1204	1	2282	4122	1204	4546	3275	4442	4269	2680	3375
2843_LRRTM1 - Leucine-rich repeat transmembrane neuronal protein 1	2843_LRRTM1 - Leucine-rich repeat transmembrane neuronal protein 1	25	1204	1	3342	1260	1465	1204	2853	2055	2453	3016	4654
139_Waist-hip ratio (female)	139_Waist-hip ratio (female)	25	1204	1	1456	1657	2931	4269	3205	4629	4536	1204	4232
3790_Daytime sleepiness / dozing	3790_Daytime sleepiness / dozing	25	1205	1	1523	3527	3896	4509	3753	2827	2281	3135	1205
1145_Insulin secretion rate (adjusted for BMI)	1145_Insulin secretion rate (adjusted for BMI)	25	1206	1	4739	1250	1860	2365	2314	2849	1206	2834	3706
2331_LGALS2 - Galectin-2	2331_LGALS2 - Galectin-2	25	1207	1	1207	1445	1210	2432	3681	4636	3989	3905	3064
1932_Parietal brain volume (FBAT, adjusted for age and sex)	1932_Parietal brain volume (FBAT, adjusted for age and sex)	25	1207	1	3736	3948	1207	4538	1295	3797	1952	2538	4493
4116_Phosphorus	4116_Phosphorus	25	1208	1	4670	2507	2284	3364	3120	2344	1208	3530	3197
2756_SELP - P-Selectin	2756_SELP - P-Selectin	25	1209	1	1209	1670	2227	1633	3911	3873	3393	3764	4380
2879_DNAJC19 - Mitochondrial import inner membrane translocase subunit TIM14	2879_DNAJC19 - Mitochondrial import inner membrane translocase subunit TIM14	25	1210	1	3923	3887	4046	2247	4142	4113	4690	1210	1493
2439_DLL4 - Delta-like protein 4	2439_DLL4 - Delta-like protein 4	25	1211	1	2812	4378	2175	3816	3459	2310	2772	3754	1211
2065_PLAT - Tissue-type plasminogen activator	2065_PLAT - Tissue-type plasminogen activator	25	1212	1	3010	1212	4028	2523	4700	3026	2954	3917	1267
842_::::X-14625	842_::::X-14625	25	1212	1	2965	3987	1212	4320	3942	1313	3627	3666	3134
420_Amino acid::Valine, leucine and isoleucine metabolism::2-hydroxyisobutyrate	420_Amino acid::Valine, leucine and isoleucine metabolism::2-hydroxyisobutyrate	25	1212	1	4565	2222	2161	1212	2591	1599	4366	2499	3398
2563_CCL22 - C-C motif chemokine 22	2563_CCL22 - C-C motif chemokine 22	25	1213	1	1213	3426	4625	1219	4464	3189	4028	4169	3247
2932_BMPR1A - Bone morphogenetic protein receptor type-1A	2932_BMPR1A - Bone morphogenetic protein receptor type-1A	25	1213	1	2096	3996	1213	2050	3956	4575	4491	1610	3531
584_Nucleotide::Purine metabolism, guanine containing::7-methylguanine	584_Nucleotide::Purine metabolism, guanine containing::7-methylguanine	25	1213	1	1612	4703	2770	3610	3721	2450	1213	3320	3265
2298_CTGF - Connective tissue growth factor	2298_CTGF - Connective tissue growth factor	25	1214	1	3994	2679	1385	1214	2804	1225	2449	1311	1441
290_CD4:%Act(DR+)	290_CD4:%Act(DR+)	25	1216	1	2469	3693	1216	2918	1356	2595	3652	2726	3605
541_Lipid::Lysolipid::1-oleoylglycerophosphoethanolamine	541_Lipid::Lysolipid::1-oleoylglycerophosphoethanolamine	25	1216	1	4120	4492	3827	1674	2291	3154	1216	4101	1857
246_CD56 on NK eff	246_CD56 on NK eff	25	1216	1	2413	2819	2195	3020	4410	2392	2533	2333	1216
1110_Subcutaneous adipose tissue volume (female)	1110_Subcutaneous adipose tissue volume (female)	25	1217	1	4160	3109	2844	3575	1217	3071	3787	3900	1754
4548_Left cuneus	4548_Left cuneus	25	1219	1	4236	3115	1219	3447	3598	1977	4292	4427	2791
2188_C1QA C1QB  C1QC - Complement C1q subcomponent	2188_C1QA C1QB  C1QC - Complement C1q subcomponent	25	1219	1	3696	2483	2631	1621	1869	1219	3986	1253	2397
4726_Posterior limb of internal capsule mode of anisotropy	4726_Posterior limb of internal capsule mode of anisotropy	25	1219	1	4218	3005	2016	2126	1380	1366	2576	3883	1219
4320_Positive affect (univariate)	4320_Positive affect (univariate)	25	1220	1	4191	1855	3367	1220	3980	2551	2988	2276	4723
1995_Survival past average life expectancy (GEE, adjusted for birth-cohort)	1995_Survival past average life expectancy (GEE, adjusted for birth-cohort)	25	1220	1	3592	2108	4524	3661	2155	1220	2356	3170	4439
119_Extreme Waist-hip ratio (adjusted for BMI)	119_Extreme Waist-hip ratio (adjusted for BMI)	25	1220	1	3216	4501	4066	3293	4670	2730	4732	1220	4001
3026_PPA1 - Inorganic pyrophosphatase	3026_PPA1 - Inorganic pyrophosphatase	25	1222	1	1222	3673	3690	3498	1906	3826	3372	3517	4088
1302_Fasting insulin (at exam 5, FBAT, adjusted for age and sex)	1302_Fasting insulin (at exam 5, FBAT, adjusted for age and sex)	25	1222	1	1642	1882	1222	4054	1547	2860	1651	3730	2669
2171_EPOR - Erythropoietin receptor	2171_EPOR - Erythropoietin receptor	25	1222	1	2667	4664	3597	3653	3984	4378	2364	2957	1222
2362_PGF - Placenta growth factor	2362_PGF - Placenta growth factor	25	1223	1	2574	2396	2254	2940	1223	2484	4231	1388	4198
4631_Right lateral ventricle	4631_Right lateral ventricle	25	1223	1	1483	3677	2864	4068	2006	3244	1223	2164	1949
32_Neuroticism (IRT)	32_Neuroticism (IRT)	25	1225	1	2857	1225	2360	3137	3300	2428	1367	3939	1417
4738_Body of corpus callosum radial diusivities	4738_Body of corpus callosum radial diusivities	25	1225	1	4391	2091	1795	1225	1917	1272	3729	3044	3280
199_Urinary albumin-to-creatinine ratio (non-diabetic)	199_Urinary albumin-to-creatinine ratio (non-diabetic)	25	1226	1	3590	2233	4420	1331	1226	2313	3755	3129	3743
4553_Left isthmus cingulate	4553_Left isthmus cingulate	25	1226	1	4381	4464	2789	1597	2434	2984	2557	3297	1226
2273_APOE - Apolipoprotein E (isoform E4)	2273_APOE - Apolipoprotein E (isoform E4)	25	1227	1	2945	1646	3794	1492	1975	2765	2590	4215	1227
1621_CD40 Ligand serum (at exam 7, GEE, adjusted for multivariable)	1621_CD40 Ligand serum (at exam 7, GEE, adjusted for multivariable)	25	1228	1	2000	1418	4373	3864	3093	1228	1832	1469	2036
2373_IL2RA - Interleukin-2 receptor subunit alpha	2373_IL2RA - Interleukin-2 receptor subunit alpha	25	1229	1	1467	3598	1229	1620	2348	3829	1511	2075	1781
13_Schizophrenia vs Bipolar disorder	13_Schizophrenia vs Bipolar disorder	25	1229	2	2519	2062	4313	2887	1229	2643	1229	1809	4499
3171_TNNI3 - Troponin I, cardiac muscle	3171_TNNI3 - Troponin I, cardiac muscle	25	1229	1	3993	3414	2597	3013	2568	1229	2223	2569	3989
653_::::X-02973	653_::::X-02973	25	1230	1	3988	2458	2778	3393	3651	1230	2769	2747	3668
3569_Why stopped smoking: Financial reasons	3569_Why stopped smoking: Financial reasons	25	1230	1	3996	1800	1538	3034	1601	2836	3312	1359	1230
3977_Lean body mass (whole body)	3977_Lean body mass (whole body)	25	1231	1	3027	4251	1231	4425	4630	4546	3886	1735	3779
3173_ALCAM - CD166 antigen	3173_ALCAM - CD166 antigen	25	1231	1	3291	2597	2096	3367	2239	3654	3774	1231	3687
552_Lipid::Lysolipid::2-stearoylglycerophosphocholine*	552_Lipid::Lysolipid::2-stearoylglycerophosphocholine*	25	1234	1	2416	3219	2265	1880	4548	1508	4322	3473	1234
2512_TNFSF8 - Tumor necrosis factor ligand superfamily member 8	2512_TNFSF8 - Tumor necrosis factor ligand superfamily member 8	25	1235	1	1495	2562	2354	2655	3488	1235	1780	1491	1580
3367_Ever had hysterectomy (womb removed) (female)	3367_Ever had hysterectomy (womb removed) (female)	25	1236	1	3494	1430	2278	1791	1236	4394	3871	4365	4285
2608_OPCML - Opioid-binding protein/cell adhesion molecule	2608_OPCML - Opioid-binding protein/cell adhesion molecule	25	1237	1	4034	3950	3850	2843	3143	1829	4225	1237	3822
3394_Ever unenthusiastic/disinterested for a whole week	3394_Ever unenthusiastic/disinterested for a whole week	25	1240	1	1503	3671	2130	4737	1384	3107	1240	2270	2251
2039_Attention function - Orienting - Child	2039_Attention function - Orienting - Child	25	1240	1	3694	4107	3600	2494	1458	2561	4275	1240	3619
4133_Monocyte count	4133_Monocyte count	25	1242	1	3726	4115	1242	2506	4481	2833	3895	4000	2752
100_Pubertal growth (male)	100_Pubertal growth (male)	25	1245	1	4308	2513	1245	2113	2415	1806	3534	2195	3690
135_Waist circumference (female, adjusted for BMI)	135_Waist circumference (female, adjusted for BMI)	25	1245	1	1324	4520	1430	1245	4307	2425	4079	2799	4083
404_Amino acid::Tryptophan metabolism::indoleacetate	404_Amino acid::Tryptophan metabolism::indoleacetate	25	1246	1	1246	1880	1920	3048	1751	4651	4150	3903	2275
2319_SIGLEC9 - Sialic acid-binding Ig-like lectin 9	2319_SIGLEC9 - Sialic acid-binding Ig-like lectin 9	25	1246	1	3913	3130	1246	2840	4115	2718	4705	2076	1534
3717_Diagnoses - secondary ICD10: Z96 Presence of other functional implants	3717_Diagnoses - secondary ICD10: Z96 Presence of other functional implants	25	1247	1	4274	3462	2599	1247	1456	1709	1497	3789	3048
3504_Non-butter spread type details: Flora Pro-Active or Benecol	3504_Non-butter spread type details: Flora Pro-Active or Benecol	25	1249	1	4702	1249	4103	2933	3269	2844	3740	3524	1563
381_Amino acid::Glycine, serine and threonine metabolism::N-acetylglycine	381_Amino acid::Glycine, serine and threonine metabolism::N-acetylglycine	25	1253	1	1475	2045	3253	3212	4679	2103	4100	3988	1253
594_Peptide::Dipeptide::leucylleucine	594_Peptide::Dipeptide::leucylleucine	25	1254	1	1254	3774	2179	2454	2950	3973	3589	2721	3496
2418_SFRP1 - Secreted frizzled-related protein 1	2418_SFRP1 - Secreted frizzled-related protein 1	25	1254	1	1338	3394	1254	4444	4648	1566	3690	3198	2868
1278_Sabuctaneous fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	1278_Sabuctaneous fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	1254	1	3142	2042	4715	2908	4631	2681	1372	1991	1254
2786_MDM2 - E3 ubiquitin-protein ligase Mdm2	2786_MDM2 - E3 ubiquitin-protein ligase Mdm2	25	1255	1	4608	2749	1255	4704	1882	2650	4689	2154	2385
2658_CST4 - Cystatin-S	2658_CST4 - Cystatin-S	25	1255	1	2530	4282	3728	2279	3808	1255	1341	4200	2675
3050_EPHA10 - Ephrin type-A receptor 10	3050_EPHA10 - Ephrin type-A receptor 10	25	1255	1	1563	3243	1421	1868	2220	3916	1255	2696	3767
204_Urinary albumin-to-creatinine ratio	204_Urinary albumin-to-creatinine ratio	25	1255	1	2484	4174	2542	3317	3283	4043	4047	3865	1255
809_::::X-12847	809_::::X-12847	25	1258	1	4380	4345	1258	4132	3394	3016	4664	1290	3745
2390_F7 - Coagulation Factor VII	2390_F7 - Coagulation Factor VII	25	1258	1	4301	1976	3888	2814	2203	4359	4572	1258	2035
3391_Ever depressed for a whole week	3391_Ever depressed for a whole week	25	1259	1	3942	1259	1890	4302	2915	1942	2735	3752	3933
140_Waist-hip ratio (male, adjusted for BMI)	140_Waist-hip ratio (male, adjusted for BMI)	25	1260	1	3114	1365	3652	1415	4239	3676	3241	1260	3241
1233_Usual weekday bedtime (GEE, adjusted for age, sex and BMI)	1233_Usual weekday bedtime (GEE, adjusted for age, sex and BMI)	25	1261	1	1261	4040	4260	1656	2806	3498	1716	1727	4044
1938_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	1938_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	25	1261	1	3672	1597	1261	3361	3728	2689	4319	2264	1466
3362_Mother's age at death	3362_Mother's age at death	25	1261	1	3306	2918	2731	2210	1261	3709	2307	3028	4476
508_Lipid::Glycerolipid metabolism::glycerol 3-phosphate (G3P)	508_Lipid::Glycerolipid metabolism::glycerol 3-phosphate (G3P)	25	1261	1	2101	1639	1798	3512	2693	1261	3703	2618	2292
1863_Neck cross-sectional moment of inertia (GEE, female, adjussted for age)	1863_Neck cross-sectional moment of inertia (GEE, female, adjussted for age)	25	1262	1	1262	2648	1492	3374	1283	3146	3116	2997	4671
3528_Never eat eggs, dairy, wheat, sugar: Eggs or foods containing eggs	3528_Never eat eggs, dairy, wheat, sugar: Eggs or foods containing eggs	25	1263	1	3851	2770	1263	2596	1847	3084	3342	3615	3115
812_::::X-12855	812_::::X-12855	25	1263	1	3017	3497	2611	2612	1263	4676	2025	3980	2485
932_Pyruvate	932_Pyruvate	25	1263	1	1817	1840	2149	3339	3458	3707	1820	3031	1263
1208_FEV1	1208_FEV1	25	1265	1	4156	3551	1265	3298	4163	4644	3482	4655	3785
693_::::X-11317	693_::::X-11317	25	1266	1	3769	3123	1491	1266	2495	3398	4119	2962	1560
4703_Posterior corona radiata mean diusivities	4703_Posterior corona radiata mean diusivities	25	1267	1	3084	1267	2908	1381	4423	1990	1846	4263	3263
2463_ACY1 - Aminoacylase-1	2463_ACY1 - Aminoacylase-1	25	1268	1	3408	4145	4687	1268	1345	3540	1800	2389	3569
3005_EIF4A3 - Eukaryotic initiation factor 4A-III	3005_EIF4A3 - Eukaryotic initiation factor 4A-III	25	1268	1	1789	3960	4479	3050	1971	1577	4404	1532	1268
1492_Remnant lipoprotein triglycerides (at exam 4, FBAT, adjusted for age and sex)	1492_Remnant lipoprotein triglycerides (at exam 4, FBAT, adjusted for age and sex)	25	1269	1	1269	4046	3842	4633	1778	4540	1449	2917	1276
3863_Platelet count (two-way meta)	3863_Platelet count (two-way meta)	25	1269	1	3276	1269	3274	2098	4254	4550	2902	3782	3899
690_::::X-11261	690_::::X-11261	25	1270	1	1270	4293	1974	4279	4537	2411	2700	4634	2790
2684_AIP - AH receptor-interacting protein	2684_AIP - AH receptor-interacting protein	25	1270	1	4051	4004	4742	4623	2534	1270	2063	2080	1330
1902_Frontal lobe volume (FBAT, adjusted for multivariable)	1902_Frontal lobe volume (FBAT, adjusted for multivariable)	25	1270	1	2665	2982	2961	4304	2890	4169	1270	3665	3506
534_Lipid::Lysolipid::1-eicosadienoylglycerophosphocholine*	534_Lipid::Lysolipid::1-eicosadienoylglycerophosphocholine*	25	1272	1	2035	4028	1970	1272	3404	4607	3709	3571	4215
4497_Right precentral	4497_Right precentral	25	1273	1	1273	4645	3201	1668	4541	2981	2517	4558	1533
3152_DLL1 - Delta-like protein 1	3152_DLL1 - Delta-like protein 1	25	1273	1	3005	1273	4564	3307	3541	2438	2256	2890	2486
205_Microalbuminuria	205_Microalbuminuria	25	1275	1	4294	1367	1275	3836	2979	1347	4250	1399	2522
4661_Posterior thalamic radiation (include optic radiation) fractional anisotropy	4661_Posterior thalamic radiation (include optic radiation) fractional anisotropy	25	1275	1	3559	2804	1713	1275	2532	3236	1945	1752	3833
1001_Macrophage migration inhibitory factor (glycosylation-inhibiting factor)	1001_Macrophage migration inhibitory factor (glycosylation-inhibiting factor)	25	1276	1	4210	1629	2527	1276	3998	1614	2200	3744	1621
1408_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for age and sex)	1408_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	1278	1	2496	3727	3968	1397	1494	1553	1278	2635	4084
2901_IL6 - Interleukin-6	2901_IL6 - Interleukin-6	25	1279	1	4035	2828	4122	3669	2531	3103	2554	1279	3433
2537_RPS6KA3 - Ribosomal protein S6 kinase alpha-3	2537_RPS6KA3 - Ribosomal protein S6 kinase alpha-3	25	1281	1	2102	1281	3819	2402	3359	2784	4072	1461	1549
1836_Neck width (FBAT, male, adjusted for multivariable)	1836_Neck width (FBAT, male, adjusted for multivariable)	25	1282	1	3807	2628	1282	1711	3990	3948	3075	2603	3327
4485_Right lateral orbitofrontal	4485_Right lateral orbitofrontal	25	1282	1	4353	3689	3935	3944	2033	1282	3162	2079	1356
2116_EFNA4 - Ephrin-A4	2116_EFNA4 - Ephrin-A4	25	1282	1	2972	2337	3485	2964	2499	3721	1433	3421	1282
3070_LAG3 - Lymphocyte activation gene 3 protein	3070_LAG3 - Lymphocyte activation gene 3 protein	25	1283	1	1818	4102	2478	1283	2382	2680	3834	1739	2604
2491_SERPINA5 - Plasma serine protease inhibitor	2491_SERPINA5 - Plasma serine protease inhibitor	25	1283	1	2832	2469	3123	4624	2034	1283	4653	4367	2365
3272_Handedness (chirality/laterality)	3272_Handedness (chirality/laterality)	25	1284	1	3687	2889	2986	1284	4681	2753	3595	3916	1399
1541_White matter hyperintensity volume (GEE, adjusted for multivariable)	1541_White matter hyperintensity volume (GEE, adjusted for multivariable)	25	1284	1	1685	3300	4594	3025	1284	4360	4223	1802	3614
2424_ANGPTL3 - Angiopoietin-related protein 3	2424_ANGPTL3 - Angiopoietin-related protein 3	25	1285	1	1619	4701	4514	2328	2173	3614	1285	2707	2182
2149_CAPN1 CAPNS1 - Calpain I	2149_CAPN1 CAPNS1 - Calpain I	25	1287	1	1325	3936	1515	3432	1450	1287	2949	2700	4259
4445_Left caudal anterior cingulate	4445_Left caudal anterior cingulate	25	1289	1	1289	1822	3293	4355	3148	1665	2040	3364	2920
4719_Corticospinal tract mode of anisotropy	4719_Corticospinal tract mode of anisotropy	25	1290	1	1290	2766	1942	2100	3434	2054	2456	3446	4437
2707_CDC37 - Hsp90 co-chaperone Cdc37	2707_CDC37 - Hsp90 co-chaperone Cdc37	25	1291	1	4088	1920	2264	3213	1291	3778	3245	3806	1369
331_NKeff:%Act(314+)	331_NKeff:%Act(314+)	25	1292	1	1292	4560	1820	3201	3083	4503	2903	4050	3893
4603_Right superior parietal	4603_Right superior parietal	25	1292	1	1473	3354	2670	4455	4737	3432	2170	3084	1292
1175_Excessive daytime sleepness	1175_Excessive daytime sleepness	25	1294	1	3213	2644	4417	3627	3176	1778	2739	3362	1294
4690_Uncinate fasciculus axial diusivities	4690_Uncinate fasciculus axial diusivities	25	1295	1	3922	1295	3329	4684	2629	1465	3656	2403	1838
589_Nucleotide::Pyrimidine metabolism, uracil containing::pseudouridine	589_Nucleotide::Pyrimidine metabolism, uracil containing::pseudouridine	25	1296	1	4681	2530	3465	1296	2365	4135	4706	3695	4248
3324_Relative age of first facial hair (male)	3324_Relative age of first facial hair (male)	25	1296	1	3399	3388	1873	3011	2390	1296	2648	3166	3031
4257_Facial attractiveness (male-coder)	4257_Facial attractiveness (male-coder)	25	1296	1	1946	2011	3019	3652	2352	2606	1900	3761	1296
2953_LGALS8 - Galectin-8	2953_LGALS8 - Galectin-8	25	1297	1	1297	3366	2001	2799	3778	1604	4134	1658	4239
2341_PTN - Pleiotrophin	2341_PTN - Pleiotrophin	25	1297	1	1684	1297	3477	1349	4158	2369	2914	3643	3825
4080_Waist-hip ratio (adjusted for BMI)	4080_Waist-hip ratio (adjusted for BMI)	25	1297	1	3952	3289	3435	1297	3596	2901	2885	2687	2866
1716_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for multivariable)	1716_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for multivariable)	25	1297	1	1962	2961	4052	3273	2335	4035	1297	2648	2986
2934_NTRK2 - BDNF/NT-3 growth factors receptor	2934_NTRK2 - BDNF/NT-3 growth factors receptor	25	1298	1	3354	3006	1895	4572	4242	2087	1302	2095	1298
1959_MMSE score (at exam 5, GEE, adjusted for multivariable)	1959_MMSE score (at exam 5, GEE, adjusted for multivariable)	25	1299	1	3395	4259	1855	2428	4352	3492	3199	1503	1299
3427_Fluid intelligence test - FI4 : positional arithmetic	3427_Fluid intelligence test - FI4 : positional arithmetic	25	1300	1	4136	2030	4392	2179	1839	1300	2574	1550	2670
271_CD4:%CD244+ Naïve	271_CD4:%CD244+ Naïve	25	1300	1	2330	1934	4383	3553	3124	3500	4076	3836	1300
3800_Total blood hemoglobin	3800_Total blood hemoglobin	25	1301	1	4302	4375	4671	4058	2410	3940	2711	3896	1301
2969_STC1 - Stanniocalcin-1	2969_STC1 - Stanniocalcin-1	25	1302	1	3205	1902	2346	2536	1302	2305	3773	2060	4341
141_Waist-hip ratio (female, adjusted for BMI)	141_Waist-hip ratio (female, adjusted for BMI)	25	1302	1	3208	1577	3334	4158	1312	1908	2742	4207	1302
482_Lipid::Carnitine metabolism::laurylcarnitine	482_Lipid::Carnitine metabolism::laurylcarnitine	25	1305	1	1305	4500	3991	2747	1671	2040	4723	3683	3954
1548_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for multivariable)	1548_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for multivariable)	25	1305	1	3917	2756	1837	4559	2351	1534	3439	4429	1305
848_Xenobiotics::Food component/Plant::X-14977--vanillin	848_Xenobiotics::Food component/Plant::X-14977--vanillin	25	1306	1	3989	4066	3171	2734	2866	1306	2263	3176	3725
1168_HOMA-IR	1168_HOMA-IR	25	1306	1	1492	3876	3658	2649	2828	2682	4053	1306	3411
1772_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for age and sex)	1772_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for age and sex)	25	1308	1	1509	3833	3358	3023	2323	1887	1308	3318	3266
2509_CAMK1D - Calcium/calmodulin-dependent protein kinase type 1D	2509_CAMK1D - Calcium/calmodulin-dependent protein kinase type 1D	25	1311	1	4363	1642	3580	1311	3718	2790	3622	4109	2368
3574_Pain type(s) experienced in last month: Hip pain	3574_Pain type(s) experienced in last month: Hip pain	25	1311	1	3237	1995	3924	3363	2556	3955	1311	4284	2905
2656_CA3 - Carbonic anhydrase 3	2656_CA3 - Carbonic anhydrase 3	25	1311	1	2067	2544	1678	3177	1823	2124	3640	2152	1311
3647_Illnesses of mother: Severe depression	3647_Illnesses of mother: Severe depression	25	1312	1	1312	2200	1684	4118	2770	3126	3254	3223	2408
1176_Excessive daytime sleepness (male)	1176_Excessive daytime sleepness (male)	25	1315	1	2915	2028	4223	3442	1315	1839	3963	4604	2954
3975_Total body BMD (15-30 years old)	3975_Total body BMD (15-30 years old)	25	1316	1	1316	3705	2855	2821	4019	2673	1400	1338	3881
4720_External capsule mode of anisotropy	4720_External capsule mode of anisotropy	25	1317	1	1317	1549	3951	3757	2232	3289	4634	1348	2309
4171_Loneliness	4171_Loneliness	25	1317	1	3870	1903	4327	3485	1317	1605	1942	2089	1876
137_Weight (female)	137_Weight (female)	25	1317	1	2769	2566	2209	2564	2889	4632	3764	1317	4472
3704_Diagnoses - secondary ICD10: Z37 Outcome of delivery	3704_Diagnoses - secondary ICD10: Z37 Outcome of delivery	25	1318	1	1677	4273	1318	4439	3959	1424	2058	3138	2430
2736_FST - Follistatin	2736_FST - Follistatin	25	1320	1	2660	2584	2746	1320	3674	2449	3274	2900	4411
2806_LCORL - Ligand-dependent nuclear receptor corepressor-like protein	2806_LCORL - Ligand-dependent nuclear receptor corepressor-like protein	25	1321	1	1321	1587	4607	3253	1550	4261	4377	1587	4220
3747_Happiness and subjective well-being - Belief that own life is meaningfull	3747_Happiness and subjective well-being - Belief that own life is meaningfull	25	1321	1	3261	1321	3638	1581	3836	2927	4010	3707	1776
3225_Hands-free device/speakerphone use with mobile phone in last 3 month	3225_Hands-free device/speakerphone use with mobile phone in last 3 month	25	1322	1	1322	3046	3807	3009	1979	1796	3927	4229	1762
1599_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for age and sex)	1599_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for age and sex)	25	1324	1	4351	3363	1711	2250	1324	3777	3527	2035	2340
1804_PNN50 HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1804_PNN50 HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	1326	1	4450	1326	2479	3949	3964	1441	1631	2286	3010
536_Lipid::Lysolipid::1-heptadecanoylglycerophosphocholine	536_Lipid::Lysolipid::1-heptadecanoylglycerophosphocholine	25	1327	1	3421	1327	2913	1424	2958	1770	4666	2433	4173
2601_LY86 - Lymphocyte antigen 86	2601_LY86 - Lymphocyte antigen 86	25	1327	1	3606	4602	2477	3983	4416	1327	3402	3409	4630
4285_PEF	4285_PEF	25	1328	1	1712	2397	4678	3972	1541	1328	2279	4307	2131
332_NKeff:%Act(335+)	332_NKeff:%Act(335+)	25	1329	1	4165	3563	4222	4594	2998	1329	3837	3809	2962
4197_Waist-hip ratio	4197_Waist-hip ratio	25	1330	1	2978	1330	2356	4380	3050	3489	3865	2371	2757
405_Amino acid::Tryptophan metabolism::indolelactate	405_Amino acid::Tryptophan metabolism::indolelactate	25	1330	1	3273	2351	2683	1616	1330	3448	1674	3301	1817
3828_Primary biliary cirrhosis	3828_Primary biliary cirrhosis	25	1330	1	3524	3116	3010	4510	3587	3736	1330	2114	1381
1566_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for age and sex)	1566_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for age and sex)	25	1331	1	1331	1415	2666	3231	2217	3719	3600	3432	2538
1121_Pericardial adipose tissue volume (adjusted for height and weight, male)	1121_Pericardial adipose tissue volume (adjusted for height and weight, male)	25	1331	1	2159	2727	4613	2035	2711	2033	1331	3570	3625
1270_Epworth Sleepiness Scale (FBAT, adjusted for age, sex and BMI)	1270_Epworth Sleepiness Scale (FBAT, adjusted for age, sex and BMI)	25	1332	1	4528	2911	4225	4195	3675	3092	3624	4689	1332
1904_Hippocampal volume (FBAT, adjusted for multivariable)	1904_Hippocampal volume (FBAT, adjusted for multivariable)	25	1336	1	3512	3697	2405	4024	4484	1336	4745	2826	3670
39_Memory	39_Memory	25	1336	1	1715	3868	2900	4033	2284	2027	1336	3670	4148
2323_SERPINF2 - Alpha-2-antiplasmin	2323_SERPINF2 - Alpha-2-antiplasmin	25	1337	1	3015	3477	1337	2357	3145	3427	3354	2927	1490
1457_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1457_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	1337	1	2138	4377	4004	1337	3358	4543	2390	1511	4079
2147_TNFRSF17 - Tumor necrosis factor receptor superfamily member 17	2147_TNFRSF17 - Tumor necrosis factor receptor superfamily member 17	25	1337	1	4135	2884	2454	2876	1337	3656	4489	3584	2823
1173_Chronotype (continuous)	1173_Chronotype (continuous)	25	1338	1	1732	3290	3972	1338	3772	2706	1592	1460	2937
3873_Sum eosinophil basophil count (three-way meta)	3873_Sum eosinophil basophil count (three-way meta)	25	1340	1	3616	2210	3141	1662	2308	3113	1340	2773	1351
595_Peptide::Dipeptide::phenylalanylphenylalanine	595_Peptide::Dipeptide::phenylalanylphenylalanine	25	1340	1	3927	3859	4244	1469	2617	1768	3351	1528	1340
3146_S100A9 - Protein S100-A9	3146_S100A9 - Protein S100-A9	25	1341	1	1341	4564	2644	2894	4579	1557	3106	2964	2104
1011_Tumor necrosis factor beta	1011_Tumor necrosis factor beta	25	1341	1	1713	3094	1341	4522	2816	3256	4712	3645	4740
2739_IGHE IGK@ IGL@ - Immunoglobulin E	2739_IGHE IGK@ IGL@ - Immunoglobulin E	25	1341	1	4311	2075	4670	2125	4041	1341	4665	3112	4317
1731_Chronic kidney disease (at exam 7, GEE, adjusted for age and sex)	1731_Chronic kidney disease (at exam 7, GEE, adjusted for age and sex)	25	1342	1	2332	4463	1357	3658	1342	4064	2291	4008	2089
2070_C5 - Complement C5	2070_C5 - Complement C5	25	1343	1	4700	4586	1343	1770	1512	2888	2917	1840	4055
2979_ATP5B - ATP synthase subunit beta, mitochondrial	2979_ATP5B - ATP synthase subunit beta, mitochondrial	25	1343	1	3595	3146	1368	4399	4585	1343	4266	3678	2382
3154_TNFRSF14 - Tumor necrosis factor receptor superfamily member 14	3154_TNFRSF14 - Tumor necrosis factor receptor superfamily member 14	25	1344	1	1464	2795	1943	1344	4006	3020	3507	2136	3416
1619_CD40 Ligand serum (at exam 7, GEE, adjusted for age and sex)	1619_CD40 Ligand serum (at exam 7, GEE, adjusted for age and sex)	25	1344	1	1727	3015	3500	3215	4219	1344	1655	2630	4274
468_Lipid::Bile acid metabolism::glycodeoxycholate	468_Lipid::Bile acid metabolism::glycodeoxycholate	25	1346	1	3477	1346	3808	1595	4048	1524	2540	2046	4104
1918_Total cerebral brain volume (FBAT, adjusted for multivariable)	1918_Total cerebral brain volume (FBAT, adjusted for multivariable)	25	1346	1	1937	4036	1346	2054	3887	1512	4253	2460	4617
591_Peptide::Dipeptide::aspartylphenylalanine	591_Peptide::Dipeptide::aspartylphenylalanine	25	1346	1	2263	1433	2809	1346	1366	3994	3766	4144	2437
1_Attention deficit hyperactivity disorder	1_Attention deficit hyperactivity disorder	25	1350	1	3570	1350	1521	3998	1933	3644	2562	3407	3842
4431_Toxoplasmosis IgG levels	4431_Toxoplasmosis IgG levels	25	1352	1	3219	2675	3394	3494	1352	4685	4302	2710	4385
330_CD4mem:%R6+	330_CD4mem:%R6+	25	1353	1	3505	1353	2234	2712	2616	2117	3461	1936	4594
2854_TPM2 - Tropomyosin beta chain	2854_TPM2 - Tropomyosin beta chain	25	1353	1	2801	4523	3441	2089	4129	1353	3541	3698	3294
3189_Number of self-reported cancers	3189_Number of self-reported cancers	25	1354	1	2833	2808	3606	4534	2349	1354	2887	2875	3703
1000_Macrophage colony-stimulating factor	1000_Macrophage colony-stimulating factor	25	1355	1	1355	3402	3447	2110	4657	2341	3073	2584	2774
472_Lipid::Bile acid metabolism::taurodeoxycholate	472_Lipid::Bile acid metabolism::taurodeoxycholate	25	1357	1	1576	1357	1751	2146	4331	2430	1541	4249	2181
2898_PPY - Pancreatic hormone	2898_PPY - Pancreatic hormone	25	1358	1	4254	1750	2715	1378	2838	1358	2339	4710	4063
654_::::X-03003	654_::::X-03003	25	1361	1	2156	1361	2814	1576	2864	1711	3645	3032	1469
236_CD123 on pDC	236_CD123 on pDC	25	1361	1	2641	1756	4738	1361	1920	2354	3903	3011	3318
521_Lipid::Long chain fatty acid::myristate (14:0)	521_Lipid::Long chain fatty acid::myristate (14:0)	25	1361	1	2005	4721	1811	2423	3105	1810	2728	1361	4240
772_::::X-12405	772_::::X-12405	25	1362	1	2481	4555	1362	1516	2601	2440	2969	3327	4075
3094_TNFRSF19 - Tumor necrosis factor receptor superfamily member 19	3094_TNFRSF19 - Tumor necrosis factor receptor superfamily member 19	25	1363	1	1437	1363	4379	3884	3590	4518	2577	1862	3171
1583_D-dimer (at exam 6, GEE, adjusted for age and sex)	1583_D-dimer (at exam 6, GEE, adjusted for age and sex)	25	1364	1	3803	1364	1459	1804	2430	4361	2262	2708	2441
336_NKeff:%2-158a+	336_NKeff:%2-158a+	25	1365	1	3404	4652	3151	3690	1714	4298	1517	4522	1365
1944_Total cerebral brain volume (FBAT, adjusted for multivariable with APOE)	1944_Total cerebral brain volume (FBAT, adjusted for multivariable with APOE)	25	1367	1	1734	4211	1763	4070	4245	3514	3462	1367	2126
836_Peptide::Dipeptide::X-14304--leucylalanine	836_Peptide::Dipeptide::X-14304--leucylalanine	25	1372	1	1372	1472	2879	4726	4651	1969	1693	2293	2176
2348_IL4R - Interleukin-4 receptor subunit alpha	2348_IL4R - Interleukin-4 receptor subunit alpha	25	1372	1	4101	2978	4422	4189	3168	2615	2463	1372	3238
4106_Non-albumin protein	4106_Non-albumin protein	25	1373	1	2835	1775	2539	4073	3088	4270	1373	4439	3519
2014_Response following 8-week treatment of MDD subjects	2014_Response following 8-week treatment of MDD subjects	25	1377	1	2421	3217	4630	1377	3760	1637	3719	2776	3003
1665_Alanine transaminase (at exam 2, GEE, adjusted for multivariable)	1665_Alanine transaminase (at exam 2, GEE, adjusted for multivariable)	25	1378	1	1378	4050	1514	1407	2753	3863	4358	1718	3114
3557_Medication for pain relief, constipation, heartburn: Aspirin	3557_Medication for pain relief, constipation, heartburn: Aspirin	25	1382	1	1554	1382	3588	3999	1708	4089	4539	1778	3964
788_::::X-12645	788_::::X-12645	25	1383	1	1383	2350	3166	2559	2639	3848	4583	4092	1571
1220_Mean Amygdala	1220_Mean Amygdala	25	1384	1	3090	1384	3763	3814	1672	4565	3818	3337	2364
4530_Right lateral ventricle	4530_Right lateral ventricle	25	1384	1	2624	4023	2129	4207	1762	3745	2321	1384	3854
4517_Left lateral ventricle	4517_Left lateral ventricle	25	1386	1	1386	4216	4070	1826	1681	2873	2511	3300	2455
1082_Hemoglobin A1C level in conventional treatment group	1082_Hemoglobin A1C level in conventional treatment group	25	1387	1	1387	2854	2287	4573	2630	3716	3944	3115	4595
1802_Low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1802_Low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	1388	1	3461	1954	2510	1388	4677	2550	3493	1661	1656
4466_Left precentral	4466_Left precentral	25	1389	1	1799	2346	2722	3761	1389	3142	2995	2340	2640
2691_NACA - Nascent polypeptide-associated complex subunit alpha	2691_NACA - Nascent polypeptide-associated complex subunit alpha	25	1390	1	4154	1390	4405	4374	1414	3168	2542	2960	4324
1226_Intracranial Volume	1226_Intracranial Volume	25	1390	1	3428	4006	2328	2092	4289	1390	2212	2210	1835
2867_MMP12 - Macrophage metalloelastase	2867_MMP12 - Macrophage metalloelastase	25	1392	1	2702	1398	3117	3297	2926	2204	2472	2429	1392
3659_Cancer register - Type of cancer: ICD10: C50 Malignant neoplasm of breast	3659_Cancer register - Type of cancer: ICD10: C50 Malignant neoplasm of breast	25	1396	1	2322	3821	4295	1396	4285	3583	4308	4043	3765
4394_Heavy vaginal discharge	4394_Heavy vaginal discharge	25	1397	1	3689	3771	2174	4359	2488	1397	2173	4220	4743
1160_Fasting insulin main effect (adjusted for BMI)	1160_Fasting insulin main effect (adjusted for BMI)	25	1397	1	4357	3228	2496	3650	4283	4084	1930	1397	2939
2602_PRSS27 - Serine protease 27	2602_PRSS27 - Serine protease 27	25	1400	1	4422	1400	4057	4017	3801	3366	1934	3823	3974
1924_Hippocampal volume (FBAT, adjusted for age and sex)	1924_Hippocampal volume (FBAT, adjusted for age and sex)	25	1401	1	4123	4048	1401	4000	3645	4264	4733	2777	3801
259_CD8:%TM-like	259_CD8:%TM-like	25	1402	1	1414	2429	2757	3209	3930	1402	2502	3514	3133
2665_FGFR3 - Fibroblast growth factor receptor 3	2665_FGFR3 - Fibroblast growth factor receptor 3	25	1402	1	2679	2307	4622	4191	1561	4105	1402	3373	2508
1496_Triglycerides (at exam 1, FBAT, adjusted for multivariable)	1496_Triglycerides (at exam 1, FBAT, adjusted for multivariable)	25	1403	1	4239	1676	4044	2122	2982	4279	3185	1403	4540
2541_MPL - Thrombopoietin Receptor	2541_MPL - Thrombopoietin Receptor	25	1404	1	2163	4459	2041	1404	3692	4037	3044	3428	1619
1882_Shaft cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	1882_Shaft cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	25	1406	1	3729	1831	3789	1406	3877	3471	3814	2257	1772
1357_Total cholesterol (at exam 1, GEE, multivariate adjusted)	1357_Total cholesterol (at exam 1, GEE, multivariate adjusted)	25	1410	1	2629	4095	1512	4403	2457	1410	3332	1780	3874
4324_Positive affect (MA GWAMA)	4324_Positive affect (MA GWAMA)	25	1413	1	3514	1413	3118	3608	3271	4410	2228	2231	3705
1337_HOMA-IR (at exam 5, GEE, adjusted for age, sex and BMI)	1337_HOMA-IR (at exam 5, GEE, adjusted for age, sex and BMI)	25	1413	1	3407	4598	4591	1743	1413	4572	3499	3404	1498
2526_IL18R1 - Interleukin-18 receptor 1	2526_IL18R1 - Interleukin-18 receptor 1	25	1413	1	2251	1932	4628	4718	2334	1413	3518	4705	2748
3516_Heating type(s) in home: Gas central heating	3516_Heating type(s) in home: Gas central heating	25	1421	1	4281	1421	3841	4488	1767	4605	1704	3594	1966
1919_Total cerebral brain volume (GEE, adjusted for multivariable)	1919_Total cerebral brain volume (GEE, adjusted for multivariable)	25	1421	1	3684	3604	2293	1864	2326	3062	1421	3743	3012
3086_ROBO3 - Roundabout homolog 3	3086_ROBO3 - Roundabout homolog 3	25	1423	1	1423	4687	1848	2331	3252	2365	2930	4617	1575
1818_Inter-trochanteric buckling ratio (FBAT, female, adjussted for multivariable)	1818_Inter-trochanteric buckling ratio (FBAT, female, adjussted for multivariable)	25	1427	1	2207	4222	1427	4083	3320	1769	3916	2583	2972
3733_Depression - Thoughts of death during worst depression	3733_Depression - Thoughts of death during worst depression	25	1427	1	4421	2902	1797	4394	1857	1427	3805	4609	1592
3766_Depression - Recent thoughts of suicide or self-harm	3766_Depression - Recent thoughts of suicide or self-harm	25	1428	1	2780	2017	1428	3521	4382	1943	2731	3295	1775
513_Lipid::Ketone bodies::3-hydroxybutyrate (BHBA)	513_Lipid::Ketone bodies::3-hydroxybutyrate (BHBA)	25	1428	1	2684	3686	3164	1428	4488	1779	2651	2949	1888
547_Lipid::Lysolipid::1-stearoylglycerophosphoethanolamine	547_Lipid::Lysolipid::1-stearoylglycerophosphoethanolamine	25	1429	1	2505	1707	3340	3745	1429	3122	2328	2207	4110
2935_VEGFA - Vascular endothelial growth factor A, isoform 121	2935_VEGFA - Vascular endothelial growth factor A, isoform 121	25	1429	1	3122	1431	3119	4499	1962	4187	1429	4321	3006
1536_Ankle-brachial index (at exam 7, FBAT, adjusted for multivariable)	1536_Ankle-brachial index (at exam 7, FBAT, adjusted for multivariable)	25	1432	1	2373	2744	1887	1432	3725	3661	3512	2259	4566
384_Amino acid::Glycine, serine and threonine metabolism::threonine	384_Amino acid::Glycine, serine and threonine metabolism::threonine	25	1433	1	3954	1985	3630	4579	4234	1433	3027	2247	3358
2219_ANGPT1 - Angiopoietin-1	2219_ANGPT1 - Angiopoietin-1	25	1433	1	4728	4367	2388	4261	4507	2270	4522	1433	3871
2455_NTN4 - Netrin-4	2455_NTN4 - Netrin-4	25	1434	1	1664	1857	4109	4015	3177	2654	1434	3904	2081
4452_Left isthmus cingulate	4452_Left isthmus cingulate	25	1435	1	4596	3365	2810	1435	4112	4736	3169	3429	2846
997_Interferon gamma-induced protein 10 (CXCL10)	997_Interferon gamma-induced protein 10 (CXCL10)	25	1436	1	4726	2755	3714	1436	4154	3083	4068	4462	1720
4496_Right posterior cingulate	4496_Right posterior cingulate	25	1436	1	1848	2535	2351	3392	3055	2232	1772	1436	2188
66_Insulin sensitivity index (combined influence of the genotype effect adjusted for BMI and the interaction effect between the genotype and BMI on ISI)	66_Insulin sensitivity index (combined influence of the genotype effect adjusted for BMI and the interaction effect between the genotype and BMI on ISI)	25	1438	1	3805	2720	2869	1438	4518	3933	1862	3375	3020
1602_tPA (at exam 5, FBAT, adjusted for age and sex)	1602_tPA (at exam 5, FBAT, adjusted for age and sex)	25	1439	1	2395	3248	2225	1439	4601	3497	2678	3841	2881
580_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::hypoxanthine	580_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::hypoxanthine	25	1439	1	3388	4550	3094	3130	4022	1439	2572	4272	4631
1677_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for multivariable)	1677_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for multivariable)	25	1442	1	3312	3839	2487	3417	3719	1997	1442	2489	2255
2646_IL5 - Interleukin-5	2646_IL5 - Interleukin-5	25	1444	1	2460	3018	2694	1444	3229	2048	4633	3684	3409
3479_Own or rent accommodation lived in: Rent - from private landlord or letting agency	3479_Own or rent accommodation lived in: Rent - from private landlord or letting agency	25	1444	1	2299	4727	2688	1767	3825	1625	1444	4032	3865
2454_CADM1 - Cell adhesion molecule 1	2454_CADM1 - Cell adhesion molecule 1	25	1445	1	3418	2812	2909	1445	3546	3964	2871	2394	2335
2230_KLK4 - Kallikrein-4	2230_KLK4 - Kallikrein-4	25	1445	1	3241	3908	3223	2491	4604	4707	1445	2850	3489
2324_FGF2 - Fibroblast growth factor 2	2324_FGF2 - Fibroblast growth factor 2	25	1446	1	1459	3409	3468	3897	4462	1446	3780	4472	1822
4518_Left inferior lateral ventricle	4518_Left inferior lateral ventricle	25	1448	1	2666	1448	3460	2829	3043	2289	2579	4054	2302
1219_Mean Accumbens	1219_Mean Accumbens	25	1449	1	1449	3017	4569	1953	4504	3895	2970	2267	2668
3282_Number of full brothers	3282_Number of full brothers	25	1451	1	2948	2956	4009	1451	2225	3591	2785	3133	4446
817_::::X-13429	817_::::X-13429	25	1452	1	1648	3572	2647	1452	4614	4081	2581	2396	2055
2637_PTH - Parathyroid hormone	2637_PTH - Parathyroid hormone	25	1454	1	4323	1454	4502	2759	3713	3221	2497	3357	3923
663_::::X-04500	663_::::X-04500	25	1455	1	2264	1618	4272	1455	3196	2316	3919	3522	1904
3665_Diagnoses - main ICD10: C44 Other and unspecified malignant neoplasm of skin	3665_Diagnoses - main ICD10: C44 Other and unspecified malignant neoplasm of skin	25	1455	1	1604	1631	2085	3406	2465	1455	2250	3796	3354
1328_Fasting insulin (at exam 7, FBAT, adjusted for age, sex and BMI)	1328_Fasting insulin (at exam 7, FBAT, adjusted for age, sex and BMI)	25	1456	1	4453	2401	1650	3010	3113	1456	1793	4099	4258
406_Amino acid::Tryptophan metabolism::indolepropionate	406_Amino acid::Tryptophan metabolism::indolepropionate	25	1457	1	1457	1580	4320	3125	1679	4726	4579	1539	2457
4646_Total brain volume	4646_Total brain volume	25	1460	1	3052	2872	4519	4041	1460	2446	2489	4070	3711
207_Gout	207_Gout	25	1461	1	3568	2705	4206	4351	1680	2393	3115	4312	1461
2908_APOD - Apolipoprotein D	2908_APOD - Apolipoprotein D	25	1464	1	2738	4270	2558	1464	2353	2780	4456	3057	1845
1854_Neck average buckling ratio (FBAT, female, adjussted for age)	1854_Neck average buckling ratio (FBAT, female, adjussted for age)	25	1465	1	4292	4011	4086	3687	2039	3681	4356	1465	3069
2923_ITIH4 - Inter-alpha-trypsin inhibitor heavy chain H4	2923_ITIH4 - Inter-alpha-trypsin inhibitor heavy chain H4	25	1467	1	2869	2664	3604	2422	3764	3449	2975	1467	1500
1049_Parkinson disease of sibling pairs (tier 1)	1049_Parkinson disease of sibling pairs (tier 1)	25	1469	1	1469	3652	3415	2664	1899	3597	2369	3574	2025
3356_Number of unsuccessful stop-smoking attempts	3356_Number of unsuccessful stop-smoking attempts	25	1470	1	1470	3862	2222	2737	3118	1738	1648	3541	4230
1845_Neck Section Modulus (GEE, male, adjusted for multivariable)	1845_Neck Section Modulus (GEE, male, adjusted for multivariable)	25	1470	1	2636	2897	4198	3943	4624	3145	3532	3779	1470
3247_Poultry intake	3247_Poultry intake	25	1472	1	1472	4448	2718	3703	2858	1710	2714	3722	3470
1262_Residual from predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	1262_Residual from predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	25	1473	1	2808	4209	1902	3935	4444	2628	4321	1859	1473
1272_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI and usual sleep duration)	1272_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI and usual sleep duration)	25	1474	1	3907	4710	4156	3111	4272	4419	1474	2880	2393
1181_Sleep duration	1181_Sleep duration	25	1476	1	4297	1653	1862	4614	1476	3217	2269	1787	3843
3351_Had other major operations	3351_Had other major operations	25	1478	1	2429	3036	3541	1558	4214	1478	3375	3402	4697
4274_Short sleep	4274_Short sleep	25	1482	1	1482	3717	3390	3948	2157	4688	4235	3817	3066
3358_Father's age	3358_Father's age	25	1482	1	2043	3428	3294	2445	1482	3602	1811	3213	1898
2382_ADAMTS1 - A disintegrin and metalloproteinase with thrombospondin motifs 1	2382_ADAMTS1 - A disintegrin and metalloproteinase with thrombospondin motifs 1	25	1482	1	4714	3321	1976	1865	2883	1482	1545	2977	3030
3156_TNFSF14 - Tumor necrosis factor ligand superfamily member 14	3156_TNFSF14 - Tumor necrosis factor ligand superfamily member 14	25	1483	1	4724	4556	4386	1544	1656	1483	2358	4130	1626
2636_NPPB - Brain natriuretic peptide 32	2636_NPPB - Brain natriuretic peptide 32	25	1484	1	3676	3627	3883	3629	4422	1484	1523	4576	3202
1255_Percent predicted FVC for latest exam (GEE, adjusted for multiple covariates)	1255_Percent predicted FVC for latest exam (GEE, adjusted for multiple covariates)	25	1486	1	1486	4668	4338	3167	4743	2832	2211	1583	3275
368_Amino acid::Butanoate metabolism::2-aminobutyrate	368_Amino acid::Butanoate metabolism::2-aminobutyrate	25	1486	1	3786	3474	2705	1486	4080	4319	1774	2450	3287
198_Urinary albumin-to-creatinine ratio (diabetes positive)	198_Urinary albumin-to-creatinine ratio (diabetes positive)	25	1488	1	1488	1557	3374	2105	2796	3097	3215	2439	3385
2651_TEK - Angiopoietin-1 receptor, soluble	2651_TEK - Angiopoietin-1 receptor, soluble	25	1488	1	4114	1488	2949	3471	3039	3435	4099	3650	3324
3486_Bread type: Brown	3486_Bread type: Brown	25	1488	1	1974	3045	1488	1651	2233	3620	1722	4496	4334
2474_CDK8 CCNC - Cyclin-dependent kinase 8:Cyclin-C complex	2474_CDK8 CCNC - Cyclin-dependent kinase 8:Cyclin-C complex	25	1488	1	1834	1494	1818	1552	3856	4002	3251	1488	2549
1626_Interleukin 6 (at exam 7, FBAT, adjusted for age and sex)	1626_Interleukin 6 (at exam 7, FBAT, adjusted for age and sex)	25	1489	1	1489	2885	3474	3557	2147	2581	2764	1613	3364
858_3Lhydroxybutyrate	858_3Lhydroxybutyrate	25	1489	1	1741	1489	4488	3550	3250	2108	3380	4738	4315
938_Concentration of small LDL particles	938_Concentration of small LDL particles	25	1489	1	2658	2886	4110	1489	2767	2098	2623	2196	2778
2776_HSD17B10 - 3-hydroxyacyl-CoA dehydrogenase type-2	2776_HSD17B10 - 3-hydroxyacyl-CoA dehydrogenase type-2	25	1489	1	3754	4724	3650	4136	1489	2213	4272	3833	1927
3970_GLP-1 stimulated insulin secretion	3970_GLP-1 stimulated insulin secretion	25	1495	1	2010	1495	1495	2774	2083	2745	3754	4383	4331
2690_MDH1 - Malate dehydrogenase, cytoplasmic	2690_MDH1 - Malate dehydrogenase, cytoplasmic	25	1496	1	3787	4049	3338	4644	3974	4102	1604	1496	3109
2600_LGMN - Legumain	2600_LGMN - Legumain	25	1499	1	2552	3466	4487	2674	3623	1499	4180	1832	3950
396_Amino acid::Phenylalanine & tyrosine metabolism::phenol sulfate	396_Amino acid::Phenylalanine & tyrosine metabolism::phenol sulfate	25	1499	1	3673	2175	3837	3496	4330	3971	4627	3214	1499
1627_Interleukin 6 (at exam 7, GEE, adjusted for age and sex)	1627_Interleukin 6 (at exam 7, GEE, adjusted for age and sex)	25	1500	1	1838	4427	3178	1594	2737	1875	1521	1500	2381
3674_Diagnoses - main ICD10: K62 Other diseases of anus and rectum	3674_Diagnoses - main ICD10: K62 Other diseases of anus and rectum	25	1501	1	4620	3342	3289	4539	2182	1976	4418	1501	4492
2891_NXPH1 - Neurexophilin-1	2891_NXPH1 - Neurexophilin-1	25	1506	1	4609	2788	4314	2032	1506	3270	4291	3110	3476
4261_Facial attractiveness (male-coder, female samples)	4261_Facial attractiveness (male-coder, female samples)	25	1507	1	3731	1725	3887	1507	3970	2697	3303	2541	1854
4311_Diverticular disease	4311_Diverticular disease	25	1507	1	2039	2641	1633	4527	2927	1752	1507	3324	2224
3949_MYCN amplification neuroblastoma	3949_MYCN amplification neuroblastoma	25	1508	1	2633	4413	3205	1508	1848	3678	1613	2350	2311
1498_Triglycerides (at exam 1, FBAT, adjusted for age and sex)	1498_Triglycerides (at exam 1, FBAT, adjusted for age and sex)	25	1508	1	4356	1721	1959	1884	1508	2482	4287	4252	1983
3513_Gas or solid-fuel cooking/heating: A gas hob or gas cooker	3513_Gas or solid-fuel cooking/heating: A gas hob or gas cooker	25	1511	1	2463	3013	1511	3239	1928	1668	2469	1929	3017
2322_CTLA4 - Cytotoxic T-lymphocyte protein 4	2322_CTLA4 - Cytotoxic T-lymphocyte protein 4	25	1514	1	1514	3376	2895	3830	3582	2867	4443	1817	3910
4667_Sagittal stratum fractional anisotropy	4667_Sagittal stratum fractional anisotropy	25	1514	1	2008	1514	1688	3913	3957	2947	1657	2165	2481
1020_Neck Cross-Sectional Moment of Inertia (FBAT, adjusted for age and sex)	1020_Neck Cross-Sectional Moment of Inertia (FBAT, adjusted for age and sex)	25	1518	1	1518	3029	2589	1920	4212	1935	3029	1983	3235
2830_SLPI - Antileukoproteinase	2830_SLPI - Antileukoproteinase	25	1519	1	2958	3450	1519	4442	4070	3648	3283	3728	4564
1059_Diabetic Nephropathy in Type 1 Diabetes	1059_Diabetic Nephropathy in Type 1 Diabetes	25	1521	1	1521	1975	4503	4052	2059	4056	2421	2943	2492
2628_ALB - Serum albumin	2628_ALB - Serum albumin	25	1523	1	2183	2590	1523	1585	1819	4155	1788	2230	4442
2055_Remission after 12 weeks of antidepressant treatment in MDD	2055_Remission after 12 weeks of antidepressant treatment in MDD	25	1523	1	4033	2136	4561	1559	2429	4592	2123	1523	2350
3318_Weight change compared with 1 year ago	3318_Weight change compared with 1 year ago	25	1523	1	4320	3588	2370	4125	3935	3395	2934	4102	1523
358_earlyB:%27+	358_earlyB:%27+	25	1527	1	2826	2570	1527	4031	4085	3218	2475	2017	4508
3355_Ever stopped smoking for 6+ months	3355_Ever stopped smoking for 6+ months	25	1527	1	2632	4031	4236	2038	2951	2704	3751	2883	1527
3078_NOTCH3 - Neurogenic locus notch homolog protein 3	3078_NOTCH3 - Neurogenic locus notch homolog protein 3	25	1529	1	2337	2417	3826	1529	1988	4566	3286	4345	1919
1086_Pancreatic cancer	1086_Pancreatic cancer	25	1530	1	2081	1726	4354	3594	3697	4057	4688	4352	1530
3098_TNFRSF12A - Tumor necrosis factor receptor superfamily member 12A	3098_TNFRSF12A - Tumor necrosis factor receptor superfamily member 12A	25	1532	1	2405	4149	3929	2099	2548	1532	2363	2974	1579
1103_Insulin - Birth cohorts	1103_Insulin - Birth cohorts	25	1537	1	3695	4528	4292	2556	4562	3039	3816	1537	3526
3974_Total body BMD (30-45 years old)	3974_Total body BMD (30-45 years old)	25	1538	1	3041	2990	4357	3092	3186	3073	3964	1538	3844
453_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::biliverdin	453_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::biliverdin	25	1540	1	4552	3265	4573	4148	1934	1540	4391	1970	4339
1170_Leptin (adjusted for BMI)	1170_Leptin (adjusted for BMI)	25	1541	1	3549	1956	3133	3739	4669	2538	2442	4047	1541
1244_Mean FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1244_Mean FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	1546	1	4037	3770	4673	2619	3504	1732	4735	3219	1546
2404_KLK5 - Kallikrein-5	2404_KLK5 - Kallikrein-5	25	1548	1	1583	2426	1548	3071	3958	1701	1856	3756	3896
14_Posttraumatic stress disorder	14_Posttraumatic stress disorder	25	1548	1	4440	2532	1730	3194	1972	2931	2959	2459	1548
3620_Treatment/medication code: amlodipine	3620_Treatment/medication code: amlodipine	25	1549	1	2037	2574	4084	1549	4186	2230	2897	1870	2387
2067_TIMP2 - Metalloproteinase inhibitor 2	2067_TIMP2 - Metalloproteinase inhibitor 2	25	1552	1	4687	4027	1655	4582	1645	2387	4199	1758	1552
262_CD8:%Naive	262_CD8:%Naive	25	1554	1	1891	4015	4585	2439	1554	4141	1634	2456	1824
2633_IFNGR1 - Interferon gamma receptor 1	2633_IFNGR1 - Interferon gamma receptor 1	25	1556	1	2707	3054	1880	1556	3828	2796	2251	3582	4519
2144_MAPT - Microtubule-associated protein tau	2144_MAPT - Microtubule-associated protein tau	25	1558	1	2388	4407	2026	2704	3781	4224	1558	4166	1981
2079_PLA2G2E - Group IIE secretory phospholipase A2	2079_PLA2G2E - Group IIE secretory phospholipase A2	25	1559	1	2387	3186	2971	2205	4246	1835	4558	4551	1559
2681_RGMA - Repulsive guidance molecule A	2681_RGMA - Repulsive guidance molecule A	25	1561	1	2590	3750	1561	3872	4402	3175	1671	1716	2472
1191_PGC cross disorder	1191_PGC cross disorder	25	1562	1	2895	3938	2815	2181	1562	3308	2342	3075	3462
3408_Average weekly intake of other alcoholic drinks	3408_Average weekly intake of other alcoholic drinks	25	1564	1	2279	2958	4276	1926	1564	2622	3687	3174	1622
2579_BSG - Basigin	2579_BSG - Basigin	25	1566	1	1566	2620	1698	4245	4095	2454	2796	3674	4179
4247_Ambidextrousness	4247_Ambidextrousness	25	1567	1	2309	2955	4702	4714	1567	3258	2935	3950	2583
2943_WNT7A - Protein Wnt-7a	2943_WNT7A - Protein Wnt-7a	25	1572	1	2295	4410	1754	1572	2822	1687	2203	2617	3753
3683_Diagnoses - main ICD10: R19 Oth symptoms and signs involving the dgstv sys and abdomen	3683_Diagnoses - main ICD10: R19 Oth symptoms and signs involving the dgstv sys and abdomen	25	1573	1	2501	2554	2152	4505	4613	2556	4027	1573	3360
108_Coronary artery disease	108_Coronary artery disease	25	1575	1	3852	3213	2039	2114	1575	3769	2619	1744	4268
4_Autism spectrum disorder	4_Autism spectrum disorder	25	1576	1	3323	3557	2241	2844	1646	4003	4056	1576	1873
2217_ACVR1B - Activin receptor type-1B	2217_ACVR1B - Activin receptor type-1B	25	1578	1	3265	2138	3074	4408	1652	3928	3807	1578	4510
445_Carbohydrate::Nucleotide sugars, pentose metabolism::arabinose	445_Carbohydrate::Nucleotide sugars, pentose metabolism::arabinose	25	1579	1	4701	1820	4568	4418	2207	1579	3850	3229	2526
3783_Depression - Waking too early	3783_Depression - Waking too early	25	1588	1	2140	1588	2751	2073	3288	3409	4002	3680	1994
1135_Eczema	1135_Eczema	25	1588	1	3965	2763	4648	1993	2996	2322	1588	3885	2623
284_CD4:%Act(38+)	284_CD4:%Act(38+)	25	1591	1	2743	3925	4101	4009	2644	1936	1591	3775	2807
4237_Antihistamines for systemic use	4237_Antihistamines for systemic use	25	1596	1	3054	2857	4674	4409	4275	4091	4013	1596	1742
341_NKeff:%314-R7-	341_NKeff:%314-R7-	25	1597	1	1597	2988	2037	4082	4647	4051	1966	3878	2567
2963_LYZ - Lysozyme C	2963_LYZ - Lysozyme C	25	1597	1	4507	2142	1597	3879	1612	2159	2151	2474	2466
650_::::X-01911	650_::::X-01911	25	1601	1	1601	2325	3730	2342	3734	4494	3281	4465	4023
4737_Average across all tracts radial diusivities	4737_Average across all tracts radial diusivities	25	1603	1	1945	1796	3510	2917	4159	4583	1603	4112	2294
1733_Chronic kidney disease (at exam 7, GEE, adjusted for multivariable)	1733_Chronic kidney disease (at exam 7, GEE, adjusted for multivariable)	25	1605	1	4103	2624	3056	4182	1605	4509	2963	1975	4049
2983_CA2 - Carbonic anhydrase 2	2983_CA2 - Carbonic anhydrase 2	25	1606	1	1606	4696	2504	1923	4525	4650	3762	3244	1997
300_CD4mem:%Th1* (3)	300_CD4mem:%Th1* (3)	25	1608	1	4603	1698	3787	1608	4126	3972	4483	4406	2473
1659_Alkaline phosphatase (at exam 2, GEE, adjusted for age and sex)	1659_Alkaline phosphatase (at exam 2, GEE, adjusted for age and sex)	25	1612	1	2924	4669	2337	2404	2218	1612	3119	1969	1875
2425_TGFBI - Transforming growth factor-beta-induced protein ig-h3	2425_TGFBI - Transforming growth factor-beta-induced protein ig-h3	25	1615	1	3619	4120	1675	4398	2970	2269	2186	1615	1779
335_NKeff:%314-158a+	335_NKeff:%314-158a+	25	1616	1	4186	3382	1858	4328	1616	2472	2326	2149	4073
2263_CCL28 - C-C motif chemokine 28	2263_CCL28 - C-C motif chemokine 28	25	1618	1	3580	2636	3911	2475	4454	4720	3799	1868	1618
2822_INHBA INHBB - Inhibin beta A chain:Inhibin beta B chain heterodimer	2822_INHBA INHBB - Inhibin beta A chain:Inhibin beta B chain heterodimer	25	1621	1	3045	3489	4360	2394	1621	4194	1726	3888	4305
255_CD3 on 127+DN T	255_CD3 on 127+DN T	25	1625	1	2246	3198	3564	3847	3671	1962	1625	2143	3412
862_Creatinine	862_Creatinine	25	1627	1	1627	3939	4325	2925	3385	3482	2891	3989	2560
1116_Visceral sdipose tissue volume (adjusted for BMI, female)	1116_Visceral sdipose tissue volume (adjusted for BMI, female)	25	1627	1	3140	1627	2407	3806	3744	2938	2824	3182	3733
4238_Antiglaucoma preparations and miotics	4238_Antiglaucoma preparations and miotics	25	1628	1	3795	1983	2120	1628	3010	2711	3242	3348	2813
278_CD8:%Act(25+38+)	278_CD8:%Act(25+38+)	25	1631	1	2941	3668	3200	4364	1915	3710	3547	1631	3108
2113_CST3 - Cystatin-C	2113_CST3 - Cystatin-C	25	1633	1	1633	4236	3398	3282	3165	2675	3496	3673	3735
4655_Fornix (column and body of fornix) fractional anisotropy	4655_Fornix (column and body of fornix) fractional anisotropy	25	1636	1	1636	2012	3433	3992	3601	2863	3887	3612	2111
3967_Asthma (random effect model)	3967_Asthma (random effect model)	25	1636	1	2480	3399	3993	2117	3479	3041	4563	4195	1636
2316_NCR3 - Natural cytotoxicity triggering receptor 3	2316_NCR3 - Natural cytotoxicity triggering receptor 3	25	1638	1	3413	2092	3385	3214	2946	4009	1638	3009	4107
304_CD4mem:%Th1* (5)	304_CD4mem:%Th1* (5)	25	1640	1	4235	1640	1806	2403	4201	1951	2304	4670	4515
3043_CD226 - CD226 antigen	3043_CD226 - CD226 antigen	25	1644	1	2640	4740	4391	1644	3923	4740	3172	3330	2781
2566_CXCL12 - Stromal cell-derived factor 1	2566_CXCL12 - Stromal cell-derived factor 1	25	1644	1	1991	4230	4713	2517	2333	2405	1644	3686	2326
1676_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for multivariable)	1676_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for multivariable)	25	1647	1	1647	2654	4304	4464	2140	3926	3078	2183	2403
3276_Facial ageing	3276_Facial ageing	25	1647	1	4557	2371	1647	3267	2492	2351	4596	2825	4496
2270_TNFSF11 - Tumor necrosis factor ligand superfamily member 11	2270_TNFSF11 - Tumor necrosis factor ligand superfamily member 11	25	1650	1	1650	4214	2707	3626	3891	3132	2798	2627	3791
518_Lipid::Long chain fatty acid::dihomo-linoleate (20:2n6)	518_Lipid::Long chain fatty acid::dihomo-linoleate (20:2n6)	25	1650	1	1833	3276	2433	2301	4193	2575	1650	4654	3714
234_Lymph:%NK	234_Lymph:%NK	25	1651	1	2320	1919	3831	4122	2251	4670	3686	1651	2667
1873_Shaft average buckling ratio (GEE, male, adjussted for multivariable)	1873_Shaft average buckling ratio (GEE, male, adjussted for multivariable)	25	1652	1	3758	1652	4312	3774	3401	2503	3206	2040	2609
2450_LRIG3 - Leucine-rich repeats and immunoglobulin-like domains protein 3	2450_LRIG3 - Leucine-rich repeats and immunoglobulin-like domains protein 3	25	1653	1	1700	2324	1653	2441	3215	2235	2309	4210	4072
4064_Estimated glomerular filtration rate based on cystain C	4064_Estimated glomerular filtration rate based on cystain C	25	1653	1	3521	3767	3817	2116	3754	1653	1755	3567	3373
2152_EGFR - Epidermal growth factor receptor	2152_EGFR - Epidermal growth factor receptor	25	1653	1	2285	2177	4332	3093	3395	4635	3714	1653	2351
3180_STIP1 - Stress-induced-phosphoprotein 1	3180_STIP1 - Stress-induced-phosphoprotein 1	25	1656	1	3617	3151	1656	3589	3331	1863	3123	4326	1716
178_Waist circumference (female, adjusted for BMI)	178_Waist circumference (female, adjusted for BMI)	25	1661	2	4734	2615	2580	2378	4592	2395	3763	1888	1661
35_Loneliness (linear)	35_Loneliness (linear)	25	1663	1	1970	2273	1663	3800	3239	4595	4244	3520	2517
2415_SERPINE2 - Glia-derived nexin	2415_SERPINE2 - Glia-derived nexin	25	1663	1	2255	3091	4447	2833	4304	1663	3548	1697	3406
2325_CAST - Calpastatin	2325_CAST - Calpastatin	25	1666	1	1666	2946	3583	2830	4693	4470	2419	4191	2447
1674_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for age and sex)	1674_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for age and sex)	25	1668	1	2840	4290	3953	4690	4524	4482	2826	1668	2250
712_::::X-11483	712_::::X-11483	25	1668	1	1964	2258	4656	1824	2275	2800	1983	2531	1668
213_Lymph:%CD4	213_Lymph:%CD4	25	1670	1	4008	2149	1670	3480	3481	2045	4462	2622	3895
3163_TNFRSF13C - Tumor necrosis factor receptor superfamily member 13C	3163_TNFRSF13C - Tumor necrosis factor receptor superfamily member 13C	25	1670	1	4439	2097	4077	2765	1670	2311	3698	2301	3596
2958_CGA CGB - Human Chorionic Gonadotropin	2958_CGA CGB - Human Chorionic Gonadotropin	25	1672	1	2546	4167	1865	4630	1768	2000	1672	3746	3026
306_CD4mem:%cFTH (2)	306_CD4mem:%cFTH (2)	25	1674	1	3868	1674	2183	3623	1893	3598	4458	1775	2465
3964_Gestational weight gain (offspring, early)	3964_Gestational weight gain (offspring, early)	25	1676	1	1676	2090	3412	3561	4470	3246	2385	3444	4071
2216_ACE2 - Angiotensin-converting enzyme 2	2216_ACE2 - Angiotensin-converting enzyme 2	25	1676	1	2169	1917	1676	3017	2903	3546	2803	2805	3369
1664_Alanine transaminase (at exam 2, FBAT, adjusted for multivariable)	1664_Alanine transaminase (at exam 2, FBAT, adjusted for multivariable)	25	1677	1	1852	3398	2432	1677	2637	4127	3635	2248	1894
588_Nucleotide::Purine metabolism, urate metabolism::urate	588_Nucleotide::Purine metabolism, urate metabolism::urate	25	1677	1	4652	2205	3188	2728	2757	4266	3588	1677	1724
3969_Asthma (random effect model)	3969_Asthma (random effect model)	25	1681	1	1681	2424	3146	2304	3853	2436	4528	3058	3564
3075_RTN4R - Reticulon-4 receptor	3075_RTN4R - Reticulon-4 receptor	25	1683	1	2379	4582	3181	3765	1683	1895	3782	1684	3947
3179_SRC - Proto-oncogene tyrosine-protein kinase Src	3179_SRC - Proto-oncogene tyrosine-protein kinase Src	25	1683	1	1764	2505	4144	1933	3996	4104	3190	1683	3551
2865_IL12B IL23A - Interleukin-23	2865_IL12B IL23A - Interleukin-23	25	1688	1	1949	2899	3742	1744	1688	1802	1801	3641	4639
4602_Right superior frontal	4602_Right superior frontal	25	1690	1	2573	4397	4542	1690	4532	4243	4474	3893	3664
3546_Mouth/teeth dental problems: Bleeding gums	3546_Mouth/teeth dental problems: Bleeding gums	25	1691	1	1691	1691	4242	1781	1763	3317	2426	4582	2056
3511_Reason for reducing amount of alcohol drunk: Other reason	3511_Reason for reducing amount of alcohol drunk: Other reason	25	1692	1	3439	3275	2193	4739	3783	4333	3901	4684	1692
1561_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1561_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	1693	1	3102	4243	3268	3509	2559	1693	3674	2612	2638
3965_Gestational weight gain (offspring, total)	3965_Gestational weight gain (offspring, total)	25	1696	1	4303	2504	2937	1696	3915	2894	4326	3371	2003
2013_Response following treatment of MDD subjects	2013_Response following treatment of MDD subjects	25	1697	1	1697	3088	2841	3097	4530	2533	2283	2847	3823
2755_SERPINA3 - alpha-1-antichymotrypsin complex	2755_SERPINA3 - alpha-1-antichymotrypsin complex	25	1700	1	2154	3311	3674	3458	1700	2886	2791	3701	3326
1167_HOMA-B	1167_HOMA-B	25	1710	1	3120	3817	4090	1710	4322	1881	4414	4237	3570
2498_STAB2 - Stabilin-2	2498_STAB2 - Stabilin-2	25	1712	1	3767	2867	1757	4621	3189	2489	1712	4096	4195
227_mDC:%CD1c-	227_mDC:%CD1c-	25	1713	1	2125	1928	3102	4668	4177	1713	2748	3733	4459
4125_Fibrinogen	4125_Fibrinogen	25	1717	1	1885	1717	2182	3637	2793	3905	1859	4488	2057
2358_IL2 - Interleukin-2	2358_IL2 - Interleukin-2	25	1724	1	4039	4255	2023	2914	2812	1724	2032	3338	4320
125_Body Mass Index (female)	125_Body Mass Index (female)	25	1725	1	4246	4674	3947	1725	2377	4150	3832	2928	3559
3348_Age when last used oral contraceptive pill (female)	3348_Age when last used oral contraceptive pill (female)	25	1729	1	2085	3322	1729	3975	3965	3139	1798	4001	2067
4545_Total brain volume	4545_Total brain volume	25	1730	1	2420	2440	3376	3058	1730	2568	2399	4742	4207
1969_MMSE score (at age 65, GEE, adjusted for birth-cohort)	1969_MMSE score (at age 65, GEE, adjusted for birth-cohort)	25	1732	1	1967	4111	1732	3113	2423	3160	4401	2941	3644
4190_Type 2 Diabetes	4190_Type 2 Diabetes	25	1732	1	4296	3476	4150	4127	4093	3684	2169	4643	1732
4347_Coronary artery disease and low-density lipoprotein cholesterol (bivariate)	4347_Coronary artery disease and low-density lipoprotein cholesterol (bivariate)	25	1733	1	3762	4278	4135	1733	4204	3660	4049	3064	3389
1936_Total cerebral brain volume (FBAT, adjusted for age and sex)	1936_Total cerebral brain volume (FBAT, adjusted for age and sex)	25	1734	1	3626	4303	1750	3276	3469	1740	1734	2413	3272
3059_IL23R - Interleukin-23 receptor	3059_IL23R - Interleukin-23 receptor	25	1736	1	3987	3970	1736	4236	2462	2808	3779	1855	3404
398_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetylglutamine	398_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetylglutamine	25	1736	1	3562	4678	2476	3255	2791	2636	3153	2717	1736
1578_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	1578_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	25	1737	1	4203	2294	2122	2866	3428	4725	1737	4170	2725
4470_Left superior frontal	4470_Left superior frontal	25	1742	1	3489	1742	3115	1796	1774	2085	2816	4549	3273
1565_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1565_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	1749	1	4257	3824	2928	2048	1749	3530	3819	2280	2839
1419_High-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	1419_High-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	25	1751	1	4665	3561	3700	2220	3607	3028	2880	1751	2434
2210_MMP7 - Matrilysin	2210_MMP7 - Matrilysin	25	1755	1	2706	4601	3591	3242	4332	2253	4263	1755	3363
4194_Systolic Blood Pressure	4194_Systolic Blood Pressure	25	1764	1	3452	3658	4528	2778	3707	3754	4054	1764	2221
1182_Sleep duration (male)	1182_Sleep duration (male)	25	1765	1	3053	3756	1765	4514	3867	3623	2225	4432	3616
3966_Asthma (fixed effect model)	3966_Asthma (fixed effect model)	25	1765	1	3105	3940	2805	3237	4625	1765	4343	4292	1821
3336_Ever had breast cancer screening / mammogram (female)	3336_Ever had breast cancer screening / mammogram (female)	25	1766	1	4268	2887	1766	4060	2847	3372	2274	3234	3214
4729_Splenium of corpus callosum mode of anisotropy	4729_Splenium of corpus callosum mode of anisotropy	25	1766	1	2300	3114	2060	1948	1814	4427	1807	2253	1766
1663_Alanine transaminase (at exam 2, GEE, adjusted for age and sex)	1663_Alanine transaminase (at exam 2, GEE, adjusted for age and sex)	25	1768	1	2178	3661	4154	3680	3051	3237	3601	1768	3770
2272_APOE - Apolipoprotein E (isoform E3)	2272_APOE - Apolipoprotein E (isoform E3)	25	1769	1	1882	3810	4175	3328	1896	3165	2981	2453	1769
1667_Aspartate aminotransferase (at exam 2, GEE, adjusted for age and sex)	1667_Aspartate aminotransferase (at exam 2, GEE, adjusted for age and sex)	25	1770	1	1770	4653	2103	4020	3180	3038	2448	2161	1784
2826_FGF8 - Fibroblast growth factor 8 isoform A	2826_FGF8 - Fibroblast growth factor 8 isoform A	25	1772	1	4093	2908	1832	1772	1871	3949	3954	4504	2979
253_CD123 on 11c+123+DC	253_CD123 on 11c+123+DC	25	1772	1	3296	2619	3210	2793	2676	1772	3065	4621	1847
947_Sphingomyelins	947_Sphingomyelins	25	1775	1	3529	3330	2942	1815	2607	2639	1775	2643	4601
4491_Right pars opercularis	4491_Right pars opercularis	25	1780	1	4581	1780	3182	2974	3662	4039	3035	3395	2559
3512_Type of tobacco previously smoked: Manufactured cigarettes	3512_Type of tobacco previously smoked: Manufactured cigarettes	25	1786	1	4722	4505	3957	3063	4741	4355	4450	1786	1958
3861_Plateletcrit (two-way meta)	3861_Plateletcrit (two-way meta)	25	1789	1	3905	2264	3834	2905	4619	3528	2022	3884	1789
2930_GPC3 - Glypican-3	2930_GPC3 - Glypican-3	25	1798	1	2908	1798	3521	2499	3528	2141	2446	2348	3629
4463_Left pericalcarine	4463_Left pericalcarine	25	1804	1	3077	3892	4345	2787	1804	4304	2802	3496	3454
4081_Waist-hip ratio (adjusted for BMI, male)	4081_Waist-hip ratio (adjusted for BMI, male)	25	1809	1	3246	4658	1977	3568	4005	4334	4564	3183	1809
379_Amino acid::Glycine, serine and threonine metabolism::betaine	379_Amino acid::Glycine, serine and threonine metabolism::betaine	25	1810	1	2514	3329	3466	2280	2660	2319	1810	4389	3313
3142_F2 - Prothrombin	3142_F2 - Prothrombin	25	1811	1	3022	3387	4355	2241	1964	3444	2310	3973	1811
1274_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	1274_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	25	1818	1	3889	3007	4271	3612	2590	4734	1818	2838	4412
3221_Time spent driving	3221_Time spent driving	25	1821	1	2602	1987	2484	1821	4373	2303	4571	3332	1945
196_Estimated glomerular filtration rate based on serum creatinine	196_Estimated glomerular filtration rate based on serum creatinine	25	1824	1	3230	3148	2501	3958	1824	2961	2247	2990	3078
2245_CHEK1 - Serine/threonine-protein kinase Chk1	2245_CHEK1 - Serine/threonine-protein kinase Chk1	25	1825	1	2620	2680	4016	3235	3240	1825	2137	2994	2975
2964_CCL19 - C-C motif chemokine 19	2964_CCL19 - C-C motif chemokine 19	25	1827	1	2873	4217	2042	3783	1827	3015	2940	2647	3941
1956_Wide Range Achievement Test (FBAT, adjusted for multivariable)	1956_Wide Range Achievement Test (FBAT, adjusted for multivariable)	25	1827	1	2483	2172	4300	2040	3992	1958	2398	1827	4736
3509_Reason for reducing amount of alcohol drunk: Illness or ill health	3509_Reason for reducing amount of alcohol drunk: Illness or ill health	25	1832	1	3416	1832	3344	3284	4540	3677	2569	3043	4206
2767_EIF4EBP2 - Eukaryotic translation initiation factor 4E-binding protein 2	2767_EIF4EBP2 - Eukaryotic translation initiation factor 4E-binding protein 2	25	1834	1	2744	2694	3012	2852	2856	1834	2145	3785	2210
2086_TNFSF12 - Tumor necrosis factor ligand superfamily member 12	2086_TNFSF12 - Tumor necrosis factor ligand superfamily member 12	25	1836	1	1850	2203	2451	2223	2079	3239	2643	2991	1836
689_::::X-11247	689_::::X-11247	25	1839	1	3551	1839	3262	3776	3072	4070	2879	2554	3624
4015_Central corneal thickness	4015_Central corneal thickness	25	1841	1	1841	3633	2861	4239	2602	2513	4166	1931	4379
794_::::X-12719	794_::::X-12719	25	1847	1	3169	3683	4014	4162	2234	1847	1998	4524	3727
2884_GPR114 - Probable G-protein coupled receptor 114	2884_GPR114 - Probable G-protein coupled receptor 114	25	1851	1	4139	3626	4321	3173	1851	2785	2781	2911	4678
3506_Non-butter spread type details: Olive oil based spread (eg: Bertolli)	3506_Non-butter spread type details: Olive oil based spread (eg: Bertolli)	25	1853	1	3752	3976	3038	1853	4109	3533	2454	4709	2208
2848_RASA1 - Ras GTPase-activating protein 1	2848_RASA1 - Ras GTPase-activating protein 1	25	1865	1	1985	2561	2317	2252	3604	3572	4577	1865	2015
581_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::inosine	581_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::inosine	25	1869	1	2606	2494	2742	1869	2145	2284	3879	2874	4013
563_Lipid::Monoacylglycerol::1-oleoylglycerol (1-monoolein)	563_Lipid::Monoacylglycerol::1-oleoylglycerol (1-monoolein)	25	1881	1	3981	3984	3544	3909	3521	3580	4502	1881	3697
3275_Childhood sunburn occasions	3275_Childhood sunburn occasions	25	1888	1	2494	2599	4698	1945	2369	1888	3641	2998	4626
3084_RELT - Tumor necrosis factor receptor superfamily member 19L	3084_RELT - Tumor necrosis factor receptor superfamily member 19L	25	1890	1	4720	3624	1978	3555	2381	4220	3802	1890	4438
1943_White matter hyperintensity volume (GEE, adjusted for multivariable with APOE)	1943_White matter hyperintensity volume (GEE, adjusted for multivariable with APOE)	25	1896	1	1896	4524	3130	3519	2205	2693	3407	2006	4683
128_Hip circumference (male)	128_Hip circumference (male)	25	1898	1	3624	2750	1898	2651	3809	4133	3644	3091	2290
4419_Measles seropositivity	4419_Measles seropositivity	25	1920	1	1920	3533	2651	3871	2090	3891	3950	4595	3712
4107_Albumin/globulin ratio	4107_Albumin/globulin ratio	25	1941	1	3025	4708	3237	1941	4059	4292	1962	4493	2999
4262_Facial attractiveness (female-coder, female samples)	4262_Facial attractiveness (female-coder, female samples)	25	1945	1	4392	2585	3506	2160	4735	1945	4378	4736	2994
226_B Mem:%IgG	226_B Mem:%IgG	25	1948	1	4706	3480	2365	3402	4364	3692	2896	2758	1948
3316_Frequency of solarium/sunlamp use	3316_Frequency of solarium/sunlamp use	25	1949	1	4578	4220	4653	3357	3223	3917	3820	1949	3919
671_::::X-06350	671_::::X-06350	25	1954	1	3398	3751	1954	3928	4366	3209	2488	2399	3259
1338_HOMA-IR (at exam 7, FBAT, adjusted for age, sex and BMI)	1338_HOMA-IR (at exam 7, FBAT, adjusted for age, sex and BMI)	25	1955	1	3525	2652	2889	4745	3064	3493	3096	1955	3611
4577_Right caudal anterior cingulate	4577_Right caudal anterior cingulate	25	1959	1	3019	1959	3567	2101	4340	4478	1985	2242	4554
3940_Body Mass Index (male)	3940_Body Mass Index (male)	25	1965	1	1965	2087	2749	4475	3880	2206	4379	4387	2770
1058_Amyotrophic lateral sclerosis	1058_Amyotrophic lateral sclerosis	25	1965	1	2214	2718	3833	1965	2821	4299	2524	2191	2241
1940_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	1940_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	25	1970	1	3123	4554	2918	1970	2983	3134	4146	4668	3642
3092_SCARF1 - Scavenger receptor class F member 1	3092_SCARF1 - Scavenger receptor class F member 1	25	1972	1	3405	4269	4358	1972	2563	4052	3957	2661	3127
685_::::X-10506	685_::::X-10506	25	1988	1	4144	4540	1988	4004	4190	3675	3680	4466	2225
1004_Macrophage inflammatory protein-1 (CCL4)	1004_Macrophage inflammatory protein-1 (CCL4)	25	1989	1	3536	2677	2871	4204	2960	1989	2799	3149	4377
2714_LMNB1 - Lamin-B1	2714_LMNB1 - Lamin-B1	25	1993	1	2757	2237	2668	2545	3933	1993	4612	4647	2655
280_CD8:%DR+73+39-25-	280_CD8:%DR+73+39-25-	25	2007	1	2435	2007	4608	4525	4224	4313	4517	3970	3523
387_Amino acid::Histidine metabolism::histidine	387_Amino acid::Histidine metabolism::histidine	25	2007	1	4047	2775	3488	3962	2007	2926	3503	3919	4236
2334_IL1B - Interleukin-1 beta	2334_IL1B - Interleukin-1 beta	25	2008	1	4133	2486	2008	4090	3579	3155	4420	3120	2788
2716_MBD4 - Methyl-CpG-binding domain protein 4	2716_MBD4 - Methyl-CpG-binding domain protein 4	25	2012	1	3400	4087	4008	2012	2709	3993	2938	4063	3876
2393_TMPRSS15 - Enteropeptidase	2393_TMPRSS15 - Enteropeptidase	25	2017	1	3599	3331	4632	4485	2604	2967	3150	4150	2017
4434_Measles IgG levels	4434_Measles IgG levels	25	2027	1	2485	2027	2858	3514	3691	4045	3134	4189	4490
688_::::X-11204	688_::::X-11204	25	2027	1	4657	4210	4449	2686	4178	2592	4375	2027	2879
4606_Right transverse temporal	4606_Right transverse temporal	25	2038	1	4693	2131	2825	4430	2214	3740	4628	2038	4280
1539_White matter hyperintensity volume (GEE, adjusted for age and sex)	1539_White matter hyperintensity volume (GEE, adjusted for age and sex)	25	2043	1	2342	2959	3670	3258	2583	2043	3266	2218	2249
4176_Type 2 Diabetes	4176_Type 2 Diabetes	25	2049	1	2049	3431	2518	4037	3153	2325	2927	2596	2178
4354_Infantile hypertrophic pyloric stenosis	4354_Infantile hypertrophic pyloric stenosis	25	2054	1	2054	3905	2538	4315	2530	3356	3591	3691	3984
2762_MMP2 - 72 kDa type IV collagenase	2762_MMP2 - 72 kDa type IV collagenase	25	2058	1	2058	4625	2323	2932	2142	3136	3987	4314	2133
281_CD8:%Act(25+38+RO+)	281_CD8:%Act(25+38+RO+)	25	2058	1	4388	2674	2571	3628	2595	2082	3080	2058	4504
2528_INSR - Insulin receptor	2528_INSR - Insulin receptor	25	2061	1	3028	3852	3904	4003	4568	4588	2061	2175	4000
555_Lipid::Medium chain fatty acid::caprate (10:0)	555_Lipid::Medium chain fatty acid::caprate (10:0)	25	2063	1	4566	2063	2146	4589	3286	4663	2846	2438	2130
592_Peptide::Dipeptide::cyclo(leu-pro)	592_Peptide::Dipeptide::cyclo(leu-pro)	25	2081	1	4157	4575	2081	4036	3484	4464	2366	2109	3610
138_Waist-hip ratio (male)	138_Waist-hip ratio (male)	25	2085	1	3966	3942	2167	2695	2085	4529	2950	3879	2334
2676_MAPK8 - Mitogen-activated protein kinase 8	2676_MAPK8 - Mitogen-activated protein kinase 8	25	2089	1	4245	4353	3007	4187	2231	2089	3605	4060	3201
3262_Average weekly red wine intake	3262_Average weekly red wine intake	25	2094	1	2639	3065	3197	2094	4489	2443	3918	2933	4047
984_Interleukin-16	984_Interleukin-16	25	2103	1	3075	2103	3927	4270	2264	4158	3796	3018	4408
640_Xenobiotics::Xanthine metabolism::1,3,7-trimethylurate	640_Xenobiotics::Xanthine metabolism::1,3,7-trimethylurate	25	2119	1	2453	4517	2119	4533	4308	2661	2688	4542	4233
3760_Depression - Recent feelings of inadequacy	3760_Depression - Recent feelings of inadequacy	25	2127	1	2296	3797	3918	2310	4333	4573	4151	2127	4511
3961_Gestational weight gain (maternal, early)	3961_Gestational weight gain (maternal, early)	25	2134	1	2338	3851	2134	2480	4350	3220	2276	3852	4200
4531_Right inferior lateral ventricle	4531_Right inferior lateral ventricle	25	2141	1	3975	3027	4323	2355	2469	4431	3275	2141	3573
3929_QT interval	3929_QT interval	25	2154	1	2534	3542	4340	3799	3014	2154	2597	3225	3952
103_Late pubertal growth (male)	103_Late pubertal growth (male)	25	2161	1	3251	4283	3559	4512	2161	2437	2806	2886	3754
3712_Diagnoses - secondary ICD10: Z87 Personal history of other diseases and conditions	3712_Diagnoses - secondary ICD10: Z87 Personal history of other diseases and conditions	25	2166	1	4593	4643	3113	3990	3869	2646	2166	3518	2523
696_::::X-11374	696_::::X-11374	25	2171	1	3013	2823	3636	4168	4046	3998	4419	2171	4290
2883_FUT5 - Alpha-(1,3)-fucosyltransferase 5	2883_FUT5 - Alpha-(1,3)-fucosyltransferase 5	25	2171	1	3820	2266	3227	4494	4448	3726	3790	2674	2171
1861_Neck cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	1861_Neck cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	25	2182	1	2182	3317	4071	2773	4164	3913	2491	3218	3597
3699_Diagnoses - secondary ICD10: K57 Diverticular disease of intestine	3699_Diagnoses - secondary ICD10: K57 Diverticular disease of intestine	25	2191	1	3267	4718	4374	2191	3920	3596	3330	3961	4094
299_CD4mem:%Th1* (2)	299_CD4mem:%Th1* (2)	25	2196	1	4350	2196	2686	2465	2609	2328	3290	2711	3568
1734_Serum phosphorus (at exam 2, FBAT, adjusted for age and sex)	1734_Serum phosphorus (at exam 2, FBAT, adjusted for age and sex)	25	2212	1	4364	3063	3331	4088	4658	2212	4243	4732	4416
2459_TFPI - Tissue factor pathway inhibitor	2459_TFPI - Tissue factor pathway inhibitor	25	2223	1	3790	4139	4589	4065	2413	2251	2807	2223	3472
2161_PECAM1 - Platelet endothelial cell adhesion molecule	2161_PECAM1 - Platelet endothelial cell adhesion molecule	25	2229	1	2800	2382	2307	3256	2800	3912	4658	2229	4270
361_mDCL%274+	361_mDCL%274+	25	2238	1	3831	4535	4626	2460	2238	2683	4163	4395	4575
8_Major depressive disorder	8_Major depressive disorder	25	2239	1	4378	4471	2537	3391	3823	3868	4444	2239	2660
314_CD4nv:%TFH (2)	314_CD4nv:%TFH (2)	25	2240	1	4010	2542	2240	3032	2474	2668	4126	3910	4663
1065_Schizophrenia	1065_Schizophrenia	25	2242	1	2348	2772	4347	2352	3483	3382	2580	4579	2242
3224_Weekly usage of mobile phone in last 3 months	3224_Weekly usage of mobile phone in last 3 months	25	2255	1	3491	4289	4686	2683	2255	3673	2393	2783	2414
2185_INHBA - Inhibin beta A chain	2185_INHBA - Inhibin beta A chain	25	2261	1	4434	4456	4399	2691	3873	2261	3960	3749	4410
2911_PDIA3 - Protein disulfide-isomerase A3	2911_PDIA3 - Protein disulfide-isomerase A3	25	2272	1	4004	2272	3872	4327	3127	2572	2916	3474	2958
662_Amino acid::Butanoate metabolism::X-04499--3,4-dihydroxybutyrate	662_Amino acid::Butanoate metabolism::X-04499--3,4-dihydroxybutyrate	25	2283	1	4134	3039	2927	4598	2695	2408	2690	2559	2283
1382_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	1382_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	25	2300	1	4501	4175	2696	3845	2833	3898	3894	2300	2650
4078_Waist-hip ratio (male)	4078_Waist-hip ratio (male)	25	2301	1	2301	3800	4142	3506	2803	3251	2750	2632	3231
1177_Excessive daytime sleepness (female)	1177_Excessive daytime sleepness (female)	25	2324	1	4735	4659	3172	3069	4230	2324	3845	2485	2536
2798_P4HB - Protein disulfide-isomerase	2798_P4HB - Protein disulfide-isomerase	25	2329	1	4741	2329	3026	2751	3762	3377	3370	2397	3095
3160_PIM1 - Serine/threonine-protein kinase pim-1	3160_PIM1 - Serine/threonine-protein kinase pim-1	25	2376	1	4211	2457	3497	2859	4052	4674	2376	2660	3329
4341_Moderate intesity	4341_Moderate intesity	25	2385	1	4639	2472	3000	2385	4375	3323	2639	2512	2929
2555_CXCL6 - C-X-C motif chemokine 6	2555_CXCL6 - C-X-C motif chemokine 6	25	2385	1	2692	3843	4148	4483	2940	3941	3970	2385	3087
3057_IL20RA - Interleukin-20 receptor subunit alpha	3057_IL20RA - Interleukin-20 receptor subunit alpha	25	2399	1	2399	3170	3688	2662	4189	4474	2543	4648	3255
2475_CHEK2 - Serine/threonine-protein kinase Chk2	2475_CHEK2 - Serine/threonine-protein kinase Chk2	25	2426	1	3437	3102	3584	3870	3507	2653	3387	2426	2683
1034_Neck Section Modulus (FBAT, adjusted for multivariable)	1034_Neck Section Modulus (FBAT, adjusted for multivariable)	25	2431	1	4503	4204	3645	2921	2952	2612	2431	2698	3229
988_Interleukin-1 receptor antagonist	988_Interleukin-1 receptor antagonist	25	2447	1	2694	4002	2447	3468	3416	4452	3110	3869	3981
700_Amino acid::Phenylalanine & tyrosine metabolism::X-11423--O-sulfo-L-tyrosine	700_Amino acid::Phenylalanine & tyrosine metabolism::X-11423--O-sulfo-L-tyrosine	25	2516	1	2516	3755	4579	4502	3063	3171	2604	4097	4637
2236_FRZB - Secreted frizzled-related protein 3	2236_FRZB - Secreted frizzled-related protein 3	25	2535	1	3632	4257	3838	3395	4082	3958	2535	2813	3820
3592_Mineral and other dietary supplements: Fish oil (including cod liver oil)	3592_Mineral and other dietary supplements: Fish oil (including cod liver oil)	25	2547	1	3749	4621	3043	3742	3013	2547	2727	4357	4278
3899_Platelet count (three-way meta)	3899_Platelet count (three-way meta)	25	2581	1	3909	3060	2744	3054	4197	3518	3792	2581	3744
2668_FYN - Tyrosine-protein kinase Fyn	2668_FYN - Tyrosine-protein kinase Fyn	25	2588	1	3288	3882	4664	4146	3997	3927	2588	4268	4103
2630_GPT - Alanine aminotransferase 1	2630_GPT - Alanine aminotransferase 1	25	2728	1	2728	3920	4093	3938	3439	3616	4169	2793	4640
4458_Left parahippocampal	4458_Left parahippocampal	25	2741	1	3915	3701	3096	2741	4718	4495	3323	2910	3405
507_Lipid::Glycerolipid metabolism::glycerol	507_Lipid::Glycerolipid metabolism::glycerol	25	2827	1	3577	3121	2827	4563	4401	3544	3234	3398	2923
2290_CLEC11A - Stem Cell Growth Factor-beta	2290_CLEC11A - Stem Cell Growth Factor-beta	25	2862	1	2862	4258	4015	4523	3018	4516	4652	3687	4485
2347_HP - Haptoglobin	2347_HP - Haptoglobin	25	3108	1	4462	4212	3108	4258	4243	3884	3867	4677	3588
4401_Menstruation quality of life impact: Headache	4401_Menstruation quality of life impact: Headache	25	3179	1	3634	3615	3215	4156	4037	4541	4560	3529	3179
3140_ELANE - Neutrophil elastase	3140_ELANE - Neutrophil elastase	25	3190	1	3745	3972	3190	3790	4457	3906	4614	4045	3435
